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Abstract 
Background 
Leadership is essential to the effectiveness, strategy, and direction of teams, 
organisations and professions. Pharmacy leadership begins as pharmacists first 
engage with the profession. 
Aim 
The aim of this research was to investigate and identify areas that impact the 
leadership development capability of Early Career Pharmacists (ECPs). 
Methods 
The aim was addressed by employing qualitative and quantitative research 
methods as part of a larger research project. The qualitative study set out to 
explore and define pharmacy leadership in the Australian healthcare context, 
employing a grounded theory approach examining twenty-nine in-depth interviews 
with pharmacy leaders. The qualitative findings informed in part the quantitative 
study which investigated the important leadership development relationship that 
exists between intern pharmacists, ‘interns’ and their mentors, preceptor 
pharmacists, ‘preceptors’. The quantitative study further investigated interns’ 
(n=430) leadership development needs. Furthermore, the psychometric properties 
of the Multifactor Leadership Questionnaire (MLQ) were examined in the Australian 
pharmacy context using Confirmatory and Exploratory Factor Analysis. 
Findings 
Six themes emerged from the qualitative study that constitute the Australian 
Pharmacy Leadership Theory (APL Theory). Theme 1: Pharmacy leadership 
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definition; Theme 2: Pharmacist identity; Theme 3: Community pharmacy 
leadership; Theme 4: Pharmacy industry influences; Theme 5: The transformation 
challenge; and Theme 6: Pharmacy leadership development. 
Recommendations for pharmacy leadership development were received from both 
top leadership positions in the profession, pharmacy leaders, and those starting 
their careers, interns. Pharmacy leaders believed that unstructured leadership 
development is needed to develop future pharmacy leaders, whilst interns starting 
their professional careers were seeking structured leadership development training 
and mentorship. This provides some evidence of an inter-generational disconnect. 
Interestingly, interns who received a transformational leadership style (in their 
intern year from their preceptor) that focused on personalised coaching, 
development and mentorship, reported an increased willingness to work harder, 
demonstrated greater satisfaction with their preceptor leadership style and 
believed their preceptors adopted a more effective leadership style. Confirmatory 
Factor Analysis (CFA) of all known leadership models using the MLQ indicated a 
poor fit in the intern population (N=430). The factorial structure of the MLQ was 
explored employing Exploratory Factor Analysis (EFA) which indicated four 
leadership factors that was confirmed to fit the data using CFA. A CFA on the three 
outcomes of leadership identified a high correlation approaching unity causing 
doubt that the factors are separate. 
Conclusions 
New insights into understanding pharmacy leadership and the formative leadership 
development relationship between interns and preceptors have been identified. We 
anticipate that the findings will inform preceptor training and subsequently improve 
intern training and development. Findings will assist with the development of 
 vi 
 
is needed to understand the leadership phenomenon in the pharmacy profession 
throughout the entire workforce, enabling a better contextual understanding as 
evident in the nursing and medical professions. Future research that examines the 
impact of a leadership development intervention is needed to provide a more 
holistic understanding to pharmacy leadership development. 
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Chapter 1: Introduction 
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 Thesis Structure and Presentation 
This thesis is presented in four main parts. Part 1: Background; Part 2: A 
qualitative study exploring Australian pharmacy leadership; Part 3: A quantitative 
study investigating intern pharmacists’ leadership development; Part 4: 
Discussions and conclusions. Figure 1.1 provides an overview of the parts that 
constitute this thesis. 
Part 1 
This first section (Chapters 1 and 2) provides the background to the research and 
an overview of the literature forming the introduction to this thesis. The narrative 
literature review provides an examination of the leadership theories most 
applicable to the Australian healthcare system, and an exploration of leadership 
development. 
Part 2 
This part of the thesis (Chapters 3 to 11) focuses on the qualitative study exploring 
and defining Australian pharmacy leadership. The study employed a grounded 
theory approach and examined twenty-nine in-depth interviews with pharmacy 
leaders. Chapter 3 outlines the qualitative methods, with Chapter 4 providing 
details of participants and an explanation of the presentation of qualitative findings 
across Chapters 5 to 10. Chapters 5 to 10, represents each of the emerging 
themes, subthemes and codes. Chapter 11 discusses the findings emerging from 
all qualitative chapters. 
Part 3 
This part (Chapters 12 to 13) of the thesis covers the quantitative study 
investigating leadership development amongst intern pharmacists, statistically 
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testing the psychometric properties of the MLQ in the Australian pharmacy context, 
examining specifically the leadership development that exists between intern 
pharmacists and preceptor pharmacists. Chapter 12 provides a detailed summary 
of the quantitative methods employed and presents the fundamental statistical 
analyses of the MLQ. The chapter further presents MLQ descriptive statistics, 
participant demographics, intern pharmacists’ admired leadership traits and 
recommendations for areas to improve professional and leadership development. 
The chapter examined the influence of workplace and demographic variables on 
intern pharmacist perceived leadership. Chapter 13 presents the full psychometric 
properties of the MLQ in the Australian pharmacy context, presenting all CFA and 
EFA findings. At the end of Chapter 13, there is a combined discussion for the 
quantitative findings chapters (Chapter 12 and 13). 
Part 4 
This section of the thesis (Chapter 14) interprets the significant findings derived 
from both the qualitative and quantitative studies, and explores implications of 
these findings on current pharmacy practice and outlines future research 
directions. 
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 Thesis Overview and Summary 
 Background and Aims 
The phenomenon of leadership has existed since the times of antiquity, and is 
fundamental to the effectiveness, strategy, and direction of teams, organisations 
and professions. Numerous leadership theories have emerged, all indicating that 
the influence of the leadership environment is paramount to understanding the 
leadership phenomenon in a given context. The Australian pharmacy profession is 
a defined context that falls within the Australian Commonwealth Government’s 
broader health governance and planning. The literature provides an abundance of 
research that examines pharmacy practice and management, pharmacy 
organisational culture and health leadership, namely leadership in the medical and 
nursing professions. However, only a handful of studies have examined pharmacy 
leadership, with the majority providing only a descriptive review of the leadership 
literature with anecdotal correlations to the pharmacy profession. 
In contrast to the many studies on pharmacy management, practice change, 
organisational flexibility and culture, there are limited studies investigating 
pharmacy leadership and pharmacy leadership development. An understanding of 
pharmacy leadership will provide important insights into what is needed to improve 
the profession’s capacity for leadership development. 
Understanding the relevance of leadership theory to the pharmacy profession is 
therefore of great value. The most widely used and validated transformational 
leadership instrument, is the Multifactor Leadership Questionnaire (MLQ). The use 
of the MLQ within the pharmacy profession provides a unique opportunity to 
understand and investigate pharmacy leadership, particularly examining leadership 
development with early career pharmacists. 
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The overall aim of this thesis was to address the research question, How will the 
pharmacy profession improve the leadership development capability of Early 
Career Pharmacists (ECPs) e.g. intern pharmacists? Hence, this thesis aimed 
to investigate and identify areas that would impact the leadership development of 
Early Career Pharmacists. The overall aim was addressed by employing qualitative 
and quantitative research techniques, with the qualitative study set out to explore 
and define pharmacy leadership in the Australian healthcare context, informing in 
part the quantitative study which investigated the important leadership 
development relationship that exists between intern pharmacists and their mentors, 
preceptor pharmacists. Preceptor pharmacists are charged with the pivotal role of 
teaching, guiding and mentoring intern pharmacists through a practical year of 
work experience “internship” before general pharmacist registration. 
 Methods 
Part 1: Literature review 
The first stage of this thesis was a narrative literature review examining pharmacy 
leadership. This review started with a focused search strategy (stage one) and 
then moved to a broader search strategy (stage two), due to the limited literature 
found. The narrative review included a review of contemporary leadership theories, 
Australian health leadership and pharmacy practice research related to leadership. 
The findings of the review identified research gaps in the existing knowledge, and 
resulted in the development of the following thesis objectives: 
1. Identify, define and explain Australian pharmacy leadership. 
2. Construct an Australian Pharmacy Leadership Theory (APL Theory) grounded 
in the data that reflects the emerging theoretical explanation of the 
phenomenon. 
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3. To identify leadership traits that are specific to the pharmacy profession 
(leadership traits include leadership attributes, skills and styles). 
4. To identify leadership development strategies designed to improve the training 
and leadership capacity of Early Career Pharmacists (ECPs) e.g. intern 
pharmacists. 
5. Explore the emerging findings from the APL Theory with ECPs employing 
quantitative methods to examine leadership development. 
6. To investigate the intern pharmacist-preceptor pharmacist leadership 
development relationship. 
The review also identified the need for an in-depth understanding of the contextual 
factors that influence Australian pharmacy leadership, forming the impetus for the 
qualitative exploratory study. 
Part 2: A qualitative study exploring Australian pharmacy leadership 
The second stage of this thesis was a qualitative study designed to explore and 
define pharmacy leadership. The specific qualitative objectives were to: 
• Define pharmacy leadership from the perspectives of pharmacy leaders through 
exploring the definition and traits of effective pharmacy leadership. 
• Examine leadership development and mentorship in the pharmacy profession. 
• Explore the contextual challenges and opportunities facing the pharmacy 
profession. 
Participants were recruited employing a selection frame identifying pharmacy 
leaders in the pharmacy profession. After the selection of the purposive sample 
consisting of six participants, participant recruitment followed theoretical sampling 
with participants recruited based on defining the emerging codes, subthemes, and 
themes. The research employed a grounded theory approach, embracing the core 
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methodological principles of coding, writing memos, constant comparison, 
theoretical sampling and theoretical coding. Twenty-nine in-depth interviews 
(average length 55 minutes) were conducted with individual participants. The 
interviews followed a semi-structured interview guide designed to address the 
qualitative study objectives of exploring and defining pharmacy leadership. The 
interviews were audio-recorded, transcribed verbatim and analysed using a 
grounded theory approach. Participants were representative of a diverse range of 
professionals across the pharmacy sector, that included military pharmacy, 
community pharmacy, hospital pharmacy, the medicines industry, pharmacy 
organisations, government and consumer health groups. 
Qualitative data collection and analysis was ongoing, forming an iterative process 
until data saturation was reached during the analysis of the twenty-ninth interview. 
Document collection and analysis in the form of content analysis was conducted in 
conjunction with qualitative interview collection as a method of secondary data 
collection to overcome challenges with recruiting government health participants. 
Characteristics of the Australian pharmacy leadership were identified and defined, 
as well as the contextual variables influencing pharmacy leadership. Furthermore, 
strategies and recommendations were identified to improve the leadership 
development of early career pharmacists. 
Part 3: A quantitative study examining leadership development with intern 
pharmacists 
Finally, a national quantitative study (survey) employing a framework of 
transformational leadership theory to examine leadership training and development 
of intern pharmacists was conducted. The aim of this study was determine intern 
pharmacists’ perceptions of their preceptor pharmacists’ leadership styles. The first 
specific objective of the study was to determine demographic and workforce 
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influences that impact intern pharmacists’ perceived leadership being employed by 
preceptor pharmacists. The second specific objective was to determine the 
leadership development training needs that intern pharmacists are seeking, and 
the leadership traits that intern pharmacists believe are important for pharmacists 
in leadership positions. Intern pharmacists are the crucial subset of early career 
pharmacists that mark the transition from university training as a pharmacy student 
to general registration as an Australian pharmacist. Pharmacy organisations 
offering the intern training program (Internship), known as Intern Training Providers 
(ITPs), were invited to participate in the study by sharing the Australian Pharmacy 
Leadership Questionnaire (Questionnaire) with their pharmacy members, intern 
pharmacists. 
The questionnaire consisted of five sections, pharmacy practice setting questions 
(Section 1); preceptor pharmacist questions (Section 2); Multifactor Leadership 
Questionnaire (Section 3); Australian pharmacy components examining intern 
pharmacists’ admired leadership traits and preferred leadership and professional 
development opportunities (Section 4); and participant cultural and demographic 
questions (Section 5). A paper and electronic version of the questionnaires were 
designed to facilitate mixed modal administration. 
The Multifactor Leadership Questionnaire (MLQ) was the transformational 
leadership instrument that was most appropriate to investigate the aims and 
objectives of this research. A key strength of the MLQ is that it measures a full-
range of leadership behaviours, including nine leadership factors across three 
types of leadership styles (Table 12.3). First style, transformational leadership: 1) 
Idealized influence (attributed) 4-items; 2) Idealized influence (behavior) 4-items; 3) 
Inspirational motivation 4-items; 4) Intellectual stimulation 4-items; and 5) 
Individualized consideration 4-items. Second style, transactional leadership: 6) 
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Contingent reward 4-items; and 7) Management-by-exception (active) 4-items. 
Third style, passive-avoidant leadership: 8) Management-by-exception (passive) 4-
items; and 9) Laissez-faire leadership 4-items. The MLQ further measures three 
outcomes of leadership: 1) Extra effort 3-items; 2) Satisfaction 2-items; and 3) 
Effectiveness 4-items to determine the relationship with the nine leadership factors. 
The leadership outcomes determine the association between nine leadership 
factors and: 1) Intern pharmacists’ willingness to exert extra effort; 2) Intern 
pharmacist’s satisfaction with their preceptor’s leadership; and 3) Intern 
pharmacist’s belief that their preceptor’s leadership is effective. The MLQ 
leadership factors and outcomes of leadership are scored by averaging the score 
for the items that constitute the scale. 
The MLQ was employed to measure intern pharmacists’ leadership experienced 
from their preceptor pharmacists. A further study aim was to investigate the 
psychometric properties of the MLQ, and to identify whether the factor structure of 
the MLQ, representing the full range leadership model fits the Australian pharmacy 
context, specifically the leadership development relationship that exists between 
intern pharmacists and preceptor pharmacists. 
The questionnaire was piloted, found to be valid and reliable, and was sent to 
intern training providers to disseminate to intern pharmacists either online via email 
(Electronic mail recruitment) or during a scheduled pharmacy workshop (Pharmacy 
workshop recruitment). The response rates were 18.5% (n=20) and 91.3% (n=410) 
for the electronic mail and pharmacy workshop, respectively. This resulted in a 
final combined sample of 430 completed surveys (combined response rate 77.2%), 
which was considered sufficient to perform descriptive statistical analyses, and 
confirmatory and exploratory factor analyses. 
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Statistical software IBM SPPS 21.0.0.0 was employed to perform descriptive 
statistical analyses needed to examine demographic data, leadership factors and 
outcomes of leadership data. Data on leadership factors were compared between 
hospital and community pharmacy respondents. The influence of sex, workplace 
related training, prior leadership experience, formal training with preceptors, 
electronic communications with preceptors and intern pharmacist competence 
(self-assessed) on leadership factors were examined using Mann-Whitney U tests 
or Kruskal-Wallis tests, as appropriate. The correlations between leadership 
factors and outcomes of leadership were also investigated (using Spearman’s 
correlation). Finally, content analysis of responses to open ended questions was 
also conducted to explore intern pharmacists preferred leadership traits and 
professional development pathways. 
We examined the intern pharmacist participant data to determine if the data fit any 
of the previous leadership models found in the literature. All previous models were 
investigated by Confirmatory Factor Analysis (CFA) using IBM AMOS 21.0.0. 
Following the CFAs, Exploratory Factor Analysis (EFA) was employed to examine 
the leadership factors from the intern pharmacist population. An additional CFA 
was performed on the three outcomes of leadership: 1) Extra effort; 2) Satisfaction; 
and 3) Effectiveness) to determine fit. The leadership outcomes determine the 
association between the nine leadership factors and intern pharmacists willingness 
to exert extra effort, intern pharmacists satisfaction with their preceptors leadership 
and intern pharmacists beliefs that the leadership is effective. 
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 Key Findings 
Part 1: Literature review 
There were relatively few studies that met the selection criteria using the search 
terms in Stage 1. The 42 studies that fitted the criteria were included in the 
narrative review. This point marked a change in the literature review strategy to 
broaden the narrative review and include leadership literature. 
The review identified existing pharmacy leadership and related pharmacy practice 
research articles. There were two aspects to the pharmacy leadership articles. The 
first set of articles focused on pharmacy leadership. The second set of articles 
identified the pharmacy leadership needed to expand the role of the pharmacist 
and advance pharmacy practice. 
The review highlighted that transformational leadership is the most applicable 
theory to Australian healthcare primarily due to the central focus on mentorship. 
Mentorship is central to transformational leadership and leadership development 
and is an appropriate leadership theory to be applied to Australian healthcare 
leadership. Transformational leadership theory describes the essence of a style of 
leadership, where there is a transformation in the attitudes and motivations of 
followers, effectively resulting in changes in followers’ behaviours. 
Transformational leadership theory is one of the most investigated and validated 
leadership theories, and has been identified as the most incorporated leadership 
theory into the majority of Australian health leadership programs. Furthermore, the 
core elements of transformational leadership theory form the nucleus of Australia’s 
health leadership framework, the Health LEADS Australia. The review identified 
that research investigating Australian pharmacy leadership is significant for the 
following reasons: 
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1. Research is needed to understand the role of external context and its influence 
on Australian pharmacy leadership. 
2. There is limited empirical research to explore leadership development and 
mentorship in the pharmacy profession.  
3. There is limited empirical research that has examined the definition of 
leadership and the traits of effective pharmacy leaders. 
Part 2: A qualitative study exploring Australian pharmacy leadership 
The qualitative study found that the Australian pharmacy leadership exhibited six 
major themes influencing leadership that constitute the Australian Pharmacy 
Leadership Theory (APL Theory; Figure 1.2). 
Figure 1.2 Australian pharmacy leadership—six major themes. 
 
The first theme (Chapter 5) sets the scene and provides a definition for pharmacy 
leadership, including unique leadership traits inherent to the pharmacy profession, 
and outlines the importance of followership within the pharmacy leadership 
definition. Pharmacy leadership was defined using the traits: vision, social 
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capacity, cognitive flexibility, decisiveness, tacit knowledge, emotional intelligence 
and pharmacy leadership motivators (Section 5.1). It was found that developing 
followers is associated with leadership development and pharmacy mentorship. 
The critical components that made the reciprocal mentorship relationship work 
were trust, respect, commitment and an openness from both the mentor and 
mentee. An unstructured approach to mentorship, specific to areas of practice was 
considered fundamental. Finding and training mentors to assume the role of a 
mentor was a major barrier to pharmacy mentorship. 
The second theme, pharmacist identity (Chapter 6), discovers the differences in 
views that exist between employee pharmacists and pharmacist business owners 
with regards to professional services leadership. It was found that some 
pharmacists have factors that influence their personality: 1) Pharmacist technical 
and scientific focus; 2) Clinical skills; 3) Pharmacist resistance to change; and 4) 
pharmacist clinical indecision. These four personality factors influence pharmacist 
identity and leadership. There was a limited career diversity and poor employment 
conditions, particularly for ECPs. This indicates that followers’ needs are not being 
met and there was a fixed pharmacy leadership vision focussed on limited 
community employment opportunities. 
The third theme, community pharmacy leadership (Chapter 7) constituted a 
significant component of participants’ understandings of pharmacy leadership due 
to the economic size and impact of the community pharmacy sector. Pharmacy 
owners’ who were in positions of leadership have the choice to adopt a service or 
discount leadership approach. It was found that the service leadership approach 
was associated with utilizing pharmacist clinical skills to enact expanded role 
opportunities needed to transform the profession. Pharmacy owner’s resistance to 
change despite the reducing profitability was a major barrier to implementing the 
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service leadership approach. There was a need for business support and strategy 
from a professional leadership level (pharmacy organisations) to assist pharmacist 
owners in developing their businesses and implementing the service leadership 
approach.  
The fourth theme, pharmacy sector leadership influences (Chapter 8) identifies and 
describes the organisations, opportunities and threats in the external environment 
that influence pharmacy leadership at a community pharmacy and professional 
level. The influences were identified to be government, rigid pharmacy regulations, 
rapidly changing health context, commodifying medicines and pharmacy 
organisational leadership. At the community pharmacy level, the influences impact 
community pharmacy leadership and the pharmacy owner’s leadership approach. 
At a professional level, the sector influences are impacting the profession’s top 
level leadership facing outwards into the wider health context. 
The fifth theme, the transformation challenge (Chapter 9) identifies the need for a 
profession-wide transformation and the challenges that are preventing pharmacy 
leadership from achieving this professional transformation. The profession’s 
disconnect with the external context expressed as an inarticulate policy vision, and 
the need to better understand health consumerism is preventing the profession’s 
leadership from expanding the role of the pharmacist that is needed to transform 
the profession. Furthermore, rampant organisational disunity between pharmacy 
organisations signifies failed pharmacy leadership and is challenging the 
profession’s transformation. 
The sixth theme, pharmacy leadership development identified a series of 
leadership development recommendations needed to develop the leadership 
capacity of early career pharmacists. The study highlighted that unstructured 
pharmacy mentorship specific areas of practice emerged as most prominent 
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leadership development recommendation from pharmacy leaders. The intern 
training program was identified as a pivotal leadership development program with 
flexible structure that provides a pathway to navigate graduates from university 
through their internship, and on to general pharmacist registration. However, not 
much is known about the leadership development needs and experiences of intern 
pharmacists during this critical period of leadership development. Therefore, part 3 
of this thesis, investigated the leadership development needs and experiences of 
intern pharmacists employing quantitative methods. 
Part 3: A quantitative study examining leadership development with intern 
pharmacists 
The third stage of this thesis was a quantitative study investigating leadership with 
intern pharmacists employing the validated MLQ, and pharmacy specific sections 
underpinned by the qualitative findings. In total, 430 intern pharmacists completed 
the questionnaires. The MLQ measures nine leadership factors 
The MLQ scales had a high reliability (0.72-0.83), except the factor Laissez-faire 
(α=0.67). Mean (M) and standard deviations (SD) were determined for all 
leadership factors. Transformational idealized influence attributed (M=2.80; 
SD=0.83) was the most prominent preceptor leadership behaviour adopted by 
preceptor pharmacists. With the scale relating to frequency of leadership 
behaviours (0=Not at all; 1=Once in a while; 2=Sometimes; 3=Fairly often; and 4) 
Frequently, if not always). Transformational inspirational motivation (M=2.71, 
SD=0.91), transformational individualised consideration (M=2.61; SD=0.93) and 
transactional contingent reward (M=2.55; SD=0.88) closely followed with regards 
to the frequency of the preceptor leadership behaviours occurring from the 
perspective of intern pharmacists. 
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There were several variables that influenced intern pharmacists’ perceptions of 
their preceptors leadership (Section 12.10.5-12.10.11). The following variables: 1) 
Hospital practice setting; 2) female preceptors; 3) increased frequency in meeting 
face-to-face with preceptor; 4) increased frequency of communicating electronically 
with preceptor; 4) additional workplace related internship training provided to intern 
pharmacists; and 5) intern pharmacist competence (self-assessed) resulted in a 
significant increase in all five transformational leadership behaviours: 1) idealized 
influence (attributed); 2) idealized influence (behaviour) 3) Inspirational motivation; 
4) Intellectual stimulation; 5) Individualised consideration. Criticisms of the MLQ 
factor structure in the literature were the impetus for further psychometric testing of 
the MLQ factor structure (Chapter 13). 
The hypothesised 9-factor CFA model showed the best fit out of all tested models 
(Section 13.6.1; Table 13.1), however, it still indicated to be a poor fit (N=430). 
Despite the high χ2 (1592, df =558, p < 0.001), the comparative fit indices were well 
below the 0.90 or 0.95 target levels (CFI = 0.82, TLI = 0.79) and the Root Mean 
Square Error of Approximation (RMSEA) was above the 0.06 target level (0.071). 
In an attempt to improve fit, cross-loading items were removed and correlated error 
terms were created that made theoretical sense, the result provided final fit 
statistics (χ2 = 930, df = 426, p < 0.001, CFI = 0.90, TLI = 0.87, RMSEA = 0.057). 
Despite the reasonable fit, the model was rejected on theoretical grounds due to a 
high number of factors overlapping excessively, indicating a lack of parsimony with 
the model. 
Since no acceptable fit could be achieved using any of the models, the decision 
was made to explore the factorial structure of the MLQ among intern pharmacists 
working in Community Pharmacy (N=269) employing Exploratory Factor Analysis 
(EFA), and to then investigate the emerging factor structure with Confirmatory 
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Factor Analysis (Section 13.6.3) with intern pharmacists working in Hospital 
Pharmacy (N=157). After specifying correlations between two error items, a four 
factor leadership model provided fit statistics which reached target levels, hence 
demonstrating a better fit than any of the previous models (χ2 = 620, df = 369, p < 
0.001, CFI = 0.91, TLI = 0.89, RMSEA = 0.056). Several further tests were 
conducted (Section 13.6.4) providing confirmation that the factorial structure holds 
for intern pharmacists working in Community Pharmacy (N=269). This four-factor 
model (Section 13.6.2; Table 13.2) accounted for 46% of the total variance, the 
factor names and number of items in each factor were (factor 1-Strategic visionary 
leadership; 8 items), (factor 2-Passive avoidant leadership; 7 items), (factor 3-
Personalised leadership; 10 items), (factor 4-Failure focused leadership; 4 items). 
Finally, the factor structure for the outcomes of leadership was conducted (Section 
13.6.5) on the whole group (N=430) and provided acceptable fit statistics (χ2 = 61, 
df = 24, p < 0.001, CFI = 0.99, TLI = 0.97, RMSEA = 0.060). However, the two 
leadership outcomes, Effectiveness and Satisfaction, were combined due to an 
observed correlation of unity. The outcomes measured by the MLQ to determine 
the leadership effectiveness of preceptors. In the final step of the model 
development, the four leadership factors were combined with the two leadership 
outcomes in a new CFA model, providing acceptable fit statistics (χ2 = 1434, df = 
648, p < 0.001, CFI = 0.91, TLI = 0.90, RMSEA = 0.053), with Table 13.3 providing 
evidence of convergent validity of all of the scales. 
The new four factor leadership model with two outcomes of leadership was tested 
in a structural model (Section 13.5.7). The model explained 96% of the variation in 
Effectiveness/Satisfaction and 77% of the variation in Extra Effort. The 
personalised leadership factor was significantly positively associated with Extra 
Effort (β = 0.63, p < 0.001) and on Effectiveness/Satisfaction (β = 0.97, p < 0.001). 
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The strategic visionary leadership factor was significantly associated with Extra 
Effort (β = 0.25, p < 0.001). The passive avoidant leadership factor was negatively 
associated with Effectiveness/Satisfaction (β = -0.11, p = 0.008). 
The Questionnaire identified pharmacy leadership traits that intern pharmacists 
believed people in pharmacy leadership positions need to have. Intern pharmacists 
resonate with the following leadership traits with pharmacist leaders: effective 
communication, clinical knowledge, respect, active listener and responsibility. The 
least five admired leadership traits were reported to be courage, creative, 
conviction, power and financial success (Section 12.10.13; Table 12.9). Intern 
pharmacists identified three key areas of professional development that they 
believed were needed to improve their leadership capacity: 297 intern pharmacists 
identified that further clinical training and experience was needed; 145 intern 
pharmacists reported that further business training was needed; and 120 intern 
pharmacists identified training in areas beyond pharmacy was needed. Structured 
mentorship was identified by 87 intern pharmacists as the leadership development 
practice effective to delivering clinical, business and training beyond pharmacy. 
 Conclusions 
The overall aim of the research presented in this thesis was to investigate and 
identify areas that impact the leadership development capability of early career 
pharmacists (ECPs). Qualitative and quantitative methods were used as part of a 
larger leadership project to achieve this aim. This research has provided a novel 
definition of Australian pharmacy leadership and identified the traits needed to be 
an effective pharmacy leader. This research has added unique insights into 
training recommendations from the perspective of pharmacy leaders and intern 
pharmacists. These recommendations will be essential to improving the leadership 
capacity of ECPs and training future pharmacy leaders. Demographic and 
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workplace factors including 1) Preceptor sex; 2) Additional workplace training; 3) 
Frequency of formal training with preceptor; 4) Frequency of electronic 
communications with preceptor; and 5) Intern pharmacist self-assessment of their 
competence influence leadership development. These unique insights into factors 
that influence pharmacy leadership development will be critical to developing future 
training programs for both intern pharmacists and preceptors to improve the 
capacity of intern pharmacist leadership development. 
The quantitative study identified that the 9-factor MLQ when tested in the 
Australian pharmacy context, the psychometric properties do not fit Australian 
intern pharmacists’ perceptions of their preceptor pharmacists. It was identified 
from the interpretation of survey responses, that intern pharmacists conceptualise 
a four-factor MLQ leadership model from the leadership experienced from their 
preceptors. There was clear evidence provided by both the qualitative and 
quantitative studies that a leadership style focusing on personalised development 
tailored to the needs of individual intern pharmacists, aimed at building 
relationships through mentorship, is not only desirable by intern pharmacists, but 
may be more effective for the pharmacy profession to improve the leadership 
capabilities of early career pharmacists. The leadership effectiveness was a result 
of increased transformational leadership behaviours being received by intern 
pharmacists. This led to an increased willingness to work harder, and greater 
satisfaction with their preceptors leadership style. There is a need to provide 
training for those in leadership development positions, such as preceptor 
pharmacists, to improve their understanding of their own leadership styles needed 
to train and develop early career pharmacists. 
Pharmacy leaders believed that unstructured leadership development was needed 
to develop future pharmacy leaders, whilst interns starting their professional 
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careers were seeking structured leadership development training and mentorship. 
This provides some evidence of an inter-generational disconnect. The challenge 
for the profession will be incorporating the leadership development 
recommendations and strategies desired by intern pharmacists and recommended 
by pharmacy leaders into pharmacy workplace settings and into pharmacy training 
programs that enable intern pharmacists and pharmacy students to improve their 
leadership capabilities. 
This research has significant implications for future pharmacy practice, namely the 
opportunity around personalising the leadership experience of intern pharmacists, 
catering to individual needs and areas of professional development. However, the 
real research implication will be to use these new leadership development insights 
to develop resources for pharmacy organisations to assist with improving the 
training and development of preceptor pharmacists. This will directly impact intern 
pharmacist training and development by training those charged with the paramount 
role of developing future pharmacy leaders, providing adequate mentorship and 
facilitation as pharmacy students merge from university training and enter real-life 
pharmacy practice. Furthermore, findings provide unique insights to assist with the 
development of leadership programs that can be designed to improve the 
leadership capacity of early career pharmacists. 
Future research directions lie in the opportunity to understand the leadership 
process in the pharmacy profession more clearly, particularly around pharmacists 
in middle management and leadership positions, across all pharmacy practice 
areas. There is a need to conduct further quantitative research to examine 
leadership at multiple levels of the pharmacy workforce, everything in-between 
intern pharmacists (quantitative research) and pharmacy leaders (qualitative 
research). Therefore, there is a need to develop a leadership survey that can be 
 22 
 
flexible to fit the pharmacy profession across different pharmacist levels and 
practice settings, that can be employed as a leadership development aid to 
improve the leadership capacity and understanding of Australian pharmacists. 
The originality of the research in this thesis has been twofold, first was to define 
and examine pharmacy leadership employing qualitative methods, generating a 
leadership theory (APL Theory Figure 4.1) which uniquely fits to the pharmacy 
profession, and then to explore these leadership findings, particularly the 
leadership development of intern pharmacists, employing the MLQ. This research 
has advanced the understanding of pharmacy leadership, particularly in Australia 
as it has provided insights into the environmental factors influencing pharmacy 
leadership. This research has provided recommendations for pharmacy leadership 
development, from both the top leadership in the profession, and those starting 
their careers, the intern pharmacists. This research provides the platform for the 
implementation of leadership development strategies intended to inform pharmacy 
organisations and universities charged with the development of intern pharmacists 
and training pharmacy students. In light of these findings, there is now a platform 
to conduct further Australian pharmacy leadership research. 
  
 23 
 
Chapter 2: Australian Pharmacy Leadership: A Literature Review 
 
 
The focus of this narrative literature review is to provide a greater understanding of 
the leadership in the context of the Australian pharmacy profession. 
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 Introduction 
This chapter examines the pharmacy leadership literature, with an Australian 
focus. Australian pharmacy leadership continues to be an emerging field, whilst 
currently there are relatively few studies that investigate pharmacy leadership, 
several related pharmacy management studies which consider aspects of 
leadership have been included in this narrative review. This review has drawn from 
leadership research emerging from the related Australian nursing and medical 
professions to gain a deeper understanding of the context and implications for 
Australian pharmacy leadership. An understanding of Australian pharmacy 
leadership is critical to improving the leadership development and capacity of 
Australian pharmacists. 
 Background 
The pharmacy profession is a vital element of the healthcare systems in numerous 
countries around the world, ensuring the timely access to and quality use of 
medicines to the community, with pharmacists playing an active role in ensuring 
and delivering the supply of medicines across a range of health care settings (1). 
The role of pharmacists continues to expand beyond the supply of medicines to 
include a range of professional services. This is evident in Australia with the 
development of Advanced Pharmacy Practice Frameworks (APPF), setting the 
direction for pharmacists to expand their professional roles and responsibilities (2). 
Community pharmacy is the dominant employer of pharmacists in Australia, with 
smaller numbers of pharmacists employed in the military, hospital, and the 
medicines industry (3). Approximately three-quarters of Australian pharmacists are 
employed in the country’s 5450 community pharmacies (4). To fully understand the 
leadership process, there needs to be an in-depth understanding of the external 
environment in which leadership exists (5, 6). 
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The pharmacy profession continues to undergo significant changes in both the 
international (1) and domestic context (7-9). Internationally pharmacists are 
redefining their professional role to include the provision of numerous health 
services such as administering immunisations, providing medicines reviews and 
expanding roles in prescribing and disease state management (10, 11). There is 
also continuous pressure placed on the Commonwealth Australian Government 
(Government) to reduce healthcare and pharmaceutical costs, with cost savings 
being achieved through the reform of the Pharmaceutical Benefits Scheme (PBS) 
driving fiscal savings (12, 13). 
The community pharmacy sector has recently transitioned into the sixth 
Community Pharmacy Agreement (6CPA) between the Government and the 
Pharmacy Guild of Australia (Guild), which negotiates the funding, and 
remuneration for community pharmacy over five year periods. The pharmacy 
sector is facing numerous challenges; (1) increasing number of registered 
pharmacists driving what some people refer to as an “oversupply”; (2) increased 
competition across pharmacy business models (7, 14); (3) challenges to the 
existing pharmacy regulations; pharmacist ownership regulations and pharmacy 
location rules (15, 16); (4) rapidly changing health context due an increase in the 
ageing population, obesity rates and chronic illness, leading to an increased 
demand the Australian health system including the timely and affordable access to 
medicines through the PBS (17). These challenges in the wider health environment 
continue to influence the pharmacy leadership context, as context is central to the 
leadership process (18, 19). Several pharmacy researchers have identified that 
practice change, organisational flexibility, managerial capability and organisational 
culture directly influence community pharmacy leadership (8, 20-23). An in-depth 
understanding of pharmacy leadership will assist the profession to improve the 
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leadership capacity of pharmacists to meet the increasing demands of the health 
system and ensure a progressive profession. 
 Methods 
This section describes the approach and methods adopted in this narrative 
literature review. This review started with focused search strategy (stage one) and 
then moved to a broader search strategy (stage two). 
 Aims 
1. Identify pharmacy leadership and leadership development research in the 
literature (stage one); 
2. Investigate the literature related to Australian leadership, health leadership and 
pharmacy leadership (stage two); 
3. Examine contemporary leadership theories relevant to pharmacy (stage two); 
4. Identify a leadership theory suitable for further investigation in the pharmacy 
context (stage two). 
 Search Strategy 
A range of sources of information were searched for work published between 1987 
and February 2017 in the databases PsycINFO, Informit, EMBASE, International 
Pharmaceutical Abstracts, PUBMED and MEDLINE. Relevant literature was 
defined as published original research studies, surveys, critical analyses, 
commentaries, and other literature reviews. The search strategy employed a 
combination of free text words and headings in the databases. Words and subject 
headings relating to pharmacy were combined with leadership, leadership 
development, Australian and health leadership terms (Table 2.1). 
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Table 2.1 Search Terms and Search Strategy 
Pharmacy Health leadership Leadership 
Pharmacist Pharmacy leadership Leadership theory 
Community pharmacy Clinical leadership Leadership model 
Pharmacy practice Australian health 
leadership 
Leadership traits 
Clinical pharmacy Medical leadership Leadership development 
Pharmacist traits Nursing leadership Leadership mentoring 
Pharmacist culture Australian leadership Leadership training 
Pharmacist personality  Leadership framework 
Search words in each category were combined using ‘or’, and all three categories were combined using ‘and’. 
2.3.2.1 Stage One Search 
The search terms in these databases included ‘pharmacy’ or (pharmacist, 
community pharmacy, Australian pharmacy) and leadership (or pharmacy 
leadership and health leadership) and leadership development (or leadership 
mentoring and leadership training). Reference lists of retrieved papers were also 
reviewed to identify other relevant literature. 
2.3.2.2 Stage Two Search 
Relevant Australian healthcare and pharmacy related websites were also searched 
for information and were useful to attain policy documents. The websites of the 
Pharmacy Guild of Australia, Pharmaceutical Society of Australia and the 
Department of Health were most employed for these purposes. Specific journals, 
including leadership and pharmacy practice journals, were also searched online 
using search engines provided by the publisher. The following leadership and 
management journals were particularly relevant in this research: Leadership, The 
Leadership Quarterly, Journal of Management, Journal of Leadership Studies, 
Journal of Small Business Management. The following pharmacy practice journals 
were useful: Research in Social and Administrative Pharmacy, The Annals of 
Pharmacotherapy, Australian Journal of Pharmacy, Australian Pharmacist, Journal 
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of Social and Administrative Pharmacy, Australian Health Review, Journal of 
Pharmacy Practice and Research, American Journal of Health-System Pharmacy, 
and International Journal of Pharmacy Practice. Reference lists of retrieved articles 
were also reviewed to identify other relevant sources to include in the review. 
 The Selection Criteria 
The titles and abstracts of the articles and other references were reviewed in 
Endnote (version X7.6) Reference Manager. In keeping with the first aim of this 
review, only pharmacy leadership studies or closely related studies were included. 
If studies appeared to meet the inclusion criteria they were retained for review of 
the full text to ensure they met the selection eligibility. Searches were limited to 
content in English over the date range 1987 to 2016. 
 Results 
There were relatively few studies that met the selection criteria using the search 
terms in Stage 1. The 42 studies that fitted the criteria were included in this review. 
This point marked a change in the literature review strategy to broaden the 
narrative review to include contemporary leadership and health leadership 
literature to provide context to pharmacy leadership. The resulted in the 
development of aims 2-4 (Section 2.3.1). The following sections (2.4.1 to 2.4.9) set 
out the results of this narrative literature review, starting with an introduction to 
mainstream leadership theories. 
 Leadership Research 
An understanding of existing leadership theories is important to investigating 
leadership in new contexts. The following is a succinct summary of the major 
contemporary leadership theories. The “great man” theory developed in 1907, put 
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forward the premise that “great men” are born rather than made. The influence of 
the First World War led to the empirical leadership research (24). The trait 
leadership approach, gained traction between the 1930s and 1940s, outlining a 
set of traits that result in effective leadership (19, 25-28). More recently traits have 
emerged as central to newer leadership theories, for example, transformational 
leadership (see below) (29, 30). The skills leadership approach, developed in 
the early 1950s, moved away from the trait focus, and was one of the first 
approaches to state that leadership can be developed over time (5). The 
behavioural leadership approach emerged during the 1950s and 1960s, 
cemented the shift in leadership research, that leaders can be taught and 
developed over time, as opposed to so called “born leaders” (31). The approach 
reported that leaders adopt multiple behaviours changing to the needs of the 
environment (5, 31), to accommodate people-orientated and task-orientated goals 
(32). Contingency and situational theories emerged between the 1960s and 
early 1980s, reiterating the importance of the situation (environment) to influencing 
the leadership process (5). Fiedler’s Contingency Theory (31) and Hershey and 
Blanchard’s 1982 model (5) were two major leadership approaches influenced by 
the changing context/situation. New leadership theories include transformational, 
charismatic leadership and visionary leadership theories (5), emerged in the 
1980s, providing a more holistic understanding of the leadership process and focus 
on a leadership vision (33). Charismatic leadership describes leaders motivating 
followers towards a vision using charismatic traits (32). Visionary leadership 
focuses on a leadership vision (32) while Transformational leadership inspires 
followers to higher levels of purpose and motivation towards a vision (29, 34). 
Several researchers have stated that the new leadership theories are essential in 
that they focus on the leadership vision (35). Transactional leadership occurs 
when leaders gain compliance and performance by offering rewards or punishing 
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deviations from standards in exchange for followers’ acceptance of their leadership 
(34, 36). Transformational leadership, transactional leadership and laisezz-faire 
leadership constitute the full-range leadership theory (37, 38). Authenticity 
Leadership theory was developed as leadership theorists felt there was a need 
for more ethical leaders in times of scandal, uncertainty and an age of increased 
flow of information (39). Authentic leadership stems from transformational and 
ethical leadership (see below) theories (18, 39, 40). Emotional intelligence (EI) is 
a leadership approach that proposes that effective leaders are distinguished by a 
high degree of emotional intelligence, which includes self-awareness, self-
regulation, motivation, empathy, and social skill (5). Servant leadership theory is 
based on the leader’s first and foremost desire to serve their followers (41), and 
leadership focus on behaviours that resonate with follower development (41). 
Ethical leadership combines elements of Authentic Leadership, Transformational 
Leadership and Servant Leadership (30, 41, 42). The area has gained much 
attention in recent years due to business, organisational and political leadership 
scandals. Team-based leadership has emerged alongside other contemporary 
leadership theories and describes leadership and organisational team performance 
operating in complex and dynamic environments (18, 43). 
 Leadership Research and Australia 
Researching into culture and leadership, the Global Leadership and Organizational 
Behavior Effectiveness Research project (GLOBE Project) has identified unique 
leadership differences between related country clusters (44, 45) Australia is 
grouped in the “Anglo cluster” with Canada, USA, Ireland, England, South Africa 
(Anglo and Dutch populations) and New Zealand (46). Within this cluster, there are 
Australian leadership nuances that exist (47). Australia’s unique cultural 
idiosyncrasies are associated with the country’s origins, unique environment and 
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identity (47, 48). Australia’s unique origins support the need for a culturally specific 
approach to leadership development (49, 50). Leadership research in Australia 
started in the mid 1990s (50), largely instigated by the Karpin Report (51). The 
report highlighted that at the time Australians were adept in hard skills 
(management) and relatively weak in soft skills (leadership) (51). 
 Australian Healthcare Leadership and Challenges 
Australian healthcare leadership encompasses the influence of the wider 
healthcare context. The challenges were unique to this context and directly 
influence Australian healthcare leadership. A review by Health Workforce Australia 
was undertaken to identify the leadership needed in training and developing 
Australian healthcare professionals’ to meet the needs and challenges of the 
Australian healthcare context. The review identified that transformational 
leadership was the most applicable theory to Australian healthcare primarily due to 
the central focus on mentorship (52). Mentorship is central to transformational 
leadership and leadership development and is an appropriate leadership to be 
applied to Australian healthcare leadership. The identification of transformational 
leadership to be utilized in the leadership development of Australian health 
professionals seems justified given the extensive evidence supporting 
transformational leadership in overseas health context (53) and more broadly in 
the leadership literature (18, 31, 54). 
Transformational leadership forms the structure of the current Australian health 
leadership framework, Health LEADS Australia (55). The framework consists of 
five domains: (1) Leads self; (2) Engages others; (3) Achieves outcomes; (4) 
Drives innovation; (5) Shapes systems. The framework has been incorporated into 
the pharmacy competency standards (56) and advanced practice frameworks (2). 
To understand Australian health leadership it is imperative to understand the 
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challenges influencing healthcare (5, 31, 32, 52). The challenging environment of 
the health sector presents the need to further understand the influence of context 
when using existing leadership theories in health (57). Australian healthcare 
leadership faces the numerous challenges that are concentrated with the 
increasing pressure to provide greater accessibility of healthcare services with 
fewer resources (17, 52). The Productivity Commission in their report entitled 
“Efficiency in Health” (58) reiterated this challenge around controlling 
unsustainable health costs. Health LEADS Australia identified the need to improve 
health outcomes for Aboriginal and Torres Strait Islander people (59). 
 Australian Nursing Leadership: Implications for the Pharmacy Profession 
Given the limited literature examining pharmacy leadership, this review has 
included this section on Australian nursing leadership. In the same health context, 
the nursing profession has taken significant steps to transform the role of nurse 
practitioners. Despite the health sector challenges, the nursing profession 
continues to exhibit effective leadership, manifested by the profession’s expansion 
into advanced nursing practice (60). This is despite internal and external 
challenges. The nursing profession’s culture has been identified as an internal 
challenge within the nursing profession to clinical and nursing leadership (60). 
Externally, medical hegemony which describes control of the health decisions by 
medical doctors (61) has been reported to influence nurse leadership (62). Nursing 
leadership has been reported to exist at several levels, at one level a nurse 
practitioner can be a clinical leader at the forefront of patient care (60). At a senior 
level, nurse leaders are in management roles, involved with strategic decisions and 
wider health policy (60). This dual role has been identified when examining the 
identities of pharmacists (63). The influence of conflicting roles within pharmacy 
leadership is not known. A barrier to nursing leadership is balancing the 
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expectations of these two leadership levels with the need of a challenging health 
context (62). There is a difference between clinical nurse traits and leadership 
traits within nurse leadership (64), leadership theories applied to nursing may not 
be congruent with clinical nurse leadership (64). The implications for the pharmacy 
leadership are clear, there is need to investigate existing leadership theories are 
relevant to pharmacy leadership. 
 Pharmacy Leadership 
This part of the review will examine the existing pharmacy leadership and related 
pharmacy practice research. There are two aspects to the literature pertaining to 
pharmacy leadership. The first type of articles relate specifically to pharmacy 
leadership styles and leadership development. The second type of articles relates 
to the leadership needed to advance the profession and deliver patient centered 
professional services. 
Several studies have examined leadership at a pharmacist level using existing 
leadership frameworks (65, 66). Employing a pre-existing instrument that 
measures “task” and “relationship”, the majority of US community pharmacists self-
reported a dominant selling leadership style, high task and relationship orientated. 
This meant that community pharmacists’ operational leadership was associated 
with completing daily pharmacy tasks and motivated by the need to develop 
patient-centered relationships. Low task and relationship orientation was 
associated with less effective leadership in the community pharmacy sector (65, 
66). Another study using Bolman and Deal’s theoretical framework for 
management and leadership styles, investigating pharmacist leadership style when 
implementing asthma professional services, identified four different leadership 
styles: 1) Structural; 2) Human resource focused; 3) Political; and 4) Symbolic (67). 
The pharmacy owner’s drive to lead the service and aligning the owner’s values 
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and vision with their team were reported to be critical factors to the service 
leadership approach (67). 
Several studies have examined pharmacy leadership needed at a professional 
level.  Specifically, the professional leadership and community pharmacy 
leadership that was required to deliver expanded professional services (21, 68-70). 
There was utmost importance for the profession to create a unified leadership 
vision for the profession. This vision was designed to motivate pharmacists and 
gain support from all pharmacy stakeholders to expand pharmacist practice 
through professional service delivery (68, 69).  
Transforming the profession to focus on expanded patient-centred care involves 
identifying and developing pharmacist leadership strengths (71). In Australia, there 
is the potential for community pharmacies to be so called “health destinations” 
(72), embracing pharmacist skills to expand and offer health consumers 
professional services (72). However, there needs to be support and policy 
guidance to facilitate the transformation, and further investigation to identify the 
solutions to overcome barriers that are preventing the leadership needed to 
transform (72). An independent report commissioned by the Royal Pharmaceutical 
Society (RPS) outlined that pharmacy leadership was key to the success of future 
models that advance the role of the pharmacist through the provision of services 
(73). The main barrier for the UK pharmacy profession was a coherent vision that 
fits within the broader NHS framework (73). Although emerging from the UK, the 
report has been recognised by the peak organisation representing pharmacy 
owners’ in Australia as a significant report that was relevant to Australian 
pharmacy (74). The next several sections (2.4.5.1-2.4.5.5) will examine pharmacy 
practice research related to leadership. 
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2.4.5.1 Pharmacy Leadership and Organisational Culture 
Pharmacy organisational culture was determined as the culture within community 
pharmacies. Community pharmacy organisational culture was intrinsically 
correlated to pharmacy leadership (75, 76). It was determined that a community 
pharmacy culture that fosters learning and development, providing support for 
pharmacy staff to make decisions is essential to influencing community pharmacy 
leadership (77). A recent review of community pharmacy organisational culture (1) 
identified the importance of pharmacy leadership style to the operational 
leadership of community pharmacies. 
Changing community pharmacy culture and leadership has been associated with 
the re-professionalisation of pharmacists. The organisational culture of community 
pharmacy was instrumental to transform the profession, as new and expanded 
pharmacist roles in the health care system require significant leadership that 
impact organisational culture (77). The need for pharmacists to re-professionalise 
in New Zealand, required effective leadership and professional culture change at a 
community pharmacy leadership level (22).  An analogy in the Australian 
community pharmacy setting has been the re-emergence of specialised 
compounding (78). Advanced compounding practices has allowed Australian 
pharmacists to transform, shifting from their technical medicine supply role to 
expanded role opportunities for pharmacists.   
2.4.5.2 Pharmacy Leadership and Pharmacist Identity 
This section is about the influence of pharmacist identity and personality on 
pharmacy leadership. A Canadian paper proposed potential pharmacists’ traits that 
seem to prevent pharmacists expanding their role from a technical medication 
supply function to patient-centred service models (79). Empirical research from the 
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UK investigating pharmacists’ perception of their professional identity found that 
there are nine pharmacists’ identities that exist and include; the scientist, the 
medicines advisor, the social carer, the clinical practitioner, the medicines maker, 
the supplier, the business person, the manager, and the unremarkable character. 
The scientist however emerged as the most dominant identity for pharmacists 
through an in-depth qualitative study examining eighty-five participants that 
included pharmacists and non-pharmacists (80). A study examining pharmacists’ 
personality related to their practice setting employing the Gordon Personal Profile 
Inventory (GPPI)(81), demonstrated that pharmacists’ are not a homogenous 
group, with personality significantly differing between the different practice settings 
(81). Community pharmacists scored high in traits related to patient-orientated 
care, and scored significantly high in cautiousness and responsibility, personality 
traits associated with change resistance and not taking risks (81). In a study that 
examined personality traits of hospital pharmacists employing a survey instrument 
designed from the “Big Five” personality traits (extraversion, agreeableness, 
conscientiousness, neuroticism and openness) (10). The correlation between 
these personality traits and leadership has been well researched in the literature 
with neuroticism, extraversion, openness and conscientiousness related to 
leadership (24). 
Hospital pharmacists self-reported a stronger association to extraversion, 
agreeableness, conscientiousness and openness (10). Understanding pharmacist 
personality traits may be useful to facilitating training and development towards 
professional services that deliver patient care and facilitate a profession-wide 
leadership transformation. Poor self-confidence and clinical decision making skills 
(82) have been reported to be traits that pharmacists possess when entering the 
profession. Furthermore, there seems to be ambiguity with defining pharmacist 
identity, preventing the expanded role of the pharmacist (82). 
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2.4.5.3 Pharmacy Leadership and Practice Change 
Decision-making is an essential leadership trait that is associated with the leader’s 
cognitive intelligence and tacit knowledge in changing contexts (83). 
Entrepreneurial orientation is the decision-making activities that result in the 
development of new and innovative services (84). Entrepreneurial orientation in 
community pharmacies is associated with practice change; when the 
proactiveness and autonomy of pharmacy staff are supported, resourced, and 
developed (85). This orientation requires a pharmacy leadership that empowers 
and motivates staff at various levels of the organisation to implement practice 
change (85). The greater the entrepreneurial orientation, the increased likelihood 
of implementing successful innovative services (84). Similar findings have 
emerged from the UK, where the success of coordinated transformation of 
community pharmacy practice to meet consumer needs was determined by a 
pharmacist leader taking ownership of the service, motivating and transforming the 
team (86). Strong pharmacy leadership, effective teamwork, motivated staff all 
result in the increase in business service provision and promotion (87). 
Furthermore, in Australia a successful element of a change model in pharmacy is 
to have clear and distinctive leadership at a pharmacy level to lead the team of 
community pharmacists and their staff who are all engaged in achieving the 
desired outcome (88). The capacity for organisational change in community 
pharmacies can be increased by providing greater autonomy to followers 
(pharmacy employees) (85). 
Australian research investigating pharmacy practice change has identified 
facilitators to assist community pharmacies to implement the service leadership 
approach (20, 89). Leadership was identified as a significant facilitator promoting 
practice change (90). Organisational theory was used as an underlying theoretical 
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framework, incorporating the important aspects of wider organisational change 
(91). Change leadership was identified as instrumental to the practice of 
community pharmacies in the implementation of significant change within the 
community pharmacy (88). The success of a community pharmacy organisation 
will depend on the environment and members within the team (88). These findings 
are very similar to situational and team-based leadership theories that have 
emerged from the wider literature (5). The effective leadership needed to transform 
pharmacy practice reliant upon technical skills, needs to incorporate leadership 
skills, goal setting and teamwork (20), all which form the fundamentals of 
contemporary leadership theories (5). Several studies have reported a resistance 
to practice change, community pharmacists were not supportive of expanding their 
leadership roles outside of their specific scope of practice and taking a leadership 
role in wider the primary healthcare team (92). Furthermore, there was significant 
pharmacist variability with regards perceptions for pharmacy leadership across 
sixteen clinical and managerial activities (92). 
2.4.5.4 Organisational Flexibility and Pharmacy Leadership 
In Australia, research using the theoretical framework of organisational flexibility 
has been used to investigate community pharmacies flexibility to transform to a 
service focused pharmacy (93). Australian pharmacies exhibit four types of 
organisational flexibility; structural flexibility, strategic flexibility, operational 
flexibility and steady state (93). Pharmacy leadership style was a determining 
factor in community pharmacies exhibiting different types of organisational 
flexibility (93, 94). A pharmacy exhibiting steady state flexibility, exemplified by 
classic community pharmacies, with a leadership focused on maintaining the 
status quo, showing neither a controlling or empowering leadership style (93). 
Retail focused pharmacies tended to exhibit operational flexibility, marked by a 
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controlling leadership style. Health destination pharmacies display strategic 
flexibility, with these pharmacies exhibiting an empowering leadership style that 
engages staff. Networked pharmacies displayed operational flexibility, the 
leadership style exhibited was evident of a controlled leadership approach. Overall 
the majority of pharmacy owners exhibited described a controlling approach to 
their leadership style (93). Interestingly, the leadership positions adopted by 
community pharmacies were determined by the philosophical standpoint of the 
pharmacy owner (leader). 
The majority of Australian community pharmacies tended to have a reactive 
leadership style to external changes in the environment (93). Effective community 
pharmacy leadership is achieved when pharmacy staff are actively engaged and 
provided support as part of the pharmacy culture (89, 93). This community 
pharmacy leadership approach resembles elements of team-based leadership, 
where adaptability to the environment is critical to the successful leadership of the 
team (5, 43). The study identified that a pharmacy sector leadership approach is 
needed to facilitate pharmacy owners, leaders of community pharmacies, the 
ability to transition to provide pharmacy services in challenging context (93). 
2.4.5.5 Advanced Pharmacy Practice and Leadership 
The Royal Pharmaceutical Society (RPS) released a leadership framework for 
pharmacy professionals, influenced by the National Health Service (NHS) clinical 
and medical leadership frameworks (95). The five domains include: demonstrating 
personal qualities, working with others, managing services, improving services and 
setting direction. These domains mirror Health LEADS Australia (Section 2.4.3) 
which has influenced Advanced Pharmacy Practice Frameworks (APPF). The aim 
of advanced practice is to develop a profession-wide position on pharmacist 
prescribing and to assist in the implementation of an advanced pharmacy practice 
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recognition model (96). The APPF stemmed from the National Competency 
Standards Frameworks for Pharmacists (NCSFP) in Australia and was designed to 
set out entry-level competency standards for pharmacists (56). The NCSFP have a 
specific leadership and management domain. 
The APPF (2) defines leadership as: 
“...The process of influencing the behaviour of others toward a pre-
determined goal...” 
Advanced practice is defined as: 
“... practice that is so significantly different from that achieved at 
initial registration that it warrants recognition by professional peers 
and the public of the expertise of the practitioner and the education, 
training and experience from which that capability was derived...”(2). 
The leadership competencies in the NCSFP are extended throughout the APPF. 
Competencies are outlined under three progressive levels of advanced 
professional practice starting from transition level, moving to consolidation level, 
and finally the advanced level. 
 Pharmacy Leadership Development 
In order for the pharmacy profession to achieve its full potential, it is critical to 
identify and apply the strengths of individual pharmacists to various practice 
settings (71, 97), with the awareness of strengths essential for leadership self-
development and mentoring (71, 98). Mentorship is an effective leadership 
development practice (99), which allows the development of a personalised and 
flexible relationship between mentor and mentee (100). Mentorship using 
continuing professional development (CPD) plans develop leadership skills in 
pharmacy students (101), with the majority of students finding that the CPD 
 41 
 
focused cycles improved their leadership development through a structured 
training plan. 
At a pharmacy level, leadership development through the provision of mentoring 
programs is a facilitator that stimulates pharmacy practice change (90), and more 
broadly in the leadership literature has been identified as one of the five key 
leadership development practices (99). In the pharmacy profession, mentorship 
falls under the factor ‘communication and teamwork’ (20), importantly mentorship 
needs to be supported by policy makers and the wider profession to ensure 
pharmacy transformation (20). 
Mentorship is an effective strategy to develop professionals from their formal 
training at university transitioning into professional practice, and may be beneficial 
to overcoming the potential disillusionment that some early-career pharmacists 
experience (102, 103). Transformational leadership has been empirically linked 
with the mentorship functions, professional and career development (37, 102). 
There is a further need to investigate leadership development recommendation 
and strategies in the pharmacy profession. 
 Discussion 
The original strategy was to perform a systematic approach to searching and 
retrieving articles. However, due to identification of limited studies, the search 
approach transitioned to examine a broader scope of literature in addition to 
pharmacy leadership, including contemporary leadership theories, leadership 
theories applicable to health and research in related pharmacy practice areas 
(Section 2.3.1). There were few studies that examined pharmacy leadership 
research in the extant literature. Several studies examined related pharmacy 
practice areas; practice change, organisational culture, organisational flexibility and 
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pharmacist personality and identity. Overall, the findings of the narrative review 
highlighted a lack of research devoted to pharmacy leadership. The stage two 
search strategy was limited in scope. Literature review quality checking was a 
methodological limitation of the search approach adopted in this narrative literature 
review. Nonetheless, gaps in the literature were identified. 
Australian pharmacy leadership research presents a unique opportunity to build 
upon extant pharmacy practice research. There were several studies that identified 
the role of leadership development, particularly mentorship in the pharmacy 
profession (Section 2.4.6). 
Investigation of the literature relating to Australian leadership identified that there 
are unique cultural nuances that influence the leadership process in the Australian 
context (Section 2.4.2). Health leadership exists in a challenging environment, 
there is a need to further understand the influence of context when using existing 
leadership theories in health (57). There are several challenges in Australia’s 
health context such as ageing population, increase in chronic conditions and 
disadvantaged populations (Section 2.4.3). Contemporary leadership theories were 
examined (Section 2.4.1). Leadership theories need to be carefully adapted before 
being applied to the pharmacy profession as the unique nature of the sector may 
present challenges when using leadership theories (104, 105). Transformational 
leadership focusing on the individual level of analysis is the most relevant and 
applicable to the pharmacy profession and has been incorporated in the Australian 
health leadership framework, Health LEADS Australia (Section 2.4.3) (53, 106, 
107). The importance of leadership in transforming Australian pharmacies has 
been identified in the literature (8, 20, 93). However, there has been limited 
empirical research to explore and better understand how leadership in the 
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pharmacy profession is manifested in the face of the emerging contextual 
challenges.   
This research sets out to explore Australian pharmacy leadership and develop an 
understanding of the strategies and recommendations to improve the leadership 
capacity of early career pharmacists. Building on the findings of previous work 
conducted in pharmacy practice research and this narrative review, the present 
research is significant for the following reasons: 
1. Research is needed to understand the role of external context and its influence 
on Australian pharmacy leadership (6). 
2. There is limited empirical research to explore leadership development and 
mentorship in the pharmacy profession. 
3. There is limited empirical research that has examined the definition of 
leadership and the traits of effective pharmacy leaders. 
 Research Gaps 
The overarching research question of this thesis is directed at: 
How will the profession improve the leadership development 
capability of Early Career Pharmacists? 
However, to understand the first question it is necessary to first explore the 
following three research questions: 
1. What is leadership in the pharmacy profession? 
2. What leadership traits are specific to the pharmacy profession? 
3. What are the contextual challenges influencing pharmacy leadership and 
leadership development? 
 44 
 
 Aims and Objectives 
In light of these research gaps identified the following research thesis aim and 
specific objectives have been presented to address the research question “How 
will the pharmacy profession improve the leadership development capability of 
Early Career Pharmacists (ECPs) e.g. intern pharmacists?”. 
 Thesis Aim 
To investigate and identify areas that would improve the leadership development 
capacity of early career pharmacists. 
 Thesis Specific Objectives 
1. Identify, define and explain Australian pharmacy leadership. 
2. Construct an Australian Pharmacy Leadership Theory (APL Theory) grounded 
in the data that reflects the emerging theoretical explanation of the 
phenomenon. 
3. To identify leadership traits that are specific to the pharmacy profession 
(leadership traits include leadership attributes, skills and styles). 
4. To identify leadership development strategies designed to improve the training 
and leadership capacity of ECPs e.g. intern pharmacists; 
5. Explore the emerging findings from the APL Theory with Early Career 
Pharmacists (ECPs) employing quantitative methods to examine leadership 
development, to investigate the crucial intern pharmacist-preceptor pharmacist 
leadership development relationship. 
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 Qualitative Research Aims and Objectives 
A qualitative research study is the most appropriate method that provides sufficient 
flexibility to answer the research question (108, 109): 
How will the profession improve the leadership development 
capability of Early Career Pharmacists? 
Specific qualitative research aims and objectives were developed to respond to the 
primary research question. 
2.5.5.1 Specific Qualitative Objectives 
• Define pharmacy leadership through pharmacy leaders’ participation in semi-
structured interviews exploring the definition and traits of effective pharmacy 
leadership. 
• Examine leadership development and mentorship in the pharmacy profession. 
• Explore the contextual challenges and opportunities facing the pharmacy 
profession. 
This qualitative study forms part of a larger leadership project that will employ 
quantitative methods to answer the overall thesis aim. Initial qualitative interviews 
were used to define pharmacy leadership through the construction of the 
Australian Pharmacy Leadership Theory (Figure 4.1). The results of the qualitative 
study informed and developed in part, this quantitative study design (Figure 2.1). 
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Figure 2.1 Research project. 
 
 Quantitative Research Aims and Objectives 
The aim of this study was to determine intern pharmacists’ perceptions of their 
preceptor pharmacists’ leadership styles. 
 Specific Quantitative Objectives 
1.  To quantify intern pharmacists’ (followers) perceptions of their preceptor 
pharmacists (leader) leadership style. 
2.  To compare intern pharmacists perceived leadership styles being employed by 
preceptor pharmacists across different pharmacy practice settings e.g. 
Community Pharmacy versus Hospital pharmacy. 
3.  To investigate the relative influence of preceptor pharmacists’ leadership style 
on intern pharmacists’ outcomes of leadership outcomes. 
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4.  To determine demographic and workforce influences that impact intern 
pharmacists perceived leadership being employed by preceptor pharmacists. 
5.  To determine the leadership development training needs that intern 
pharmacists are seeking to facilitate their pharmacy leadership development. 
6.  To determine the leadership traits that intern pharmacists believe are important 
for pharmacists in leadership positions. 
7.  To investigate the psychometric properties of the MLQ among Australian intern 
pharmacists; and determine the association between the derived leadership 
dimensions and outcomes of leadership. 
The next chapter of this thesis (Chapter 3) will report the qualitative methods 
employed in this research. 
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Chapter 3: A Qualitative Study Exploring Pharmacy Leadership in Australia 
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 Introduction 
Chapter 2 previously outlined the existing literature and identified the notable gaps 
that exist in the knowledge related to leadership with a specific focus on the 
pharmacy profession. This chapter forms Part 2 of the research in this thesis, 
discussing the rationale for the design of a qualitative study and the ontological 
and epistemological underpinnings to explore leadership in the pharmacy 
profession. This chapter starts off with addressing the question “What is leadership 
in the pharmacy profession”, which drives a larger research project investigating 
pharmacy leadership and pharmacy leadership development. 
 Background 
Australian community pharmacies are a significant component of the small to 
medium business sector (SME) in Australia, consisting of a unique network of 
5,500 privately owned pharmacies with an estimated $5 billion of private 
investment in pharmacy business capital assets (110), and employing 74.15% of 
Australian pharmacists (20,865 of the 28,141 practising pharmacists) (111, 112). In 
Australia, only pharmacists can own community pharmacies, either as an individual 
pharmacist, or as part of pharmacist partnerships under the applicable Australian 
State and Territory government legislation (113). Community pharmacies are 
integral to Australia’s health care system, geographical spread (through legislation) 
across the country to ensure the principles of Australia’s National Medicine Policy 
are met (114). This affords that all Australians receive timely and affordable access 
to the medicines they need through the Pharmaceutical Benefits Scheme (PBS), 
forming the foundation of medicine supply in the National Health Act 1953 (113, 
115). The manifestation of this unique relationship between small business and 
national medicine policy is encapsulated in the Community Pharmacy Agreement 
(CPA), an agreement between the Pharmacy Guild of Australia (Guild) and the 
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Commonwealth of Australia (Government) (115, 116) that commenced in 
December 1990 as a result of a robust political confrontation between the Guild 
and Government initiated by proposed changes to pharmacist proprietors medicine 
mark-up affecting pharmacy profitability (116). Pharmacist owners closed their 
pharmacies in protest, threatening medicine supply to Australians. The Guild and 
the Government have since negotiated six successive CPAs, each of five years in 
length outlining the remuneration arrangements for community pharmacies and 
ensuring PBS medicine accessibility and the provision of cognitive pharmaceutical 
services (93, 94) (hereafter referred to as “services”) to the Australian public (7, 
116). The current success of leadership in Australian community pharmacy can be 
measured by the continual ability of the Guild to negotiate successive Community 
Pharmacy Agreements (CPAs) with the Government (117), although this has been 
widely debated in the broader Australian health sector. Three significant 
Government led projects have coalesced to influence a formal review of pharmacy 
remuneration and regulation. The Australian Government; Competition Policy 
Review, Productivity Commission; Efficiency in Health Research Paper and the 
Australian National Audit Office; and Administration of the 5th Community 
Pharmacy Agreement have all placed significant pressure on the current 
community pharmacy model, questioning remuneration and regulation (118, 119). 
 Current Context in Pharmacy 
The three aforementioned reports (15, 58, 120) support recommendations to 
increase competition to Australian pharmacies through the removal of 
Commonwealth Government pharmacy location regulations and State and 
Territory Government’s pharmacy ownership regulations. With the 6th CPA a full-
year into the five year term, and the current and ongoing independent Review of 
Pharmacy Remuneration and Regulation releasing a discussion paper, 
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commissioned by the Federal Minister for Health electing an expert panel to 
consider the following terms of reference; 1) Pharmacy Remuneration for 
dispensing; 2) Regulation; 3) Wholesale, Logistics and Distribution Arrangements; 
Accountability and Regulation; and 5) Consumer Experience (16).The focus of the 
review is to provide recommendations for the future pharmacy remuneration and 
regulation to ensure that they meet the needs of the Government and Australian 
public (121). The review will take consideration of the Australian health context, 
with attention to the Australian Government’s Reform of Federation White Paper, 
Australia’s National Medicines Policy (NMP) and broader government health 
policies and initiatives (16, 121). The Review of Pharmacy Remuneration and 
Regulation released a discussion paper in late July 2016 marking the first 
independent review of pharmacy remuneration and regulation in 20 years in 
Australia. The discussion paper critically analysed the current system of pharmacy 
remuneration and formally welcomed a series of public consultation periods during 
2016 (16). The review panel designed a pharmacy financial survey to develop a 
comprehensive financial analysis of the sector which informed the panel’s interim 
report release in June 2017 (122, 123). The interim report reported findings from 
five-hundred submissions across the pharmacy sector, and presents alternative 
options to current pharmacy remuneration and regulations, consistent with a 
forward-looking twenty-year vision for the pharmacy sector (123). 
The review comes at a time when community pharmacies in Australia are under 
significant structural, competitive and legislative pressure, with several prominent 
industry stakeholders identifying that the pharmacy profession is experiencing 
demanding challenges (7, 8, 124-126) (Table 3.1). Community pharmacies are 
simultaneously attempting to transform to the provision of services in a 
(hyper)competitive environment (7, 8, 11). Potential changes to pharmacy 
remuneration and regulation is a fine balance between ensuring the network of 
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community pharmacies in Australia are financially viable and sustainable to meet 
the needs of Australia’s National Medicines Policy and ensuring there is adequate 
competition in the pharmacy sector (127). The Review of Pharmacy Remuneration 
and Regulation will make recommendations to the Commonwealth Government on 
how to navigate these conflicting pressures (121). The leadership at multiple levels 
in Australian pharmacy is being influenced by the contextual challenges 
(Table 3.1). Building from the literature review (Chapter 2), the relationship 
between the external context and the manifestation of leadership is significant and 
has been identified in several health, organisational and professional contexts in 
the literature (6, 18, 19, 128-130). Little is known about the current contextual 
pressures influencing leadership in Australian pharmacy (5, 6, 131-133). 
Table 3.1 Community Pharmacy Contextual Challenges 2010 to Present 
Continual and accelerated PBS reform has resulted in the declining profitability of 
community pharmacy (7, 109). Most recent changes threaten the closure of 276 
community pharmacies (123). 
Significant increase in pharmacist workforce from about 12,000 community 
pharmacists employed across 4,992 community pharmacies in 2009 (133) to 29,150 
registered pharmacists in 2015 employed across 5,500 community pharmacies (110), 
increasing pharmacist underutilisation (134, 135) and resulting in pharmacist 
professional dissatisfaction (134). Pharmacy Guild analyses estimate that 
approximately 10.7% of community pharmacist employment positions are expected to 
be made redundant due accelerated PBS reform (109). 
Community pharmacy in Australia has high levels of government regulation that has 
been questioned repeatedly in the reviews by the Competition Policy Review (15), the 
Productivity Commission (58) and the Australian National Audit Office (119) (see 
Figure 3.1). All three external reviews propose to open the pharmacy market to 
stimulate competition recommending the removal of pharmacist ownership and location 
rules in an attempt to increase competition and reduce government regulation (7, 15, 
16, 112, 119, 124, 125, 134). 
The pharmaceutical industry is heavily fragmented and there are increasingly 
competitive pressures facing community pharmacies with the proliferation of ‘discount’ 
community pharmacies (7, 118, 124, 125, 136). 
There is a slow uptake from community pharmacies to transition to the implementation 
of services (9, 11, 88) with significant reliance on the existing community pharmacy 
profitability intrinsically linked to the supply of medicines and cost of goods sold. 
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A great deal of Australian pharmacy research has investigated practice change 
(20, 89, 90, 134), organisational flexibility (9, 93, 94), managerial capability (8, 13), 
organisational climate (135) and service implementation (11, 136, 137) in 
community pharmacies, but none have focused specifically on the leadership 
needed in Australian pharmacy. The organisational and management research 
conducted has significant implications for leadership and demonstrates the need to 
further understand and explore leadership in Australian pharmacy. The level of 
change required in Australian pharmacy has been identified as ‘complex’ and is 
likely to require the assistance of professional pharmacy organisations to provide 
assistance for pharmacies to integrate in the current context (94), with the required 
transformation ultimately being considered as a test of leadership (74). The 
leadership required within the community pharmacies and the professional 
organisations to assist the transformation of community pharmacies in the current 
context of change and challenges are not currently known. Furthermore, there is 
limited research in what leadership exists in the face of the emerging contextual 
challenges. 
 Significance of this Research 
The importance of leadership in transforming Australian pharmacies has been 
identified in the literature (8, 20, 93). However, there has been limited empirical 
research to explore and better understand how leadership in the pharmacy 
profession is manifested in the face of the emerging contextual challenges. This 
research sets out to explore the leadership process in the pharmacy profession, 
with a focus on the Australian context. 
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 Qualitative Study Aims and Objectives 
To meet the broad thesis aims, research aim and specific objectives were 
developed for the qualitative study, responding to the primary research question: 
How will the profession improve the leadership development 
capability of Early Career Pharmacists (ECPs)? 
In order to answer the primary research question, it is important to first define 
leadership in the pharmacy profession, considering the differences between 
leadership in other health professions, international pharmacy settings and 
leadership more broadly in the literature. 
The qualitative study aim was to develop a substantive Australian pharmacy 
leadership theory grounded in the qualitative data. The emerging theory will 
complement a quantitative study of early career pharmacists which will constitute 
the distribution of an Australian Pharmacy Leadership Questionnaire 
(Questionnaire) and that forms part of a larger leadership research project.  
The specific objectives of this qualitative study set out to: 
• Define pharmacy leadership from the perspectives of pharmacy leaders through 
exploring the definition and traits of effective pharmacy leadership. 
• Examine leadership development and mentorship in the pharmacy profession. 
• Explore the contextual challenges and opportunities facing the pharmacy 
profession. 
 Ontological and Epistemological Position 
This study employed a constructivist research paradigm ontology that was 
grounded in the data. The constructivist grounded approach to this study is most 
suitable to the Australian pharmacy profession as the problem under investigation 
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is socially complex and consists of many views, opinions and perspectives from 
both individuals and organisations (138). The primary researcher (DR) was actively 
involved with participants in a dialectical relationship eliciting multiple constructs of 
knowledge, with the ultimate aim of producing a grounded theory that is influenced 
by the context and the interactive and interpretative relationship between DR and 
participants. 
 Qualitative Research on Leadership 
Prior to the 1980s qualitative research on leadership was virtually non-existent, in 
comparison with today where there exists greater methodological diversity (109). 
Leadership research is a field of investigation that is dominated by the quantitative 
data-collecting instrument, the self-administered questionnaire (108, 109, 139). 
Whilst quantitative research on leadership has addressed a wide range of research 
questions (109), there are numerous limitations to leadership research that 
employs quantitative methods. These methods are found to be insufficient for 
explaining the phenomena (140). Quantitative research on leadership has been 
characterised by a tendency towards an input-output model, where the researcher 
is orientated to how leaders behave (141) and the impacts of leadership (109). 
Leadership is a social influence process (5, 108) and the legitimacy of quantitative 
methods becomes less clear when examining the social constructions of the 
leadership process (108, 141, 142). Quantitative researchers do include context 
variables in their research design, but conceptualise them abstractly, ignoring the 
impact of context specific forces (142). Quantitative methods are less flexible in 
their methodological diversity to cater to complexities, relationships and influence 
of leadership context (142).The numerous advantages for employing qualitative 
methods in this research are explored below in Table 3.2. 
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Table 3.2 Advantages of Qualitative Methods in Leadership Research (108, 109, 
141-144) 
1. Qualitative research has greater implications, specificity and sensitivity for context. 
2. Iterative and flexible to follow unexpected ideas during research and explore the leadership process effectively. 
3. Useful when exploring individual’s beliefs, attitudes, opinions and studying different forms of leader behaviour. 
4. Theory emerges from the data, and the ability to study symbolic dimensions and social meaning. 
5. Useful to explore phenomena where there are very little or no empirical evidence that exists. 
6. The ability to employ the existing theory and research as a springboard for the research approach. 
7. Opportunity to develop new ideas and theories. 
8. Enables further research allowing longitudinal explorations of the leadership phenomenon. 
 
In this chapter qualitative research methods are described which were used to 
examine pharmacy leadership. The use of qualitative methods was motivated by 
the scarcity of leadership knowledge in the pharmacy profession and the ability to 
focus on the specificity within a given context, in this case the pharmacy 
profession. The pharmacy environment is complex, competitive and under 
pressure from multiple factors (7, 8). Qualitative research methods provide 
methodological advantage to investigate the contextual nuances (6, 108) in the 
pharmacy context, with the ability to cater for unique pharmacy sensitivities, 
providing greater scope to answer the specific research questions. 
 Methods 
 A Grounded Theory Approach 
Grounded Theory (GT) was originally developed by Glaser and Strauss in the 
1960s in reaction against extreme positivism, and is a process where theory 
emerges from, and is grounded in the data (108, 145, 146), and explains complex 
social phenomena in context (147). In the forty-nine years since the inception of 
GT there has been many procedural and epistemological divergences between 
Glaser, Strauss and their colleagues (138, 147, 148). Hence it is important to note 
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that GT is an inductive approach that does not specify one single research 
technique. Despite this the core principles of GT, constant comparison and 
theoretical sampling remain intact (146). Through the use of a set of systematic 
approaches data is collected and analysed simultaneously (144, 145). GT employs 
a constant comparison method where data is analysed, observed, compared and 
contrasted to new data until a point known as theoretical saturation occurs, where 
no new data, ideas or concepts emerge (144, 145, 149), and there is a generation 
of a substantive formal theory that explains the data set (150). The approach is 
inductive, iterative and interactive deriving a constructed theory (151) about a 
phenomenon that is grounded in the data and specific to the context from which 
the data emerges (108, 141), with the final theory that is judged by fit, relevance, 
workability and modifiability (145) as opposed to truth, value, validity or reliability. 
In GT meaning is constructed through the use of participants’ language, symbols 
and signs, with the researcher adopting position of participants and interpreting 
meaning (138, 147). GT approach is best used to interpret everyday life situations 
where there is little previous research that has occurred, and the where processes, 
relationships, and meanings are the focus (144). 
 The Grounded Theory Approach in Pharmacy Practice and Leadership 
Research 
The leadership process is significantly influenced by the context (5, 19, 44) with 
leadership research more recently employing GT approaches to understand the 
role of the external context and subsequent influence on the leadership process (6, 
131, 152). Pharmacy practice research often employs methods axiomatic of GT 
approaches and other qualitative research methods to understand specific 
pharmacy management contexts (8, 90, 93). GT has the ability to understand 
particular substantive contexts through investigation of the nuances specific to the 
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context (152). A theory grounded in the emerging data following the principles of 
GT will be applicable and match that specific context (153). 
 Grounded Theory Approach and this Study 
The paucity of research on pharmacy leadership shaped our decision to employ a 
GT approach in this study. It is important to note that there is significant 
methodological dynamism in GT approaches (148), ranging from the 
postpositivism original approach outlined by Glaser and Strauss (145) to the 
symbolic interactionist approach offered by Corbin and Straus, through to the 
Charmaz’s constructivist GT approach (138, 151). 
GT is an approach with vast methodological dynamism; conveying that there is not 
one specific research technique. The three GT approaches advocate the same 
core methodological principles which should be followed (138, 144, 148) in terms 
of coding, theoretical sampling, theoretical sensitivity, interaction with participants, 
and theory generation. The GT approach employed in this research was indicative 
of the GT methodology and theory construction approach outlined by Charmaz 
(138, 148, 151), which views the GT approach as a constructivist methodology with 
symbolic interactionist underpinnings, fostering writing as a method due to the 
facilitative nature of reconstructing events and regeneration of data (148). A 
constructivist GT approach was suitable for this research due to the fact that 
leadership in the pharmacy profession is constructed from multiple realities of 
participants with diverse professional experiences across multiple practice settings, 
and incorporates organisational leadership factors. Similar methodological 
approaches employing constructivist GT have been used in the pharmacy 
profession (154, 155). 
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 Data Collection 
Qualitative research in this study consisted of in-depth semi-structured interviews 
and document analysis (Government transcripts pertaining to the pharmacy 
profession). The interviews were the primary source of data collection and were 
employed to explore the leadership process in the Australian pharmacy context. 
3.7.4.1 Individual Interviews 
In this study, in-depth individual interviews were conducted allowing participants to 
provide detailed descriptions of their personal experiences and behaviours, and 
provided the opportunity for immediate clarification and flexibility to probe 
participant responses (156). When considering the qualitative nature of this study, 
rich data can be obtained from the participant’s experiences, feelings and views 
described as ‘truths’, and hence the suitability of this method is appropriate to gain 
insights into the leadership phenomenon (156). Qualitative interviews provided the 
flexibility to follow unexpected ideas during data collection and study the symbolic 
dimensions and social meaning of the leadership phenomenon (141). To address 
the aims of this research, individual interviewing was recognised as the most 
suitable qualitative method to permit an in-depth exploration of the research 
subject (138) and has the important advantage of eliciting the in-depth participant 
views and opinions without the influence from other participants, for example, 
which can occur during focus groups (150). Furthermore, focus groups require 
greater research investment (two researchers) and are influenced by group 
dynamics. The flexibility of this method is central to the potential significance of this 
research. 
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3.7.4.2 Semi-structured Interview Guide 
A qualitative instrument in the form of an interview guide was designed to achieve 
the qualitative study and broader thesis aims. The interview guide was partly 
influenced by the literature review and adapted to the pharmacy profession 
accommodating for the importance of the pharmacy context. The interview guide 
was designed with the ability to identify, explore and investigate pharmacy leaders’ 
perceptions around: 
• The definition of leadership and traits of effective leadership needed in the 
pharmacy profession; 
• The relationship between leadership development e.g. mentorship, and 
leadership in the pharmacy profession; 
• The contextual challenges that influence the leadership process in the 
Australian pharmacy profession; 
• Recommendations to improve the leadership capacity of pharmacy students 
and ECPs leadership development. 
The full interview guide (Appendices: Appendix C) consisted of seven exploratory 
questions directed to investigating the research questions. The interview guide was 
designed to include open-ended questions (and prompts) and provide the interview 
with general direction, shaping the design, yet allowing for new and emerging data 
and a flexible approach to explore unexpected themes (138), with the semi-
structured design allowing flexibility to seize opportunities to ask further questions 
in response to significant replies as they emerged (157). The questions were 
designed to facilitate a natural conversation flow and consisted of five leadership 
areas: definition of leadership, leadership traits, leadership development, 
leadership training recommendations and leadership challenges in the pharmacy 
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profession. The interview guide was adapted to the pharmacy profession by 
employing relevant indigenous typologies and prompts that are unique to the 
pharmacy context. The interview guide started by allowing participants to define 
their understanding of, providing a robust departure point to compare and contrast 
the exploration of specific pharmacy contextual leadership issues that emerged 
throughout the interview with reference to their original leadership definition. 
Importantly, the interview guide was sent to participants prior to the designated 
interview date, clarifying the areas to be examined in a semi-structured process by 
the primary researcher and participants (139). This allowed participants time to 
contemplate their responses prior to the interview. The semi-structured design of 
the interview guide provided adequate flexibility for the primary researcher to 
explore and examine concepts and emerging ideas of the participants as part of 
the grounded approach to this research. After participant consent, and prior to 
each participant interview, DR researched the participants’ background and 
experiences which allowed DR the flexibility and reflexivity to probe emerging 
themes when they related to the participant’s professional career. 
3.7.4.3 Interview Guide: Face and Content Validity 
The interview guide was pre-tested with one senior academic in the research team 
to establish face and content validity, ensuring interview technique and interview 
questions would achieve study objectives. No changes were made to the interview 
guide. The decision was made to cease pilot testing, as the literature has identified 
the difficulties with interviewing elite participant groups, such as scheduling, 
resource requirements and low pool of potential participants (147). To ensure 
validity of the interview guide during the initial stages, two other researchers 
experienced in qualitative methods reviewed the interview process and provided 
feedback after reading the participant transcripts which contained DR’s emerging 
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themes (158). After the researchers reviewed the interviews, no significant 
changes were made to the interview guide and it was deemed that the interview 
guide in its current form (Appendices: Appendix C) would achieve the qualitative 
study aim and specific objectives. 
3.7.4.4 Document Analysis 
Document collection and analysis in the form of content analysis was conducted in 
conjunction with qualitative interview collection as a method of secondary data 
collection to overcome challenges with recruiting government health participants. 
The documents for investigation consisted of two government and/or government 
health affiliated publicly available transcripts relating to the Australia pharmacy 
profession. Although not the primary data collection method, the document 
analysis provided validity for the interview data collected in this study and allowed 
several theoretical assumptions to be clarified and defined (139). 
 Sampling and Recruitment 
In-depth semi-structured interviews commenced after institutional ethical clearance 
was approved by the University of Sydney’s Human Research Ethics Committee 
(HREC) ‘Project no. 2012/2884 (Appendices, Appendix B). After there was 
agreement by the participant to take part in the study, DR emailed further study 
information that included the semi-structured interview guide, participant 
information statement and participant consent form (Appendices, Appendix C). 
Interview date and time logistics were organised during the email correspondence. 
A ‘Safety protocol’ was designed to reduce the risk to DR and participants when 
interviews were conducted in public places and places of business (Appendices, 
Appendix C). Prior to active participation in the study, a signed copy of the consent 
form was attained from participants, ensuring that they understood the study, their 
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commitment, the study requirements and most importantly to ensure informed 
consent. Skype interviews were implemented when face-to-face interviews were 
not possible. While in-depth interviews are generally completed in person (159), 
the use of current e-technology e.g. Skype; allowed DR to effectively engage with 
participants overcoming geographic limitations, resource constraints and time 
barriers that prevented in some cases face-to-face interview. In all four participant 
interviews that employed Skype software, there was no difference found in the 
interview length, flow and ability to communicate effectively during the in-depth 
interview. The recruitment in this research employed a combination of purposive 
and theoretical sampling. 
 Purposive Sampling 
Purposive sampling was employed as the initial sampling technique (138, 157), 
after which, theoretical sampling was employed as ubiquitous of the GT approach 
(138, 144, 157), with the emerging data directing the theoretical sampling (in 
Section 3.8.3) (138, 157). Prior to data collection, a selection frame was designed 
(Purposive sample selection frame) to screen for pharmacy leaders (153) that 
facilitated the selection of participants in the purposive sample. Participants 
included in the purposive sample had significant experience and represented a 
broad range of industry leaders and strategists from multiple facets of Australian 
and international pharmacy. The purposive study population sought to include 
pharmacy professionals in leadership positions from comparable countries in North 
America and Europe, that had an understanding of the Australian healthcare 
system, to determine during the initial stages of this research whether there were 
differences in pharmacy leadership between these comparable countries with 
developed healthcare systems. 
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 Purposive Sample Selection Frame 
The purposive sample frame was influenced by the research aim, providing a 
sampling guide to explore pharmacy leadership within predetermined limits (153, 
160, 161). Participants were considered for inclusion based on the selection frame 
below (Table 3.3). The purposive sample merely provided a point of departure, and 
added no theoretical elaboration or refinement (138) which is distinctive of the 
theoretical sampling approach (Section 3.8.3) that was adopted after preliminary 
data analysis of the purposive sample (157). Participants in the purposive sample 
needed to meet the following selection criteria (Table 3.3). 
Table 3.3 Purposive Sample Selection Frame 
1. Diversity in both sex, pharmacy sector position and place of work; 
2. Have diverse professional and pharmacy organisational experience; and 
3. Held both formal and non-formal leadership positions in the pharmacy profession; and 
4. Held both formal and non-formal qualifications; and 
5. Track record of organisational leadership experience; and 
6. Be a current domestic and/or international pharmacy leader; and 
7. Have a broad clinical, professional and/or business experience within the pharmacy profession. 
 
A list of pharmacy leaders was generated that met the requirements of the 
purposive selection frame; seventy-eight pharmacy professionals met the selection 
frame criteria. Six participants from the seventy-eight were selected to form the 
initial purposive sample (160, 162). The selection of the six participants was 
determined by convenience to coincide with a national pharmacy conference.  The 
approach ensured that we included participants representative of diverse practices 
that exist in the pharmacy profession and were recognised as decision-makers, 
leaders in the pharmacy profession covering the following professional areas; 
research and academia, hospital pharmacy, community pharmacy, military 
pharmacy, pharmaceutical industry, professional organisations’, Government, 
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consumer groups and retail/business groups. All of the participants in the 
purposive sample had leadership and professional experience across multiple 
professional areas. The purposive sample was represented by both sexes and 
included non-pharmacist pharmacy professionals. 
 Theoretical Sampling 
A theoretical sampling approach was employed from the seventh participant 
interview onwards, for the remaining twenty-three participant interviews, which 
followed the participant communication and interview logistics outlined above. 
Theoretical sampling was guided by the preliminary findings from the purposive 
sample, which directed the sampling direction (138). As codes and themes were 
identified, their properties formed the foundation of forthcoming sampling on 
theoretical grounds, known as ‘theoretical sampling’. The emerging data acted as 
pieces of information that needed to be explored and investigated to understand 
new and unexpected areas that emerged from the data (138). Hence, theoretical 
sampling discards the notion of hypothesis testing in that the direction of the new 
data is not influenced by a priori hypotheses, but by ongoing analysis of the data 
and emerging conceptual codes and themes (146). Theoretical sampling is driven 
by the emerging codes, themes and subthemes with the aim to determine how the 
themes vary within their individual properties, whilst providing detailed definitions to 
understand specific attributes (149). Theoretical sampling has the flexibility to 
investigate change incidents, allowing for the selection of participants that are 
guided by themes and codes emerging from the initial data collection. The 
theoretical findings and insights are used to determine the new sampling direction 
and ongoing participant recruitment (147, 153), and whether more data are needed 
to further define and explain the properties of data themes that have emerged 
(157). A theoretical sampling approach was employed in this research axiomatic of 
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the GT approach and manifested concurrently with data collection, data analysis 
and continued throughout the analytical process, with recruitment guided to fill the 
conceptual gaps and defining the themes until theoretical saturation was reached 
(138, 157). 
There was no predetermined sample size as a quantitative research project 
requires, and participants were recruited until data saturation occurred (see Data 
Saturation section below) (163, 164). This allowed for the pharmacy leadership 
phenomena to be investigated longitudinally and in-depth, with participants 
selected through a process of theoretical relevance to the iterative areas of 
investigation and emerging data (131, 149). For this study, this meant that 
participants were sought who would deliver information on the Australian pharmacy 
leadership process. This approach fits the constructivist research paradigm as the 
researcher and participants are interactively linked in a subjective interrelationship 
in the process of data collection, interpretation and analysis (138, 165-167). 
 Data Analysis 
Data analysis in this study occurred in two stages. The first stage was the 
preliminary data analysis of six participants in the purposive sample. The second 
stage included the data analysis of the remaining twenty-three participants. 
 Data Transcription Process 
Twenty-nine interviews were digitally recorded with two electronic devices, de-
identified and transcribed verbatim into a Microsoft Word ® document, allowing for 
the simultaneous ability to take notes and adopt a flexible approach to guide the 
interactive conversation into areas of more depth and related areas that appeared 
as a priority to the topic. Data collection and analysis was conducted over a three-
year period. Theoretical sampling allowed the flexibility to explore several 
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contextual change events and incidences (138) in the pharmacy profession, for 
example, participant opinions on the important transition between the 5th and 6th 
CPA; and contentious pharmacy remuneration affairs, for example, community 
pharmacy chemotherapy funding and the controversial HMR 5th CPA funding 
issues (16, 168). This facilitated the longitudinal grounded investigation of the 
pharmacy leadership phenomenon allowing for true investigation of the change 
events and the role of the external context (131). This provided a more in-depth 
understanding of pharmacy leadership  (108). 
Figure 3.1 Data transcription process. 
 
Above, Figure 3.1 illustrates the data transcription process. The mean audio 
interview duration was 54 minutes and 55 seconds (mean interview word count 
7,288 words) and ranged from 29 minutes to 118 minutes in duration. The twenty-
nine interviews yielded 25 hours and 45 minutes of audio (total interview word 
count 204,061 words). The initial four interviews were transcribed by DR to build 
sensitivity between the emerging data and the preliminary data analysis. From the 
fifth interview forward the company Josalent Pty Ltd was contracted for the 
DR completed second validation check 
during data analysis
DR completed first interview validation 
check upon receiving completed transcript
Subsequent twenty-five interviews sent to 
Josalent Pty Ltd for transcription
First four interviews transcribed by DR
Interviews tape recorded
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verbatim transcription of the remaining twenty-four transcripts. A written privacy 
statement was included in all outsourced interview transcriptions to ensure 
confidentiality, privacy and ethical considerations were met. All participants’ names 
were de-identified in the outsourced transcription and data analysis process. 
Upon receiving the twenty-four interview transcripts a confirmatory check was 
conducted by DR, which involved listening to the audio recording of the participant 
interview in length whilst simultaneously reviewing the outsourced transcription 
line-by-line, ensuring the pharmacy indigenous typologies and general transcription 
was precise. There were minor changes implemented on all discrepancies found 
during the transcription check that were mainly attributed to participants employing 
specific pharmacy and health acronyms for pharmacy organisation and business 
names, community pharmacy terms and services, and Australian healthcare 
policies. In some cases, there were indistinct words that required multiple audio 
playbacks to ensure transcript accuracy. Every transcript was then re-read whilst 
listening to the audio a second time during the initial stages of data analysis. 
Completed transcripts were placed into password protected electronic Microsoft 
Word ® files. Printed copies were filed and then placed under lock and key in a 
filing cabinet at the University of Sydney. Of the twenty-nine interviews completed, 
one participant agreed to take part in the interview, however requested that the 
interview not be recorded. In this instance, permission to take hand written notes 
during the interview was granted by the participant. There was a notable loss of 
richness of information gained from the interview primarily due to the decrease in 
transcript attained from the process. 
 Preliminary Data Analysis 
Data collection and analysis occurred in an iterative process following each 
interview. Notes were taken before, during and after each interview with 
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participants. Preliminary data analysis of the six purposive interviews occurred 
manually and was assisted by the use of computer programs Microsoft Word ® 
and Microsoft Excel ®. During the preliminary data analysis coding involved 
naming segments of data with a short name that summarised and accounted for 
each piece of data providing meaning (138, 169). After each interview a summary 
sheet, ‘face sheet identifier’, was created by DR and placed at the front of the 
transcript which included issues identified and questions to explore further in 
forthcoming interviews and data analysis (150). This was the start of the analytical 
process and continued for all six interviews leading to the construction of a basic 
analytical frame that emerged illustrating a broad range of codes and themes 
reflecting participant opinions and beliefs. Data analysis during this purposive 
stage followed Charmaz’s constructivist GT approach to data analysis (138). 
 Preliminary Data Validation 
The first six interviews were completed by DR with the guidance of a researcher 
experienced in qualitative analysis, ensuring interpretive rigor and providing a 
validation throughout the preliminary analysis. After the implementation of minor 
feedback from the experienced researcher, it was decided that the interview guide 
would continue to meet the study objectives and the analysis would continue 
primarily with DR performing further data analysis. To maintain dependability and 
confirmability the experienced researcher reviewed the ongoing data collection and 
analysis staggered at approximately four participant intervals. The continuous 
consultative approach offered reflexivity and allowed for the exploration of 
relationships between the emerging themes. 
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 Use of NVivo Software 
Throughout the iterative process of developing the preliminary analytical frame and 
code definitions, DR identified that it was increasingly difficult to manage, collect 
and analyse the large amount of data emerging from the interviews. The decision 
was made to employ a computer-assisted qualitative data analysis software. QSR 
NVivo for Mac Version 11.4.0 ‘NVivo 11’ (QSR International, Australia) was 
employed to assist with the data analysis facilitating storage and categorising of 
participant interview transcripts, writing notes or ‘memos’, audio and other 
documents, assisting in the creation of codes, subthemes and themes through 
computer assisted coding and supporting the development of a conceptual theory 
of themes and subthemes. The preliminary data obtained from the first six 
participants during preliminary data analysis was uploaded into NVivo 11. To gain 
familiarity with the new software, DR re-coded the first six participant transcripts 
allowing for the comparison between the two analytical methods. The comparison 
between methods found no difference in the key themes that emerged, the only 
difference was that the NVivo11 software allowed DR the ability to code data 
fragments at a greater frequency and intensity. NVivo 11 was employed henceforth 
to manage the storage and categorisation of all remaining data collected. Despite 
ease of use, power and flexibility of NVivo 11 to handle emerging data, this did not 
substitute employing the rigorous analytical and inductive coding needed to induce 
the data to higher levels of abstraction that is required in GT (138, 151, 157). 
 The Coding Process 
The initial coding process induced lengthy participant interviews line-by-line into 
categories as part of a general process of data reduction and abstraction (139, 
170). Initial coding was the first step in the analytical process for all twenty-nine 
participant interviews, and generated meaningful meaning units, known as codes 
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which labelled the emerging data into categories (138, 167, 170). A focused 
approach to coding followed this initial phase which cultivated the development of 
themes and subthemes. Emerging events, actions, processes and interactions 
were grouped and regrouped together to form the emerging themes and 
subthemes, the emerging data was continually compared and contrasted in an 
iterative and inductive process of data analysis designed to achieve higher levels 
of abstraction and understanding about the pharmacy leadership phenomenon 
(138). This approach to coding developed a preliminary set of themes and 
subthemes that were examined further through writing about them, ‘writing memos’ 
(138). The researcher DR implemented the following analytical process during 
focused coding: 
1. NVivo 11 was used to analyse new transcripts, determining whether the new 
transcripts matched the properties of existing codes, subthemes and themes 
through a process of constant comparison. 
2. Once a code, subtheme and/or theme had its properties defined in full, the 
relevant code, subtheme and/or theme was exported to Microsoft Word, printed 
out and read several times. Manual coding and data checks ensued through 
constant comparison, ensuring all data extracts met the code, subtheme and 
theme properties. 
3. A written memo was then immediately conducted that connected the data at a 
theoretical level forming the foundation for the forthcoming findings chapters. 
This iterative process is fundamental of the GT approach undertaken in this 
research (138). 
 Writing Memos and Data Saturation 
Writing memos assisted DR to record the major analytical themes as they emerged 
and acted as the intermediate step between data collection and the final theory 
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generation (138). The writing process enabled DR to make connections between 
different codes, subthemes and themes and to identify gaps in the data to explore 
with future participants. Data analysis and the writing of memos and subsequent 
development of findings chapters continued until theoretical saturation occurred, 
which following the advice of Charmaz, “...categories are saturated when gathering 
fresh data no longer sparks new theoretical insights, nor reveals new properties of 
your core theoretical categories...” (138, 151). 
 The Role of the Primary Researcher and Theoretical Sensitivity 
DR was the primary researcher throughout the data analysis, independently 
conducted initial coding, focused coding and writing memos as part of the broader 
thematic analysis, allowing him to develop theoretical sensitivity to the emerging 
data and pharmacy leadership GT (108). Two additional researchers (PA and AM), 
with extensive qualitative and pharmacy practice research provided feedback on 
the qualitative findings. Neither conducted nor observed any interviews, however, 
they were able to be an objective ‘devil’s advocate’ of the findings that emerged. 
DR is a pharmacist with twelve years’ experience in the pharmacy profession, 
spanning across various sectors; pharmaceutical industry, community pharmacy 
management, military pharmacy and pharmacy academia. DR’s experience 
provides a platform for his ethnographic assessment, facilitating the relationships 
between leadership, pharmacist culture, community pharmacy and external 
context. This abductive approach allowed DR to engage in reflexive and subjective 
auto ethnographic assessment of these phenomena based on his experience and 
understanding of data insights (108), a benefit utilised by similar research studies 
(6, 147). 
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Chapter 4: The Study Sample and Presentation of Qualitative Data in this Thesis 
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 Introduction:  
The aim of this qualitative study was to develop a novel Australian pharmacy 
leadership theory grounded in data and supported by the opinions and views of 
participants. This study is part of a broader leadership project investigating 
leadership in the Australian pharmacy profession. This chapter presents the 
findings of the participant demographics, beginning with a broad summary of 
participant demographics (Table 4.1) and then displays individual participant 
professional practice experience (Table 4.2). Participant anonymity is maintained 
through de-identification. The chapter then outlines the six themes emerging from 
the data analysis of the in-depth qualitative interviews with pharmacy leaders 
(Figure 3.2). Finally, Table 4.3 provides a roadmap to navigate the forthcoming six 
chapters outlining the study findings (Chapter 5–10) and the qualitative findings 
discussion in Chapter 11. 
 The Study Sample 
The initial purposive study sample comprised six participants including males and 
females, and covering a diverse range of pharmacy practice areas and leadership 
positions across the pharmacy sector. Participants in the purposive sample were 
from North America, Europe, New Zealand and Australia. A further 23 interviews 
were completed as part of the Grounded Theory (GT) approach adopted in this 
study, employing a combination of purposive and theoretical sampling techniques 
(Figure 3.2). 
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Figure 3.2 Qualitative sampling process. 
 
The total study sample consisted of 29 participants (5 female, 24 male) 
representative of a diverse range of areas in the pharmacy profession: stakeholder 
groups, peak industry bodies, hospital pharmacy practice, community pharmacy 
practice, military pharmacy practice, the pharmaceutical industry, consumer health 
groups, advanced pharmacy practice, retail pharmacy practice, international 
pharmacy practice, academia and pharmacy organisational leadership. Full details 
of participants’ areas of practice in the pharmacy sector are provided in Table 4.1. 
The transcripts from two speeches from the Australian federal government that 
specifically concerned the pharmacy profession formed part of the thematic 
analysis to fill conceptual gaps (see below). 
 Data Saturation 
Twenty-seven participants were recruited over a 15-month period (February 2013–
April 2014) until there was a limited flow of emerging new concepts, codes and 
Document	analysis	(n=2	documents)
Government	health	minister	transcript Pharmacy	review	chair	transcript
The	study	sample	(n=29	participants)
n=4	female	participants;	n=25	male	participants. Participants	representing		diverse	practice	areas	across	profession
Theoretical	sample	(n=23	participants)
Purposive	sample	(n=6	participants)
Male	and	female	participants North	America,	Australia,	Europe	and	New	Zealand
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themes, indicating that theoretical data saturation was being approached according 
to the principles of GT (138, 144, 151, 164). During the process of coding themes, 
DR (the primary researcher) identified several codes that required further data 
collection to define their conceptual properties. The specific areas requiring further 
clarity were around the relationship between the government and key stakeholders 
representing pharmacy organisations in the profession. To achieve conceptual 
clarity in the thematic analysis, two speech transcripts were reviewed: the first was 
from the Hon Sussan Ley MP, Minister for Health and Aged Care and the second, 
from Professor Stephen King, appointed Chair of the Review of Pharmacy 
Remuneration and Regulation established by the Commonwealth Government and 
Pharmacy Guild of Australia as part of the sixth Community Pharmacy Agreement. 
These speeches pertained directly to the pharmacy profession and were given at 
the 2016 Australian Professional Pharmacy Conference and Exhibition. In addition, 
two more participants were recruited in late 2015 following theoretical sampling to 
ensure saturation of the conceptual properties, following Charmaz’s constructivist 
GT approach (138). Data saturation occurred following the thematic analysis of the 
speech transcripts and participant interview 28. Confirmation of data saturation 
occurred during the analysis of the twenty-ninth participant interview transcript, as 
no new information emerged relating to the relationship between the government 
and key stakeholders representing pharmacy organisations in the profession. This 
meant the conceptual properties were saturated, indicating that data saturation had 
been achieved (138, 164). Saturation was independently determined by DR, with 
the findings communicated to other researchers (AM and PA). 
 Ethical Restrictions and General Participant Demographics 
Given the position and experience of participants in this study, all of whom held 
leadership positions in the pharmacy sector at the time of the study, ethics 
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approval (Appendix B) required the restriction of full participant details to respect 
and protect participant anonymity, maintain confidentiality and respect potential 
sensitivities of the emerging data. This presented a significant challenge in 
balancing portrayal of the level of leadership of many participants in this study with 
presenting important participant information in a de-identified manner. Table 4.1 
and Table 4.2 are designed to provide basic descriptions of participants while 
providing sufficient de-identifiable information to demonstrate the level of 
experience and breadth of leadership positions held by them at the time of the 
study. 
Table 4.1 Summary of Participant Demographics 
Demographic # of participants (n = 29) 
Non-pharmacist participants   
Business professional (accountant) 2 
Business professional (board/company director) 4 
Lobbyist/government 1 
Country of pharmacy practice   
Australia 24 
Europe 3 
North America 1 
New Zealand 1 
Australian region of primary pharmacy practice 
 
New South Wales 9 
Tasmania 1 
Australian Capital Territory 4 
Victoria 1 
Queensland 6 
South Australia 3 
Highest level of education 
 
Bachelor degree 17 
Double bachelor’s degree 3 
Master degree 4 
Doctoral degree 5 
Participant age group (years) 
 
20–30  1 
30–40  1 
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Demographic # of participants (n = 29) 
40–50  6 
50–60  13 
60–70  6 
70–80  2 
Sex  
 
Male 24 
Female 5 
Currently registered pharmacist  
 
Yes 22 
No  7 
Stakeholder groups* 
 
Pharmacy organisation 22 
University sector 7 
Government  7 
Health consumer group 8 
Pharmaceutical industry 4 
Retail pharmacy group 3 
Business group 7 
Position in pharmacy sector^ 
 Pharmacy proprietor 12 
Academic pharmacist 6 
Board member/director 21 
Company director 15 
Hospital pharmacist 4 
Accredited pharmacist 8 
Advanced practice pharmacist 3 
Community pharmacist 17 
Military pharmacist 2 
Organisational pharmacist 8 
*Participants’ current and past positions covered a diverse array of pharmacy practice across the sector; hence their 
positions in pharmacy practice were not mutually exclusive. Participants currently hold or had previously held several 
leadership positions that are representative across multiple stakeholder groups; hence the stakeholder themes are not 
mutually exclusive. 
^This includes participants’ current and past pharmacy practice positions to indicate diversity in practice; the positions 
are not mutually exclusive. 
NB: Details pertaining to the document analysis were not included in this table. 
To provide a better understanding of individual participants in this study, their 
professional practice, primary leadership position, primary pharmacist classification 
and country of origin are presented in Table 4.2, providing a distinct description for 
each participant. In the qualitative chapters, participant quotations extracted from 
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interview transcripts are used to reflect emerging codes, subthemes and themes. 
Participant quotations are identified with the relevant number from the table to 
provide context and guide the participant quotations and emerging findings 
throughout Chapters 5–10. The level of detail in the participant description 
associated with each quote satisfies the need to provide the level of leadership 
experience of participants while protecting their identity. 
Table 4.2 Individual Participants and Their Professional Area of Practice, 
Pharmacist Classification and Country 
Participant  Professional area of practice, pharmacist classification-
country 
Participant 1 Professional organisation, Board director, Organisational 
pharmacist-Australia 
Participant 2 Professional organisation, Board director, Community pharmacist 
proprietor-New Zealand 
Participant 3 University sector, Professional organisation, Director, Hospital 
and academic pharmacist-Australia 
Participant 4 Professional organisation, Company director, non-Pharmacist-
Australia 
Participant 5 Professional organisation, Company director, non-Pharmacist-
Australia 
Participant 6 Professional organisation, Company director, Community 
pharmacist proprietor-North America 
Participant 7 University sector, Professional organisation, Academic 
pharmacist-Australia 
Participant 8 Professional organisation, Government organisation, Consumer 
organisation, Community pharmacist proprietor-Australia 
Participant 9 Government organisation, Consumer organisation, 
Organisational pharmacist-Australia 
Participant 10 Professional organisation, Consumer organisation, Board 
director, Community pharmacist proprietor-Australia 
Participant 11 Professional organisation, Board director, Community 
pharmacist-Australia 
Participant 12 Professional organisation, Consumer organisation, Advanced 
practice pharmacist-Australia 
Participant 13 Professional organisation, Government organisation, non-
Pharmacist-Australia 
Participant 14 Professional organisation, Community pharmacist-Australia 
Participant 15 Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia 
Participant 16 Professional organisation, University sector, Community 
pharmacist proprietor-Australia 
Participant 17 Professional organisation, Board director, University sector, non-
Pharmacist-United Kingdom 
Participant 18 Professional organisation, University sector, Accredited 
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Participant  Professional area of practice, pharmacist classification-
country 
pharmacist-Australia 
Participant 19 Company director, Pharmaceutical industry, Retail pharmacy 
group director, non-Pharmacist-Australia 
Participant 20 Board director, Professional organisation, Community pharmacist 
proprietor-Australia 
Participant 21 Board director, Pharmaceutical industry, non-Pharmacist-
Australia and Europe 
Participant 22 Professional organisation, Consumer organisation, 
Pharmaceutical industry, Community pharmacist proprietor-
Australia 
Participant 23 Professional organisation, Company director, Pharmaceutical 
industry, non-Pharmacist-Australia 
Participant 24 Professional organisation, Community pharmacist-Australia 
Participant 25 Board director, Pharmaceutical industry, non-Pharmacist-
Australia and Europe 
Participant 26 Board director, Community pharmacist proprietor-Australia 
Participant 27 Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia 
Participant 28 Professional organisation, Military organisation, University sector, 
Military pharmacist-Australia 
Participant 29 Professional organisation, Organisational pharmacist-Australia 
Transcript 1 Pharmacy Review Panel Chair (Speech Transcript Australian 
Professional Pharmacy Conference 2016) 
Transcript 2 Minister for Health and Aged Care (Speech Transcript Australian 
Professional Pharmacy Conference 2016) 
 
 Presentation of Data in This Thesis 
The six chapters that follow present the qualitative findings: each chapter relates to 
a major theme influencing the pharmacy leadership process (see Figure 4.1). 
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Figure 4.1 Australian pharmacy leadership—six major themes. 
 
Figure 4.1 depicts a sunburst diagram generated from NVivo 11 to illustrate 
visually the six themes that emerged from the participant interviews and that form 
the Australian Pharmacy Leadership Theory ‘APL Theory’. Following Figure 4.1, in 
a clockwise direction, in orange, the theme Pharmacy leadership development, 
in grey, the theme Pharmacy sector leadership influences, in yellow, Pharmacy 
leadership definition, in green the theme, Community pharmacy leadership, in 
red, the theme The transformation challenge, and in blue, the theme 
Pharmacist identity. The five layers in Figure 4.1 from the inner circle to the fifth 
outer circle represent the levels of coding that formed the thematic analysis of the 
participant interviews. The APL Theory consisted of five layers of coding. The first 
layer (theme), the second layer (subthemes), the third layer (Codes), the fourth 
and fifth layers (Code properties). The six themes are presented as chapters, each 
with an overall theme definition consisting of theme properties (subthemes) that 
are further unravelled into codes and code properties. 
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Table 4.3 examines the six themes and the corresponding subtheme properties to 
illustrate the qualitative data components that make up the theme. The first theme, 
Pharmacy leadership definition, summarises participants’ broad understanding 
and definition of pharmacy leadership, setting the scene for the forthcoming 
findings chapters with respect to the definition of pharmacy leadership. The second 
theme, Pharmacist identity, arises from participants describing the traits, 
characteristics and personality that are inherent and unique to pharmacists and 
that influence pharmacy leadership, namely, pharmacist technical and clinical traits 
that significantly influence the leadership approach adopted by pharmacists in 
community pharmacy and clinical settings. The third theme, Community 
Pharmacy leadership, explores factors that influence the leadership approach 
adopted by pharmacy owners. Participants identified that pharmacy owners have 
two choices for their small business leadership: the service or discount leadership 
approach. The fourth theme, Pharmacy sector leadership influences, reflects 
participants’ understanding around the sector influences that are driving leadership 
change and challenging the pharmacy profession. Sector influences include the 
numerous external and internal stakeholders influencing leadership across the 
pharmacy profession. The fifth theme, The transformation challenge, arises from 
participants describing the pharmacy profession as being tested by significant 
demands in the external operating environment, highlighting participants’ 
understandings of the need for a profession-wide transformation to meet the 
demands placed on the Australian healthcare system. The transformation 
challenge was a pharmacy leadership challenge that calls for the profession to 
become more congruent with the external context. The sixth theme, Pharmacy 
leadership development, reflects participants’ recommendations to develop 
pharmacists’ leadership capacity, particularly that of ECPs; covers participants’ 
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recommendations for pharmacist training; and describes the role of mentorship in 
the pharmacy profession.   
Table 4.3 Australian Pharmacy Leadership Themes, Subthemes and Chapter 
Reference 
Theme Subthemes Chapter 
Pharmacy leadership 
definition 
Traits used to define pharmacy leadership 5 
 Followership  
 Leadership defined by describing bad/failed 
leadership 
 
Pharmacist identity Competing pharmacist identities 6 
 Pharmacist personality and leadership  
 Pharmacist technical traits  
 Pharmacist workforce influences  
 Pharmacist self-recognition and belief  
Community pharmacy 
leadership 
Pharmacy business leadership  7 
 Declining profitability  
 Consumer-driven strategy  
 Service leadership approach  
 Discount leadership approach  
Pharmacy industry 
influences 
Commodifying medicines 8 
 Discount pharmacy impacts  
 Regulated and fixed frameworks  
 Pharmacy Guild of Australia dominance  
 Pharmacy vested interests  
 Pharmaceutical Society of Australia weakness  
 Changing health context  
 Government influences  
 Pharmacy stakeholders  
The transformation 
challenge 
Expanded role opportunity 9 
 Disconnect with context  
 Organisational disunity  
 Changing pharmacy remuneration  
 Recognition from within pharmacy  
 Professional unity challenge  
 Pharmacy unity challenge  
 Leadership emergence  
 Repressive leadership  
Pharmacy leadership 
development 
University and practice disconnect 10 
 Experiential leadership development  
 Leadership development programs  
 Mentorship in the pharmacy profession  
 Pharmacy training recommendations  
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In each of the findings chapters, the themes, subthemes and code properties are 
examined in detail to provide an understanding of the pharmacy leadership 
process, which coalesces to form the APL Theory. Transcript extracts from 
participant interviews are used to exemplify and contextualise the findings. The 
next chapter (Chapter 5) will be the first of six findings chapters, and will provide a 
definition of Australian pharmacy leadership.  
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Chapter 5: Definition of Pharmacy Leadership 
 
 
Leadership is more than being there and doing 
things and operating, leadership is about someone 
having a vision. It is about that same person who 
can take their staff on a journey to achieve their 
vision. That brings in the concept of potentially 
mentoring ... the concept of motivating people, 
enthuse people, to bring everybody together and 
achieve your vision and the common goal… 
(Participant 5: Professional organisation, Company director, non-
Pharmacist-Australia) 
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 Definition of Pharmacy Leadership 
Definition of pharmacy leadership (Theme)=> 
In this chapter, the definition of pharmacy leadership in the pharmacy profession is 
explored from the viewpoint of the participants. Participants shared a broad range 
of views on their definition of ‘leadership’ in the context of the Australian pharmacy 
profession. When providing their definition of leadership, participants first defined 
the concept around their understanding of leadership, which often included the 
exploration of leadership traits, elements of the leadership process and the 
influence of the context on pharmacy leadership. Most participants used a variety 
of examples, analogies, stories, traits and personal experiences to articulate and 
define leadership. There were no differences between Australian and international 
participants’ responses under this theme. Some sex differences were identified, 
with female participants highlighting the importance of emotional intelligence traits 
in their definition of pharmacy leadership. The majority of participants defined 
pharmacy leadership at a higher level, with the main findings illustrating higher-
level pharmacy leadership. Of particular interest was mention of a distributed 
leadership across all levels of the profession. Distributed leadership identifies that 
pharmacy leadership exists at all levels within the profession, and is not solely 
designated to formal and higher-level leadership positions. At distributed levels, 
one-third of participants identified pharmacy leadership to encompass the 
following: 
it’s not having a title, it’s not being asked to speak at a conference; 
you can be a leader within your own pharmacy or work environment 
… different levels… 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
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not everyone will be a leader at the top of the field, but they will lead 
in different ways … everyone can be a leader in their own way… 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
It doesn’t matter if you’re high up in the rank or low, you can make 
positive changes if you know exactly where you are, right, and then 
know your environment… 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
The participants’ definition of pharmacy leadership produced as a summary of all 
participants’ definitions is presented in Table 5.1.  
Table 5.1 Definition of Leadership, Theme Properties and Description 
Theme Theme description Subthemes 
Definition of pharmacy 
leadership 
Participants’ definition of leadership in 
the pharmacy profession. 
Traits used to define pharmacy leadership 
Followership 
Leadership defined by describing 
bad/failed leadership 
Challenging external context 
 
 Traits Used to Define Pharmacy Leadership 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme) 
When defining leadership, the majority of participants described a series of traits, 
skills, behaviours, styles and attributes that are needed in leadership. ‘Leadership 
traits’ was used as a holistic term to describe aspects of personality, attributes, 
skills, qualities, leadership styles and behaviours. The most commonly identified 
leadership traits by participants are presented in Table 5.2. Each trait is further 
examined, with the use of participant quotations to contextualise the trait. These 
details are represented by the ‘codes’ in each section. 
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Table 5.2 Leadership Traits in the Pharmacy Profession, Subtheme Definition 
and Properties 
Subcategory Subcategory description Subcategory properties 
Leadership traits in the 
pharmacy profession 
Leadership traits including attributes, skills, 
qualities, leadership styles and behaviours. 
Traits that are important in pharmacy 
leadership, identified by participants as 
integral to leadership and to the leadership 
development of pharmacy professionals 
Vision 
Tacit knowledge 
Social capacity 
Self-confidence 
Competence (track record) 
Credibility (believability) 
Strategy 
Decision making 
Cognitive flexibility 
Pharmacy leadership motivators 
Responsibility 
Honesty 
Ethics/morals 
Other leadership traits 
 
 Vision 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Vision (Code). 
The majority of participants identified the importance of vision in their definition of 
leadership. When deconstructing participants’ understanding of vision, several core 
properties constituted pharmacy leadership vision: capacity of the leader to 
construct a vision; need for a clear vision; and the ability to inspire a shared vision: 
a pharmacy leader is a person who has to have the vision to lead the 
profession… 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
Half of the participants identified that effective leadership requires the capacity to 
construct a vision; often this involves a well-developed understanding of strategy 
and broader perspective of the context: 
 89 
 
They need to have strategic vision and the ability to be forward 
looking … So there lies sort of broad characteristics that I would say 
honesty and integrity, competence and credibility, vision and the 
ability to be forward looking… 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
where they have the ability to strategically look where pharmacy 
should be going, in their minds, from a community pharmacy 
perspective, and just their ability to look forward of how it would look, 
you know… 
(Participant 23: Professional organisation, Company director, Pharmaceutical 
industry, non-Pharmacist-Australia) 
think good leaders need to be able to interpret policy, and good 
leaders need to be able to interpret legislation, and potential 
legislation, and they need to be able to analyse that and project their 
view to their audience. Now I'm not saying from an authoritarian 
perspective that from a forward thinking, analytical solution 
perspective… 
(Participant 28: Professional organisation, Military organisation, University sector, 
Military pharmacist-Australia) 
Eight participants identified the importance of a clear leadership vision: 
a leader should have a single, clear, unambiguous vision of what 
they see as being the goal they’re trying to get to … A leader leads 
other people. And they need to have a clear understanding of what 
you’re trying to achieve… 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
you know we know what we do … we know what we don’t do, and 
we know why we do it, and I think that all of my staff, which is about 
70, I’d be disappointed if any of them couldn’t just zip through that 
really easily… 
(Participant 9: Government organisation, Consumer organisation, Organisational 
pharmacist-Australia) 
Half of the participants identified the need for inspiring a shared vision, motivating 
and engaging followers and eliciting their support to achieve their leadership vision: 
that process by which you animate people to move in a particular 
way of interest … but that idea of being able to work with people, to 
share their ideas in a way that is constructive to allow those people 
to achieve their goals. And if you think about a leader they are 
 90 
 
leading a group of people, going back to that quote, ‘your success is 
our success’ that idea of sharing the goals… 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
leadership is being able to inspire people to do better than they 
would if you weren’t around … I think leadership is about being able 
to sell a vision, um to have a vision to start with, to sell it, to sell it in a 
simplified enough fashion for people to join in the energy … being 
able to have the passion and the enthusiasm to be able to encourage 
... to bring your people with you… 
(Participant 9: Government organisation, Consumer organisation, Organisational 
pharmacist-Australia) 
 Tacit Knowledge 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Tacit knowledge (Code). 
Tacit knowledge emerged as a significant leadership trait identified by two-thirds of 
the participants examining unique knowledge, expertise and experience, both 
within the pharmacy context and more broadly in Australian healthcare. One-third 
of the participants acknowledged the importance of pharmacy tacit knowledge in 
effective leadership for the pharmacy profession: 
pharmacy leaders need to have an understanding of the issues that 
are particular to health, and obviously to pharmacists and pharmacy 
owners, so they need to understand the difficult tensions that sit 
between being a pharmacy owner and being a pharmacist, without 
the financial responsibilities obviously that the owners have, but 
there’s also the health and ethical obligations you have… 
(Participant 2: Professional organisation, Board director, Community pharmacist 
proprietor-International) 
I've got a good knowledge of defence pharmacy. I've been in retail 
pharmacy. I've been in hospital pharmacy. I've worked as a poison 
information specialist at the … Hospital … I've run a 24-hour 
pharmacy. I've worked for Medicare as a professional review 
pharmacist investigating Medicare fraud, PBS fraud. And I've worked 
on the Medicare doctor shopping team … So I've got a lot of 
knowledge… 
(Participant 28: Professional organisation, Pharmacy organisation, University sector, 
pharmacist-Australia) 
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Several participants recognised the need to develop tacit knowledge outside of the 
profession, to develop experience and expertise into wider health policy, as they 
felt that an effective leader should also have knowledge of the environment within 
which pharmacy sits: 
leaders need to be able to interpret policy, and good leaders need to 
be able to interpret legislation, and potential legislation, and they 
need to be able to analyse that and project their view to their 
audience...from a forward-thinking, analytical solution perspective… 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
pharmacy leaders, they need to understand politics, they need to 
understand doctors, they need to have a bit of an understanding 
about every single other health professional … There’s a lot of 
different stakeholders… 
(Participant 2: Professional organisation, Board director, Community pharmacist 
proprietor-International) 
You’ve got to present and know the environment, both within the 
pharmacy, but because pharmacy doesn’t sit in isolation you’ve got 
to know the health care environment, or primary health care 
environment first … And then the wider health environment and then 
the world environment… 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
A few participants identified that a deep knowledge and understanding of the 
context is pivotal to the leadership vision, with several participants describing that 
this tacit knowledge is developed by a broad range of experiences and education, 
which further develop leadership: 
They didn't just do pharmacy and saw that was the end of their 
education. They went and did something extra, whether it was 
military, whether it was an MBA, whether it was doing their CPA. 
They went and did something more … I just think that we're very 
inwardly focused. I think pharmacy leaders need to look outside our 
industry and I've tried to get as much experience as possible in areas 
other than pharmacy because I just find we tend to be so inwardly 
focused and we tend to get a bit full of ourselves and think that 
pharmacy is the cornerstone of everything… 
(Participant 8: Professional organisation, Government organization, Consumer 
organisation, Community pharmacist proprietor-Australia) 
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 Social Capacity 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Social capacity (Code) 
A leadership trait identified by an overwhelming majority of participants was social 
capacity, which emerged as a broad term covering a constellation of emotional 
intelligence traits and traits essential to developing followership relationships often 
manifested through the leadership capacity to communicate, listen and inspire and 
motivate followers. 
5.2.3.1 Self-reflection 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Social capacity (Code)=>Self-reflection (Code property) 
Interestingly, although not provided in their direct leadership definitions, a few 
participants during the course of their interviews reviewed their own strengths and 
weaknesses, illustrating the importance of the emotional intelligence traits of self-
awareness and self-reflection: 
Yeah. I suppose I don’t know that I’m particularly strong in the 
political side … So, yeah, the political thing, I … yeah, I actually don’t 
think I’m terribly strong on… 
(Participant 2: Professional organisation, Board director, Community pharmacist 
proprietor-International) 
that’s right … Know what you’re good at … I’m a good change agent. 
That’s what I do well… 
(Participant 9: Government organization, Consumer organisation, Organisational 
pharmacist-Australia) 
I haven’t fully grasped my own self which I think is the number one 
thing of being a leader … you sort out yourself before you can step 
into a position of leadership … Then you’ve got to worry about your 
clients or your stakeholders as well. It goes in that order for me and 
you’ve got to have that first step… 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
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One-third of participants identified the importance of a deep understanding of 
oneself, having the ability to reflect on and draw lessons from past experiences. 
This self-awareness and self-reflection were regarded as important skills in 
developing and maintaining leadership: 
you can reflect, and sometimes it’s simply not fair or just … but you 
can always do things better … And knowing your own boundaries, 
your own skillset, and forever trying to expand on that. So that’s a 
reflective process. What could you do? What did you do well, 
whatever you’re doing? Talking here. And what could I have done 
better? … And that’s why you continue to grow and continue to learn 
… I’m an introvert … I’m a shy person. But I’ve learnt the skills to 
release that… 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
Self-reflection I think is very important, and self-improvement. So you 
can’t have the same skills throughout your career, you develop, you 
look at things differently … You’ve got to look, because when you 
look back you learn and then you can look forward … And I think the 
more experiences you have and the more you reflect on those 
experiences the more you develop as an individual and as a leader… 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
5.2.3.2 Fair-mindedness 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Social capacity (Code)=>Fair-mindedness (Code property) 
Six participants identified that leaders need to adopt a fair-minded approach to 
leadership situations and decisions. This trait was also regarded as integral to 
effective communication skills: 
leadership is about compromise as well so you’ve got to have your 
ideal scenario that you want to achieve because you know you’ve got 
to do deals with so and so along the way and you end up modifying 
those ideals and that’s just politics, that’s just business, that’s just the 
way things are unfortunately… 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
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need to be good listeners and be fair minded and have a view in 
regard to equity of access in terms of how policy is put together, and 
that means they need good two-way communication skills and 
communication skills that appeal to the broad range of the 
professions members … they need that fair mindedness and equity 
of access to the policy process in the development of policy and in 
the execution of it and in the discussions with government… 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
5.2.3.3 Communication Skills 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Social capacity (Code)=>Communication skills (Code property) 
More than half of the participants identified good communication skills as essential 
social capacity traits for pharmacy leadership: 
leadership and leaders need to be excellent communicators, they 
need to be able to communicate and be as good at listening as they 
are at speaking and that idea of communicating in a timely and 
appropriate manner/style for their audience, whether that is with a 
colleague or with a broader audience or to a room full of people. So 
communication becomes critical, not just in the manner in which they 
do it, how they go about in making that a priority… 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
Open and timely communication was identified as critical by several participants: 
they need to have good open communication skills … And his 
communication skills, open communication skills with people and 
staff was unbelievable. And the customers love him, he's just an 
easy going guy and he knew everyone's name, and he could deal 
with problems and give the advice. So that had a big influence on me 
as a young pharmacist or an intern pharmacist… 
(Participant 28: Professional organisation, Military organisation, University sector, 
Military pharmacist-Australia) 
The ability of leaders to listen to followers’ needs was identified by one-third of the 
participants as an important communication skill in pharmacy leadership. In 
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particular, the delicate balance between listening to followers and making 
leadership decisions was identified as essential: 
They need to listen to all the views and try and pool those views and 
push them in the positive direction that they're trying to achieve… 
(Participant 28: Professional organisation, Military organisation, University sector, 
Military pharmacist-Australia) 
and be as good at listening as they are at speaking… 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
But also you’ve got to be aware that you can’t be so single minded 
that every decision you make is right. You’ve got to listen. So you 
need to listen… 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
You’ve got to be able to talk to everyone, be on their level, 
understand and listen … in the same kind of sphere, you need to be 
firm about your opinions, but listening … making sure you have the 
full picture is certainly critical when you’re making decisions … 
talking to everyone … you’re leading is so important… 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
The communication skills needed in public presentation and when chairing 
meetings was raised by some participants as superficial and not definitive of the 
leadership process in Australian pharmacy. They believed that just being a good 
public speaker or meeting chair, in itself, does not constitute good leadership: 
I think there is some superficial things, you know, being a good 
speaker, dressing well, I think all of those things are superficial… 
(Participant 6: Professional organisation, Company director, Community pharmacist 
proprietor-International) 
A lot of people think, ‘Oh, he’s a great leader, he’s a great speaker’. 
Well leadership is not about giving a good oration. It’s a much deeper 
thing than that and that’s why I think it’s hard for our… 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
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5.2.3.4 Inspiration and Motivation 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Social capacity (Code)=>Inspiration and motivation (Code property) 
More than half of the participants identified the importance of inspiring and 
motivating followers as a social capacity trait instrumental to pharmacy leadership 
and developing followership relationships: 
So a good leader will inspire others, enthuse others … in the 
pharmacy level that execution is winning the hearts and minds of 
your staff … You could be a great leader but if you don’t take your 
staff on that journey… 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
think inspiration and motivation is another characteristic that leaders 
and pharmacy need … and the ability to appeal to the profession’s, 
you know, hopes and dreams and aspirations… 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
a leader is someone who will work with you in an engaging way, who 
will inspire you to pursue similar passions … A leader will work with 
you to motivate you, discuss difficult decisions. Work with you to 
maximise your position in an organization… 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
5.2.3.5 Leadership Style 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Social capacity (Code)=>Leadership style (Code property) 
Eight participants identified the leadership style adopted—a manifestation of social 
capacity traits—as either collegiate or authoritative within the profession. While 
being collegiate was considered more effective, an autocratic style was regarded 
by participants as inferior: 
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my form of leadership is very … collegiate … very flat structure, very 
much built upon leading by example, very much built on shared 
passion… 
(Participant 9: Government organization, Consumer organisation, Organisational 
pharmacist-Australia) 
leaders in pharmacy … are quite … autocratic … it’s my way or the 
highway sort of thing. And I don’t believe that’s true leadership… 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
 Self-confidence 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Self-confidence (Code) 
Self-confidence was identified by one-third of participants as an essential trait for 
pharmacy leadership: 
the two most important ingredients are confidence, cause nobody will 
follow you unless you’re confident, and you have to have a direction. 
So confidence and direction. I think it’s a combination of confidence 
and direction… 
(Participant 22: Professional organisation, Consumer organisation, Pharmaceutical 
industry, Community pharmacist proprietor-Australia) 
you’ve got to be strong and confident and … in what you’re doing… 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
what differentiates leaders from followers in my mind … they believe 
in their own … ability… 
(Participant 23: Professional organisation, Company director, Pharmaceutical 
industry, non-Pharmacist-Australia) 
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Self-confidence, manifested through courage and strength of conviction was 
identified as important by the majority of participants: 
a leader is a person who stands up for what they believe in, who 
leads the people around them … you’ve really got to have the 
strength of your convictions and be able to review things … but when 
a hard call has got to be made they’re the people who make them. 
You know when something’s on the line they say this is what we 
should do… 
Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
you have to believe in yourself enough and in what you’re doing 
enough to go forward even when it’s tough because without that 
you’re going to let yourself down, you’re going to let your people 
behind you down… 
(Participant 14: Professional organisation, Community pharmacist-Australia) 
in the pharmacy profession … it’s having the courage to get up there 
and say stuff, and hopefully say stuff that resonates with the 
audience … takes courage and a whole heap of other factors … 
Good leadership is an individual that shows strength of character, 
conviction… 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
Participants believed that effective leadership instils confidence in followers to 
ensure suitable development that fosters competence. However, several 
participants identified the confidence and competence gap as a factor influencing 
leadership and the ability to be an effective leader. This ‘confidence–competence’ 
gap relates to the mismatch between how confidently a person projects 
themselves in meetings, in the workplace or in practice, compared with their actual 
abilities or ‘competence’ in that setting: 
some people have a confidence–competence gap, and making sure 
people feel confident, in what they are doing, but also have the 
chance to gain in their competence to be able to do it along the 
way… 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
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Participant views on competence of leaders is further unpacked in the following 
section. 
 Competence (Track Record) 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Competence (track record) (Code) 
More than one-third of participants identified the importance of track record and 
competence in pharmacy leadership. They believed that the leadership trait of 
competence is essential to effective leadership, with leaders needing to develop a 
track record to instil confidence in their leadership, while having high self-
confidence in their own leadership: 
leadership fails is the execution element … people have got ideas, or 
they can exhibit leadership. It’s another thing to bring along the 
troops, bring along a workforce, execute a plan, have key transition 
points where the plan can be reviewed if things go wrong … 
leadership is about measured executed results that make a 
difference… 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
they also have to have professional competence and if they don’t 
have professional competence then they don’t have credibility. So 
they need to have a high degree of competence and credibility… 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
 Credibility (Believability) 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Credibility (believability) (Code) 
More than half of the participants identified the importance of the leadership traits 
of credibility and what they referred to as ‘leadership believability’: 
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People need to look to a leader and say they have credibility in what 
they say and the perspective they bring. Part of that means that not 
everyone will be a leader at the top of the field, but they will lead in 
different ways and I do think credibility becomes very important … 
credibility and track record… 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
pharmacy leaders need to have … should have … trust, 
believability… 
(Participant 14: Professional organisation, Community pharmacist-Australia) 
it’s not just theory, it’s track record. It’s believability. At the end of the 
day people will … even if they’ve never met me, it’s about … a good 
leader is, ‘Is this person believable?’… 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
More than one-third of participants identified credibility via the phrase ‘lead by 
example’: 
leadership is, or in my view is about what a person does, so it’s about 
actions … leadership’s defined in people’s actions, so its defined in 
what they do … lead by example … OK … so they walk the walk and 
they talk the talk … pharmacy practice environment … they’re 
actually there doing it the way it should be done … lead by 
example… 
Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
people have to believe in you so you have to show them that and 
that's leading by example and having the traits to actually have 
people say ‘You know what? I'd follow this guy into battle’… 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
able to lead and guide by example and by doing things that are 
required to complete the task or goal of the activity… 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
More than half of the participants identified that mentors lead by example, through 
describing their own mentorship experiences: 
for a pharmacy leader it’s about being a role model and a listening 
post to enable pharmacists and their staff I might add, to reach 
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decisions based on their own ability and you know to be able to take 
a range of issues into account… 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
Even a subtle way, you know, because a great mentor doesn’t have 
to tell you to do something, tell you then that’s wrong, it’s most, most 
of the time it’s leadership by example… 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
 Strategy 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Strategy (Code) 
A quarter of the participants identified the role of strategy in pharmacy leadership. 
They believed that a leader should have a strategic vision and plan: 
Leadership is a lot longer term kind of higher level strategic thinking 
… you got to have a strategic vision for where you want to go, and at 
an individual pharmacy level… 
(Participant 21: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and Europe) 
working out a plan of where you want to get to, monitoring that plan, 
implementing that plan, measuring how you go, communicating with 
the right people at the right time. I think those aspects are much 
more important than the nebulous quality called ‘leadership’… 
(Participant 25: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and Europe) 
 Decision Making 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Decision-making (Code) 
More than half of the participants identified the essential nature of the leadership 
trait of decision making in the pharmacy profession; in particular the need for 
decisiveness among pharmacy leaders: 
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making decisions … making decisions on a timely basis, and making 
them, I know it is a bit repetitive, but making the decisions 
decisively… 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
taking people with them. To achieve it, whether it’s hard decisions or 
just easy decisions… 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
taking on the responsibility of being able to be the person that makes 
the decisions and conveys those decisions and is able to lead and 
guide by example and by doing things that are required to complete 
the task or goal of the activity… 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
a leader is … a hard call has got to be made they’re the people who 
make them … Somebody’s got to make a call because if you don’t 
make a call you’re left behind … in the pharmacy practice space we 
have too many people who don’t make decisions and so you end up 
with a status quo… 
Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
A quarter of participants identified that a pharmacy leader often mentors followers 
and guides and supports them through the decision making process: 
a good mentor is a person who can activate in other people that 
decision making process… 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
ability to openly look at a situation and calmly facilitate people around 
… to come to some decision making processes… 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
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 Cognitive Flexibility 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Cognitive flexibility (Code) 
One-third of participants acknowledged cognitive flexibility as an important 
component of pharmacy leadership. Cognitive flexibility is a leadership trait 
epitomising a leader’s openness to change and their ability to adapt to new 
circumstances and modify their position based on new information within a 
changing context: 
Plans don’t always follow the script, so what happens to readjust that 
plan? … a test of leadership in terms of adaptability and that’s 
another good key thing on leadership is being adaptable… 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
no plan survives first contact with the enemy, no plan, cause as soon 
as you go into contact it becomes dynamic … depends on how 
you’ve planned and how flexible you’ve been and how well your 
logistics are… 
(Participant 14: Professional organisation, Community pharmacist-Australia) 
to be a change agent … have a capacity to be able to make change. 
I think if you look at the direction pharmacy needs to go to … 
address … what’s happening in the pharmaceutical market… 
(Participant 21: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and Europe) 
you have to be flexible. You have to be able to stay abreast of the 
data that’s streaming in front of you on a daily basis. You have to be 
able to accept things… 
(Participant 22: Professional organisation, Consumer organisation, Pharmaceutical 
industry, Community pharmacist proprietor-Australia) 
To be flexible and dynamic, participants believed that pharmacy leaders need to be 
aware of and respond to external influences. Eleven participants identified that 
pharmacy leadership is influenced by the often challenging external context: 
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Ultimately leadership is not one thing … This is why leadership is so 
hard to define, because ultimately it is deeply ingrained in the 
context, it’s not a leadership for all contexts, it’s a leadership style 
which is deeply matched to the context of the moment, and moments 
change … for pharmacy what is needed … understanding of the 
context is what needs to happen first… 
(Participant 7: University sector, Professional organisation, Academic pharmacist-
Australia) 
when circumstances change I change my view … That’s a changing 
situation … leadership … is … absorbed from the environment… 
(Participant 14: Professional organisation, Community pharmacist-Australia) 
 Pharmacy Leadership Motivators 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Pharmacy leadership motivators (Code) 
With few exceptions, the participants identified the different leadership motives that 
are driving pharmacy leaders in the pharmacy profession. These ranged from 
perceived negative motives such as self-interest, to positive motives such as 
patient care. 
5.2.10.1 Self-interest 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=> Pharmacy leadership motivators (Code)=> Self-interest (Code property) 
A quarter of the participants identified that pharmacy leaders are motivated by self-
interest with respect to power, money and self-importance. These were viewed as 
negative traits, and participants believed that motivators should be altruistic and 
work for the ‘greater good’. However, power was also seen by participants as a 
positive motivator if the power was used positively and for the benefits of followers 
and the profession (see Section 5.2.10.5): 
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some of the leaders of the profession are the ones that perhaps for 
their own gain or their own benefit… 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
current leaders … all of them and especially mainstream politics. 
They are in it for the money and the power that the position brings, 
not in it for the greater good that they can create… 
(Participant 8: Professional organisation, Government organization, Consumer 
organisation, Community pharmacist proprietor-Australia) 
our leaders … They’re there for their own power and self-importance. 
And we need more people that are out there driven for more I guess 
altruistic reasons… 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
power is part of leadership and power’s unfortunately what can sour 
leadership … you know power does corrupt, you see it, absolutely 
see it… 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
5.2.10.2 Passion and Enthusiasm 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=> Pharmacy leadership motivators (Code)=> Passion and enthusiasm (Code 
property) 
Passion and enthusiasm were leadership motives recognised by nine participants. 
They felt that a leader should demonstrate passion and enthusiasm for their job 
and what they do, as this can be a motivator for those who follow: 
the key thing is passion. You have passion for the job … You’re 
never going to make an argument or run a case unless they’ve got 
some passion in it… 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
leadership to me is having passion for what you do, day in and day 
out, for those things that you care about. For me that passion is 
pharmacy … the biggest is passion, I think passion can go along 
long way… 
(Participant 6: Professional organisation, Company director, Community pharmacist 
proprietor-International) 
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absolutely need passion and enthusiasm … leaders have to be 
passionate … and they have to be enthusiastic… 
(Participant 9: Government organisation, Consumer organisation, Organisational 
pharmacist-Australia) 
5.2.10.3 Personal Ownership, Drive and Initiative 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=> Pharmacy leadership motivators (Code)=> Personal ownership, drive and 
initiative (Code property). 
Personal ownership, drive and initiative were reported as requirements in 
pharmacy leadership by two-thirds of participants: 
pharmacy leaders … they have set goals … it’s their consistency and 
drive, it’s their determination to reach a point… 
(Participant 22: Professional organisation, Consumer organisation, Pharmaceutical 
industry, Community pharmacist proprietor-Australia) 
desire or a passion, and that passion there will create a drive and 
energy and be accompanied by a whole bunch of thinking that will 
hopefully turn that person into a good leader… 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
5.2.10.4 Patient Care 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=> Pharmacy leadership motivators (Code)=>Patient care (Code property). 
A quarter of the participants identified that patient care is a leadership motive in the 
pharmacy profession: 
pharmacy leaders … really need to care about patients … so 
everything we’re trying to do at the end of the day is about doing 
something better for patients, but it’s about trying to lead a body of 
health professionals in a direction that ensures there are better 
outcomes for patients… 
(Participant 2: Professional organisation, Board director, Community pharmacist 
proprietor-International) 
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they have to have a desire to help their fellow human being. I think 
empathy and care for the patient is really really up there because 
that is a big driver for a lot of us in healthcare today. We want to see 
the system work better, so we can take care of our patients… 
(Participant 6: Professional organisation, Company director, Community pharmacist 
proprietor-International) 
5.2.10.5 Power and Influence 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=> Pharmacy leadership motivators (Code)=>Power and influence (Code property). 
Leadership constitutes numerous social interactions, with leaders influencing 
followers in a set direction through influence. Interestingly, power and influence 
can have both positive and negative effects on the pharmacy leadership process. 
One-third of participants identified the role of power and influence in the 
profession: 
a leader is a person who has the capacity and vision to influence 
others and exercise power effectively by utilising a range of qualities, 
characteristics and competencies that others will willingly follow… 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
influence and direct in such a way as to elicit their support, respect 
and confidence … a lot of its influences and influencing, directing 
and eliciting support … influencing, directing, getting everyone to 
work in that way… 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
5.2.10.6 Tenacity, Resilience and Perseverance 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=> Pharmacy leadership motivators (Code)=>Tenacity, resilience and perseverance 
(Code property) 
Eleven participants identified that tenacity, resilience and perseverance are 
important pharmacy leadership motivators. They believed that an effective leader 
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should demonstrate their tenacity and resilience to move forward and take their 
team and followers with them. Participants felt that a true leader should never give 
up and continuously persevere despite the barriers and challenges they face in 
their work: 
leadership … you have to be able to go forward when things are 
tough … call it resilient … believe in yourself enough and in what 
you’re doing enough to go forward even when it’s tough… 
(Participant 14: Professional organisation, Community pharmacist-Australia) 
leadership so you’re always going to be pulled down and I think you 
need to be very, very resilient to be in the game for a long period of 
time... So resilience I think is a fundamental… 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
Thick skins, no matter which organisation you belong to … leaders 
have got to have… 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
if you fall down, get up again and do it, yeah, that’s the most 
important thing… 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
Never, never, never, never, never, never, never, never give up … 
you can never give up. If you are a leader and if you have passion for 
what you do, you just can’t give up, you get knocked down over and 
over in the ring, but you just keep getting back up. I think that is 
another mark of a true leader… 
(Participant 6: Professional organisation, Company director, Community pharmacist 
proprietor-International) 
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 Responsibility 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=> Responsibility (Code) 
Leadership encompasses people taking ownership, accountability and 
responsibility. One-third of participants identified the importance of the pharmacy 
leadership trait of responsibility: 
taking on the responsibility of being able to be the person that makes 
the decisions … in pharmacy is someone that actually takes on the 
responsibility to make the decisions about … the strategy is in 
relation to customer service… 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
the leader as someone who has responsibility for an organisation … 
in terms of setting the tone, the values, the culture… 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-International) 
leadership is around responsibility. I think it’s being responsible for 
creating a better world … whatever your world is … whether that be 
in family, or school, or your community, or your job, or wherever your 
passion is, or whatever you’re involved in, it’s being responsible for 
the best outcomes… 
(Participant 2: Professional organisation, Board director, Community pharmacist 
proprietor-International 
 Honesty 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Honesty (Code) 
More than one-third of participants identified the need for honesty, trust and 
integrity in pharmacy leadership. They believed that leaders should be trusted, and 
that leaders should be honest and have high integrity if they are to lead their teams 
forward: 
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pharmacy leaders need to have … honesty and trust and integrity. 
That goes with the profession… 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
and to be honest a leader needs to be able to trust their team, and 
the team needs to be able to trust the leader… 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
 Ethics/Morals 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Ethics/Morals (Code) 
Participants identified that pharmacy leaders not only need to be honest, 
trustworthy and have integrity; they also need to have both professional and 
business ethics. They felt that all these traits came together. A quarter of 
participants identified the need for pharmacy leaders to have strong morals, ethics 
and values to balance the pharmacy–ethics dichotomy and ensure that they 
demonstrate their professional ethics to their patients and colleagues, and their 
business ethics to their clients: 
You know there’s a saying you’re moral compass is really important, 
and I think that is a challenge for some of our leaders… 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
Leading a group of people … At the same time in all of that 
upholding common values… 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
pharmacy leaders need to have … health and ethical obligations… 
(Participant 2: Professional organisation, Board director, Community pharmacist 
proprietor-International) 
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 Other Leadership Traits 
Definition of pharmacy leadership (Theme)=>Traits used to define pharmacy leadership 
(Subtheme)=>Other leadership traits (Code) 
Interestingly, only two participants, both women, identified unique leadership traits 
inherent to women in leadership positions, including nurturing, providing support 
and emotional intelligence. They believed that female leaders have an added 
advantage through this inherent skill, which can be very useful for effective 
leadership (although they did not suggest that male leaders cannot have emotional 
intelligence): 
that’s a female thing … you touch people with emotion… 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
skills that women … can bring to the table, the people skills, are as 
important, if not more important … than … technical skills … it is true 
that women do approach things a little differently than men … 
pharmacy would be much better served if we had more women in 
senior leadership positions… 
(Participant 9: Government organization, Consumer organisation, Organisational 
pharmacist-Australia) 
Only two participants identified that pharmacy leadership requires financial 
knowledge and acumen: 
leaders must have some financial acumen, they have got to be able 
to understand the financial impacts of their decisions and the vision 
they have… 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
you've got to have a whole unique skill set to be a director of an 
organisation. And the number one reason that directors fail is 
because of their lack of financial knowledge… 
(Participant 8: Professional organisation, Government organization, Consumer 
organisation, Community pharmacist proprietor-Australia) 
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 Followership 
Definition of pharmacy leadership (Theme)=>Followership (Subtheme) 
Followership is the reciprocal social influence process of leadership, whereby 
followers willingly connect and accept the leadership direction. The majority of 
pharmacy leadership definitions offered by the participants identified followership. 
This was specifically focussed on the need for leaders to inspire and motivate 
followers, which relies on a leader’s social capacity traits, such as communication 
skills, as key components of developing and maintaining followership relationships 
(as examined in Section 5.1.3): 
A leader by definition has to have followers so the question I think is 
really, what attracts followers… 
(Participant 14: Professional organisation, Community pharmacist-Australia) 
leadership is about getting people to follow you … having the 
courage to get up there and say stuff … that resonates with the 
audience… 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
if you're going to change directions … tell people and that's the other 
thing. It brings you back into your communication … If you don't tell 
your team what's going on … they'll go about their own business and 
you'll get isolated very quickly… 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
An important part of followership recognised by five participants was leaders caring 
and nurturing followers, which was closely associated with a leader’s emotional 
intelligence: 
there are people around you, if that’s about ensuring that they’re 
doing well as well … being in charge of firstly yourself, and then your 
team around you … good leadership is the people that … they care 
about people… 
(Participant 2: Professional organisation, Board director, Community pharmacist 
proprietor-International) 
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encourage them in a silent way to make positive change and if you 
know how they feel … their emotional state … the biggest thing … for 
a leader to have is to know people you lead. The only way to know is 
to get to know them… 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
Six participants recognised that leaders need to provide followers with self-
determination, empowerment and responsibility to take action and make decisions 
themselves, ultimately enabling the leader to build the followership: 
provide a good working environment for the employees, have them 
empowered where they can make decisions. I think that a good 
leader needs to be able to have ideas come from his people and 
bring those into his vision… 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
allow people to try and that's what good leaders do, they give them 
an opportunity. The way I word it is you give them an opportunity to 
succeed or fail but it's their opportunity. You'd rather have someone 
try to do something better, and potentially fail, rather than not try at 
all and just sit back… 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
One-third of participants identified the importance of gaining followers’ trust and 
respect, which linked with the leadership traits of honesty, trust and integrity: 
the minute you don't know what you're talking about people will suss 
that out. They won't follow you. You'll lose your leadership … and 
knowing the areas and the subjects … get their support and 
respect… 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
Six participants identified the importance of having the right people in a leaders’ 
followership to increase the leadership capacity of the entire group. To achieve 
this, leaders need to develop their followers, for example through mentoring: 
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having an amazing group of people around you … that’s also part of 
leadership … sort of leads on with … mentoring… 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
two things to succeed in business, is the right ideas and the right 
people … You … need the right people… 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
 Leadership Defined by Describing Examples of Poor or Failed Leadership 
Definition of pharmacy leadership (Theme)=> Leadership defined by describing bad/failed 
leadership. 
One-third of the participants defined leadership by describing what ‘it is not’, for 
example by detailing instances of poor or failed leadership. Some of the leadership 
traits that encapsulate participants’ descriptions of poor or failed leadership 
pertained to pharmacy leaders being reported by the participants to be egotistical, 
overly critical, lacking effective communication skills (e.g. listening), not nurturing 
and developing followers, and having a limited leadership vision: 
the problem has been at the leadership level; regrettably most of the 
pharmacy leaders have been people who … what am I trying to say 
here? People for whom there is no form of human endeavour that 
they haven’t lasted. They often had extraordinary faith in their own 
judgement, often without any reason to have that… 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
some of our leaders … they’re quite egotistical and … I mean I’ll be 
really honest with you. They’re there for their own power and self-
importance… 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
I believe a good leader has to know when not complain. I want to say 
not complain about the vote, because sometimes you get caught up 
on one side of the issue and you don’t want to let it go … sometimes 
if you continue to be that nagging noise then you are not an effective 
leader… 
(Participant 6: Professional organisation, Company director, Community pharmacist 
proprietor-International) 
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you might be a poor leader because you don’t convey it, you have 
the wrong vision, you have the wrong direction and you’re all over 
the place… 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
people who are not effective communicators or lack a vision, don’t 
make good leaders… 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
That is the rub of bad leadership, and the lack of mentoring in 
leadership we are seeing in pharmacy… 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
 Chapter Summary 
All participants during their interviews described their definition of pharmacy 
leadership, which was the focus of this chapter. Throughout the interview process, 
participants described leadership at numerous levels across the pharmacy 
profession. Over the next four chapters, parallels will be drawn between the 
different levels of pharmacy leadership and the definition of leadership arrived at in 
this chapter, which will act as a departure and reference point. In Chapter 6, 
findings on the theme of pharmacist identity are reported. As the findings were 
unpacked, strong associations between the themes of identity and leadership were 
observed. In Chapter 7, participants’ opinions about community pharmacy 
leadership are reported, and throughout the presentation of findings, parallels are 
drawn to the definition of pharmacy leadership in this foundation chapter (Chapter 
5). Similarly, Chapters 8 and 9 report on participants’ understanding of the 
profession facing outwards into the external operating context, identifying the 
importance of the profession’s leadership. Throughout the presentation of findings, 
links are made with this foundation chapter (Chapter 5), which sets the compass 
for the definition of pharmacy leadership. Finally, Chapter 10 presents participants’ 
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pharmacy leadership development recommendations, which are linked back to 
important leadership traits needed to develop a followership. 
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Chapter 6: Pharmacist Identity 
 
 
there are plenty of failures of pharmacy to move on; 
Hepler and Strand talked about pharmaceutical 
care. I’m terrified to say that that was well over 20 
years ago. It was an idea which gained a lot of 
traction as an idea, but I believe it’s the fixated 
identity of pharmacists that stopped it from being a 
revolution… 
(Participant 7: University sector, Professional organisation, Academic 
pharmacist-Australia) 
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 Pharmacist Identity 
Pharmacist identity (Theme) 
This chapter examines the theme ‘Pharmacist identity’ and its influence on 
pharmacy leadership. Pharmacist identity comprised the six subthemes presented 
in Table 6.1. The majority of participants described this theme in relation to 
community pharmacy practice. There were no differences between Australian and 
international participants in this respect, nor were differences noted between males 
and females. 
Table 6.1 Pharmacist Identity Theme—Description and Properties 
Theme Theme description Subthemes 
Pharmacist identity Factors that influence pharmacist identity, personality and leadership 
Competing pharmacist identities 
Pharmacist technical traits 
Pharmacist clinical traits 
Pharmacist personality and leadership 
Pharmacist workforce conditions 
Pharmacist self-recognition 
 
 
 Competing Pharmacist Identities 
Pharmacist identity (Theme) => Competing pharmacist identities (Subtheme) 
In Australia, generally, a community pharmacist can be broadly classified as 
belonging to one of two identity groups: an employee or a business owner. In 
recent times there has been increased competition across the community 
pharmacy sector, highlighting the distinction between these two identity groups. 
Participants believed that these competing pharmacist identities are influencing 
professional services leadership and delivery through community pharmacies, and 
are driven by the leadership motivations of power and influence (Section 5.2.10.5) 
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to gain control of service funding. More than half of the participants identified 
differences in views on leadership that exist between employees and business 
owners, particularly around the funding of professional services, delivery of 
services and leadership; most notably medication review services, for example, 
home medication reviews (HMRs) and in-pharmacy medicine review checks 
(MedsChecks). Participants believed that these competing identities influenced 
pharmacists’ abilities to be leaders with regard to professional service delivery. 
For pharmacy leaders to be effective, participants believed that they need to 
understand the unique differences and needs of the two main pharmacist identity 
groups. A quarter of the participants recognised the importance in pharmacy 
leadership of understanding the differing needs of employee pharmacists and 
pharmacist business owners. They believed that effective pharmacy leaders draw 
on their cognitive flexibility (in a challenging and changing external context; see 
Section 5.2.9) and their pharmacy tacit knowledge (characterised by expertise and 
understanding in the profession; see Section 5.2.2) to navigate and understand 
these key identity groups: 
What I believe needs to occur is that there needs to be a 
fundamental understanding that there is a difference between 
pharmacies and pharmacists, that those two human phenomena, of 
the phenomenon of pharmacies, the phenomenon of a group of 
pharmacists, have a lot of common needs, but a lot of different ones. 
And as we move into the future there needs to be an understanding 
that those directions, and indeed the needs, to be expressed in 
different ways … there is by definition going to be probably a 
competition between the two… 
(Participant 7: University sector, Professional organisation, Academic pharmacist-
Australia) 
whilst you can actually say the needs of pharmacies can go in one 
direction, and the needs of pharmacists can move in a slightly 
different direction, at the moment we have pharmacy owners who are 
both deeply connected and integrated with their pharmacies and 
they’re also pharmacists. And of course the pharmacy enterprise is 
the dominant employer … So trying to gain a leadership direction 
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which honours those two important different directions is going to be 
exceedingly difficult … and because of the number of unemployed 
pharmacists, or underemployed pharmacists … the environment has 
sort of controlled outlets or employment, it’s not surprising that the 
needs of each group are now rather easy to see as being different… 
(Participant 7: University sector, Professional organisation, Academic pharmacist-
Australia) 
 Pharmacist Personality and Leadership 
Pharmacist identity (Theme) =>Pharmacist personality and leadership (Subtheme) 
A quarter of the participants identified unique personality traits of pharmacists that 
influence leadership. One participant explained these traits in terms of DISC 
profiling, which is a behaviour assessment tool that focusses on the personality 
behaviours of dominance, inducement, submission and compliance (171). This 
participant believed that pharmacists score poorly on the dominance and 
inducement personality behaviours essential for team leadership: 
analysis of pharmacists using the DISC profiling methodology. 
Pharmacist score extremely well … at the S and C … it’s about one 
thing at a time, it’s about being able to do these things day in day 
out, month in month out, decade in decade out, and not change … 
And yet the essence of leadership is to move pharmacists on from 
having a purely technical degree that they apply to learning broader 
skills set. And the S and C skills sets that pharmacists have are really 
holding them back … we need … leaders in the industry that have a 
little less of that style of attributes, but have a lot more the D and the 
I, which are about integration, team leadership, it’s about change… 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
 Pharmacists’ Resistance to Change 
Pharmacist identity (Theme) => Pharmacist personality and leadership 
(Subtheme)=>Pharmacists’ resistance to change (Code) 
The leadership traits of cognitive flexibility and adaptability to the external context 
were identified as necessary for effective pharmacy leadership (see Section 
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5.1.7.3). One-third of participants identified that some pharmacists are resistant to 
change, and this is central to their personality; it seems to manifest as these 
pharmacists wanting to simply focus on being a technician and dispensing, rather 
than interacting with patients and delivering professional services. Some 
participants have the view that this may have an effect on remuneration of 
pharmacists in the workplace: 
I've had pharmacists who own a business but they sit out the back, 
they do the prescriptions, they do not talk to customers, they do not 
talk to their staff, they employ someone to do it. Now maybe they've 
identified that they have a weakness and were never shown how to 
get out of that weakness so they've defaulted to the lowest common 
denominator… 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
You’ve got to look at how you can move a lot of, pharmacists that are 
very focused in what they’ve done for years and years into a very 
much different business model … I think it’s very interesting because 
pharmacy in general to be a change agent, it doesn’t come naturally 
for pharmacist… 
(Participant 21: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and International) 
cracking the culture, building the programs, getting people to do 
them. Some people don’t want to follow those programs, they don’t 
want to work with patients in the medicines section, if all they want to 
be is an overpaid glorified technician, then pay them $26 an hour 
because that is all they are worth … the pharmacists … at the front, 
dealing with their patients, helping them … They are worth a lot more 
to the … patient health outcome, financial sense they are worth a lot 
more to the pharmacy owner, so they should be paid a lot more than 
that… 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
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 Pharmacist Clinical Indecision 
Pharmacist identity (Theme) => Pharmacist personality and leadership 
(Subtheme)=>Pharmacist clinical indecision (Code) 
Some pharmacists in practice lack decisiveness when faced with clinical decisions, 
resulting in a lack of leadership (Section 5.2.8). Five participants described that 
pharmacists tend to have an inability to make timely and appropriate decisions 
reflecting poor clinical leadership: 
where a pharmacist identifies a drug-related problem, goes to the 
prescriber, we’ve got a problem and the prescriber goes well what do 
you think, oh I didn’t think that far down the track … So from a 
leadership perspective … you haven’t had the foresight to think 
what’s the next step … So how is that leadership? It’s not… 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
 Pharmaceutical Scientists 
Pharmacist identity (Theme)=>Pharmacist personality (Subtheme)=>Pharmaceutical scientists 
(Code). 
The term ‘pharmaceutical scientist’ refers to a pharmacist personality trait that is 
associated with the precision and rigour of being a scientist and that may influence 
cognitive flexibility (Section 5.2.9). This perceived personality trait can negatively 
influence effective leadership and communication, with pharmacists not being able 
to articulate what they want. More than a quarter of the participants identified 
pharmacists’ scientific nature and training as influencing their personality and 
practice: 
Even the notion of the pharmaceutical scientists that we are, the 
rationalistic scientific approach to things, the way in which we do our 
science, it is precise, it requires strict procedures, milligram doses 
need to be milligram doses, very little variation … So even the nature 
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of our profession … our identity, is deeply, deeply fixated in 
precision, which requires rigidity… 
(Participant 7: University sector, Professional organisation, Academic pharmacist-
Australia) 
I have met so many scientists over the years when I was working in 
the Prime Ministers Department … so many scientists and I put 
pharmacists in that theme … really had no ability whatsoever to 
articulate to lay people what they actually wanted… 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
 Pharmacist Technical Traits 
Pharmacist identity (Theme)=>Pharmacist technical traits (Subtheme) 
More than half of the participants identified pharmacists’ overwhelming technical 
supply traits, which were related specifically to the dispensing process. Leadership 
in pharmacy is a transformation that changes pharmacist behaviour from the 
technical dispensing process to utilising clinical skills in the implementation of 
professional services. This transformation represents a shift from the technical 
dispensing process. The participants believed that leadership at both the pharmacy 
and industry level was still focussed on technical traits and seemed to be lacking in 
necessary skills to ensure professional services leadership transformation: 
And yet the essence of leadership is to move pharmacists on from 
having a purely technical degree that they apply to learning broader 
skills set… 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
too often, we get put into this almost supply-type function, and 
dispensing-type function and I don't mean to underplay that. It is a 
very important service… 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
making too much money for the clerical task, the administrative task 
of supplying a pharmaceutical … the same old same old, triaging, 
dispensing… 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
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 Technical Supply Limiting the Profession 
Pharmacist identity (Theme) =>Pharmacist technical traits (Subtheme)=>Technical supply 
limiting the profession (Code) 
Participants reported that too often, pharmacists focus on being a technician and 
performing the technical process of dispensing and supply of medicines to the 
health consumer. When the focus of pharmacists’ practice is on the technical 
supply side as opposed to professional or clinical services that utilise pharmacist 
clinical skills, pharmacists and pharmacies in which they work, are not exhibiting 
clinical and pharmacy leadership. More than half of the participants identified that 
the pharmacist technical supply function is limiting pharmacies, and may be 
contributing to the professions’ disconnect from the external health context (further 
explored in Section 9.3, Disconnect with context): 
pharmacy owners … their starting point is in being a technician … A 
guy that owns a pharmacy, was a pharmacist, and so their history of 
what consumed their day and their thinking was being a good 
technician, was being good behind the dispensary … When they 
become an owner … They forget to swap caps and they believe that 
if they continue to be a really good technician they are showing good 
leadership… 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
we have to try and crack this culture, lead pharmacist out of the 
dispensary, that technical role, to patient, customer engagement role, 
delivering superior health benefits to consumers, we got to crack the 
culture and that is where the leadership needs to go at a community 
pharmacy level… 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
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 Pharmacist Workforce Influences 
Pharmacist identity (Theme) =>Pharmacist workforce influences (Subtheme) 
Almost a quarter of the participants identified several generational leadership 
challenges influencing pharmacy workplace leadership. With an increasing number 
of pharmacists registering each year, a generational disparity is emerging between 
younger employee pharmacists and older pharmacist business owners: 
And I think a part of the problem today … you get young people who 
want to be leaders but don’t want to work hard to get there or they 
have a misconception to what working hard means … everyone 
wants to talk and no one wants to listen … or they will listen and they 
won't take it on you know… 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
 Limited Career Diversity 
Pharmacist identity (Theme) =>Pharmacist workforce influences (Subtheme)=>Limited career 
diversity (Code) 
Almost one-third of participants recognised that there was a lack of professional 
career diversity and employment opportunities available to pharmacists, 
particularly early career pharmacists. The current state of pharmacy career options 
was believed to be a manifestation of pharmacy leadership that is focussed on 
existing employment and career avenues, without demonstrating a future vision. 
Vision is an essential pharmacy leadership trait (see Section 5.2.1). Pharmacy 
career diversity and employment opportunities were believed to be a manifestation 
of the pharmacy profession’s leadership vision. Limited career diversity and 
employment were reported to be a result of a fixed pharmacy leadership vision. 
Participants felt that providing limited career diversity was resulting in professional 
dissatisfaction and, in some cases, younger pharmacists leaving the profession: 
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there's no career opportunities at your fingertips to be able to dive in 
and do those things that you've been trained to do … So why do we 
lose those terrific graduates to other professions… 
(Participant 12: Professional organisation, Consumer organisation, Advanced 
practice pharmacist-Australia) 
I don’t think we offer enough diversity. Perhaps we do in the hospital 
setting. But you look at other professions … they can work in a 
variety of environments. We’ve got hospitals … community … 
industry … we don’t have a very diverse structure … around our work 
environments … We don’t have … different experiences, different 
opportunities… 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
 Oversupply of Pharmacists 
Pharmacist identity (Theme)=>Pharmacist workforce influences (Subtheme)=>Oversupply of 
pharmacists (Code) 
In addition to the limited career diversity and employment, participants believed 
that the pharmacy profession was experiencing higher numbers of graduates 
entering the profession each year, resulting in what some participants called an 
‘oversupply’ of pharmacists in workplaces that have limited employment capacity 
because of the regulated number of community pharmacies in Australia. Some 
argued that this was the result of poor leadership across the pharmacy sector that 
was producing more pharmacists than the current pharmacy environment can 
accommodate given the fixed number of pharmacies. Others suggested that this 
meant pharmacists were well placed to pursue other non-traditional roles. More 
than one-third of the participants identified that there was an oversupply of 
pharmacists, adding further pressure to pharmacy workforce conditions and in turn 
affecting pharmacy leadership at a community pharmacy and professional level: 
pushing out too many pharmacy students so it cheapens the 
profession. The discounters are paying a very low wage and it's 
being accepted … We have too many faculties pushing out … 
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There's not enough jobs right now and when you have an oversupply 
… it affects the whole industry… 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
If all these new increasing pharmacy graduates want to come out 
and want a job and want to you know really expand this profession 
… And I can’t actually see it happening and that’s what’s holding the 
profession back … Increasing number of graduates where are they 
going to go… 
(Participant 14: Professional organisation, Community pharmacist-Australia) 
Four participants identified that this oversupply of pharmacists presented an 
opportunity for the profession to use the additional pharmacist workforce to grasp 
expanded role opportunities within the profession. Participants reported that simply 
stating that there was an opportunity with an increased workforce did not deliver 
tangible pharmacist employment options, which seemed to indicate a disconnected 
leadership perspective: 
So I guess perhaps that perception that maybe if there’s some hard 
short-term pain for themselves may actually benefit the profession 
overall and lead the long-term gain for all … there isn’t an oversupply 
of pharmacists, this is a great opportunity for pharmacists to put their 
hand up for new and alternative roles … utilise the extra capacity we 
have in the workforce… 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
 Pharmacist Pay and Employment Conditions 
Pharmacist identity (Theme) =>Pharmacist workforce influences (Subtheme)=>Pharmacist pay 
and employment conditions (Code) 
Almost half of the participants identified that pharmacist pay and employment 
conditions were a concern to young pharmacists that needed to be addressed to 
ensure effective future leadership. Followership is central to the definition of 
pharmacy leadership (see Section 5.3), and addressing the needs of followers is 
critical to coalescing effective leadership: 
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the profession needs to be represented … wages have been slightly 
down … basically remained stagnant … younger inexperienced 
pharmacists are being employed on the Award or near it, and then 
the older more experienced pharmacists are being paid what would 
be considered a reasonable wage … the Award is just simply a 
safety net now… 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
the money that young pharmacists are being paid is a concern … 
individual who did four years and a year internship … getting a 
couple of dollars more than bloody Coles… 
(Participant 23: Professional organisation, Company director, Pharmaceutical 
industry, non-Pharmacist-Australia) 
Because at the moment there's a lot of young pharmacists who are 
more concerned about the poor remuneration, so that's an issue that 
needs to be solved… 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
 Pharmacist Self-recognition and Belief 
Pharmacist identity (Theme) =>Pharmacist self-recognition and belief (Subtheme). 
Pharmacist self-recognition and belief was identified as lacking, by one-third of 
participants. Participants believed that the profession must recognise, value and 
believe in the role of the pharmacist, and this self-recognition and belief was 
reported as central to pharmacy leadership. Participants had previously highlighted 
that recognising, valuing and believing in one’s skills and abilities was associated 
with the pharmacy leadership trait, self-confidence (see Section 5.2.4): 
You could bottle it. Um, but we don’t sell it that way, do we, to 
ourselves … I mean we don’t sell it out there, but we don’t sell it to 
ourselves. You can’t sell it to someone else if you don’t actually 
believe it … believe the role that pharmacists can take… 
(Participant 9: Government organisation, Consumer organisation, Organisational 
pharmacist-Australia) 
so we don’t have this vision of the other value of the pharmacist you 
know we need to go out in a way and demonstrate that value, and in 
a way convince whether it be the aged sector government or private 
health funds or whatever but it would in fact be an efficient use of 
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money, money would be saved, the quality of life would be improved 
and so forth… 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
pharmacists need to be able to acknowledge the value they have in 
terms of their health knowledge now … need to acknowledge … the 
value that these … pharmacists have for the profession and the 
community … delivering better health … they need to be able to 
recognise the value they have… 
(Participant 28: Professional organisation, Military organisation, University sector, 
Military pharmacist-Australia) 
 Chapter Summary 
This chapter presents participant’s views on the theme of pharmacist identity. The 
findings relating to this them were reported and related back to the definition of 
pharmacy leadership (Chapter 5), and to leadership broadly. Pharmacist identity 
describes factors that influence identity, personality and leadership. Competing 
identities that exist between employee pharmacists and pharmacy business 
owners were viewed by participants as influencing professional services leadership 
across community pharmacies (Section 6.2). Participants reported that 
pharmacists’ personalities are characterised by clinical indecision (Section 6.3.2), a 
rigid pharmaceutical focus (Section 6.3.3) and resistance to change (6.3.1). These 
were reported by some participants as unique pharmacist personality traits that 
affect pharmacy leadership. Pharmacist technical traits were reported as the traits 
intrinsically linked to the technical process of dispensing (Section 6.4). Participants 
identified that technical traits were a significant limiting factor preventing the 
services leadership approach and utilisation of pharmacist clinical skills, inhibiting 
the expanded role opportunities available to pharmacists. Participants identified 
limited career diversity, an oversupply of pharmacists, poor pharmacist 
remuneration and employment conditions as pharmacy workforce influences on 
pharmacist identity (Section 6.5). These workforce conditions highlight that 
followers’ needs are not being addressed and that there is a fixed pharmacy 
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leadership vision. Participants identified that there was deficiency in pharmacist 
self-recognition, and belief of the value of pharmacists and their leadership 
capacity across the health sector (Section 6.6). Self-recognition and belief was 
related to the leadership trait of self-confidence identified as part of the pharmacy 
leadership definition (Section 5.2.4). 
The next chapter examines the theme of community pharmacy leadership (Chapter 
7). The chapter builds upon the findings in this chapter to move beyond the 
technical process of dispensing and implement professional services that utilise 
pharmacists’ clinical skills, enacting the service leadership approach that is 
required to transform the profession.  
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Chapter 7: Community Pharmacy Leadership 
 
 
“...the leadership in community pharmacy in terms 
of ownership has been very poor. If anything it has 
been non-existent...owners of these pharmacies 
have been going along for the ride for the past 23 
years making very easy money dispensing... They 
have not transitioned to a service style of 
pharmacy, they have not taken opportunities...” 
(Participant 5: Professional organisation, Company director, non-
Pharmacist-Australia) 
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 Community Pharmacy Leadership 
Community pharmacy leadership (Theme)=> 
This chapter of the thesis examines the theme, Community pharmacy leadership, 
which relates to the small business leadership of Australian pharmacies. The 
majority of participants were from the community pharmacy sector, therefore, 
community pharmacy leadership forms an important part of the findings of this 
research. Participants reported that the pharmacy small business owners are in 
positions of leadership in their community pharmacies. Participants reported that 
Community pharmacy leadership was associated with financial sustainability, 
business profitability levers and small business leadership. Participants recognised 
that pharmacist business owners, as community pharmacy leaders, have the 
choice to implement one of two key leadership approaches into their businesses. 
Participants believed that pharmacies can either implement the discount or service 
leadership approach. 
Community pharmacy leadership has a significant influence on the leadership 
within pharmacy organisations. Participants reported that the leaders of community 
pharmacies (pharmacist business owners) were represented by pharmacy 
organisations, in areas such as protection of pharmacy ownership to developing 
pharmacy standards. Pharmacy organisations derived their purpose and direction 
through catering to the needs of community pharmacies and the pharmacists 
which were employed by these pharmacies. The influence of pharmacy 
organisations will be examined in the next chapter (Section 8.6; Pharmacy 
stakeholder leadership). 
Participants described who community pharmacy leadership was influenced by 
regulated and fixed frameworks within the pharmacy profession, such as the 
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community pharmacy agreement, pharmacist ownership legislation and the 
pharmacy locations rules (Section 8.5; Regulated and fixed frameworks). These 
were reported by participants as contextual regulations that impact community 
pharmacy leadership. For example, the majority of participants reported that if 
there were changes to pharmacy ownership laws, this would result in a major 
challenge to community pharmacy leadership due to increased competition. 
Previously (Section 6.4), the implementation of professional services was 
described as representing transformative pharmacy leadership. In this chapter, this 
finding will be further developed, highlighting that community pharmacies that 
adopt professional services are identified as taking a service leadership approach. 
A so called “service leadership approach” transforms community pharmacies and 
enables them to deliver increased professional services, diversify their income 
streams and provide expanded career and employment opportunities to 
pharmacists. Community pharmacies maintaining a strictly “business model”, 
where the technical process of dispensing is central to the business, are exhibiting 
a so called “discount leadership approach”, which may be profitable, however, is 
static with regards to expanding and advancing the professional role of the 
pharmacist within the community as it ties the practice to technical dispensing 
based on medication supply and volume. Table 7.1 presents Community pharmacy 
leadership definition and subthemes, as reported by the participants. 
Table 7.1 Community Pharmacy Leadership Theme Description and 
Properties 
Theme Theme description Subthemes 
Community pharmacy 
leadership 
The leadership across the network of community 
pharmacies throughout Australia. 
Pharmacy business leadership 
Declining profitability 
Consumer driven strategy 
Service leadership approach 
Discount leadership approach 
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 Pharmacy Business Leadership 
Community pharmacy leadership (Theme)=>Pharmacy business leadership (Subtheme). 
Pharmacy business leadership is the first subtheme of community pharmacy 
leadership. The subtheme examines the pharmacist owner's leadership within the 
business. The owner's mentality was reported to be intrinsically linked to the 
pharmacy's approach to leadership. 
“... because I own a business, therefore I am displaying leadership. 
You know. If you are the owner, you are the leader, but the question 
is whether you are displaying good leadership. And so in a sense 
that is where you can find good and bad leadership...people have to 
not confuse ownership with leadership...” 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
Interestingly, one participant clearly identified the link between community 
pharmacy leadership and pharmacy stakeholder leadership. 
“...there are sometimes problems in terms of leadership for 
Pharmacy at local level and I think particularly for community 
Pharmacists, that it's difficult because they're disperse. They're all in 
their own shops or practices. It's hard physically just to get together 
and meet, let alone decide who's going to lead, or... lead the group of 
Pharmacists. And I think there is something important there about the 
kind of structure and ownership of Pharmacy, so the community 
Pharmacy where I think it's... it probably doesn't even see itself as 
needing to be led some of the time... 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-United Kingdom) 
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 Owners’ Financial and Leadership Responsibility 
Community pharmacy leadership (Theme)=>Pharmacy business leadership 
(Subtheme)=>Owners’ financial responsibility (Code). 
One third of the participants discussed the pharmacy business owner’s financial 
and leadership responsibilities which they believed strongly influenced the impact 
of the owner’s leadership. Whilst specific to the community pharmacy practice 
setting, it also resonated with the general definition of leadership and the specific 
trait of taking responsibility (Section 5.2.11). 
“...I mean a leader… particularly in a commercial situation...If you’ve 
got a commercial interest, then that person’s got their money with 
their balls on the line. And they make decisions to protect their 
interests, and to expand them and to maximise the return for their 
money. So I guess from that point of view, that’s my definition of a 
leader...” 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
“...I’ve got to admire people who are prepared to invest in a 
business...they deserve a lot of respect for that and in a way perhaps 
that’s the example of leadership, having, have faith in yourself that 
you can run a business and make it viable and sustain yourself and 
others...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
 Increasing Ownership Demands 
Community pharmacy leadership (Theme)=>Pharmacy business leadership 
(Subtheme)=>Increasing ownership demands (Code). 
Several participants, all with retail pharmacy and business ownership experience, 
stated that there were greater demands being placed on pharmacy business 
leadership. These were specifically related to running a community pharmacy 
business. Participants believed that financial pressures demanded that pharmacist 
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owners were required to be better planned and prepared in their leadership 
approach. 
“...but the whole ownership of the pharmacy has changed in the last 
five years...harder to get your finance. Running the business is far 
more critical than it was before in the past so you have to be better 
prepared... So now pharmacists actually have to work in their 
business and on their business...” 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
“...So the economic climate’s going to be changing. It’s really, really 
unsteady. Once upon a time you were really confident that your 
pharmacy was… you were going to earn… you were going to have a 
good career, you were going to earn really well from your pharmacy 
and there was potential for growth if you put… if the work you put 
in… you got back what work you put in. Now you can’t depend on 
that. Now it feels like you’re putting in work to break even...” 
(Participant 22: Professional organisation, Consumer organisation, Pharmaceutical 
industry, Community pharmacist proprietor-Australia) 
 Financial Pressure Motivating Leadership Change 
Community pharmacy leadership (Theme)=>Pharmacy business leadership 
(Subtheme)=>Financial pressure motivating leadership change (Code). 
Four participants identified that pharmacy businesses experiencing financial 
pressures was driving pharmacist owners to change their community pharmacy 
leadership. They believed that pharmacy businesses were experiencing increased 
financial demands, and that community pharmacies only seemed to change their 
leadership approach when the owners endured significant financial stress. Due to 
the increased financial pressures, pharmacy owners become more motivated, agile 
and flexible, adopting new leadership approaches. The majority of participants 
equated the position of pharmacy ownership with leadership, however, more than 
a third of participants reported that the simple fact of being an owner does not 
signify effective leadership. 
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“...A lot of pharmacists don’t actually react to a sort of a change 
unless there is pain. If there is pain, some of them will still go broke, 
and do what they have always done in spite of these issues. I have 
seen it, it’s bizarre. And others, will see the pain for what it is, it’s a 
warning...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
“...unfortunately I think until we get more… pharmacies going broke 
and we get to that crisis, that real deep… I mean we’re in crisis now, 
but when we get to that, oh my god that’s a real crisis we can’t do the 
same thing forever. Until we get to that stage, I can’t see anything 
change and it’s an awful thing to say...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
 The Importance of Business Confidence 
Community pharmacy leadership (Theme)=>Pharmacy business leadership (Subtheme)=>The 
importance of small business confidence (Code). 
Chapter 5 identified that self-confidence was an essential leadership trait in the 
definition of pharmacy leadership (Section 5.2.4). Four participants identified the 
importance of small business confidence in community pharmacy leadership. They 
identified that a lack of business confidence caused uncertainty, which could 
negatively impact community pharmacy leadership. 
“...The majority of pharmacists are doing reasonably well, maybe not 
as well as they were before, and they’re getting uncertain because 
they think their future’s uncertain, and uncertainty is the kiss of death 
to anything...” 
(Participant 14: Professional organisation, Community pharmacist-Australia) 
“...when there’s $5.5B worth of private infrastructure invested in 
community pharmacy...there needs to be some recognition that if 
there is to be dramatic change to the model, that there needs to be 
some awareness of the investments being made in that...community 
pharmacy...business needs certainty...given that pharmacy does 
provide support to the population as a whole...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
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 Flexible Business Leadership 
Community pharmacy leadership (Theme)=>Pharmacy business leadership 
(Subtheme)=>Flexible business leadership (Code). 
Five participants recognised the need for pharmacist owners to possess the 
leadership trait of cognitive flexibility, which they believed was needed to change 
the direction and leadership of their pharmacies when needed, adapting to the 
changing context. Cognitive flexibility was recognised as a leadership trait 
imperative to leadership, particularly in changing circumstances (Section 5.2.9). 
Pharmacist owners adopting a flexible approach to their business leadership 
through adapting and changing to the external context were reported by 
participants to exhibit effective leadership. 
“...I mean if you go around pharmacy you can see there’s people that 
are very business orientated and they are changing...” 
(Participant 21: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and Europe) 
“...I think the flexibility for community pharmacists, so they have to be 
proactive rather than just copping it. And they have to be flexible and 
they have to be unafraid of finding out what to do...” 
(Participant 22: Professional organisation, Consumer organisation, Pharmaceutical 
industry, Community pharmacist proprietor-Australia) 
“...I think there’s two different approaches to it. Some are sort of 
buckle down, batten the hatches, teach a status quo and fight damn 
hard to make sure that everything we have to face stays the same, 
and others who have responded by being innovative and doing, 
trying new and different things and thinking outside of the 
box...innovators will ultimately prevail because they’re the ones who’ll 
survive...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
One participant described the focus that current pharmacy owners have on 
profitability was a leadership approach based solely on operating a dispensary. 
This participant believed that the current approaches to community pharmacy 
leadership could result in the potential for “leadership failure”, and felt that it was 
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important to change the thinking of pharmacy owners, as they were in leadership 
positions. 
“...to maintain the status quo in pharmacy means that a lot of 
pharmacies won't survive if they don’t adapt to the changing nature 
of the industry...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
“...maximising dispensing through put, maximising generic 
substitution, ram private label down people throats because that’s 
how we make money...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
The participant further reported that pharmacy owners needed to change their 
approach to small business leadership. Four other participants also identified with 
this finding. 
“...We need to change the thinking of the owners...We need to 
change the thinking of the owners, leadership or whatever it is; we 
need to make it simple. What they are doing is not sustainable, but 
they need to start redeveloping their pharmacies to go down this line 
of making the pharmacy a health destination...to help people’s 
health...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
 Ownership Resistance to Change 
Community pharmacy leadership (Theme)=>Pharmacy business leadership 
(Subtheme)=>Ownership resistance to change (Code). 
More than half of the participants acknowledged that pharmacy small business 
owners were exhibiting a leadership approach that was resistant to change. This 
manifested as a reliance on the technical process of dispensing, limiting 
professional services and the service leadership approach (Section 7.5). The 
ability of a leader to be flexible and dynamic in response to changing 
circumstances was previously identified (Section 5.2.9) as central to effective 
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leadership. Pharmacy owners adopting leadership approaches that were resistant 
to change in their businesses, signified a leadership that failed to consider the 
environment, which may result in poor community pharmacy leadership. 
Ownership resistance to change was closely correlated with pharmacist resistance 
to change (Section 6.3.1). 
“...If you are the owner, you are the leader, but the question is 
whether you are displaying good leadership... most business 
owners...there starting point is in being a technician... They forget to 
swap caps and they believe that if they continue to be a really good 
technician they are showing good leadership... you've got a lot of 
owners out there who aren't coping, or don’t know how to cope or 
don't know how to address the changing market place...” 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
“...I've had pharmacists who own a business but they sit out the 
back, they do the prescriptions, they do not talk to customers, they 
do not talk to their staff, they employ someone to do it...they've 
defaulted to the lowest common denominator...They hire someone to 
do the job for them...” 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
Several participants thought that the resistance of owners to change was due to 
the lack of small business knowledge, skills and support to manage the changes in 
their business leadership approach. 
“...I think the challenge for community pharmacists is to equip 
themselves with the knowledge of how to deal with the changes...” 
(Participant 22: Professional organisation, Consumer organisation, Pharmaceutical 
industry, Community pharmacist proprietor-Australia) 
“...the Guild’s experience would be that a lot of community pharmacy 
owners are crying out for that high level business management skills 
and the leadership of the team to get them on board to drive their 
community pharmacy to perform...” 
(Participant 29: Professional organisation, Australia) 
Interestingly, one participant (who was not a pharmacist) identified that pharmacy 
businesses have relied on the leadership success of pharmacy organisations, 
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which have created an environment of sustained pharmacy profitability, causing 
community pharmacies to become reliant on the current pharmacy dispensing 
model of medication supply, and many pharmacists have failed to appreciate the 
favorable business conditions, becoming complacent. 
“...Community pharmacy has just looked at the leadership at an 
industry level (of the Guild) and agreements, taken advantage of the 
generics discounts and have made a lot of easy money and they 
have not looked at the risky nature of their businesses...they have 
just sat back and taken it easy, a lot of them think they are extremely 
hard done by, but they are well off compared to virtually every 
country around the world...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
7.2.6.1 Distant Patient Interaction 
Community pharmacy leadership (Theme)=>Pharmacy business leadership 
(Subtheme)=>Ownership resistance to change (Code)=>Distant patient interaction (Code 
property). 
Several participants when describing the technical process of dispensing, reported 
reduced and limited interactions with patients. “Distant patient interaction” was 
believed to be a manifestation of a pharmacy model focusing on the technical 
dispensing of medicines as central to community pharmacy leadership approach. 
As a result of the dispensing focus, participants believed that the pharmacist was 
tied up in the technical process, which reduced the time to interact with patients, 
resulting in poor community pharmacy leadership that is not transformative. 
“...the Pharmacist is usually out the back. They're at the back of the 
shop. They're out... you don't see them very much, or they just come 
out to... there's some symbolism there about being slightly hidden 
back and getting on with the work and just coming out, perhaps, to 
see the, hand over the packet of drugs...” 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-United Kingdom) 
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“...I think, too often, we get put into this almost supply-type function, 
and dispensing-type function and I don't mean to underplay that. It is 
a very important service. But we’ve got to be sort of, be able to use 
our skills better, and get better outcomes...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...the patient has always separated us, by that pharmacy counter. 
You know the pharmacists are behind the counter, and then we go 
out from the counter with the patient, and I think a lot of the new 
models are going to have the pharmacist in different area with no 
barrier and I think that the simple pharmacy counter has hurt us as a 
profession for delivering care...” 
(Participant 6: Professional organisation, Company director, Community pharmacist 
proprietor-North America) 
 Declining Profitability 
Community pharmacy leadership (Theme)=>Declining profitability (Subtheme). 
Declining profitability in community pharmacy business was identified by more than 
half of the participants and linked to the finding that the community pharmacy 
network was experiencing declining business profitability and reduced economic 
viability, primarily due to Pharmaceutical Benefits Scheme reform. Participants 
believed that this in turn resulted in increased financial pressure across the 
pharmacy sector. Declining profitability was recognised as a significant financial 
pressure impacting on the owners’ leadership behaviour and the direction of their 
community pharmacies. This theme was closely associated with the themes 
described in Section 7.2.3 above, financial pressure motivating leadership change. 
In Chapter 5 (Section 5.2.2), pharmacy tacit knowledge described that a deeper 
understanding of the context was pivotal to the leadership vision. Pharmacy 
business owners are leaders, the environment was experiencing financial 
pressure, a tacit knowledge and understanding of these demands would facilitate 
effective pharmacy leadership, through the owners flexibility to be dynamic in 
response to the external influences (Section 5.2.9). 
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“...two big issues with the profession itself, the changes that's 
happening there both from the financial point of view and things like 
that and that's going to affect... it affects the pharmacists' income 
which all bounces down the track to membership of associations...” 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
“...The cost of money in pharmacy is higher... There is pressure from 
suppliers on wages and raw material so the cost of the goods are 
going to go up. There is the cost of the P.B.S reform with the 
discounts...” 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
“...difficulties of running a community pharmacy are a lot tighter than 
any community pharmacist would have looked from 20 years ago, 
where the success that has been heard before is that with a licence 
to print money...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
“...there is a lot of pressure, economic pressure on the business 
model of pharmacy and I think that will be forced to change...” 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
 Increasing Pharmacy Expenses 
Community pharmacy leadership (Theme)=>Declining profitability (Subtheme)=>Increasing 
pharmacy expenses (Code). 
Participants believed that there were several mechanisms that were causing the 
declining profitability in the community pharmacy. Increasing pharmacy expenses 
were identified by one third of participants as significant. These increasing 
pharmacy expenses were placing increased financial pressure on community 
pharmacies and subsequently the owner’s leadership approach. 
“...major shopping centres and the rents that pharmacists pay, will 
the rents become prohibitive that pharmacy has to move out of 
shopping centres...” 
(Participant 23: Professional organisation, Company director, Pharmaceutical 
industry, non-Pharmacist-Australia) 
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“...if pharmacists react to that by culling their staff, they’re shooting 
themselves in the foot...If they react to the turnover, it’s a bad way to 
react to the turnover...having less staff just means you’re probably 
going to lose more business not… you’re not saving yourself, you’re 
shooting yourself in the foot...” 
(Participant 22: Professional organisation, Consumer organisation, Pharmaceutical 
industry, Community pharmacist proprietor-Australia) 
 Profitability Levers 
Community pharmacy leadership (Theme)=>Declining profitability (Subtheme)=>Profitability 
levers (Code). 
Participants believed that it was absolutely essential for pharmacy owners to be 
flexible and dynamic to the changing environment which was placing increased 
financial pressure on the pharmacy business model. Profitability levers were one 
such way that pharmacy owners were implementing dynamic strategies in 
response to declining profitability. A quarter of the participants identified that 
generic substitution has been a strategy widely adopted by community pharmacies 
to increase profitability.   
“...if you are substituting generics in the dispensary and you’re 
embracing professional services, you can maintain your gross 
profit...” 
(Participant 22: Professional organisation, Consumer organisation, Pharmaceutical 
industry, Community pharmacist proprietor-Australia) 
“...taken advantage of the generics discounts and have made a lot of 
easy money and they have not looked at the risky nature of their 
businesses...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
Another strategy identified by a few participants described pharmacy owners 
changing their pharmacy stock mix as a way to improve profitability. 
“...We need to change our merchandise in order to reflect that, we 
need less gifts, less cosmetics, less chocolate, no chocolate, get rid 
of the jewellery, get rid of the junk and focus on these big 
 145 
 
departments, adding these services and skills sets, change the way 
we think about the dispensary...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
 Consumer Driven Strategy 
Community pharmacy leadership (Theme)=> Consumer driven strategy (Subtheme) 
Several participants discussed the need to understand the consumer, driving 
business models to meet consumer demands. The two prominent market positions 
expressed by the majority of participants, was the service and discount leadership 
approaches to pharmacy business. Regardless of the leadership approach, 
whether the pharmacy owner adopted a “discount leadership approach” (Section 
7.6) or a “service leadership approach” (Section 7.5), the most important factor 
reported was that the needs of the health consumer were met, and that the 
leadership approach and business strategy adopted by the pharmacy owner and 
their staff, leaders of community pharmacies, was driven by consumer needs. 
“...CEO of Walgreen...put drive-throughs in their pharmacy and there 
were a few uppity people in the audience saying how on earth can 
you give any kind of professional interaction if someone’s driving 
through in a car? And he completely and unashamedly said we did a 
survey and we respond to what our consumers want, if they say we 
want a drive-through, we’ll give them a drive-through...” 
(Participant 22: Professional organisation, Consumer organisation, Pharmaceutical 
industry, Community pharmacist proprietor-Australia) 
“...different approaches to pharmacy, both serving customer 
needs...You are serving consumers’ needs in different ways. And 
that should be recognised. And it’s a lot more than one degree of 
separation at the moment...Pharmacy isn’t pharmacy, as I’ve already 
learnt in the short time that I have been involved in this review. There 
are very different pharmacy models serving different communities 
with different needs throughout Australia...” 
(Pharmacy Review Panel Chair; Speech Transcript Australian Professional Pharmacy 
Conference 2016) 
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 Service Leadership Approach 
Community pharmacy leadership (Theme)=>Service leadership approach (Subtheme) 
The majority of participants identified that community pharmacies need to adopt a 
service leadership approach to their business. They believed that the service 
leadership approach connected community pharmacy leadership to a higher level 
leadership of the profession facing outwards into the wider health sector. The 
service approach to leadership is a transformative community pharmacy 
leadership, and the leader of the community pharmacy, the pharmacy owner, 
implements professional service strategies within their pharmacy, diversifying 
income streams, transforming the role of the pharmacist from a technical 
dispensing focus to providing professional services. In Chapter 9, participants 
report on the pharmacy profession and how it is currently undergoing a leadership 
transformation challenge. The findings illustrated that at the nucleus of this 
challenge, was the opportunity of pharmacy embracing an expanded role, currently 
available to the pharmacy profession (Section 9.2). The service approach to 
leadership is this expanded role opportunity, available to the network of community 
pharmacies throughout Australia. A service approach to leadership, with consistent 
service quality, will allow the community pharmacy sector the necessary leadership 
essential to transforming the profession and overcoming the challenge. 
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“...let’s talk about the way pharmacy should go and what it should 
look like in 2018. It’s got to be service driven pharmacy model. 
Service driven is more than just doing HMRs and doing medschecks, 
it’s a broad service concept...it is about a pharmacist that can help an 
asthmatic manage his condition better and understand his food 
allergies and reduce the triggers in his day-to-day life, or her. It’s 
about working with diabetics so you can improve their nutrition so 
you can reduce their medication and lifestyle. It is about working with 
obese people, reverse their obesity so they don’t get to be type 2 
diabetes or reverse their pre-diabetes. So that is really where we 
need to go...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
“...So what are we doing to entrench ourselves in a community that 
has significant issues around health, an ageing population, you know 
ranges of issues in the chronic disease space...obviously having 
people take... dispensing the right stuff and people taking it properly 
would seem like pretty fundamental...it’s not just that, you know 
we’ve got to create a population...where wellness is significantly... is 
front and centre. Pharmacists are in a great position to do that...I 
think we need to think that way, rather than think about well...who’s 
going to pay?...” 
(Participant 9: Government organization, Consumer organisation, Organisational 
pharmacist-Australia) 
 Professional Pharmacy Services 
Community pharmacy leadership (Theme)=>Service leadership approach 
(Subtheme)=>Professional pharmacy services (Code). 
One-third of participants identified that the profession needs to seize to opportunity 
related to expanded professional services to enable development of the service 
leadership approach. Professional pharmacy services are the manifestation of the 
service approach to leadership at a community pharmacy level. Pharmacy owners 
currently have numerous expanded service opportunities to implement service 
leadership. 
“... look in the aged care sector, I think it’s appalling that we don’t 
have pharmacists employed by aged care facilities...people who are 
really old, who have multiple comorbidities who take a lot of 
medicines who would benefit from having a pharmacist on the 
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staff...Why aren’t pharmacists part of that process, there is so much 
work out there that we could do...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
“...pharmacists can play a far greater role in the discharge of patients 
from hospitals...Pharmacists should be vaccinating...travel 
vaccination... got to be pharmacists, because they’re in every 
location. And I really believe that is a real opportunity for pharmacists 
to get involved...” 
(Participant 23: Professional organisation, Company director, Pharmaceutical 
industry, non-Pharmacist-Australia) 
One of the challenges identified to delivering pharmacy services was overcoming 
the technical focus on dispensing and medication supply functions, this can be a 
barrier to pharmacist-patient interactions. Four participants identified that 
overcoming this barrier will enable greater pharmacist-patient interactions, 
increased professional services, and the realisation of the service approach to 
leadership in pharmacy. 
“...I'm wanting our pharmacists to not behind that little counter with 
the shutter they can pull up and down, I want them to really get out 
there, get involved with promoting better health... I want to see 
pharmacists to be undertaking forward dispensing... get the retailer 
monkey off our back...” 
(Participant 28: Professional organisation, Military organisation, University sector, 
Military pharmacist-Australia) 
“...a lot of the new models are going to have the pharmacist in 
different area with no barrier and I think that the simple pharmacy 
counter has hurt us as a profession for delivering care and I think the 
new models are going to that barrier away and put the pharmacist 
right there with the patient and I think that is going to help us in the 
long run...” 
(Participant 6: Professional organisation, Company director, Community pharmacist 
proprietor-North America) 
There are several funding issues impacting the service leadership approach. The 
tensions of which were discussed earlier (Section 6.2; competing pharmacist 
identities). Several participants identified the political tensions impacting 
professional services funding. 
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“...this is making things make sense to pharmacy owners, and so the 
idea was to basically reduce...their money being lost to HMRs so 
they brought in medschecks...the owner could control the meds 
checks process and make sure the money went straight to them and 
similar with the clinical interventions...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia 
“...when a direct referral came in...now become a career path for 
some people...somebody making a career out of it, it was never 
envisaged when it first came in... the profession we hoped generally 
would embrace it, and everybody would do some of it... We now 
have some people wanting it for their career...But it was never set up 
that way. And that’s why the funding has become an issue, because 
as a career path, it would only allow a few of accredited pharmacists 
to go down that path...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...We used to say 90% of people worked in community pharmacy, I 
think it’s only down to about 70% now. Over the last 15 years we’ve 
had more and more people doing medication reviews. And the 
capacity for that to grow, and the need for it to grow, is as great as it 
has ever been...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
 Pharmacy Service Strategy and Support 
Community pharmacy leadership (Theme)=>Service leadership approach 
(Subtheme)=>Pharmacy service strategy (Code). 
One third of the participants identified that community pharmacy owners adopting 
the service approach to leadership require an effective leadership strategy and the 
business support to manage the change in their community pharmacy, shifting the 
focus of their business model from the dispensing technical focus to implementing 
professional services. They therefore need a pharmacy business strategy and 
support to implement professional services, to achieve the service approach to 
leadership.  
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“...it has to be with the pharmacy owner, and this is the education 
process and it’s the process of the Guild bringing in new training 
programs, running training programs which are more than just saying 
here is $100 for doing a program, here is the online site, here is a bit 
of material and off you go. They have never actually worked all these 
concepts into the fabric of community pharmacy practice...there 
needs to be resourcing of that, there needs to be change 
management teams in place, because if you throw all of those at the 
pharmacies they will actually make these changes. So that is where it 
has to go...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
“...I think the Guild’s experience would be that a lot of community 
pharmacy owners are crying out for that high level business 
management skills and the leadership of the team to get them on 
board to drive their community pharmacy to perform so well...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
“...with practice change and remodeling your pharmacy, how you can 
deliver a model of pharmacy based around professional services, 
that is a way forward for the future, and is a viable and sustainable 
model of practice...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
7.5.2.1 No Service Leadership 
Community pharmacy leadership (Theme)=>Service leadership approach 
(Subtheme)=>Pharmacy service strategy (Code)=>No service leadership (Code property) 
Several participants identified that pharmacy owners, despite receiving funding for 
professional services, for example Dose Administration Aids (DAAs) and 
medication reviews (Medschecks), did not implement professional services, 
illustrating a failed service approach to leadership. 
“...and I’m like ‘What are you doing about MedsCheck or funding 
for?’… no those guys don’t even have Guildcare. So you know, 
‘What are you doing about DAA? Because then that patient’s yours. 
They’re not gonna go somewhere else’... Sometimes they’re not 
even implementing…” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
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7.5.2.2 Services Delivering Health Outcomes 
Community pharmacy leadership (Theme)=>Service leadership approach 
(Subtheme)=>Pharmacy service strategy (Code)=>Services delivering health outcomes (Code 
property). 
Three participants identified the importance of pharmacy services delivering health 
outcomes to the consumer as integral to the service leadership approach. A 
service leadership approach would utilize pharmacist clinical skills via the provision 
of professional services. These services would deliver health consumers improved 
outcomes. 
...we’ve got to be sort of, be able to use our skills better, and get 
better outcomes. And, as a profession, I've started to speak to 
people about, even professional services... Consumers need to be 
forefront in all of this. And we need this as an opportunity to work 
with consumers, and gain better outcomes... 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
7.5.2.3 Service Quality 
Community pharmacy leadership (Theme)=>Service leadership approach 
(Subtheme)=>Pharmacy service strategy (Code)=>Service quality (Code property). 
The importance of pharmacies needing to adhere to service quality standards was 
identified by four participants. Service quality refers to the quality and consistency 
of professional services that are implemented by pharmacy owners, as part of their 
service leadership approach to community pharmacy leadership. 
“...if Quality Care was taught both in terms of its benefit and in terms 
of continuous quality improvement as a culture rather than just 
passing a QCPP exam, then I think we’d have a situation where we 
would have more leaders who could step up and do pharmacy 
programs, lead teams, go onto pharmacy leadership...” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
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Interestingly, one participant with international pharmacy experience, described a 
service quality accreditation process for community pharmacies that could be 
suitable to Australian pharmacies. Based on the accreditation and quality of the 
pharmacy, which can be regarded as a reflection of the pharmacy owner’s service 
approach to leadership, the pharmacy can access varying levels of funding to 
implement professional services. 
“...Pharmacies are moving towards a system of very strict 
accreditation. They'll be rated as excellent, good, OK and poor and 
some of that will be tied up with whether they're fit to provide 
pharmaceutical services...” 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-United Kingdom) 
 Discount Leadership Approach 
Community pharmacy leadership (Theme)=>Discount leadership approach (Subtheme). 
A discount pharmacy leadership approach was identified by eight participants. 
Participants felt that pharmacy owners who continue to focus on the technical 
dispensing process epitomise the discount leadership approach in their community 
pharmacy. They reported that profitability can be maintained or increased with this 
approach, through focusing on increased dispensing efficiencies and higher 
volumes of dispensing, as community pharmacies generate most of their 
profitability from the dispensing process. One such example provided was a major 
pharmacy group that has adopted the discount leadership approach. Participants 
believed that the discount leadership approach fails to utilize the clinical skills of 
pharmacists, and falls short of seizing the expanded role opportunities needed for 
the profession to overcome the transformation challenge (in Chapter 9). 
“...You know you've got pockets, like for all you say about discount 
pharmacy, you know that is a model, right that is a model...” 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
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“...changes...the most substantial one that everyone was frightened 
of is deregulation, which hasn’t happened. What did happen in its 
place is a different type of deregulation, which came from within, and 
that is the deregulation of how products and prices relate to 
customers, discount model...” 
(Participant 7: University sector, Professional organisation, Academic pharmacist-
Australia) 
 Discount Pharmacy Chain Leadership 
Discount pharmacy chain leadership (Theme)=>Discount leadership approach 
(Subtheme)=>Discount pharmacy chain leadership (Code) 
Four participants identified the effective discount leadership approach adopted by 
the discount pharmacy chains group. They felt that this community pharmacy 
group in Australia was an effective pharmacy group that has an unrelenting 
leadership vision and strategy that has focused on the discount leadership 
approach. 
“...They are a very effective group...Yes, they are leaders. they have 
a vision, they know what their market position is, they know it clearly, 
and they have a great structure and strategy to deliver it...they are 
certainly leading that sector of the industry...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
“...And then you have two groups in particular here. I’m thinking 
about My Chemist, Chemist Warehouse, who have got a single 
minded vision of what they are and where they want to get to and 
they’re very successful...” 
(Participant 25: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and Europe) 
“...we’ve got a lined vision and have different degrees of views, but 
it’s basically the same sort of view which is to grow the business, to 
expand, to dominate our industry, provide the product for the 
consumer, provide a good working environment for the employees, 
have them empowered where they can make decisions...we’ve got to 
empower them and as long as they understand the culture, I think 
the culture’s more important than anything else...” 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
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The participant further identified that a deregulated pharmacy ownership 
environment would facilitate the corporate vision that aims to drive the discount 
leadership approach without any limitations. 
“...Deregulation should occur, I think, because that way we can have 
corporatised environment...more efficient way of being able to 
provide the right solution to the consumers. We’re kind of like that 
because we’ve got 120 partners who are a group of people who are 
all within the law as far as ownership is concerned, and we all have 
one common understanding. But I’d like to have a corporation that 
can do that... that’s what the pharmacy guild doesn’t really want, 
because they don’t corporatise pharmacies...” 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
7.6.1.1 Discount Pharmacy Chains Service Model 
Community pharmacy leadership (Theme)=>Discount leadership approach 
(Subtheme)=>Discount pharmacy chains service model (Code). 
Several participants identified that discount pharmacies may have the capability to 
deliver professional services as part of their discount pharmacy approach. 
“...true discounters don't have the model for practice change, 
although I do see some strong discounters who are incorporating 
professional services quite well within their pharmacy...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...the rapid growth of you know Chemist Warehouse and let’s be 
open because, I’m trying to think, if they ever get their professional 
model right, but their model currently is worked on price and volume, 
and maybe they’re trying to address their professional services in the 
role of the pharmacies, could that be a threat? But there again you 
know there is an opportunity...” 
(Participant 23: Professional organisation, Company director, Pharmaceutical 
industry, non-Pharmacist-Australia) 
 155 
 
7.6.1.2 Discount Pharmacy Chains Understand the Consumer 
Community pharmacy leadership (Theme)=>Discount leadership approach 
(Subtheme)=>Discount pharmacy chains understand the consumer (Code). 
Six participants identified that this group has a significant understanding of their 
customer and effectively delivers a discount leadership approach that satisfies 
consumer needs. Regardless of the leadership approach adopted by pharmacy 
owners, participants believed that the community pharmacy leadership approach 
needs to be driven to the needs of health consumers (Section 7.4 above). 
“...Our number one priority is to satisfy as many people and give 
them the best possible price, give them the best range of products 
and give them all that sort of thing... For us we want to have a happy 
satisfied customer who’s going to buy more and who’s going to bring 
more people here to our store...” 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
“...they understand their customer better than anyone else in 
Community Pharmacy. They really understand their customer and 
how to give to them, what they are looking for...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
7.6.1.3 Discount Pharmacy Chains Relations with Peak Pharmacy Organisation 
Community pharmacy leadership (Theme)=>Discount leadership approach 
(Subtheme)=>Discount pharmacy chains relations with peak pharmacy organisation (Code). 
Six participants identified the turbulent relations between key pharmacy 
stakeholders. The participants believed that the discount pharmacy leadership 
approach adopted by some pharmacists was in conflict with the peak pharmacy 
organisations that protects the ownership of the majority of Australian pharmacy 
owners. Further, this professional organisation was believed to be trying to provide 
business support to assist pharmacy owners in their implementation of the service 
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leadership approach within their community pharmacies. The result of these 
tensions has translated into a conflict between the largest discount pharmacy chain 
and the peak pharmacy organisations. In turn, participants felt this has impacted 
the direction of community pharmacy leadership as a whole, particularly the 
“commodification” of medicines as simply items of commerce due to increased 
pharmacy competition and impact of the discount leadership approach (Section 
8.2). The influence of pharmacy stakeholders is further examined in Section 8.6. 
“...legislation basically says that the agreement is negotiated with a 
group that represents the majority of approved pharmacists. 
Approved pharmacists are the people that are approval numbers. So 
Chemist Warehouse is 280 approvals...The government can talk to 
them just like they can talk to anyone... everyone perceives that the 
government loves them. The government doesn’t like them...” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
“...The guild did things which were against our interest...they reduced 
the relocation rules which were aimed solely about our stores...we 
can’t belong to an organisation that’s trying to undermine us. So we 
pulled out...Whenever we’ve tried to do anything politically it’s always 
backfired…the guild’s too strong and powerful...most cases it’s 
against my interests because the guild is against my interests...” 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
 Chapter Summary 
This chapter has reported participant views of community pharmacy leadership. 
Community pharmacy leadership constituted a significant component of 
participants’ understandings of pharmacy leadership. This is due to the community 
pharmacy sector being the primary employer of pharmacists in Australia, with 
approximately 75% working in community pharmacies. Furthermore, there was a 
strong awareness of community pharmacies (due to the network of 5600 
pharmacies nationally) which forms the infrastructure for the medicine supply 
through the Pharmaceutical Benefits Scheme (PBS) to health consumers. 
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Therefore, for these economic reasons, participants reported community pharmacy 
leadership as the most prominent leadership in the pharmacy sector. 
Participants identified that pharmacy owners were in positions of leadership, 
however, they recognised that pharmacy ownership does not necessarily equate to 
exhibiting effective leadership. The findings of the theme community pharmacy 
leadership have been reported above and related to the definition of pharmacy 
leadership through the leadership traits of cognitive flexibility, tacit knowledge and 
vision. Cognitive flexibility was viewed by participants as essential to pharmacy 
owners (leaders) adopting a flexible approach to their business (Section 7.2.5). 
Participants believed that a lack of cognitive flexibility from pharmacy owners 
manifested as a resistance to change and was an indicator of failed leadership 
(Section 7.2.6). Participants reported that pharmacy owners adopted a vision 
depending on their consumer driven strategy which manifested as the service 
leadership approach (Section 7.5) or discount leadership approach (Section 7.6). 
Tacit knowledge was also viewed as essential to pharmacy owners’ understanding 
of the financial pressures impacting their business leadership (Section 7.3). 
Participants identified that community pharmacy leadership consisted of the 
subthemes pharmacy business leadership, declining profitability, consumer driven 
strategy, service approach to leadership and the discount approach to leadership. 
Pharmacy business leadership describes the owner’s leadership in their pharmacy 
as either flexible or resistant, and includes financial leadership and responsibility 
(Section 7.2.1). The subtheme declining profitability explains the increasing 
financial pressure impacting the leadership approach of pharmacy owners and 
identifies financial leadership strategies that can improve small business 
performance (Section 7.3.2). The subtheme consumer driven strategy describes 
the need for pharmacy owners to synchronize their leadership approach with the 
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needs of health consumers. Participants reported that the two main leadership 
approaches meeting consumer needs were the discount and service approach to 
leadership (Section 7.5 and Section 7.6). The subtheme, service leadership 
approach was reported by participants as the most important leadership approach 
needing to be adopted by pharmacy owners. Primarily, as this approach links to 
professional leadership and a broader profession-wide transformation that expands 
the role of the pharmacist (Section 9.2). Participants felt that there was a need for 
business support and strategy to ensure pharmacy owners implemented effective 
leadership (Section 7.5.2). The discount approach to leadership was explained as 
owners targeting consumer price needs and improving the efficiencies in their 
business such as focusing the technical dispensing process (Section 7.6). This 
discount approach to leadership was viewed as a barrier to the transformation of 
the profession and realising the pharmacists expanded role opportunities (Section 
9.2). 
The next chapter of this thesis (Chapter 8) will examine the theme, pharmacy 
sector leadership influences. The pharmacy sector influences directly impact the 
community pharmacy sector, as they present opportunities and threats in the 
external environment in which community pharmacies operate. For example, the 
influence of government and pharmacy regulatory frameworks impact the 
leadership and operations of community pharmacies. Therefore, these influences 
directly affect the leadership approach adopted by pharmacy owners. 
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Chapter 8: Pharmacy Sector Leadership Influences 
 
 
“...We have all these people with vested interests. 
The Guild is playing their games, PSA is playing 
their games, wholesaler looking after themselves, 
manufacturers looking after their little lot...no-one is 
putting it all together...” 
(Participant 5: Professional organisation, Company director, non-
Pharmacist-Australia) 
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 Pharmacy Sector Leadership Influences 
Pharmacy sector leadership influences (Theme)=> 
This chapter of the thesis examines influences impacting pharmacy sector 
leadership at multiple levels. Participants identified the influence and impact of 
various pharmacy and health stakeholders on leadership across the pharmacy 
sector. Participants further reported challenges and threats; such as the rapidly 
changing health context and commodifying of medicines that are influencing 
pharmacy sector leadership. At one leadership level, the sector influences are 
impacting community pharmacy leadership through influencing pharmacist owners 
and their small business leadership approach. At a professional level, the sector 
influences are impacting the profession’s leadership facing outwards, more broadly 
into the wider health context. There were no differences found between Australian 
and International participants in this chapter. There were also no differences 
reported between male and female participants. 
Table 8.1 Dimensions and Properties of the Theme: Pharmacy Sector Leadership 
Influences 
Theme Theme description Subthemes 
Pharmacy sector leadership 
influences 
The unique pharmacy sector influences impacting 
pharmacy leadership; including external changes 
and challenges in the pharmacy sector, and other 
pharmacy and health stakeholders. 
Commodifying medicines 
The influence of government 
Rapidly changing health context 
Regulated and fixed frameworks 
Pharmacy stakeholder leadership 
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 Commodifying Medicines 
Pharmacy sector leadership influences (Theme)=>Commodifying medicines (Subtheme). 
An emerging subtheme identified by one-third of participants was the 
commodification of medicines in the pharmacy profession. Commodifying 
medicines is the notion of treating medicines as a normal item of commerce 
through intensified competition that changes the widespread understanding of the 
value of medicines. Participants report that commodifying medicines, and focusing 
on retail sales and profitability, is a significant threat influencing leadership across 
the pharmacy sector at two leadership levels. They believed it impacted community 
pharmacy leadership, by intensifying competition, through the commodification of 
medicines across community pharmacy practice. In turn, this led to changes in 
consumers understanding of medicines, shifting from a respected poison to a 
normal item of commerce. At the top level, they felt that commodifying medicines 
impacted the profession’s image facing outwards; decreasing leadership credibility 
with consumer groups, as stakeholders expected more from the profession’s 
leadership across the sector. 
“...And health officials... don’t want to see health commoditised. The 
modernisation of health is you take shortcuts...” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
“...I only see things one way, which is how to maximise the sales with 
this...our main focus is on maximising the sales and ultimately 
profitability, other people’s might be maximising the self-satisfaction 
of actually treating people and provide better clinical outcomes. 
That’s important to us, but it’s not the main focus....And our focus is 
on maximising the sales...” 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
“...one could say the discount model that we’ve got currently, that’s a 
concern on community pharmacy...from a political point of view it’s 
good because it demonstrates to government that our sector has 
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competition... I get concerned that if we treat pharmacies as 
delivering just purely a commodity, well then we don’t have a point of 
difference...” 
(Participant 23: Professional organisation, Company director, Pharmaceutical 
industry, non-Pharmacist-Australia) 
“......Medicine’s becoming a commodity...everyone’s discounting 
it...the challenge is to bring it back to medicine is not an ordinary item 
of commerce...It’s not an ordinary item of commerce...It’s poison…” 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
“...consumer health forum... understanding with what pharmacy could 
do... saying, you guys can do better, do it. You know, why should we 
have to cater to you guys it’s your profession, we want you to do 
better, you go and do better...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
 Discount Pharmacy Impact 
Pharmacy sector leadership influences (Theme)=>Commodifying medicines 
(Subtheme)=>Discount pharmacy impact. 
One third of participants identified that the impact of discount pharmacies has 
caused an increase in pharmacies adopting the service leadership approach, and 
has impacted the leadership of the peak professional body representing 
pharmacist owners. They believed that the impact of the discount leadership 
approach has been significant across the community pharmacy sector (examined 
in detail in Section 7.6). They reported that the discount pharmacy impact has 
placed increased competitive pressures on pharmacy owners (community 
pharmacy leaders), resulting in community pharmacies implementing the service 
approach to leadership in order to differentiate their business, as part of their 
consumer driven strategy (Section 7.4). 
“...a professional services model that has been developed by a lot of 
people to try and maybe combat the true discounters that are out 
there... And they find they need a challenge, I guess, to compete with 
 163 
 
the discounters... those who are looking as a niche, I suppose, to try 
and compete with the strong discounters...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...discount pharmacies have a big impact on retail community 
pharmacy, and therefore the Guild, right. OK, we need to 
acknowledge the problem is there, it's going to be there forever. Love 
them or hate them you're not going to get rid of them, right. OK, 
we've got to be smarter and let those people sell their vitamins in 
bucket loads and cheap prices and let them discount the 
prescriptions, but we can be more professional...” 
(Participant 28: Professional organisation, Military organisation, University sector, 
Military pharmacist-Australia) 
Several participants acknowledged that the current impact of discount pharmacies 
has provided some support for supermarkets gaining a foothold in the pharmacy 
sector through increased competition. 
“...once the retailers came in and took over, it's just been a disaster 
and then with corporatisation happening, I mean, let's face it, we've 
got supermarket pharmacies now with the big discounters... to run 
the scare campaign about supermarkets, is pretty much irrelevant 
now. I mean, we have our own supermarkets within pharmacy...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
Five participants reported that the emergence of the discount leadership approach 
demonstrates to the government that the pharmacy sector is competitive. These 
participants were of the opinion that the profession’s leadership have used the 
increased competition caused by the discount leadership approach, as a political 
argument put to government that the sector is competitive.  
“...So you know if I had to be honest, there’s no sort of perception 
that pharmacy’s got a cosy arena. They’re very stiff. Tough 
competition. So health helps at the Guild politically...” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
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“...one could say the discount model that we’ve got currently, that’s a 
concern on community pharmacy in some way, but from a political 
point of view it’s good because it demonstrates to government that 
our sector has competition from within itself...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
 The Influence of Government 
Pharmacy sector leadership influences (Theme)=>The influence of government (Subtheme). 
This subtheme examines the influence of government and its impact on pharmacy 
policy. The subtheme covers broad areas from fixed and regulated frameworks in 
the pharmacy profession to the fiscal pressures impacting government health 
policies. A quarter of the participants provided insights into the complexities of the 
political process; such as the profession articulating a clear vision that government 
decision-makers understand, the challenging political timeframes, departmental 
silos within government which make the political process arduous, all of which 
place demands on politicians and pharmacy leaders involved with policy. 
“...bureaucrats are all… they’re only interested in their silos. So the 
silo of MBS, they don’t care what occurs in PBS... There’s a lot of 
letting go as a politician...And there’s a lot of blood sweat and tears 
put into something that either gets… never makes it past Cabinet or 
never gets it past Caucus or they get a pass and its execution is 
horrible or one or two bureaucrats have let them down who shouldn’t 
even have a job...” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
 Government Fiscal Influences 
Pharmacy sector leadership influences (Theme)=>The influence of government 
(Subtheme)=>Government fiscal influences (Code). 
A quarter of the participants identified that government health policy is influenced 
by fiscal pressures. The government is the primary payer of pharmaceutical 
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benefits, and the costs of health, including medicines, have been rapidly increasing 
due to an ageing population and increased chronic conditions (Section 8.4). 
Consequently, participants felt that Government decisions were influenced by cost 
savings measures, and they cited price disclosure and PBS reform as evidence of 
government fiscal decisions that have impacted the pharmacy sector by reducing 
pharmacy profitability and providing government savings. They believed that the 
government was reducing the amount of remuneration to community pharmacies 
for the technical dispensing process, and this placed increased financial pressure 
on community pharmacy owners to adopt a different leadership approach. 
“...government will only listen to things that save them money and 
doesn't cost any more money and doesn't involve a lot of work...if 
you come into a government proposal that shows how you can save 
money, not involve more work and as an aside actually helps the 
outcomes of the nation that's a winner and so pharmacy has to really 
push itself to head down that...” 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
“...government funding would suggest that we’ll allocate this bucket 
for pharmacy and this bucket for nursing and this bucket for physio, 
for example, and it disappeared, government see the most efficient 
and best services to deliver regardless of who delivers it...willingness 
to accept that it must change to ensure that the pharmacy as a 
profession continues to deliver and deliver in what is required by 
health consumers and by the government...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
Four participants reported that the Government is currently paying community 
pharmacies too much for their current role, which is focused on the technical 
dispensing process. 
“...Is the government going to get to a point where they feel like we 
are overpaid for what we do?...” 
(Participant 6: Professional organisation, Company director, Community pharmacist 
proprietor-International) 
“...I don’t think Pharmacy, the guild can go along representing 
pharmacy, and say to government, our income per script used be 
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$14, now it’s down to $12, we have some problems and we need you 
to increase the dispensing fee by a $1.50. Government is just going 
to laugh at them...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
In addition to the information in the Minister for Health speech transcript, one 
participant identified that government spending is influenced by achieving 
improved consumer health outcomes. 
“...And I know the, the department, the government has mentioned to 
us that in the future, they’re going to be very focused on paying for 
outcomes...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...As I have said before, the pharmacist’s role is a special one We 
share the core objective: improved outcomes for health consumers... 
primary aim of the Commonwealth Government’s regulation of 
pharmacies – to ensure that the sector is working efficiently, 
effectively and remains viable to meet the needs of consumers...” 
(Minister for Health and Aged Care; Speech Transcript) 
 Government Pharmacy Relationship 
Pharmacy sector leadership influences (Theme)=>The influence of government 
(Subtheme)=>Government pharmacy relationship (Code). 
About one third of participants acknowledged the relationship dynamics between 
the government and the pharmacy profession. The focus of their discussions was 
on the five-yearly community pharmacy agreements. The Community Pharmacy 
Agreement (CPA) is a 5-year framework that determines the leadership 
environment in which the community pharmacy sector operates. The CPA is 
negotiated between the government and the peak body representing the majority 
of pharmacists’ owners. Participants identified that the government is controlling 
the relationship with limited respect to the profession. Changing relationship 
dynamics between the government and pharmacy impacts the negotiations of the 
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CPA, directly influencing the leadership environment in which community 
pharmacies operate. 
“...the issues facing pharmacy, and it’s all to do with relationship of 
government at that strategic level, because you’ve got the monopoly, 
a government sponsored monopoly on the availability of drugs...” 
(Participant 25: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and International) 
“...That’s not to say we will agree on everything on how we get there 
– we won’t. But your sector is integral to the Government’s health 
reform plans...” 
(Minister for Health and Aged Care; Speech Transcript) 
“...Well I think the relationship for the moment is one of being taken 
for granted...there’s a lack of respect there for the sort of contribution 
that the pharmacy sector makes...respect for the fact that they 
employ 40,000 young Australian men and women...and I don’t see 
that happening at the moment...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
The controlled negotiation process that occurs with the CPA is closely correlated 
with the organisational and leadership disunity between pharmacy organisations, 
motivated by the disparity in leadership control of one dominating pharmacy 
organisation (Section 9.4). One-third of the participants identified the controlled 
negotiations between the government and the Guild impacting collaboration 
between pharmacy organisations and stifling professional services leadership. 
“...That negotiation and the control of that negotiation, and what goes 
on in that negotiation, in other words the whole understanding of the 
context of what to do in relation to context is done behind closed 
doors...I really try not to be pejorative...at the end of that agreement 
the Emperor comes out onto the balcony and announces to the 
minions in the square...Caesar’s delivered...” 
(Participant 7: University sector, Professional organisation, Academic pharmacist-
Australia) 
“...with the Pharmacy Guild being the only negotiator in the CPA... 
controlling the CPA market, controlling professional services, and 
controlling a number of things in that, with very limited probably 
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collaboration with other parts of the profession...led...to a bit of a 
divide in the profession...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...how the Guild and the agreement is sort of set up, has stifled 
some of the innovation...home medicine reviews and things probably 
haven’t taken off as strongly as they could of...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
Ten participants identified that the Community Pharmacy Agreement has caused 
tension between pharmacy organisations. 
“...the organisations and the leaders within those organisations 
probably agree on 80 or 90 percent of things but it’s the ten or 20 
which causes the issues. So its agreement and its putting aside 
vested interest in my view to achieve what they want to achieve...” 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
“...It is called... the Guild government agreement is negotiated on 
behalf of the profession by the Guild with the Commonwealth of 
Australia for the provision of the Pharmaceutical Benefits Scheme. 
Having organisations sniping at that from the sidelines is extremely... 
it serves no benefit. It serves no benefit to anybody's members. What 
people need to do is to focus on their core business and leave the 
core business of other organisations to other organisations...” 
(Participant 8: Professional organisation, Government organization, Consumer 
organisation, Community pharmacist proprietor-Australia) 
Three participants, all non-pharmacists, identified that the changed focus of the 
Government may risk damaging the medicine supply and distribution network 
around Australia through continually undermining the sustainability of the 
pharmacy network. 
“...what are the savings achieved by good healthcare and therefore 
prevention, does that far and away exceed any short term cost 
savings that may be achieved by doing something drastic to the 
pharmacy supply chain?...” 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
“...long term problem for the government in allowing this to happen in 
that the government needs this network of pharmacy throughout 
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Australia – it is the jewel in the crown...it’s the network that provides 
access for the public to pharmaceuticals within 24 hours, any 
pharmaceutical within 24 hours anywhere in Australia. And to go 
about you know introducing policies which undermine the viability of 
pharmacy...undermine the network...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
A few participants identified that the government expects pharmacy to deliver 
health services that improve consumer health outcomes. Therefore, the challenge 
for pharmacy leaders is to ensure that all pharmacist owners deliver upon 
government’s expectations consistently across the sector, as this will have a 
positive feedback on the challenging dynamic relationships between the sector and 
its leaders and the government. 
“...I see a vital role for pharmacy in providing a link with the broader 
health reform agenda to develop consumer care consistent with the 
work being undertaken elsewhere in my portfolio... The key objective 
of all these initiatives, including the pharmacy trials, is improved 
health outcomes for consumers...” 
(Minister for Health and Aged Care; Speech Transcript) 
“...So from a public point of view and a government point of view we 
need – the real challenge for any leader, pharmacy leaders now, is, if 
we say X will happen and pharmacists will do X then pharmacists 
have to do X, not half X, not two-thirds X, not X minus...” 
(Participant 14: Professional organisation, Community pharmacist-Australia) 
A quarter of the participants identified the opportunity to government when utilising 
the pharmacy profession for the delivery of cost-effective services, and believed 
that the profession’s leaders should focus on articulating these benefits more 
clearly to the government. This comes back to a leadership vision (Section 5.2.1) 
of championing the profession outside of the sector, showing the benefits that 
pharmacy and pharmacists provide to society, the health consumer and the 
government.  
“...the government needs pharmacy to provide these professional 
services so that government doesn’t have to provide them through 
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you know doctor surgeries or hospitals...these professional services 
can be provided without the government having to pay for any new...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
“...we have a situation where some patients literally go off to the 
doctor to get Panamax...The cost recovery of that is around nine 
dollars and everyone just thinks that’s the cost...The real cost is the 
doctor visit... we call administration bills... our Minor Ailments 
Scheme was never anything that wasn’t already in a pharmacist’s 
schedule...Let’s try and clear people giving administration business 
to doctors...You can scope down the cost. You can do the economic 
benefit...quantify the risk...” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
“...we will do this in order to receive that, which will save you money 
and even save the state government money...you are saving 
downstream healthcare costs, hospitalisations, through something as 
simple as good medication management....” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
 Rapidly Changing Health Context 
Pharmacy sector leadership influences (Theme)=>Rapidly changing health context (Subtheme). 
This subtheme examines the increasing demands placed on the health system by 
chronic health conditions, technology, and an ageing population, and how this will 
impact the profession’s role in the changing context. The increased demands 
impact leadership at a community pharmacy leadership level, with businesses 
needing to incorporate new technologies and change their leadership approach to 
accommodate the increasing population health demands. At a top leadership level, 
these changes influence government fiscal policies (Section 8.2.1) with pharmacy 
leadership needing to enact a strategic vision that incorporates the rapidly 
changing health context that is placing increased demands on the pharmacy 
sector. More than half of the participants identified that healthcare costs were 
increasing, namely due to an ageing population and greater burden of chronic 
diseases. 
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“...it’s the aging population, and the government trying to figure out 
how they are going to provide healthcare for their citizens. And 
where does pharmacy fit in that?...” 
(Participant 6: Professional organisation, Company director, Community pharmacist 
proprietor-International) 
“...if you look up Intergenerational Report... expenditure in each of 
the categories like health...versus the expected need for expenditure 
in 40 years’ time... Now it demonstrates that the expenditure required 
for health care alone is more than 100% of Australia’s budget...” 
(Participant 7: University sector, Professional organisation, Academic pharmacist-
Australia) 
“...There needs to be an emphasis on a better understanding of the 
pressures on government...squeeze on healthcare budgets...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
Almost a quarter of participants recognised that population health needs were 
demanding greater healthcare delivery across the pharmacy sector. They felt that 
this presented a leadership opportunity for the pharmacy profession to enact 
pharmacy’s expanded role opportunity (Section 9.2), through implementing a 
service approach to leadership (in Section 7.5) across the community pharmacy 
sector. 
“...We face significant challenges in maintaining the sustainability of 
our health system, and at the same time continuing to deliver the 
high quality care all Australians have come to expect... Pharmacy’s 
challenge is to build on its role as an important part of primary and 
hospital care; by identifying opportunities where your professional 
skills can add to the consumer’s health...” 
(Minister for Health and Aged Care; Speech Transcript) 
“...longer ago... largely dispensing and supply was what we wanted... 
now...we've got so many people living with complex long term 
conditions...technology and other things are driving change and 
individuals can do so much more self-care... there's such an 
opportunity for Pharmacists to do more...” 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-International) 
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More than one third of participants recognised that the impact and burden of 
chronic diseases placing increased pressure on the leadership within the 
community pharmacy sector. 
“...Demographic and lifestyle changes have increased our burden of 
chronic disease, not only increasing the demand for health services 
but also changing their complexity...” 
(Minister for Health and Aged Care; Speech Transcript) 
“...We live a lot longer than ever before, and the longer you live, 
opportunities or chances you have to have a debilitating or terminal 
disease increases. 75% of the all the health care spend over your 
lifetime, occurs in the last 10 years of life...” 
(Participant 6: Professional organisation, Company director, Community pharmacist 
proprietor-International) 
 Regulated and Fixed Frameworks 
Pharmacy sector leadership influences (Theme)=>Regulated and fixed frameworks 
(Subtheme). 
This subtheme examines the highly regulated and fixed frameworks in the 
pharmacy profession, and the subsequent impact on community pharmacy 
leadership as reported by the participants. A quarter of participants identified the 
regulated and fixed frameworks that exist within the pharmacy profession. They 
reported that pharmacy leadership at all levels operates within fixed frameworks in 
a highly regulated pharmacy context, and that changes to these frameworks and 
regulations will impede and impact pharmacy leadership at a professional and 
community pharmacy level. The participants believed that the highly regulated and 
fixed frameworks in the pharmacy profession resulted in a leadership that lacked 
flexibility (Section 5.2.9) because the operating environment was static. 
“...regulation...structures...frameworks and things...have had some 
impact...I think it’s almost like...trying to stem the tide of an ever 
rising tsunami. I just think it’s going to get to the point where some of 
the existing frameworks and rules that are in place will fall over 
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because of ...government ideological pressures or the pressures of 
others in the industry or pressures outside of the industry...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
“...In terms of what I observe, what I observe in pharmacy is a 
leadership which is focused on encouraging individuals in the 
profession to pursue, to enact, a fixed outcome. There is little 
flexibility in it. That’s what I observe...highly regulated...deeply fixed 
framework...the Pharmaceutical Benefits Scheme...pharmacy 
regulatory framework...it’s a deeply fixed context...reduces the 
necessity for imagination, flexibility...As a result the imagination of 
the profession...has been deprived... pharmacy is riven through with 
fixated frameworks, inflexible frameworks...” 
(Participant 7: University sector, Professional organisation, Academic pharmacist-
Australia) 
 Deregulation of Pharmacy Ownership 
Pharmacy sector leadership influences (Theme)=>Regulated and fixed frameworks 
(Subtheme)=>Deregulation of pharmacy ownership (Code). 
One-third of participants identified that pharmacy leadership is conserving current 
pharmacy ownership laws. They believed that pharmacy leadership at a top-level 
has focused on maintaining the security of pharmacy ownership, through a 
protective leadership preserving the community pharmacy operating context 
across the profession, as opposed to a visionary leadership expanding the role and 
capabilities of the profession. 
“...pharmacy leaders at the moment are doing a great job in providing 
and maintaining the security within our profession, guarding our hold 
on the ownership of pharmacy and that other professions and 
supermarkets don't take over and protecting our ground...” 
(Participant 12: Professional organisation, Consumer organisation, Advanced 
practice pharmacist-Australia) 
“...we've been fighting the risk of deregulation for the last ten years or 
15 years. Everyone's saying ownership's going to go. Well ownership 
will never bloody go. There's too many rules and acts to change for 
that to happen in my lifetime...” 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
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Six participants identified the ongoing threat of supermarkets with regards to 
community pharmacy leadership and ownership. 
“...both political parties that have shown me plans drawn up by 
Coles, by Woolworths, of where they would put their 
pharmacies...Coles always talk to people like My Chemist...their 
submissions that they put forward...advanced in...where they would 
put the pharmacies...” 
(Participant 25: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and International) 
“...Woolworths had plans in place to put a pharmacy in every major 
supermarket in capital cities. They've done their homework...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
Interestingly, only three participants recognised the economic and social costs if 
deregulation of pharmacy ownership occurred. They believed that deregulation 
would be detrimental to the government and leadership of the pharmacy sector, as 
areas of the Australian population need will not have access to essential pharmacy 
services. 
“...pharmacies within supermarkets...would they do that to the 
detriment of the service that a pharmacy...provides, needle 
exchange...” 
(Participant 23: Professional organisation, Company director, Pharmaceutical 
industry, non-Pharmacist-Australia) 
“...whichever government decided to deregulate...You’re decimating 
our communities, and you’re reducing health care to the elderly and 
to the sick...” 
(Participant 25: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and International) 
Intriguingly, only one participant identified that the pharmacy profession needs to 
deliver greater healthcare in order to maintain the right to have regulated 
ownership. 
“...You can’t argue that pharmacists should have...particular rights 
within a community, you know not to have competition...if we want to 
be able to argue that pharmacy only ownership, you know that there 
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is a reason why we have restrictions on ownership and a range of 
other things, then you’ve obviously got to have a duty of care beyond 
the door of your pharmacy...” 
(Participant 9: Government organisation, Consumer organisation, Organisational 
pharmacist-Australia) 
One participant fervently believed that pharmacy deregulation should occur. 
“...Deregulation should occur… should’ve occurred by now… I can 
own a legal practice; I can own a medical practice...but someone 
else can’t own a pharmacy? Doesn’t make sense. Deregulation 
should occur, but it probably won’t for some time because the guild is 
very strongly against deregulation...” 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
 Pharmaceutical Benefits Scheme Reform 
Pharmacy sector leadership influences (Theme)=>Regulated and fixed frameworks 
(Subtheme)=>Pharmaceutical Benefits Scheme reform (Code). 
One-third of participants identified PBS reform through price disclosure as 
significant influencing factor stimulating community pharmacy leadership change 
due to reduced profitability. They expanded on this notion by explaining that the 
continual reform of the Pharmaceutical Benefits Scheme (PBS) was placing 
financial pressure across the pharmacy sector, reducing the profitability of 
community pharmacies as the technical dispensing process was declining in 
remuneration. As presented earlier, financial pressure is a motivator of community 
pharmacy leadership change (Section 7.2.3). 
“...it’s not easy there will be pain...your income’s going to be 
dramatically reduced through the pricing system...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
“...PBS reform... deals that are being offered are being scrutinised far 
more because the government has been offering this handout for a 
long time and they've realised...” 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
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“...the impact of accelerated price disclosure, the expectation that 
government is trying to save as many dollars as they can, means that 
things continue to change and to maintain the status quo in 
pharmacy means that a lot of pharmacies won't survive if they don’t 
adapt to the changing nature of the industry...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
 Regulated Professional Services 
Pharmacy sector leadership influences (Theme)=>Regulated and fixed frameworks 
(Subtheme)=> Regulated professional services (Code). 
Greater funding for professional services across the community pharmacy sector 
will facilitate the service leadership approach (in Section 7.5). A quarter of the 
participants acknowledged that the CPA process has pigeon-holed pharmacy 
funding, which promotes the technical dispensing process as remuneration is 
linked to dispensing. Further funding for professional services across the 
community pharmacy sector to facilitate the service leadership approach (in 
Section 7.5), needs to come from other funding sources. 
“...The agreement's stopping the government negotiating with 
pharmacy on any other issue because they see it as though 
we've..."This is pharmacy's in this box of money. That's your money. 
What do you want more for?... we've given you this. Sort it out in 
there." Whereas it needs to be sorted out outside that agreement 
dollar and now I'm talking about a range of professional services...” 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
One third of participants identified that there is an agreement service farce, with 
some organisational leaders promoting service uptake to substitute loses caused 
by PBS reform in an attempt to increase pharmacy owner profitability. The 
implementation of some of these services at a community pharmacy leadership 
level, lacks quality and evidence. 
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“...some leaders within our profession will say, there’s an opportunity 
in professional services at the moment to offset...the losses you’re 
getting from price disclosure...I hope people don't view it clearly as 
that way...you don't tend to put in to it the quality you should do to get 
outcomes for the patient...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...the Guild’s given a lot of these guys 25 to 30 grand bottom line 
profit boosting a year if they implement this program...” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
“...it’s all about giving money back to the owners...a couple of meds 
checks a week, you’re not going to be 
efficient...experienced...designed to get some money in and bugger 
the quality...make sense to pharmacy owners... reduce the amount of 
money...being lost to HMRs...brought in meds checks and again 
there is very little evidence...the owner could control the medschecks 
process and make sure the money went straight to them...similar with 
the clinical interventions...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
A few participants had concerns with the sustainability of agreement service 
funding, which directly impacts the service leadership approach adopted by 
pharmacist owners. 
“...the program has got some problems that still concern me...our 
pharmacy budget that is capped... NBS is an option. Although the 
Department tells they’re not keen... it is an underfunded 
program...with the ageing population, chronic disease...we’ve just got 
to find another way of funding the HMR budget to a realistic level...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...It’s like generic substitution in the dispensary, you have to be 
ready to go on day one...limited time now, and who knows how long 
they’ll fund us PPIs. There’s always a question over whether it’s a 
recurring thing...” 
(Participant 22: Professional organisation, Consumer organisation, Pharmaceutical 
industry, Community pharmacist proprietor-Australia) 
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 Pharmacy Stakeholder Leadership 
Pharmacy sector leadership influences (Theme)=>Pharmacy stakeholder leadership 
(Subtheme). 
The majority of participants identified that the leadership of pharmacy stakeholders 
influences leadership across the pharmacy sector. Pharmacy stakeholder include 
pharmacy organisations, the hospital pharmacy sector, the university pharmacy 
sector and pharmaceutical stakeholders in the medicines industry. 
 Hospital Pharmacy Leadership 
Pharmacy sector leadership influences (Theme)=>Pharmacy stakeholder leadership 
(Subtheme)=>Hospital pharmacy leadership (Code). 
Although the majority of findings related to community and organisational 
leadership, an important insight can be gained from the hospital pharmacy sector. 
A quarter of participants identified the hospital pharmacy leadership, particularly 
with developing career diversity and increasing professional opportunities available 
to the pharmacists. They believed that hospital pharmacy leadership entrenched 
pharmacists as part of the broader healthcare team, seizing expanded role 
opportunities that increased career diversity (Section 9.2). 
“...In the hospital environment because some of the funding’s 
different there might be opportunity for unique and niche training 
opportunities and things like that so you might have more 
experiences in a hospital environment...” 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
“...hospital pharmacists have done quite well in entrenching 
themselves in the team... or are doing better at becoming an 
important part of the team, you know of the ward pharmacists and 
others...” 
(Participant 9: Government organization, Consumer organisation, Organisational 
pharmacist-Australia) 
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Several participants identified the political environment and competition faced by 
the peak hospital pharmacy organisation. 
“...The SHPA is politically weak because the State governments fund 
on a different basis...” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
“...SHPA obviously looks after its own, I think there’s been a history 
of antagonism between SHPA and PSA unfortunately because they 
are competitive or they are competing in the same area and that’s 
between you and me I think there has been some arrogance on 
behalf of some parts of the SHPA thinking they know more than the 
rest of the profession...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
 Pharmacy Student Organisation 
Pharmacy sector leadership influences (Theme)=>Pharmacy stakeholder leadership 
(Subtheme)=>Pharmacy student organisation (Code). 
A quarter of participants identified the influence of the pharmacy student 
organisation ensuring leadership development across the profession. 
“...supporting NAPSA is really valuable because that’s that 
snowballing effect of the growing pool of pharmacists that are 
perhaps the natural leaders...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
“...NAPSA has to have a stronger place in our industry to show that 
these are the future leaders...” 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
“...NAPSA has been very good...in developing... in helping to develop 
leaders for the future...a lot of those people coming through are 
getting training in their own way, to potentially be future leaders 
within the pharmacy profession...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
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Interestingly, one participant identified that the student organisation is pulled in 
different directions by other pharmacy stakeholders. 
“...NAPSA is still quite a young organization... there’s so many things 
holding it back...we’re being pulled in a few different directions...” 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
 The Pharmacy Board of Australia 
Pharmacy sector leadership influences (Theme)=>Pharmacy stakeholder leadership 
(Subtheme)=> The Pharmacy Board of Australia (Code). 
Four participants identified the leadership influence of the board in professional 
ethics and standards across the profession. They felt that the Pharmacy Board of 
Australia influenced leadership across the pharmacy sector through ensuring that 
pharmacy practice and practitioners adhered to appropriate ethical standards. 
“...behind the scene is the pharmacy board and pushing for greater 
knowledge and skills and working at higher standard and I think they 
will have to start having a bit more teeth in the next five years 
hopefully when they will be demanding that the pharmacist will be at 
a higher level...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
 The Pharmacy Guild of Australia 
Pharmacy sector leadership influences (Theme)=>Pharmacy stakeholder leadership 
(Subtheme)=> The Pharmacy Guild of Australia (Code). 
The majority of participants identified the Guild’s leadership effectiveness 
influencing the pharmacy sector, influencing government, providing member 
protection for their followers’, and maintaining financial strength to enable the 
organisation to adhere to their focused vision. They believed that this leadership 
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effectiveness was due to the leadership traits power and influence (Section 
5.2.10.5) and vision (Section 5.2.1). 
“...Guild represents its owners...has developed a process of great 
influence that also influences the decision makers in governments 
and other areas to support their particular vision... the problem is the 
Guild has so much influence over government policy...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
“...The added advantage that we have obviously is resources 
because you can’t have good leadership unless you resource those 
ideas…you buy capital. So if sometimes...go bad, like a Blackmores 
deal or something you burn capital. But luckily if you’re there for a 
while you build up capital and you can spend that capital...” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
“...Certainly outside of it one would say that the perception is the 
most powerful lobby group you’d never even heard of...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
“...the...Guild... is a very effective organisation. Probably the most 
effective lobbying organisation in Australia and they play that to great 
effect. They have delivered community pharmacy enormous benefits 
in terms of protection, remuneration, security for location rules. What 
they have been able to do with deferring the price cuts, defer the 
pain, has been nothing short of extraordinary...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
More than one-third of participants recognised the Guild’s focus to serve and 
protect their membership, in many instances through a protective leadership 
approach by lobbying to maintain many of the current pharmacy regulations, for 
example, pharmacy ownership regulations and pharmacy location rules. 
“...The Guild is almost partly considered as a Trade Union, where 
they protect the rights of the majority and the mediocrity...” 
(Participant 25: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and International) 
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“...the guild...they’ve got their interest in their own membership and 
they look after their own membership...” 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
“...the guild is very strongly against deregulation because they want 
to protect their members...” 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
Not everyone agreed with the Guild’s leadership influence across the pharmacy 
sector. Ten participants identified that in fact, the Guild has shown poor leadership 
in transforming the profession. They believed that Guild leadership had failed to 
support the service leadership approach (Section 7.5) as a leadership direction to 
combat the discount leadership approach (Section 7.6). They believed that Guild’s 
reliance on remuneration for the technical dispensing process has been threatened 
by government fiscal policy, and the organisation has not understood the wider 
health context. 
“...the Guild...completely missed the boat on how to address the 
issue on intense competition... the problem that the profession is not 
addressing...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
“...the lack of foresight, the lack of leadership from other people has 
meant that we’re now in a position where the government is going 
we’re going to take the money back...” 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
“...the leadership in the... Guild... as not being in recent years... 
recognition last year...that is the way they were taking the industry 
was down the drain and they needed to change the way they were 
operating and thinking if their membership was going to have a future 
in the current format of Community Pharmacy we see today...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
“...the leadership that’s missing...is that there is not enough 
understanding of the context led by its leaders into the 
memberships...” 
(Participant 7: University sector, Professional organisation, Academic pharmacist-
Australia) 
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These participants identified that internally within the Guild, there were several 
leadership challenges impacting the Guild’s influence across the pharmacy sector. 
The main leadership challenge perceived was the national council of the 
organisation. The continued direction to maintain remuneration for the technical 
supply of medicines, which was linked to member profitability was perceived as a 
challenge for the profession. 
“...most of the difficult stuff is getting it through Council. Getting 
through your own people is the first boom because they’re worried 
about budgets, they’re worried about, “What’s the risk… the 
reputational risk?”... Sometimes you don’t make it past the very first 
phase within your own wall...” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
“...there’s a lot of politics in the Guild and National Council and that 
probably holds them back a little bit...” 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
“...we’ve got senior leadership...which have a bit of a group 
think...the reason why the diversity of the profession is not reflected 
in the leadership group...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
“...The issue with Guild is that the people on the Guild are 
Pharmacists, who are cursed with this same problem of just sitting 
there and banging out scripts making money out of generics...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
 The Pharmaceutical Society of Australia 
Pharmacy sector leadership influences (Theme)=>Pharmacy stakeholder leadership 
(Subtheme)=> The Pharmaceutical Society of Australia (Code). 
One-third of participants identified that Society’s leadership was not effective and 
had a minimal leadership influence across the sector. They felt that the Society’s 
leadership was focused on developing professional standards and competencies 
that provided guidance and leadership in many areas of pharmacy practice within 
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the pharmacy sector. However, they believed that the leaders within the PSA 
leadership were engrained in the organisation, with the organisational vision and 
direction lacking commercial relevance, focus, structure and track record. 
“...I’ve sat on the National Board of the PSA, it’s almost, ‘oh is it my 
turn to be President, that’s right yes I was Treasurer and then I was 
Vice-President so it must be my turn to be President, where do I 
stand, what do I say, who writes...what do I...oh OK so I have to 
stand there right?...” 
(Participant 14: Professional organisation, Community pharmacist-Australia) 
“...the Pharmaceutical Society on the other hand seems to be largely 
bereft of framework, where their lack of flexibility is not because 
they’ve got an over rigid model or an idea, but because of the 
absence of it. Absence of an idea also delivers inflexibility, because 
there’s no idea to actually go with...” 
(Participant 7: University sector, Professional organisation, Academic pharmacist-
Australia) 
“...Traditionally it’s been around developing standards and 
competencies and so forth and providing education...PSA struggles 
because it is conflicted, I think it struggles to really be clear about 
where it sits within the profession... it would be great if they did 
actually fearlessly take that independent stance around that and 
work to enact that vision...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
“...For the PSA to be relevant needs to get more into the commercial 
space and have more of a commercial approach. Otherwise they will 
always be sidelined. This, to me is the nub of the issue when it 
comes to the leadership of that organisation which represents almost 
15 thousand pharmacists. They have a real challenge of becoming 
relevant...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
“...everyone’s coming up to Guild and the agreement is because no 
one’s been able to execute. PSA has put in three budget 
submissions in a row haven’t got a penny out of them...” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
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 University Pharmacy Leadership 
Pharmacy sector leadership influences (Theme)=> Pharmacy stakeholder leadership 
(Subtheme)=> University pharmacy leadership (Code). 
Five participants identified that the university sector has not provided a significant 
influence in shaping the direction of the profession, particularly around workforce 
supply and job diversity. They believed that universities were essential to the 
leadership development of pharmacy students. They were of the opinion that the 
university sector’s influence in the leadership direction of the profession has been 
limited, particular in relation to pharmacist workforce influences (Section 6.5), such 
as limited career diversity, oversupply of pharmacists and poor employment 
conditions. 
“...I actually don’t think there has been any leadership from the 
pharmacy schools in this area around where the profession should 
be going and what it should be doing...and they themselves 
should...be...finding avenues for practice for pharmacists. I mean the 
nurses have done it, turn any rock over and there’s bound to be a 
nurse underneath it...the whole profession has to take 
responsibility...the pharmacy schools have been absolutely quiet...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
“...the university that have uncapped you know. There’s no cap on 
university places. And the universities have the hide to say, ‘Well 
they don’t have a responsibility to guarantee the job at the end’... 
There’s no university head in eight years that I’ve been President of 
the Guild has ever rung me up saying, ‘Should we have increased 
numbers? Should we be decreasing them? Should we keep them the 
same?’...” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
Interestingly the following two participants presented juxtaposing perspectives with 
regards to university leadership development and training pharmacists. 
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“....at the University we have always said, and I truly believe this, that 
we are training pharmacists for the future. Not actually for tomorrow, 
to work in a shop right now and work the till. But actually people who 
will be health care professionals over the next 20-30 years of their 
career and beyond if that is the case...” 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
“...It is time that the curriculum recognises that they need to 
educate... there has to be a change to the curriculum in pharmacy. 
There has to be a module or two or three on pharmacy business, 
community pharmacy...there's no leadership training...” 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
 Pharmaceutical Stakeholders 
Pharmacy sector leadership influences (Theme)=> Pharmacy stakeholder leadership 
(Subtheme)=> Pharmaceutical stakeholders (Code). 
One-third of participants identified the numerous influences and subsequently 
vested interests of pharmaceutical suppliers, wholesalers and manufacturers, and 
their leadership impact across the sector. They stated that pharmaceutical 
suppliers, wholesalers and manufacturers played an integral part in sustaining the 
Australian medicine supply chain. They believed that the wholesalers were 
financially connected to the leadership of the Guild through the Community Service 
Obligation (CSO), part of the CPA, to ensure timely medicine supply. Wholesalers 
own and operate numerous community pharmacy groups and were therefore 
reported to be intrinsically connected to the community pharmacy leadership 
approach. 
“...over a billion dollars basically goes back to the wholesalers...why 
isn’t the government just dealing with them direct why does it have to 
go through a CPA agreement...gives the guild influence over the 
wholesalers and allows them to pick and choose and get money out 
of the wholesalers as well...” 
(Participant 18: Professional organisation, University sector, pharmacist Australia) 
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“...pharmacy as a sector...we’ve got two major wholesalers...public 
listed companies...shareholders... the minority are pharmacy 
shareholders now...over the years they’ve been vertically integrated 
for deregulation, that’s why they went out and bought all the 
groups...So are they acting in the best interest? Is that a threat? Will 
there be further rationalisation of wholesale?...” 
(Participant 23: Professional organisation, Company director, Pharmaceutical 
industry, non-Pharmacist-Australia) 
“...Leadership at the manufacturing and supplier level... Their 
leadership is to maximise their relevance in the market place, make 
money and change and adapt as they go... Is there leadership 
always in the interests of community pharmacy and the patients of 
community pharmacy? Not always. We have never had that 
alignment where what the supplier is interested in is what the 
pharmacy and the wholesaler is interested in is what the patient is 
interested in. This can therefore bring in conflicts of interest...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
Rationalisation of the pharmacy supply chain was identified by three participants 
as a challenge to pharmacy leadership, which would cause reduced delivery 
frequencies impacting community pharmacy operational leadership and stock 
management across the sector. 
“...There needs to be an understanding of all those challenges that 
pharmacy faces... The transformation of the supply chain...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
“...Do we have room for three wholesalers? Potentially maybe not. 
We have a distribution arm of a company that is now supplying one 
of the major companies direct... The future of that can affect 
pharmacy...” 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
 Chapter Summary 
This chapter presented participant observations of pharmacy sector influences 
impacting pharmacy leadership. Pharmacy sector leadership influences describe 
the organisations, opportunities and threats in the external environment that 
influence pharmacy leadership at a community pharmacy and broader professional 
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level. Participants reported that at the community pharmacy level, the influences 
impact community pharmacy leadership and the pharmacy owner’s leadership 
approach. At a professional level, they reported that the sector influences were 
impacting the profession’s top level leadership facing outwards into the wider 
health context. 
Participants identified that pharmacy sector leadership influences comprise the 
subthemes commodifying medicines, the influence of government, a rapidly 
changing health context, regulated and fixed frameworks, and pharmacy 
stakeholder leadership. Commodifying medicines describes the price and 
perception influence of discounting medicines (Section 8.2). At a community 
pharmacy leadership level commodifying medicines was believed to intensify 
competition between community pharmacies placing greater pressures on the 
owner’s leadership approach (Section 8.2.1). At a professional level, the 
participants viewed commodifying medicines as influencing the profession’s 
leadership capability through negatively impacting the profession’s image with 
other health stakeholders. The influence of government through changes to 
pharmacy remuneration was reported to impact the owner’s leadership approach 
by placing greater financial pressure and motivating small business leadership 
change (Section 7.2.3). The participants viewed the changing dynamics of the 
relationship between the pharmacy profession and government, such as contempt 
for the pharmacy profession to have negatively impacted pharmacy leadership at a 
professional level making professional representation more difficult (Section 8.3.2). 
A rapidly changing health context described by increasing chronic health 
conditions, an ageing population, and the exponential use of technology by health 
consumers was reported to influence both community pharmacy leadership and 
professional leadership (Section 8.4). 
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Participants believed that pharmacy owners need to adapt their leadership 
approaches to accommodate new technologies, and deliver healthcare to greater 
population demands. At a professional leadership level, they reported greater 
demands being placed on the pharmacy profession from government due to 
increased fiscal influences (Section 8.3.1). Regulated and fixed frameworks 
describes a highly regulated environment across the pharmacy sector in which 
community pharmacy and professional leadership operates. This rigid environment 
was viewed to have stifled leadership at all pharmacy levels and resulted in a 
leadership that lacked flexibility as there was a reduced need for innovation across 
the sector (Section 8.5). 
Pharmacy stakeholder leadership is a theme that explains the leadership of 
pharmacy stakeholders across the sector that influence pharmacy leadership at 
either a community pharmacy level or professional level. The most prominent 
influence reported was the influence of pharmacy organisations that impact 
community pharmacy leadership through representation and developing standards 
(Section 8.6). 
The next chapter of this thesis will examine the theme, the transformation 
challenge (Chapter 9), which builds on the findings from this chapter and continues 
to examine leadership at a professional level with a particular focus on the factors 
that are impacting the profession’s ability to transform and expand the role of the 
pharmacist.  
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Chapter 9: The Transformation Challenge 
 
 
“...leadership just grows naturally if there's fertile 
ground... if the current leaders could do something 
about succession planning or move to one side, 
give up their power plays and let other leaders 
come through I'm sure it would 
grow...spontaneously...” 
(Participant 12: Professional organisation, Consumer organisation, 
Advanced practice pharmacist-Australia) 
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 The Transformation Challenge 
The transformation challenge (Theme). 
This chapter examines the numerous contextual factors challenging the 
profession’s ability to transform through an expanded role in primary healthcare. 
The transformation challenge refers to top-level leadership across the profession 
needed drive the leadership change required to transform the profession. The 
majority of the participants reported what is needed to transform, explaining that at 
the heart of the transformation is the need for the pharmacy profession to 
implement leadership change. 
“...it is a role that must continually evolve, as our health needs and 
our health system evolve...” 
(Minister for Health and Aged Care; Speech Transcript) 
“...need for reprofessionalisation...there’s a huge amount of 
opportunity for pharmacists to work outside our traditional community 
pharmacy role...the hospital pharmacy role...we need to be able to 
be advocating for those positions...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
“...realisation that pharmacy needs to adapt and change with the 
expectations and demands of the current... consumers of the health 
system overall...the recognition that pharmacy needs to change...a 
willingness to accept that it must change to ensure that the pharmacy 
as a profession continues to deliver...what is required by health 
consumers...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
The transformation challenge is presented below in Table 9.1, and is made-up of 
the six subthemes emerging from the analysis of the responses from the 
participants in this research. 
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Table 9.1 Dimensions and Properties of the Theme: The Transformation 
Challenge 
Theme Theme description Subthemes 
The Transformation Challenge 
The pharmacy profession expanding, and evolving 
the role of the pharmacist to maintain relevance 
with the demands and needs of the Australian 
healthcare context 
Expanded role opportunity 
Disconnect with context 
Organisational disunity 
Pharmacy leadership emergence 
Repressive leadership 
A profession left behind 
 
 Expanded Role Opportunity 
The transformation challenge (Theme)=>Expanded role opportunity (Subtheme). 
More than half of the participants identified that there were numerous and 
significant opportunities that existed for the pharmacy profession to take a 
leadership role and expand the pharmacist scope of practice. 
“...There is so much pharmacists could be doing. There is so much 
need for our knowledge...” 
(Participant 12: Professional organisation, Consumer organisation, Advanced 
practice pharmacist-Australia) 
“...the next direction for our profession to move into different areas 
and scopes of practice...” 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
 The Responsibility of the Profession 
The transformation challenge (Theme)=>Expanded role opportunity (Subtheme)=>The 
responsibility of the profession (Code). 
The responsibility for expanded role opportunities was identified as the 
responsibility of the profession; identifying the need for the profession to take 
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ownership and seize the expanded role opportunities that exist in primary 
healthcare. 
“...looking for opportunities to do stuff besides dispensing... when 
those opportunities come along you’ve got to try to make the most of 
it…pharmacists prescribing, advance scope of practice, working from 
GP surgeries in close collaboration with GP’s. We need leaders...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
“...there has to be a broader vision...for the industry to go forward to 
the next agreement. That is where I would like to see the industry 
leadership go...united front...Opportunity to do something very 
different compared with virtually every country in the world...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
“...so much pharmacists could be doing. There is so much need for 
our knowledge. I just wish our leaders were doing something to 
promote our role out there in the big wide world a bit more...” 
(Participant 12: Professional organisation, Consumer organisation, Advanced 
practice pharmacist-Australia) 
One-third of participants recognised the need to move beyond the medicine supply 
to providing professional services. 
“... we do have a role in that drug supply system to make sure society 
is safe with the medicines... it is an important function...but it’s only 
part of what should be our practice, not the focus of it...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
“…delivering superior health benefits to consumers...service driven 
pharmacy model...more than just doing HMRs and doing 
medschecks... broad service concept…working with obese people, 
reverse their obesity so they don’t get to be type 2 diabetes or 
reverse their pre-diabetes…” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
“…pharmacists being able to prescribe more. I want to see 
pharmacists to be undertaking forward dispensing, and I want to see 
pharmacists do more on medication review…” 
(Participant 28: Professional organisation, Military organisation, University sector, 
Military pharmacist-Australia) 
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 Role Diversity in the Nursing Profession 
The transformation challenge (Theme)=>Expanded role opportunity (Subtheme)=>Role 
diversity in the nursing profession (Code). 
A quarter of participants identified role expansions in other health professions, with 
the nursing profession employed as a leadership exemplar of the direction the 
pharmacy profession needs to shift. 
“...nursing they can work in general practice, they can work in policy, 
they can work in aged care, they can work in hospitals and they can 
work in a variety of environments... 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
“...We’re seeing other professions, specifically the medical profession 
and the nurses actually do take what I call a real leadership role and 
actually look at their own profession and say...this isn’t good 
enough...they’ve gone through the re-professionalization 
process...the whole profession has to take responsibility...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
“...it’s incredibly frustrating, just watching it within the industry 
because yeah… because at the moment of lot of pharmacy has 
been… we are, we’re behind, nurse practitioners...” 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
“...you've got nurse practitioners now prescribing, you've got 
optometrists now prescribing, you've got other people wanting to 
prescribe... There's 380,000 nurses out there registered. They're all 
looking for jobs, they're all looking for extensions to their career...” 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
 Advanced Pharmacy Practice Opportunities 
The transformation challenge (Theme)=>Expanded role opportunity (subtheme)=>Advanced 
pharmacy practice opportunities (Code). 
Advanced pharmacy practice and other expanded role opportunities available to 
the pharmacy profession were identified by one-third of the participants as 
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evidence that the profession was starting to display leadership through practice 
transformation. 
“…advanced practitioners...going to be one of the greatest changes 
that we’ll do in the pharmacy profession...it will create some diversity 
within the profession, create some segmentation and create some 
aspiration...help drive the profession forward...” 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
“...advanced practitioner is somebody who shows leadership, not just 
locally or in their department but across disciplines and across 
workforce, across work boundaries...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
‘...aged care facilities... that is another area that I see a huge 
opportunity for a pharmacist in aged care... the value in employing a 
pharmacist, at least one in their own right on the payroll... to have a 
pharmacist on staff...the value that a pharmacist can bring into aged 
care...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“..., to apply medication knowledge to complex medical situations in 
all sorts of places...work with the nurse practitioners and the 
dentists...medico legal stuff… huge opportunity for pharmacists...” 
(Participant 12: Professional organisation, Consumer organisation, Advanced 
practice pharmacist-Australia) 
 Disconnect with Context 
The transformation challenge (Theme)=>Disconnect with context (Subtheme). 
The profession’s disconnect with the external context formed the second subtheme 
of the theme, The Transformation Challenge. More than half of the participants 
identified that there is a disconnect between the pharmacy profession and the 
external context. The external context was viewed as the operating environment 
that the pharmacy profession existed in. From the profession facing outwards, this 
referred to the wider health context, and included health stakeholders such as, 
government, health consumers, and others. 
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“...the challenge is...pharmacy, for too long has done things in silo 
effect. Probably within organisations within our profession, and then 
also as a profession...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...Pharmacy generally, rather than just the community 
Pharmacy...they have to wise up and get more savvy about the wider 
political and policy context... I think there's a range of reasons why 
the isolation has become a problem...” 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-International) 
“...the biggest challenge is to maintain relevance, to the health 
system and to consumers...documents that the government 
produced some years ago around primary healthcare and their 
hospital plan...we didn’t get a mention...government has sort of 
pigeon holed pharmacy...CPA tick that box and now let’s get on with 
the health system...they don’t see a role for pharmacy in that health 
system...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
“...challenge is thinking outside of the pharmacy world. Again, I 
perceive a lot of what’s said by our leaders as absolute tokenism 
when they talk about collaborative care...They don’t understand, 
either from the consumers’ perspective or from other health 
professionals... Lacks depth, lacks understanding. It’s...from a 
pharmacist’s perspective...I don’t see that they understand what the 
consumer wants... Or what health providers, including the 
government, wants... It’s an absolute disconnect...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
“...What I do perceive about it is that it isn’t particularly a view which 
is integrated with what a nation needs and what the profession 
needs. There’s not enough flexibility...understanding of the context is 
what needs to happen first...what’s missing in Australian leadership 
in pharmacy is the idea of getting a congruency between the modern 
context...” 
(Participant 7: University sector, Professional organisation, Academic pharmacist-
Australia) 
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 The Need to Change Pharmacy Funding 
The transformation challenge (Theme)=>Disconnect with context (Subtheme)=>The need to 
change pharmacy funding (Code). 
One third of participants identified the need to change pharmacy funding, despite 
the funding challenges. Participants believed that this was necessary to ensure 
greater funding for professional services e.g. pharmacist aged care and medication 
review services. They believed that a change to service funding will promote the 
service leadership approach (Section 7.5), and when implemented across 
community pharmacies will lead the profession’s transformation. 
“...Hopefully we find another model...for GP practices as well, for 
pharmacists to play a role...around medication review that’s a 
different model altogether...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...I’ve been working with the aged care sector for a number of years, 
it started off with just sending them student replacements trying to 
convince them of the value of pharmacists, and I think they’re 
convinced, but now though they’re scratching their head about 
funding...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
“...reliance on a community pharmacy agreement means that, some 
of us are looking for that as the only way of our path being changed 
or say – and I don’t think that’s the way to go. I think some of us are 
realising that we need to look outside of models and government 
funding to try and support change in the profession...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
One third of participants identified that pharmacy funding needs to come from new 
avenues. 
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“...it needs to be sorted out outside that agreement dollar and now 
I'm talking about a range of professional services, 
pharmacists...getting access to the Medical Benefits Schedule...” 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
“...there has to be a much greater focus in negotiations with 
government on individual healthcare...to introduce new PBS funding 
streams...to better manage people’s chronic conditions...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
One participant identified that funding for professional services can come from a 
variety of stakeholders including the health consumer. 
“…the fact is if you do a good job, my view is people pay now. And if 
it’s... you know, it can be the government, it can be the community. 
It’s a range...it doesn’t have to be the government…” 
(Participant 9: Government organization, Consumer organisation, Organisational 
pharmacist-Australia) 
 Understanding Health Consumerism 
The transformation challenge (Theme)=>Disconnect with context (Subtheme)=>Understanding 
health consumerism (Code). 
About a quarter of participants identified the changing health consumerism as a 
key factor impacting pharmacy leadership. In particular, they viewed the increased 
consumer access to information via the Internet (as well as the increased 
availability of information on the Internet), as evidence that health consumers feel 
that they need to be more informed and to be more active decision-makers in their 
healthcare. They stated that understanding changing health consumerism is an 
essential element of the profession’s transformation, not only to meet consumer 
needs but to drive the change needed in delivering professional services. 
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“...people have now so much access to information. You can Google 
anything on your phone or your iPad, you can Google all the 
information you want to know about drugs...” 
(Participant 28: Professional organisation, Military organisation, University sector, 
Military pharmacist-Australia) 
“...the nature of baby boomers...being actively engaged in their 
healthcare, wanting choices, not simply what you are going to give 
me. The need to be informed...” 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
“...pharmacy has to really sit down and say who is our customer? 
What is the vision for pharmacy? And at the end of the day that 
comes down to who is our customer, and are we building an industry 
that meets the needs of that customer...” 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
Despite the health consumers’ access to information, the following participant 
identified that there is a real need for pharmacists. 
“…Wherever you see people using medicines they need us...people 
do the stupidest things with medicines...They just invent rules and 
regulations about medicines...They guess how things should be 
taken. They ignore potential risk. They speculate about the risk of 
drug interactions. They ignore clearly when there's drug induced 
pathology thinking it's a new disease…” 
(Participant 12: Professional organisation, Consumer organisation, Advanced 
practice pharmacist-Australia) 
Four participants identified that the business nature of pharmacy influences health 
consumerism, often portraying a negative image of the profession that impacts 
leadership. 
“…why would I take healthcare advice from someone with big 
stickers over everywhere....” 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
“...they have to balance the role of pharmacy and what it owes...if 
you would like, both society and the individual. Because health is 
vocation that has this conflict. So pharmacy leaders need to get that 
balance right...” 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
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Four participants with organisational policy experience identified that the 
profession has a limited understanding of consumerism when designing, 
implementing and networking with consumer stakeholder groups. This disjointed 
leadership approach is affecting the profession’s ability to transform and meet the 
needs of health consumers. 
“...we need more documents out there saying this is what 
pharmacists can do for consumers...I’m involved on the Future of 
Pharmacy project...which has taken about two years...it’s just 
pharmacists. And I have said so many times when are we going to 
send this out to consumer organisations or to medical organisations? 
And they say when it’s finished...You’ve got to have it as part of the 
whole consultation process... just a lack of understanding...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
“...the profession has in recent years has managed to network 
very...most notably the Consumer Health Forum. Now the Consumer 
Health Forum’s approach has been to create the impression that the 
pharmacy has been ripping off the public...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
“...we’ve got links with consumer health forum...they’ve got a 
reasonable understanding with what pharmacy could do...not so 
much criticising pharmacy for what it does, but for what it doesn’t do 
and could do...we want you to do better...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
 Community Pharmacy Ultimatum 
The transformation challenge (Theme)=>Disconnect with context (Subtheme)=>Community 
pharmacy ultimatum (Code). 
A quarter of participants identified that the profession has a clear choice, to 
fundamentally focus on retail pharmacy or expand professional pharmacist 
services. This community pharmacy ultimatum defined by the participants, 
describes the profession through the network of community pharmacies having a 
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pharmacy (Discount leadership approach; Section 7.6), or seizing the expanded 
pharmacy service opportunities (Service leadership approach; Section 7.5). 
“...the challenge is back to Pharmacy, as to how much it wants to 
shift its focus from dispensing and supply towards pharmaceutical 
care and if it's prepared to do that... And I think there is going to be 
that profound question faced, both in the U.K and here, about 
actually, what is Pharmacy in the future? Is it about selling shampoo 
and shower gel or stuff? Or is it actually about giving flu shots, 
managing public health, managing care for people with long term 
conditions...And the challenge to Pharmacy and Pharmacists is do 
you want to do that?...” 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-International) 
“...And the only way they're going to do that is forward 
dispensing...get the retailer monkey off our back...one of the biggest 
challenges... is the pharmacist to be recognised as really true health 
practitioners, and not retailers...” 
(Participant 28: Professional organisation, Military organisation, University sector, 
Military 
Five participants identified that leadership within the profession needs the political 
will, courage and preparedness to create a sustainable pharmacy model for 
delivering professional services. 
“... until the people in positions of influence...accept, adopt and 
consciously promote genuinely the concept that pharmacy is in the 
health business and is in a position of improving health outcomes 
we’ll always have conflict...” 
(Participant 14: Professional organisation, Community pharmacist-Australia) 
“...Courage and vision...require them changing legislation...their 
goals are more about protecting what we've already got rather than 
well maybe in addition to opening up new opportunities and 
improving career opportunities for the next generation of 
pharmacists...the courage...and the guts to get out there and actually 
change things...” 
(Participant 12: Professional organisation, Consumer organisation, Advanced 
practice pharmacist-Australia) 
“...pharmacy...is potentially at risk of being irrelevant if we don’t adapt 
to change and if the current structures in pharmacy aren’t going to 
allow people who are doing innovative services and doing new and 
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changing things, the opportunity to really progress the profession 
unless we’re prepared to make change...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
A quarter of the participants recognised that pharmacists need to prove their value 
and expand their duty of care to their patients, similar to the notion of caring for 
followers (in Section 5.3). 
“...who takes responsibility for that drug once it’s dispensed, and if 
you give a patient 30 days of a medication, who is responsible? it is 
our responsibility that they finish that regimen the way the doctor 
prescribed it to them...the dispense is the beginning of the 
prescription...who is better trained to make sure that the therapy has 
been completed...us...we all need to focus on that, because we got 
prove our value...” 
(Participant 6: Professional organisation, Company director, Community pharmacist 
proprietor-International) 
“...Well if it’s not your duty of care, you’re just a retailer... you have 
duty of care to sell the right product...you’ve obviously got to have a 
duty of care beyond the door of your pharmacy, don’t you? It seems 
clear to me...” 
(Participant 9: Government organisation, Consumer organisation, Organisational 
pharmacist-Australia) 
 Inarticulate Policy Vision 
The transformation challenge (Theme)=>Disconnect with context (Subtheme)=>Inarticulate 
policy vision (Code). 
A quarter of the participants identified the profession’s inability to articulate a 
professional vision with political tact and competence to effectively influence 
Government health policies. As a result, they felt, the profession had been 
excluded from wider health policies. These participants strongly believed that 
vision was a vital pharmacy leadership trait (Section 5.2.1), and communicating a 
clear vision, internally and externally, was essential to effective pharmacy 
leadership. 
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“...rather than always giving a clear voice...Pharmacy in the wider 
health policy world...they fail to do that and for a third largest health 
profession, are largely unknown and invisible to the wider health 
policy and management world. It exists in too much isolation, so I 
would see some of that as a failure of leadership...” 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-International) 
“...last five years’ pharmacy has been so unsuccessful in actually 
getting funding for a lot of these sorts of policies...bypassed in the 
policy process...pharmacy is not one of the major facilitators of the 
electronic health record...In primary healthcare...Medicare Locals 
pharmacists have to fight to get onto those boards. There is not an 
axiomatic requirement that pharmacists be included in that 
process...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
Several participants identified disunity between pharmacy stakeholders, affecting 
the profession’s ability to articulate a sound vision to Government. 
“...get people onside and to speak with a unified voice when 
speaking to government...pharmacists need to be able to articulate 
what their profession needs in policy terms...And unless pharmacists 
have a much better capacity to articulate what they actually 
want...their aspirations, their views, their vision is lost and goes into 
the ether...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
“...it's good that we have personality running each of those 
associations...they do have to get together at least on a common 
message back to government... You cannot have people from the 
side sniping and affecting the one message. The threat going 
forward is that we don’t have a combined...” 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
A quarter of the participants recognised that the pharmacy leadership lacks the 
skills, competence and support to articulate pharmacy’s vision, resulting in poor 
leadership when influencing wider health policy. They were of the opinion that 
pharmacy leadership needed to develop a better understanding of the external 
health context to ensure that pharmacy policies addressed broader health needs. 
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“...There needs to be an emphasis on a better understanding of the 
pressures on government...It is squeeze on healthcare budgets...cost 
containment and how the profession addresses...at the same time 
promotes new professional skills to government...the profession is 
not very skilled at articulating its strategic policy and vision...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
“...role to play in helping...support Pharmacists, even practically, 
about how do you put together a service specification? How do you 
bid for services if local or national funders? ...they won't have the 
capacity and experience to do that sort of thing... Do Pharmacists 
really know how the wider health system works in Australia and 
Federal as opposed to Local funding works and all the initiatives? Do 
they really know what Medicare Locals... the hospital networks...” 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-International) 
“...we’ve got a void of great pharmacy practice leaders…we haven’t 
got enough people who are really good practitioners who could then 
be involved in policy aspects of the pharmacy practice environment 
and bring those really good clinical pharmacy practice fields to that 
sort of policy work...” 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
Four participants identified that there has been a lack of forward thinking restricting 
the profession’s ability to articulate a sound vision. Forward-thinking was regarded 
as an element of the leadership trait, vision (Section 5.2.1), which they emphasized 
was needed for pharmacy leadership to look outwards and understand the wider 
context. They pointed out that pharmacy leadership tended to look inwards, and 
focused within the profession’s highly fixated and controlled frameworks. 
“... it's a challenge...current leaders of the profession...It's about 
getting out there more, looking outwards rather than inwards...” 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-International) 
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“...the Pharmaceutical Benefit Scheme is a framework of doing 
things, it’s got fixed rules...reduces the necessity for imagination, 
flexibility...we’ve lived for generations and generations in a highly 
fixated, highly controlled, totally frame worked, precision driven 
model of identity at every level. Why would you need forward thinking 
in that?...” 
(Participant 7: University sector, Professional organisation, Academic pharmacist-
Australia) 
 Understanding Health Stakeholders 
The transformation challenge (Theme)=>Disconnect with context (Subtheme)=>Understanding 
health stakeholders (Code). 
One third of the participants identified the need to understand, learn from and 
improve collaboration with health stakeholders as essential tasks of an effective 
leadership. They stated that an integral part of pharmacy leadership was to 
develop networks and build relationships with external stakeholders to facilitate the 
profession’s integration into the wider health context. 
“...so that interaction between pharmacy and industry and tertiary 
institutions and academics and government and the people who are 
the decision makers is absolutely vital...absolutely 
essential...networking among the various health bodies to create 
various forums where we could get collective action and 
agreement...collective unified outcome...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
“...building those external relationships, influencing different 
groups...working those local and national power relationships...look 
at how the Doctors, the Nurses, the Health Managers, how they do 
it...how they get into developing new services and copy them...It's 
getting in there...shaping the leadership for yourselves.” 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-International) 
A quarter of the participants identified that competing interests between health 
professions was a barrier to inter professional collaboration, and a barrier to the 
profession’s outward leadership. 
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“...The Physicians, even though pharmacists help them take care of 
patients, the physicians don’t really have a vested interest in 
pharmacy, the nurses don’t have a vested interest in pharmacy. We 
are a companion profession...They don’t really care about 
pharmacy...” 
(Participant 6: Professional organisation, Company director, Community pharmacist 
proprietor-International) 
“...Everyone wants to do what the other's doing now so again there's 
this... pharmacy has got to be very careful it doesn't get left behind... 
there are real issues out there both within pharmacy and with 
pharmacy with other professions to make sure we don't get left 
behind...” 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
 Organisational Disunity 
The transformation challenge (Theme)=>Organisational disunity (Subtheme). 
In the previous chapter (Section 8.6), pharmacy stakeholder leadership was 
reported. The coalescing of pharmacy stakeholder leadership has resulted in 
organisational disunity and will be examined in this chapter. Most participants 
identified that the foremost influence preventing the transformation of the 
pharmacy profession is caused by the disunity within and between pharmacy 
organisations. This professional disunity has caused political tensions, factions and 
silos across the profession, inhibiting the profession’s leadership and ability to 
transform. Two-thirds of participants specifically identified the political tensions 
between pharmacy organisations as a significant factor impacting leadership. 
“...there’s a problem in the profession of factionalism. The profession 
has until, well in recent years been quite divided. There are a number 
of pharmacy organisations and some say too many...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
“...it’s very difficult for those other leaders and other organisations to 
come in to an agreement with good will… there’s an underlying 
mistrust there... those people who are leaders of those organisations 
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want to achieve an outcome which makes their organisation 
financially secure and stable and viable...” 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
“...the major organisations are quite…there’s a lot of friction…we 
spend so much time in this industry just arguing instead of actually 
achieving anything. All this arguing takes it’s time and then you’re 10 
steps back from anything...” 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
 Competing Visions and Interests 
The transformation challenge (Theme)=>Organisational disunity (Subtheme)=>Competing 
visions and interests (Code). 
A quarter of participants identified competing leadership visions and interests 
between the retail and commercial influences in the profession as a driving factor 
causing organisations to take different directions, impacting a shared leadership 
vision across the profession. They felt that a lack of a shared vision for the 
profession added to the organisational disunity, and was a barrier to the pharmacy 
leadership transformation needed. 
“…there are often conflicting interests between the professional side 
of pharmacy which is you know the responsibility of the PSA...and 
the commercial side and retail side of pharmacy...this tension 
between the business side and the professional education...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
“...leadership of the pharmaceutical profession, which is the 
pharmacy society, the pharmacy guild...two distinct bodies that lead 
in separate directions...” 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
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“...where it gets back to that shared vision, we don’t have that shared 
vision yet...a number of us out there who would have that vision and I 
would say there will be elements within PSA would have that vision, 
certainly my own committee has that vision, I don’t think the 
Guild...the current leadership have that vision...we don’t have that 
shared vision across the profession yet…” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
One third of participants reported that competing visions was dominated by one 
strong organisation, prescribing a leadership vision upon the profession, and as a 
result causing professional disunity. 
“...the Pharmacy Guild represents its owners as a particular vision 
and has developed a process of great influence...influences the 
decision makers in governments and other areas to support their 
particular vision...from a leadership point of view, yes it does read 
well for its own organisation and its growing vendors...it really doesn’t 
take into a large account a wider view...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
“...Guild focused, it’s been around remuneration for community 
pharmacy and it’s been around building the Guild incorporated group 
as opposed to developing the profession...look to the future and say 
what's the best thing for industry, the profession, not just for our 
organisation...” 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
“...The Guild, its mission is centred on a focus or a centre point of 
pharmacy, and the Pharmaceutical Society is focused on a set point, 
a focal point if you will, of pharmacists, and when you think about 
disappearing resources and a competitive environment it’s not 
surprising of course that there’s going to be tension between the 
two...we’re getting the dominant of the two organisations prescribing 
a future for all...” 
(Participant 7: University sector, Professional organisation, Academic pharmacist-
Australia) 
Ten participants identified that there were too many pharmacy organisations 
producing increased organisational competition. Numerous organisations claim to 
represent the profession, resulting in a leadership challenge influencing the 
profession. 
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“...When I first started in pharmacy there was two organisations. 
There was the Guild and the PSA. It was black and white...Now 
there's probably about ten organisations. They're all grey. No one 
knows who's doing what...There's no clear delineation between what 
organisations are doing any more...it's all gone grey and I think that's 
a challenge for our pharmacy leaders is to try and get...some 
semblance of normality back into the organisational structures...” 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
“...one of the challenges I've identified in terms of leadership in 
Pharmacy...it's very disbursed across...I'm talking at a national level 
there and this feels a bit the same in Australia, across many 
organisations and interests who claim to represent Pharmacy…” 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-International) 
“...we've got to stop the turf war. PDL, PSA, Guild, College, SHPA, all 
of these organisations evolved out of an established need. If there 
was no market they would not exist...they all exist because there is a 
need...The problem is, is now they all start overlapping and 
everyone's trying to be all things to all people...” 
(Participant 8: Professional organisation, Government organization, Consumer 
organisation, Community pharmacist proprietor-Australia) 
Seven participants recognised the competition between pharmacy organisations 
often stems from continued professional development and education for 
pharmacists. 
“...I believe there is too much competition in areas of education and 
professional development...I believe it's created a higher product for 
the consumer so the pharmacist. I believe there could be a bit of 
rationalisation...” 
(Participant 8: Professional organisation, Government organization, Consumer 
organisation, Community pharmacist proprietor-Australia) 
A quarter of the participants identified that the Guild’s leadership lacked 
collaboration and fair-mindedness (Leadership trait, Section 5.1.3.2) with other 
health stakeholders, impacting leadership across the pharmacy sector, and is a 
major influence causing organisational disunity. 
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“...They need to collaborate. Again that is another problem with the 
leadership. Mostly the Guild who seem hell bent on sidelining the 
PSA, so they can dominate everything...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
“...the vision...the Pharmacy Guild has provided has been inflexibly 
created by virtue of the fact, some evidence of that...the lack of 
consultation with the Pharmaceutical Society...” 
(Participant 7: University sector, Professional organisation, Academic pharmacist-
Australia) 
“...the Pharmaceutical Society feels a raw deal in relation to 
professional services funding...their views were largely ignored. So 
they weren’t listened to. They thought there was lack of fair 
mindedness and equity and access to the policy process...you’re 
also seeing the Consumer Health Forum wanting to have a role...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
 Professional Unity Challenge 
The transformation challenge (Theme)=>Organisational disunity (Subtheme)=>Professional 
unity challenge (Code). 
One third of the participants identified that the challenge for the pharmacy 
profession was to overcome the difficult organisational tensions needed to unite 
different pharmacy organisations; namely the competing organisational visions. A 
quarter of participants identified that there needs to be a collaborative approach 
taken to transform the profession to overcome the leadership challenge posed by 
organisational disunity. 
“...leaders at the moment, the challenge is...to more unite our 
profession…So I think the challenges that I would see that we are 
certainly trying to work on is, a better united profession within the 
pharmacy…uniting our profession...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...the current pharmacy organisation environment is probably the 
biggest challenge in the profession moving forward… if the 
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profession wants to kind of move out and expand the roles like the 
nurses have, everyone needs to work together for that to happen...” 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
 Pharmacy Leadership Emergence 
The transformation challenge (Theme)=>Pharmacy leadership emergence (Subtheme). 
About half of the participants identified the important role of mentorship (examined 
in detail in Section 10.4.2) and the need to provide opportunities to develop 
leadership experiences (examined in detail in Section 10.2) profession-wide to 
facilitate the leadership emergence needed to stimulate the profession’s 
transformation. They reported that there was a need to start succession planning 
early at a university stage, and that good leadership allows other leaders to 
emerge. 
“...It gets back to the mentoring, it gets back to the pharmacist who 
owns the business that identifies a skill or talent in a pharmacist 
that's working for them and helps them on the way and gives them 
the opportunity to succeed or fail...” 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
“...mentoring. I think that's important...one of the issues I raised 
before is allocating it, getting people involved and asking for 
volunteers or putting your name forward for mentoring. Are you 
prepared to mentor someone? So I think an allocation of those who 
want to be involved or who think they want to be or who have been 
identified as future leaders...” 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
“...I believe structurally both the professional organisations working 
with the universities could encourage succession planning better. So 
through the encouragement of succession planning we should be 
identifying those individuals at that next level down that show 
leadership potential and bringing them through...” 
(Participant 8: Professional organisation, Government organization, Consumer 
organisation, Community pharmacist proprietor-Australia) 
“...that’s an area of support that the profession could take on that we 
probably haven’t formally yet, is continue to develop...gets back to 
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that...the people coming through at NAPSA that are potentially 
leaders in that group. How do we mentor those through the 
profession?...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...involve more younger people in the various organisations and 
committees they have, cause that's where our future resource is…if I 
don't put some footprint to leave behind… what's going to 
happen?...” 
(Participant 28: Professional organisation, Military organisation, University sector, 
Military pharmacist-Australia) 
“...sometimes leadership isn’t allowed to come through because 
those above you don’t let you shine...a good leader will also delegate 
and allow others to (a) lead and (b) make mistakes...” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
Five participants recognised that there was no structured process to organisational 
leadership emergence in the profession, impacting the quality of pharmacy 
leadership. 
“...I couldn’t say I was actively groomed for the position. And I think 
that does happen a fair bit. It’s almost within our profession...when 
that opportunity comes up, it’s almost the board of that particular 
organisation looking around and saying, “Well, who do we have 
now? Who’s coming through? Who can, who can fill this position?” 
Rather than spending the last ten years grooming maybe say three 
or four people coming...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...this is probably quite relevant in pharmacy is that a lot of people 
come into leadership positions not because they actually chose to 
you know come into leadership positions... so a lot of the people who 
potentially are seen as leaders perhaps mightn’t even have the 
qualities to be great leaders because they’re just there because 
there’s nobody else at this point in time...” 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
One-third of participants identified that the profession has not been successful in 
the succession planning and leadership emergence of early career pharmacists. 
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“...most associations have tried to get young people involved in 
pharmacy and put them on committees and stuff like that. A lot of 
them only last a couple of years and then get disillusioned and 
leave...” 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
“...leaders, particularly at a NAPSA level...there’ve been some very 
good ones come through in the last few years... once they actually 
come through into the profession, a number of them then drop 
off...as sort of leaders...there is a gap in the continuing to develop 
those people who are potentially leaders...maintaining their 
enthusiasm, and a way forward through the profession...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...the challenge for younger pharmacists in being in to leadership 
roles is experience...certainly are some younger pharmacists on 
boards... from the one organisation I’ve been involved with...They’re 
just put up as the young pharmacist. And that can burn them out...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
Almost one third of participants identified the challenges to leadership succession 
planning in community pharmacy businesses, namely the limited ownership 
opportunities and financial barriers impacting the leadership emergence of young 
pharmacists in community pharmacies. 
“...How many pharmacists today are willing to sell 15 or 20 per cent 
of their business to a young pharmacist to give them an opportunity? 
Not as many as there should be. That pharmacist themselves had it 
done to them originally...the whole ownership of the pharmacy has 
changed in the last five years...” 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
“...there's a lot of young pharmacists out there, right, but there's a big 
gap between when they get to an ownership perspective, and 
whether that's because of the financial implications...” 
(Participant 28: Professional organisation, Military organisation, University sector, 
Military pharmacist-Australia) 
“...decreasing ownership opportunities within the profession as well 
for young people...” 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
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 Repressive Leadership 
The transformation challenge (Theme)=>Repressive leadership (Subtheme). 
More than half of the participants acknowledged the numerous barriers to 
leadership emergence existing at multiple levels within the profession illustrating a 
repressive leadership culture that is impacting the profession’s ability to transform. 
One third of participants identified the long organisational leadership tenures as a 
barrier to leadership flow-through. 
“...I'd like to see all the organisations have their own succession 
planning. I'd like to see a cap on how long leaders can be there... 
some of them have stayed past their use-by date with all due 
respect... some people...17 plus years at a national stage. Now that's 
not healthy...there needs to be a structured process of getting rid of 
the dead wood and bringing in the new stuff...” 
(Participant 8: Professional organisation, Government organisation, Consumer 
organisation, Community pharmacist proprietor-Australia) 
“...the same people... have been there for 20...30 years... same 
people have been running that organisation for years and years and 
years... We need to get our leaders changing more 
frequently...because the same people just vote themselves in all the 
time.’... there is a certain amount of brokering of those positions...” 
(Participant 12: Professional organisation, Consumer organisation, Advanced 
practice pharmacist-Australia) 
A quarter of participants identified that male leadership tended to dominate 
organisational positions in a female dominated workforce. 
“...There’s also huge boys club mentality... We have got too many old 
men in grey suits, or too many grey men in old suits...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
“...look at the pharmacy...across the board is about 70% female, then 
that needs to change and I’ve heard the PSA...is perhaps even 
worst. At least the Guild has recognised they’ve got issues with 
diversity in their leadership group...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
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“...I know there is a boy’s club... everyone knows each other, 
everyone looks after... you know the boys look after each other...a lot 
of them have been around for too long... it’s not in the best interest of 
the profession...” 
(Participant 9: Government organization, Consumer organisation, Organisational 
pharmacist-Australia) 
A quarter of the participants identified that a repressive leadership culture has 
manifested through a lack of career opportunities available to early career 
pharmacists, a potential risk of losing young pharmacists. This impacts the 
professions ability to transform and utilize a skilled workforce to realise expanded 
pharmacist opportunities. 
“...you're building the younger base more, but it's at your peril that 
you train lots of people and excite them and then don't give them the 
opportunities, because they won't stay. They'll go and do other 
things...” 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-International) 
“...The challenge is they join a profession, which is focused around 
the supply and the process of dispensing and the business models at 
the moment particularly in some of the discount stores are high 
volume employers, means pharmacists are not getting a chance to 
hone and develop those skills...” 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
More than a quarter of the participants identified there were structural problems 
faced by women, preventing them from emerging to pharmacy leadership 
positions. They reported that pharmacy has more women than men, and that 
pharmacy leadership would have been better served with more women in 
leadership positions. 
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“...there’s some structural problem... the mechanisms are difficult for 
pharmacists...for women in pharmacy...pharmacy would be much 
better served if we had more women in senior leadership positions... 
We still haven’t had a national president that’s a woman... we’ve had 
a female prime minister, we haven’t had a female president of the 
Guild... There’s a whole range of structural problems...” 
(Participant 9: Government organization, Consumer organisation, Organisational 
pharmacist-Australia) 
“...And especially in pharmacy...there’s not a lot of pharmacy women, 
pharmacy leaders, or in positions in organisations...the old glass 
ceiling stuff... we’ve got more women than men. And yet the majority 
of our so called leaders are men...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
Five participants identified the tokenistic leadership positions that were made 
available to women in pharmacy leadership, evidence of a repressive leadership 
culture. 
“...So in some ways I see that as detrimental for women, because 
you… they’re now saying you’ve got to have a certain percentage of 
people on the boards as women...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
“...the Guild has been saying for a very, very, very, very, very long 
time that it wants more women on National Council, well do 
something about it... there’s been a lot of tokenism, from my 
perspective, I hate tokenism... it’s not about numbers...” 
(Participant 9: Government organization, Consumer organisation, Organisational 
pharmacist-Australia) 
Interestingly, two participants identified that women in leadership positions want to 
be there based on their hard work and skills, not tokenistic gestures to ensure 
adequate female representation. 
“...Equally I work harder than anyone. I... you know, I mean I still 
foresee that I’ve got to be better... it’s a girl thing as well... you know, 
there’s lots of people who feel that way. I think that I’ve got to 
be...seen to really push that extra yard, if I expect my people to...” 
(Participant 9: Government organization, Consumer organisation, Organisational 
pharmacist-Australia) 
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“...And I would always want to be there because of my skills and 
what I can contribute, not necessarily because I’m a woman...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
 A Profession Left Behind 
The transformation challenge (Theme)=>A profession left behind (Subtheme). 
Almost one third of the participants identified that the profession was at risk of 
becoming redundant, failing and diminishing overtime if it does not actualise the 
pharmacist expanded role opportunities through actively engaging and creating 
innovative career opportunities that allow pharmacists to utilise clinical skills to 
provide expanded pharmaceutical care. The professions failure to transform will 
ultimately result in the profession being left behind. 
“...if we are not engaged there is always that threat that we can 
become redundant...I don’t want pharmacy to be one of those 
professions that goes away because society has deemed that it’s not 
important anymore...what keeps me awake at night is thinking that 
we can be replaced, is that technology going to evolve to a point 
when google becomes the method of choice for information on drugs 
not your local pharmacist. Are drugs going to be dispensed by 
machines like cola products are dispensed?...” 
(Participant 6: Professional organisation, Company director, Community pharmacist 
proprietor-International) 
“...focus on new and innovate career opportunities because in the 
end the robots can take over what we do in the back of a dispensary 
but only a trained health professional who's a good pharmacist 
can...apply medication knowledge to complex medical situations in all 
sorts of places...” 
(Participant 12: Professional organisation, Consumer organisation, Advanced 
practice pharmacist-Australia) 
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“...there's such an opportunity for Pharmacists to do more and 
indeed, I would argue, some of the dispensing and supply work could 
be taken over by technology before too long... it's at your 
peril...online Pharmacy and distribution...It's this whole question 
about, what are we going to want from Pharmacy in the future? How 
much is it going to be about dispensing and supply and how much 
about medicines optimisation and provision of pharmaceutical care? 
And Pharmacy has got to decide which it wants to do...” 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-International) 
“...It is profession diminishing, and may in fact be so professionally 
diminishing in the fullness of time that it could actually be a reason 
that the profession fails...” 
(Participant 7: University sector, Professional organisation, Academic pharmacist-
Australia) 
“...pharmacy...is potentially at risk of being irrelevant if we don’t adapt 
to change and if the current structures in pharmacy aren’t going to 
allow people who are doing innovative services and doing new and 
changing things, the opportunity to really progress the profession 
unless we’re prepared to make change...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
One quarter of participants identified that disruptive technologies and business 
models were a significant threat to the pharmacy professions’ transformation. Four 
participant identified the threats to the dispensing process. 
“...I took the profession down the electronic prescriptions route was 
that’s how mail order embedded itself in other countries. When the 
pharmacy profession lost control of the dispensing process and the 
doctors could do point to point dispensing...people know that the US 
is corrupt in that system so there’s point to point dispensing and you 
go to the doctors’ surgery they shoot it off to the HMO or the mail 
order facility...Now we fought… whatever we spent on eHealth is 
worth every penny because in Australia the prescription is an 
electronic prescription that goes to a mailbox. The chances of 
corruption...to a mail order has just disappeared...” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
“...the dispensing portion of what we do can be done by technicians, 
can be done by robots, it can be done by kiosks, it can be done 
through mail, a lot of prescriptions done in America are delivered 
through mail. We have huge factories where all they do is process 
prescriptions...They may have 100 pharmacists but be taking care of 
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a million people...If we want our profession to be replaced, all it takes 
is for pharmacists not to be engaged...” 
(Participant 6: Professional organisation, Company director, Community pharmacist 
proprietor-International) 
 Chapter Summary 
This chapter presents participant views regarding the need for a profession-wide 
transformation and the challenges that are preventing pharmacy leadership from 
achieving this professional transformation. Participants reported the transformation 
challenge to be the pharmacy profession expanding the role of the pharmacist to 
maintain relevance with the demands and needs of the Australian healthcare 
context. The leadership trait vision (Section 5.2.1) is central to the pharmacy 
leadership definition. Participants believed that a strong professional leadership 
vision was needed to expand the role of the pharmacist, through articulating an 
effective policy vision into the wider health context, enabling professional 
pharmacy leadership in the direction needed to transform the profession. 
Participants identified that the transformation challenge was made-up of the 
subthemes expanded role opportunity, disconnect with context, organisational 
disunity, pharmacy leadership emergence, repressive leadership, and a profession 
left behind. Under expanded role opportunity, participants described the numerous 
opportunities for pharmacists to expand their practice to the service leadership 
approach, which was regarded as essential to professional transformation (Section 
9.2). They regarded advanced pharmacy practice as evidence that the profession 
is starting to transform the role of pharmacists (Section 9.2.3), something which 
has been achieved on a broader-scale in the nursing profession (Section 9.2.2). 
The disconnect with context was viewed as the profession operating in isolation 
from government, consumer groups and other health stakeholders (Section 9.3). 
The current remuneration model for the community pharmacy sector was reported 
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as a contributing factor to the disconnect. The model was felt to promote the 
technical dispensing process rather than the service leadership approach that is 
required to expand the role of the pharmacist into a more collaborative primary 
healthcare role (Section 9.3.1). Participants reported that an understanding of 
health consumers was essential when pharmacy leadership designs professional 
services that expand the role of the pharmacist (Section 9.3.2). At the heart of the 
transformation challenge was the community pharmacy ultimatum. Community 
pharmacy leadership has a clear choice to focus on retail (discount leadership 
approach) or expanded professional services (service leadership approach) 
(Section 9.3.3). Participants questioned whether the profession is willing to enact 
this broader leadership vision (service approach to pharmacy) that expands the 
role of the pharmacist, and is associated with the pharmacy leadership trait vision 
(Section 5.2.1). It was felt that the profession needed to improve its ability to 
articulate an effective policy vision, as the current professional leadership 
approach has sidelined pharmacy from many wider primary health initiatives and 
was a challenge to the profession’s transformation (section 9.3.4). 
Organisational disunity describes the political tensions that exist between 
pharmacy organisations inhibiting the profession’s leadership from within, inhibiting 
transformation efforts (Section 9.4). The competing leadership visions are causing 
disunity between pharmacy organisations and impeding a shared leadership vision 
needed to expand the role of the pharmacist and transform the profession (Section 
9.4.1). The subtheme, pharmacy leadership emergence describes the professions 
leadership development pathways needed to stimulate leadership flow-through 
(Section 9.5). Pharmacy leadership development is further examined in-depth 
throughout the next chapter (Chapter 10). Pharmacy leadership emergence was 
associated with maintaining and developing followership relationships, a key 
component of pharmacy leadership definition (Section 5.3). The subtheme, 
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repressive leadership explains the inhibition of pharmacy leadership emergence 
(Section 9.6). A repressive leadership culture was evident through the reports that 
the profession was inhibiting women and early career pharmacists from emerging 
into leadership positions. This was seen as a significant challenge to pharmacy 
leadership when the majority of the workforce is female and almost two-thirds are 
below thirty-five years of age. The subtheme, a profession left behind, describes 
what will occur if the profession lacks the unified leadership and fails to transform 
(Section 9.7). Technology, competing business models and other professions 
expanding into medicine dispensing were identified as threats if pharmacy 
leadership fails to expand the role of the pharmacist. 
The next chapter of this thesis will examine the theme, pharmacy leadership 
development (Chapter 10). Pharmacy leadership development is critical to 
stimulating leadership emergence within the profession needed to transform the 
profession and expand the role of the pharmacist. 
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Chapter 10: Pharmacy Leadership Development 
 
 
“...Whereas I believe every profession has a 
responsibility to be active in training the next 
generation. It is much their future as that young 
person’s future...” 
(Participant 3: University sector, Professional organisation, Director, 
Hospital and academic pharmacist-Australia) 
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 Pharmacy Leadership Development 
Pharmacy Leadership Development (Theme)=> 
This chapter of the thesis outlines the theme, pharmacy leadership development, 
explored in-depth from the perspective of participants in this qualitative study. 
Pharmacy leadership development comprises several subcategories explored 
below in Table 10.1. 
Table 10.1 Pharmacy Leadership Development, Theme Description and 
Subcategories 
Theme Theme description Subcategories 
Pharmacy leadership 
development 
The training and development of pharmacists and 
pharmacy students in the pharmacy profession. This 
includes the leadership development practices; 
coaching, mentoring, training, and networking. 
Experiential leadership 
development 
University and pharmacy practice 
disconnect 
Mentorship in the pharmacy 
profession 
Pharmacy training 
recommendations 
 
Central to this theme is the training and development of early career pharmacists 
(e.g. intern pharmacists and pharmacy students), incorporating structured and 
unstructured leadership development practices and behaviours, such as formal 
and informal coaching, mentorship, training, professional networking and 
experiential development. The theme contains recommendations for 
undergraduate and postgraduate pharmacist leadership development and training. 
Participants shared personal experiences about their leadership development 
journeys in shaping their recommendations. 
 224 
 
 Experiential Leadership Development 
Pharmacy leadership development (Theme)=>Experiential leadership development 
(Subtheme). 
Experiential leadership development is the first subtheme, and examines the 
importance of experiences in a pharmacists’ career that they reported developed 
their leadership capability. The subtheme comprises five codes, with most of the 
participants identifying that exposure to diverse real-life experiences provide 
opportunities to train and develop early career pharmacists to develop and improve 
their leadership capacity. 
 Experiences are Essential 
Pharmacy leadership development (Theme)=>Experiential leadership development 
(Subtheme)=>Experiences are essential (Code). 
About a quarter of participants identified that diverse experiences were essential to 
develop pharmacy leadership, facilitating reflection and leadership development. 
“...so people develop by experiences and by being allowed to make 
mistakes and allowed to sort of see how things work... And I think the 
more experiences you have and the more you reflect on those 
experiences the more you develop as an individual and as a 
leader...” 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
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 Experience Develops Leadership Traits 
Pharmacy leadership development (Theme)=>Experiential leadership development 
(Subtheme)=>Experiences develop leadership traits (Code). 
One-third of the participants described that leadership positions and experiences 
developed leadership traits flexibility, confidence, and competence of pharmacy 
professionals. 
“...They [pharmacy professionals] get exposure to different ideas, it 
makes them flexible and confident and capable. It allows them to not 
be railroaded by one idea. Like I was saying that flexibility to consider 
things, to continuously be considering things and updating. So that 
was really, really good for them...” 
(Participant 22: Professional organisation, Consumer organisation, Pharmaceutical 
industry, Community pharmacist proprietor-Australia) 
“...every person who has won Pharmacy Assistant of the Year has 
moved on to bigger and better things...because it gives them 
confidence to do something... They get up and speak in front of their 
peers, it develops them as individuals, and I’ll bet my bottom dollar 
80 to 90% go on to do something more than just being in community 
pharmacies...and I think that’s what we need more of, because that 
then develops, believe it or not, leaders, or self-belief in individuals...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
 The Need to Provide Experience Opportunities 
Pharmacy leadership development (Theme)=>Experiential leadership development 
(Subtheme)=>The need to provide experience opportunities (Code). 
The majority of participants indicated that the pharmacy profession needs to 
provide a greater number and range of experience opportunities for pharmacists, 
which will help to develop their leadership skills and capacity. 
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“...and giving them opportunities to do things on their own...And I 
think it’s very important that when people do things that are good you 
praise them for what they’ve done because that encourages people 
to do things...” 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
“...a leader comes through by the experiences that they’ve had so 
you give them opportunities...you’re giving them opportunities...What 
you can do is create an environment where people develop their own 
networks... You maximise the productivity of the people who are 
likely to be leaders... So you increase productivity by giving people 
opportunities early...” 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
 Lifelong Experiential Learning 
Pharmacy leadership development (Theme)=>Experiential leadership development 
(Subtheme)=>Lifelong experiential learning (Code). 
Almost half of the participants recognised that lifelong learning through education, 
experiences and learning from others is essential to leadership development. 
“...I think before you’re a leader it’s around that growing, having a 
broad range of experiences and experience, looking around you and 
growing and learning all the time... So the sort of concept of lifelong 
learning...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
Learning from failed experiences was described by a quarter of the participants, as 
a critical reflective part of their lifelong learning experiential leadership 
development. 
“...Success does not consist in never making mistakes but in never 
making the same mistake the second time. You've got to allow 
people to try and that's what good leaders do, they give them an 
opportunity. The way I word it is you give them an opportunity to 
succeed or fail but it's their opportunity...” 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
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Six participants identified that continuously learning from others provides 
meaningful and formative leadership experiences. 
“...Because not everyone is perfect. And I might be good at 
something, but there’s other part of me that is not that good. And 
other people can feel that...it’s good to learn off a lot of people...you 
learn from people...” 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
“... I’ve certainly learnt a lot from everyone around me, there’s no 
doubt, because I’m still learning every day...” 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
 Experiences Beyond Pharmacy 
Pharmacy leadership development (Theme)=>Experiential leadership development 
(Subtheme)=>Experiences beyond pharmacy (Code). 
Half of the participants discussed the value of knowledge and experience beyond 
the pharmacy sector, in diverse areas such as business, clinical, organisational 
and political arenas in developing richer, more well-rounded and experienced 
pharmacy leaders. 
“...All these people, I suppose, they don't just have their Bachelor of 
Pharmacy. They didn't just do pharmacy and saw that was the end of 
their education. They went and did something extra, whether it was 
military, whether it was an MBA, whether it was doing their CPA. 
They went and did something more... I just think that we're very 
inwardly focused. I think pharmacy leaders need to look outside our 
industry and I've tried to get as much experience as possible in areas 
other than pharmacy because I just find we tend to be so inwardly 
focused ... Any experience you can get in any other area other than 
pharmacy I believe will only make you a richer leader in our 
profession...” 
(Participant 8: Professional organisation, Government organization, Consumer 
organisation, Community pharmacist proprietor-Australia) 
“...stepping outside of the pharmacy... And that was a big step and I 
was absolutely scared of failure...understanding the wider health 
environment helps you to understand where pharmacy can and 
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should fit in, but also to provide a different voice, a different 
leadership role...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
Three participants described the crucial need for business and leadership training 
to develop pharmacy leaders. 
“...I think if people are going to be identified as leaders and brought 
on they will need exposure to a different way of thinking apart from 
how to do a script and how to understand medicine, and so I think 
people need, they need to have exposure to working in a business 
and to the leadership book in the boardroom, and then need some 
Harvard type training... that content in rounding off and directing your 
way of thinking as a leader...” 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
Five participants identified the need for understanding the political landscape 
across the pharmacy sector as essential to pharmacy leadership development. 
“...increasingly it’s not just through the organisations that pharmacists 
need to have those skills, it’s also just in dealing with their local 
members of parliament, you know, and convincing them that this 
business is important for the services...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
Several participants recognised the importance of organisational experience and 
nurturing within the organisation, when reflecting on their leadership journey. 
“...I was involved with...Pharmacy Management...that gave me a 
profile and within a couple of years I think I was...President...And 
that’s why need to have leaders that are able to show their wares 
and nurture them through...” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
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 University and Pharmacy Practice Disconnect 
Pharmacy leadership development (Theme)=>University and practice disconnect (Subtheme). 
One of the major findings identified earlier in Chapter 6, described the disconnect 
between the pharmacy profession and the external context. This disconnect is 
evident in this subtheme ‘University and practice disconnect’. Participants identified 
a perceived disconnect in their beliefs of current university training and their 
current understanding of pharmacy practice; predominantly in community 
pharmacies. They reported that the current training of pharmacists is not being 
congruent with the current pharmacy practice. The subtheme examines the 
disconnect between clinical training at university and pharmacy practice workplace 
settings. Two-thirds of the participants perceived that retail and business elements 
of community pharmacy were missing from university training. 
“...by all accounts in Pharmacy College they get very little training in 
how to run a business, in terms of like you know it’s all on the more 
academic stuff, more for the training, and they get tossed in at the 
deep end when they start working for a commercial organisation. So 
at one level it’s just actually give them better training in what they will 
be doing...” 
(Participant 25: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and Europe) 
“...there has been no like heads up attention focused on the 
academic sector to begin to train people to be ready and have the 
skills to meet these changes. Because in most Universities, they are 
still basically clinical and technical type of training focused...” 
(Participant 5: Professional organisation, Company director, non-Pharmacist-
Australia) 
Intriguingly, a view raised by two participants, reported that universities were taking 
leadership to train pharmacists for expanded role opportunities that have not been 
realised by the profession.  
“...pharmacy education is probably a bit ahead of the pharmacy 
profession itself, is that we’re encouraging students to be much more 
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patient centred, much more clinically focused, much more clinically 
skilled, and perhaps even much more management and leadership 
skilled and the reality of the profession are that it’s not quite there 
yet...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
Two participants identified that a barrier to training pharmacists was the resistant 
culture entrenched in community pharmacy ownership. 
“…We had the naïve belief that if we went and taught our 
undergraduate students that they'd become change agents...we duly 
did that...what we didn't realise was the pressures outside, you know, 
when they leave the university, we may have given them the tools to 
think about and what's a really good practice and whatnot...when 
they're entering the workforce... the current culture just folds in upon 
them and it's just a huge battle for them to be really innovative and 
change things, simply because the culture there is so resistant...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
 Pharmacist Leadership Training is Lacking 
Pharmacy leadership development (Theme)=>University and pharmacy practice disconnect 
(Subtheme)=>Pharmacist leadership training is lacking (Code). 
Ten participants described that pharmacy student leadership training was lacking 
or under-developed. 
“...From what I've seen in my two years of lecturing to these students 
at the University is there's no leadership training at all...” 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
Two participants, with professional leadership experience described that 
leadership was something that cannot formally be trained or learned. 
“...I don't believe it's a structural problem of the universities or of the 
profession to say that we're not training leaders because a leader is 
somebody that will stand up and put their hand up and take a step 
forward...” 
(Participant 8: Professional organisation, Government organisation, Consumer 
organisation, Community pharmacist proprietor-Australia) 
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“...I think you can to some extent but the whole leadership thing is as 
much absorbed from the environment that you’re in as it is – I don’t 
think you can learn how to be a leader...” 
(Participant 14: Professional organisation, Community pharmacist-Australia) 
 The Profession is Training Effective Graduates 
Pharmacy leadership development (Theme)=>University and pharmacy practice disconnect 
(Subtheme)=>The profession is training effective graduates (Code). 
Although participants believed that the graduates were lacking in business and 
retail skills, some participants believed that overall the graduates were better 
trained. 
“...pharmacy students are 20 times better than they were 20 years 
ago. I would rate the skills and knowledge and abilities of my last ten 
interns as being three to five times better...” 
(Participant 22: Professional organisation, Consumer organisation, Pharmaceutical 
industry, Community pharmacist proprietor-Australia) 
 Pharmacy Workplace Preparedness 
Pharmacy leadership development (Theme)=>University and pharmacy practice disconnect 
(Subtheme)=>Pharmacy workplace preparedness (Code). 
Experience, expertise and knowledge in pharmacy practice areas was identified as 
an essential pharmacy leadership trait (Section 5.2.2; Tacit knowledge). However, 
four participants described that pharmacy students leaving University have minimal 
workplace experience and preparedness. 
“...Uni kids aren’t going through now and aren’t even program 
ready… “What’s the use of someone studying four years and a fifth 
year as an intern if they’re not ready...If they’re not ready to do HMRs 
on guildcare or your other software. They’re clearly not ready...” 
(Participant 10: Professional organisation, Consumer organisation, Board director, 
Community pharmacist proprietor-Australia) 
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 Mentorship in the Pharmacy Profession 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=> 
Mentorship in the pharmacy profession is the third subtheme of the theme, 
Pharmacy leadership development. Participants shared personal mentorship 
experiences and provided mentorship recommendations. The subtheme examines 
mentorship structure; structured, unstructured and/or flexible mentorship between 
mentee and mentor, a reciprocal relationship where guidance, advice and direction 
is transferred in this relationship. 
 Mentorship is Leadership Development 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=>Mentorship is leadership development (Code). 
One-third of participants through personal experience described that mentorship 
was critical to and integral with leadership development. 
“...Mentorship...I think a mentor is someone who breeds other 
leaders and breeds people to follow them. If you mentor someone 
basically you’re going to in some way influence…mentoring and 
giving them opportunities to do things on their own...” 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
“...mentoring is a very important step....... if you can give appropriate 
mentorship somehow, instil some of that, leadership will come and 
great leaders will come, not just leaders, but really good leaders 
without fear of making change... And that’s a type of leadership....” 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
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 The Importance of Mentorship 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=>The importance of mentorship (Code). 
The majority of participants acknowledged that pharmacy mentorship was critical, 
fundamental and invaluable to pharmacy leadership development. 
“...the role of mentors is just unbelievably critical... and I reckon I was 
pretty reluctant to have a mentor originally, I don’t know why I think I 
was just kind of I’ll be right...mentors are…Absolutely key...” 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
“Oh it’s fundamental...because when you’re having experiences and 
you’ve never come across those episodes before you need 
somebody to guide you...” 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
“...So I think mentorship is particularly important in professions like 
ours, in professional disciplines that idea of forming your own 
professional direction, it’s critical that you can drawer upon mentors 
and I have been lucky to have a number of them...” 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
“...I think it's invaluable and I've got a list of a dozen different people 
that I would call whenever I got stuck on a specific issue but the thing 
is it does cut both ways. I've got now other people that call me for 
advice as well and I learn just as much from helping somebody else 
as I get for asking for help of someone...” 
(Participant 8: Professional organisation, Government organization, Consumer 
organisation, Community pharmacist proprietor-Australia) 
The majority of participants experienced a mentorship relationship at some point 
during their professional career, and so drew on their experiences when thinking 
about future generations. 
“...and I mean I had a wonderful mentor in pharmacy...” 
(Participant 2: Professional organisation, Board director, Community pharmacist 
proprietor-New Zealand) 
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‘...I would certainly say that personally I’d had people who have 
guided me or people I’ve looked up to and modelled myself...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
“...I have been lucky to have a number of them... thinking about this I 
thought about three mentors who have had a big impact on me...” 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
Not everyone reported having a mentor throughout their professional career, with 
three participants acknowledging that they did not receive mentorship. 
“...You know, for me, I’ve never had a mentor, but I have mentored 
lots of people...” 
(Participant 9: Government organisation, Consumer organisation, Organisational 
pharmacist-Australia) 
“...I didn’t really have a mentor or someone who I aspired to 
professionally...” 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
10.4.2.1 Not Enough Mentorship 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=>The importance of mentorship (Code)=>Not enough mentorship (Code property). 
Half of the participants acknowledged that there was not enough mentorship in the 
profession. 
“...should we do it more often and I think we should. I don't think we 
do it well enough...” 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
“...I believe there’s not enough of it, basically. Again, I'll give you an 
example, and I still use this model to today, and I think it would be 
great within our profession if we could develop a serious model 
around mentoring...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
 235 
 
10.4.2.2 Responsibility of the Profession 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=>The importance of mentorship (Code)=>Responsibility of the profession (Code 
property). 
Seven participants reported that the profession has a responsibility to mentor early 
career pharmacists. 
“...So I think that opportunity... give back to the profession by 
ensuring that others also take on mentoring or at least an attitude of 
being a role model is reflected in the advanced practice framework... 
give back to the profession...through educational research, 
leadership and mentorship...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
“...I believe every profession has a responsibility to be active in 
training the next generation. It is much their future as that young 
person’s future...” 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
“...You know you’ve got a responsibility I think as somebody who’s at 
a higher level to help somebody who’s at a lower level...” 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
 Mentorship at Different Life Stages 
Pharmacy leadership development (Theme)=>Mentoring in the pharmacy profession 
(Subtheme)=>Mentorship at different life stages (Code). 
One quarter of the participants perceived that mentorship occurs at all stages of 
one’s career, starting with students. 
“...I thought about three mentors who have had a big impact on me. 
The first was when I became a pharmacist and I was working as 
student... As I moved into my academic career, I have obviously had 
academic supervisors and the like, and they have set me on a way of 
thinking, a way of being creative... And obviously as I moved up the 
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academic ranks I looked at more senior people to give me strategic 
advice about where I should be going...” 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
“...I reckon it should be instigated from very early on... specially for 
early pharmacists, it’s a stressful situation and you’re dealing with 
death, you know, life and death situations...And that’s the sort of 
experience that if you can translate that into another young 
pharmacist...And that’s why mentorship has to be instigated very 
early on...” 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
One participant provided an opposing view, explaining that mentorship with 
pharmacy students was too early to be of any real benefit. 
“...I almost think a mentor program with pharmacy students is too 
early... until you are actually in the real world dealing with patients 
and the real environment, that there are so many things that don’t fall 
into place...you know, as a student you are in a little bit of a 
cushioned, protected world, and I wonder whether it’s a bit early 
then. But once you’re in that first or... first or second year out, and 
you’re having to deal with the day to day realities...” 
(Participant 2: Professional organisation, Board director, Community pharmacist 
proprietor-New Zealand) 
 Unstructured Approach to Pharmacy Mentorship 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=> Unstructured approach to pharmacy mentorship (Code). 
More than half of the participants supported the unstructured approach to 
pharmacy mentorship. 
“...So you need mentors, mentors are fundamental. But you can’t 
manufacture a mentor environment…What you can do is create an 
environment where people develop their own networks...” 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
Two participants described that pharmacy organisational mentorship tends to be 
unstructured. 
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“...people haven't been mentored properly or there's been nothing 
formally in place but I think most associations have tried to get young 
people involved in pharmacy and put them on committees and stuff 
like that. A lot of them only last a couple of years and then get 
disillusioned and leave...” 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
Conversations were a common way that unstructured mentorship transpires, a 
view shared by five participants. 
“...a particular mentor, no I’ve never really had anybody that over my 
whole sort of career, it’s just people who you come across and you 
do respect and you have those conversations... testing ideas to see 
whether my thoughts were crazy or not with someone who you 
respected...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
The drive of the mentee within the mentorship relationship was a critical factor to 
the unstructured mentorship process, a view shared by one-third of participants as 
they discussed their personal mentorship experiences. 
“...mentoring from a personal perspective, I think is fantastic. I've 
always used it. I've recommended it to a number of people. And I 
guess you’ve got to find the area of where you need the mentoring. 
You could say it’s in perhaps a business. It could be in ownership. It 
could be in a range of areas where you would like that mentoring. 
But I think it’s for the person to try and identify where they need it, 
and then to be able to find that mentor...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...So it might be as simple as right OK I met Andrew McLachlan a 
few times, respect him, so when I come across an issue where I 
know his speciality is I might shoot him an email, he gives me some 
advice, geez that was really useful I might sort of go back, and you 
sort of you sort of establish your relationship because you ask 
somebody who has some expertise...” 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
Leading by example was recognised by the majority of participants as a natural 
way the unstructured mentorship process materialised. 
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“...a great mentor doesn’t have to tell you to do something, tell you 
then that’s wrong, it’s most, most of the time it’s leadership by 
example. 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
“...So I actually think in profession like ours, and particularly in the 
leadership role, leading by example is one way of mentoring 
people...” 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
“...Teaching by example. I think some of our new opportunities are 
hard to imagine until you see them in action...to be consultant 
pharmacists doing Home Medicines Reviews don't do it very well 
until they're mentored...” 
(Participant 12: Professional organisation, Consumer organisation, Advanced 
practice pharmacist-Australia) 
 A Flexible Approach to Pharmacy Mentorship 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=> A flexible approach to pharmacy mentorship (Code). 
One-third of the participants recommended a combination of both formal structured 
and informal unstructured mentoring. 
“...I think you need a bit of both. You need formal where you say to 
someone, look, you know, I will be your mentor, let’s have a formal 
arrangement where you come to me. There’s the informal which is 
the viewing what they do and mimicking some of the things they do 
and just understanding...” 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
“...Probably semi-structured would work, a bit of everything. The 
mentors sometimes don't know what they're supposed to be doing 
either (laughter)... ... so they would need some guidance but you 
want to give them the flexibility to be able to show them what they do 
in different areas...” 
(Participant 12: Professional organisation, Consumer organisation, Advanced 
practice pharmacist-Australia) 
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 A Structured Approach to Pharmacy Mentorship 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=> A structured approach to pharmacy mentorship (Code). 
Most of the participants recommended a structured approach to pharmacy 
mentorship. 
“...mentoring needs to be done... it needs to be done properly in a 
skilled way, but as part of a broader program of development which 
could involve some skills development, management programs...” 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-United Kingdom) 
“...so I think there does need to be something structured... and that’s 
why there’s this structure because obviously I’ve gone out on my own 
limb and done it, but if there’s something structured in place it would 
be a lot easier for students to engage anyway...” 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
“...what we need is a broader structure around finding a number of 
mentors in a number of areas, and then particularly to younger 
people coming through the profession, is to try and then match them 
with a mentor, if they need that expertise....” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...if you mentor somebody, you can’t just do it once every six 
months, you’ve got to have a structured programme. So I think that in 
pharmacy… if you’re going to have pharmacy leaders that want to 
follow the mentoring model, they’ve got to be dedicated to that 
mentoring model...” 
(Participant 21: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and Europe) 
Several participants who were pharmacist business owners identified that the 
intern training program provides a structured mentorship opportunity. 
“...if you take mentoring to the next step you do need regular contact 
with a person. I suppose that’s why I referred to the intern program, 
because you know when you’re working for someone, if you can 
actually set up a bit of a structured mentor program...” 
(Participant 2: Professional organisation, Board director, Community pharmacist 
proprietor-New Zealand) 
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Three participants, all with experience in professional organisations, reported their 
concern that structured mentorship does not ensure the mentor and mentee will 
connect. 
“...I don’t really know how you’d implement a mentoring process, 
because for a mentoring process to work, the two people need to get 
along……yeah, usually mentors come from ad hoc, you know it just 
kind of happens… I wouldn’t know how you put money into it to 
RSVP.com/mentors …” 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
 Multiple Mentors 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=> Multiple mentors (Code property). 
One third of participants described the benefit of having multiple mentors, providing 
the mentee the flexibility learn from differing mentors picking up numerous traits. 
“...people look, and you know, copy bits and pieces of you, and it’s 
great because some leaders, or some people who have some good 
quality, and you got to learn a little bit off everybody and combine it 
to form a really meaningful thing in life...So I think mentorship, yeah, 
alright, you might have one or two, but it’s good to learn off a lot of 
people...” 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
“...I believe that everybody has an idea or an ideal in their head of 
what they think a perfect leader would be and you'd find a dozen 
different people with two dozen different traits and you're going to 
have to cherry pick the ones that you want of different individuals...” 
(Participant 8: Professional organisation, Government organization, Consumer 
organisation, Community pharmacist proprietor-Australia) 
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 Mentorship Specific to Areas of Practice 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=>Mentorship specific to areas of practice (Code). 
Several participants acknowledged that mentorship needs to be specific and 
relevant to the particular area of pharmacy practice of both the mentor and 
mentee. 
“...And you could do it by speciality. I mean there's no good me 
mentoring a pharmacist who wants to buy seven pharmacies and do 
all this sort of stuff but I'd be happy to mentor anyone who was 
interested in getting in the administrative regulatory side, committee 
side of pharmacy...” 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
“...And I guess you’ve got to find the area of where you need the 
mentoring. You could say it’s in perhaps a business. It could be in 
ownership. It could be in a range of areas where you would like that 
mentoring. But I think it’s for the person to try and identify where they 
need it, and then to be able to find that mentor...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
 Pharmacy Mentorship Challenges 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=>Pharmacy mentorship challenges (Code). 
One-third of participants acknowledged that there were several various challenges 
influencing pharmacy mentorship, namely the relationship issues motivating 
pharmacy mentorship. They felt that generational challenges between mentee and 
mentor, worsened in part by technology, must be addressed to ensure effective 
mentorship. 
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“...The problem that we have is some of these mentors leaders may 
well not allow a student to understand or be shown the business...” 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
“...the older generations these days probably more so than many 
other periods of time have difficulty understanding younger 
generations because of the steep climb of technological intervention 
in the way they live...there are two groups of people, one in the older 
set and one in the younger set, which makes mentoring impossible, 
or in the case of the older set unwise, and that is whoever is in the 
older set whose got an entirely fixed view of the world, a totally 
ironclad certainty of how things have to be...” 
(Participant 7: University sector, Professional organisation, Academic pharmacist-
Australia) 
10.4.9.1 Mentorship Time Commitment 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=>Pharmacy mentorship challenges (Code)=>Mentorship time commitment (Code 
property). 
Several participants indicated that effective mentorship required an appropriate 
time commitment, and therefore mentors should restrict the number of mentees 
they can effectively mentor. 
“...And we’ve spoken to others about this as well and there’s always 
efforts to put things in place, but I think it’s pretty big, a pretty big 
commitment for pharmacists to be mentors...” 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
“...We had a mentoring programme where I mentored two or three 
people. It’s also important you can’t mentor five/six/seven people...” 
(Participant 21: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and Europe) 
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10.4.9.2 A Manufactured Mentorship Environment 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=>Pharmacy mentorship challenges (Code)=>A manufactured mentorship 
environment (Code property). 
A manufactured mentorship environment builds on the structured approach to 
mentorship (Section 10.4.6), forcing leadership development without taking into 
consideration important traits of the mentor and mentee. Five participants’ 
described that a so called “manufactured” mentorship environment challenged 
mentorship in the pharmacy profession. 
“...you can’t manufacture a mentor environment OK, in my view it just 
doesn't work...you either have a mentor or you don’t...what you can 
do is give mentees the skills in making them more proactive in 
consulting with people...” 
(Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
“...pharmacists are waiting for some form of...structured mentoring 
program and that's not going to work because it's based on 
individuals and there is no... you can't have a cookie cutter approach 
to leadership. You can't have a cookie cutter approach to creating a 
leader...”  
(Participant 8: Professional organisation, Government organization, Consumer 
organisation, Community pharmacist proprietor-Australia) 
10.4.9.3 The Challenge is to Find Pharmacy Mentors 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=>Pharmacy mentorship challenges (Code)=>The challenge is how to be a 
pharmacy mentor (Code property). 
Six participants expressed concerns with mentors in the profession. One of the 
challenges in the pharmacy profession was finding pharmacists to take on 
mentorship roles. Interestingly, providing training and guiding mentors was needed 
to ensure the reciprocal relationship. 
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“...Not every pharmacist/owner would be a good mentor or leader 
because they don’t have that skill..” 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
“...The mentors sometimes don't know what they're supposed to be 
doing either... ... so they would need some guidance but you want to 
give them the flexibility to be able to show them what they do in 
different areas...” 
(Participant 12: Professional organisation, Consumer organisation, Advanced 
practice pharmacist-Australia) 
“...but it’s hard to know how to be a mentor. So I think that we try and 
do it with internships, it would be nice to think that people who are 
preceptors for interns would be able to be mentors as well...I don’t 
think we teach people that they can be mentors...” 
(Participant 2: Professional organisation, Board director, Community pharmacist 
proprietor-New Zealand) 
“...I guess it’s challenging to find the mentors, first of all, in the areas 
that young people need it...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
 The Reciprocal Mentorship Relationship Founded in Respect and Trust 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=>The reciprocal mentorship relationship founded in respect and trust (Code). 
One-third of participants described mentorship as a reciprocal relationship between 
mentee and mentor, established with respect, trust, and commitment between both 
parties. 
“...I think it's invaluable and I've got a list of a dozen different people 
that I would call whenever I got stuck on a specific issue but the thing 
is it does cut both ways...So it's very much a two-way street...it's 
about people forming relationships and maintaining relationships...” 
(Participant 8: Professional organisation, Government organisation, Consumer 
organisation, Community pharmacist proprietor-Australia) 
“...So I think that sort of collaborative partnership, relationship is 
there... And it’s very valuable for both mentor and a mentee. It 
obviously has to be based on mutual respect, liking, trust and 
commitment...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
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“...he absolutely gave me responsibility and trusted me and I think I 
repaid that by…I absolutely respected the responsibility that he gave 
me...” 
(Participant 22: Professional organisation, Consumer organisation, Pharmaceutical 
industry, Community pharmacist proprietor-Australia) 
“...So it is a good relationship...it’s as a friend but it’s somebody who 
you respect as well...I have a great respect for him...” 
Participant 16: Professional organisation, University sector, Community pharmacist 
proprietor-Australia) 
“...So within the same business environment, the parties working in 
the same business, it has got to be of mutual respect...” 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
Most of the participants identified that trust was fundamental to the mentorship 
relationship, and assisted in developing a positive influence and connection which 
was especially important in developing pharmacy leaders. 
“...Leaders are a bit like this as well, leader, mentor you create an 
environment of trust...a mentor and a mentee have to develop a 
strong relationship of trust, and to be honest a leader needs to be 
able to trust their team, and the team needs to be able to trust the 
leader... and you need to create a safe environment where you can 
confidently share your ideas and thoughts, the element of trust is 
absolutely critical...” 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
Three participants described their perceptions of the impact of mentorship in 
developing and fostering pharmacy leadership. 
“...well my first preceptor had a big influence on me when I was doing 
my internship... So that had a big influence on me as a young 
pharmacist or an intern pharmacist. I thought I'd like emulate, 
emulate a positive personality like that in the profession...” 
(Participant 28: Professional organisation, Military organisation, University sector, 
Military pharmacist-Australia) 
Several participants recognised and valued the important and personal connection 
that exists in the mentorship relationship. 
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“...But you’ve got to find somebody that you connect with, and that’s 
generous to do it...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
“...And also reminded me that the personal connection that you have 
with people is very important, so if you have a personal bond, that 
idea about understanding more about the individual and respecting 
the things they do and recognising that you can achieve so much 
more together......” 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
 Mentee 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=>Mentee (Code). 
The majority of participants described the need for the mentee to have an open 
mind and willingness to learn and take new experiences to develop as a leader. 
“...You learn a lot, as I said, from being involved in committees, 
getting involved in that, getting yourself your mentor that... finding 
someone that you can work with...” 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
“...Also, there’s a lot of people aren’t good mentees either because 
they won’t accept that kind of open debate, they’re very closed...” 
(Participant 21: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and Europe) 
“...And if the mentee thinks the mentor is going to just fix everything 
then the mentee is under disillusionment. They have got to come not 
just with problems but with how they would solve the problem....” 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
Five participants reflected from their personal experiences as a mentee, the lasting 
impression of the value and impact of mentorship in their own career and 
leadership journey. 
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“...And he's been a mentor. He looked after me in my early days in 
pharmacy. I didn't know he was mentoring me because I didn't really 
know what that meant at that stage...” 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
Several participants shared personal stories of the value of sharing information and 
knowledge with their mentors, using their mentors as a sounding board. 
“...And it wasn’t so much mentoring but it was testing ideas...with 
someone who you respected... And so you could probably say they 
were mentors per se about being much clearer in where I think 
pharmacy could go and how we could do it and what we needed to 
do...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
 Mentorship; Valuable for the Mentor 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=>Mentor benefits (Code). 
A quarter of the participants described their personal pride as a result of their 
mentorship involvement in the profession, identifying that in addition to providing 
mentorship, they gained personally from the valuable experience. 
“...So I mean I feel privileged that I’ve had a strong relationship with 
all the NAPSA people over the years... I mean I know every single 
one of them well, and they come to me, and I have actually mentored 
two of them over the years, and continue to mentor one...And it’s 
very valuable for both mentor and a mentee...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
“...I look back...the idea of knowing that you’ve had a small part in 
somebody else’s success and even if that is totally amongst within 
yourself then that’s a good thing...” 
(Participant 29: Professional organisation, Organisational pharmacist-Australia) 
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“...You show them the business side and you also show them the 
patient care side and of course the mentor, they also get benefit out 
of it, they get to see that person grow. I have had several students in 
my pharmacies over the years, and I am real proud of them...” 
(Participant 6: Professional organisation, Company director, Community pharmacist 
proprietor-North America) 
“...I have mentored lots of people, a number of people over the last 
ten years or so, and I get more out of it than they do, I’m sure, sort of 
feedback...” 
(Participant 9: Government organisation, Consumer organisation, Organisational 
pharmacist-Australia) 
 Reluctant Mentors 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=> Reluctant mentors (Code). 
Three participants identified that the mentorship relationship felt strange, 
uncomfortable, and embarrassing in some instances, as the notion of being a 
mentor seemed to be associated with ego and was hard to define. 
“..., it’s embarrassing to people to look up to me and I’m not that sort 
of guy...I don’t have that big an ego, so it is bit embarrassing but you 
know people do respect your knowledge...” 
(Participant 18: Professional organisation, University sector, Accredited pharmacist-
Australia) 
“… in business people love that whole mentor concept...I’d find that a 
bit embarrassing... So I would find it really weird if anyone ever called 
me a mentor in pharmacy...So I would describe myself as a mentor 
but I’m still a little bit uncomfortable with it...the definition’s a bit 
uncertain...” 
(Participant 22: Professional organisation, Consumer organisation, Pharmaceutical 
industry, Community pharmacist proprietor-Australia) 
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 Traits of a Mentor 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=> Traits of a mentor (Code). 
One-third of the participants identified the traits of a mentor, in many instances 
describing leadership traits, such as communication skills and trust. 
“...because I think a mentor doesn’t just show what they do, but they 
also explain why they do it and why it’s important to them, what they 
do...” 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
“...and sharing ideas and listening to ideas... Leaders are a bit like 
this as well, leader, mentor you create an environment of trust, you 
listen to the ideas someone has, tweak those, give advice and back 
people to go through it...” 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
“...So in that true sense of mentorship, I think the role of a mentor is 
to firstly listen more than they speak... So I think the first 
characteristic of mentorship from the mentor's perspective, is to listen 
more than they speak...” 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
10.4.14.1 Inspiration 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=> Traits of a mentor=>Inspiration (Code property). 
Inspiration is central to the pharmacy leadership definition, forming an important 
element of the leadership traits vision (Section 5.2.1); followership (Section 5.3) 
and social capacity (Section 5.2.3). Several participants identified from their 
experience the mentor trait of inspiring followers. 
“...just very inspirational. Just so passionate about the profession, 
that you think, you know, “I've just got to get out there and do 
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something.” You know...out there playing this, what I call a lone hand 
at times, and you think, well, you know, if you can do something for 
the profession, I think you should do it... just inspired me from the 
sort of guy he is...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
“...So she gave me the vision and the inspiration to want to work in 
that area and just create one's own opportunities because no one 
else would spoon feed you those opportunities...” 
(Participant 12: Professional organisation, Consumer organisation, Advanced 
practice pharmacist-Australia) 
“...I think my Grandad was a great inspiration. He come from China 
to Vietnam and started the whole thing there. From almost nothing. 
And I think the way he deal with people, it’s instil into the younger 
generation in my family, he was generous and that’s really 
important...” 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
10.4.14.2 Providing Guidance and Advice 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=>Traits of a mentor (Code)=>Providing guidance and advice (Code property). 
Most of the participants expressed from their personal experiences that a mentor 
provides guidance, advice and direction. 
“...I've got some key people who I, sort of, go back to see if I'm at a 
point of decision or pondering about work, which I guess, would 
regard as mentorship...” 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-United Kingdom) 
“...you’ve got to learn off somebody, and you’ve got to have some 
sort of guidance...most of the time it’s leadership by example... And 
that’s the sort of experience that if you can translate that into another 
young pharmacist...a bit of direction...” 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
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“...you can talk through the issues and talk through everything else... 
he was just good to chat to, and you put a situation forward and 
because they’ve got no vested interest in it, to be able to have that 
conversation with him is just so valuable...” 
(Participant 24: Professional organisation, Community pharmacist-Australia) 
Some of the participants provided mentorship recommendations around advice 
and guidance. 
“...a mentor is a person who is prepared to work with pharmacists 
and facilitate decision making from the actual you know mentoree... 
so a good mentor is a person who can activate in other people that 
decision making process...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
“...And a good leader is someone that's going to be able to provide 
guidance and advice to the staff and people that they interact with... I 
think mentorship is to really guide the young members of the 
profession whether they're undergraduates, interns or whatever with 
newly qualified pharmacists, is to guide them in how we operate as a 
profession...a good mentor, leads you, guides you and is positive, 
that can make a big difference to your entry into the profession...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
Five participants described the need for constructive advice in the mentorship 
relationship, with the mentor exhibiting a reflective ability an acting as a role model. 
“...So it’s about bringing out in the person that rather than being the 
I’m the expert, you’re the pupil sort of thing, that doesn’t work, 
because what you’re trying to do is get that person to grow 
themselves to have that sort of reflective ability and bring out the true 
strength of the person sort of thing...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
“...A good mentor is a person who is a good role model and that 
means they have got to be a person who does not hold grudges who 
is prepared to show people the ways in which they can solve 
problems themselves without having to be told what to do...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
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The majority of participants conveyed that the advice given by a mentor should not 
be prescriptive or directive, mentors need to lead by example. 
“...a mentor doesn’t just show what they do, but they also explain 
why they do it and why it’s important to them, what they do. A mentor 
doesn’t just say, do this; do this because this is what I think is… 
etcetera...” 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
“...a great mentor doesn’t have to tell you to do something, tell you 
then that’s wrong, it’s most, most of the time it’s leadership by 
example...” 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
“...I think you do have to extend a hand, because that also means 
you start that relationship on the right footing, you have gone to them 
with an ask rather than someone says right, I am going to mentor 
you. That is someone projecting their views on you...” 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
“...So you need somebody that can guide rather than this very 
directive, because you want to bring out other peoples’ thoughts 
around it without actually kind of mandating it...” 
(Participant 21: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and Europe) 
10.4.14.3 Generosity 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=>Traits of a mentor (Code)=>Generosity (Code property). 
Several participants articulated that mentors were generous with their time and 
expertise in providing advice. 
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“...I saw that they gave their time, I saw that they gave their talent, 
and I saw that they gave their treasure to help me, you know, I 
owned a pharmacy, and I had a child, and I owed a big debt for 
buying this pharmacy. And I am going this people are sacrificing their 
weekend, they are sacrificing their vacation to work on issues to help 
me...” 
(Participant 6: Professional organisation, Company director, Community pharmacist 
proprietor-North America) 
“...being generous, being kind, I think is so important, and when you 
have the capacity. You know you don’t have to have money to be 
generous and kind. You just have to, the need to have time. You can 
share your time, that is generosity...” 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
10.4.14.4 Experience and Knowledge 
Pharmacy leadership development (Theme)=>Mentorship in the pharmacy profession 
(Subtheme)=>Traits of a mentor (Code)=>Experience and knowledge (Code property). 
More than half of the participants described the importance of a mentor needing 
experience and knowledge. 
“...So mentorship doesn’t have to be from someone great, but it 
would be nice to have someone great and someone not too great. 
Because like I said, it’s about life experience... You got to have a bit 
of direction. You got to know where you are, you got to know your 
environment and that’s where you know where to go...” 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
“...People who are starting out should gain a lot of benefit from the 
knowledge and experience of people who are good at what they 
do...” 
(Participant 25: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and Europe) 
Several participants described that age was not a factor to limit the mentorship 
relationship. 
“...There should be more people doing it, especially, it doesn’t matter 
if you’re 50 or 100, anyone can be your mentor. You know, your 
friend can be your mentor, you can bounce off each other learning 
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things. You’re not there 24 hours a day, like I said, he might be good 
at something else, you learn off him. Or you can reflect and use him 
as your mirror. You might say, look, so it doesn’t have to be someone 
who’s 50 years older than you. It can be your mate…who can mentor 
you in a different way...” 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
 Pharmacy Training Recommendations 
Pharmacy leadership development (Theme)=>Pharmacy training recommendations 
(Subtheme). 
Pharmacy training recommendations is the fourth subtheme of the theme, 
pharmacy leadership development. The majority of the participants provided 
leadership development and training recommendations for training ECPs to 
meeting future demands across business, clinical and leadership training 
recommendations. 
“...right from the start in the training of Pharmacists...they should 
have modules that are about the health system, about health policy, 
about how policy is shaped and influenced...as they move out to 
work in Pharmacy there's mentoring... there are leadership and 
development programs...” 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-United Kingdom) 
 Business Training Recommendations 
Pharmacy leadership development (Theme)=>Pharmacy training recommendations 
(Subtheme)=>Business training recommendations (Code). 
Several participants provided recommendations to offer business and retail training 
to intern pharmacists and pharmacy students. 
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“...Very clearly there has to be a change to the curriculum in 
pharmacy. There has to be a module or two or three on pharmacy 
business...At the end of the day they're running a business, it just 
happens to be in over the counter products and prescribed drugs...” 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
“...by all accounts in Pharmacy College they get very little training in 
how to run a business, in terms of like you know it’s all on the more 
academic stuff, more for the training, and they get tossed in at the 
deep end when they start working for a commercial organisation. So 
at one level it’s just actually give them better training in what they will 
be doing...” 
(Participant 25: Board director, Pharmaceutical industry, non-Pharmacist-Australia 
and Europe) 
 Clinical Training Recommendations 
Pharmacy leadership development (Theme)=>Pharmacy training recommendations 
(Subtheme)=>Clinical training recommendations (Code). 
Five participants provided clinical training recommendations, mainly around 
training to improve communication and clinical decision-making. 
“...The need to be informed, I think that has important implications for 
professionals of the future and particularly as we train pharmacists 
who have a strong focus on the translation of information and 
communication. That will be a really important skill going forward...” 
(Participant 3: University sector, Professional organisation, Director, Hospital and 
academic pharmacist-Australia) 
“...I think we’ve trained people who are really good, have you know 
very good understanding about drugs, you know and how they work, 
and I think we’re getting better at teaching young pharmacists how to 
communicate. I don’t think they taught us how to communicate at 
all...” 
(Participant 9: Government organisation, Consumer organisation, Organisational 
pharmacist-Australia) 
Interestingly, one participant with leadership experience in dealing with 
Government, provided a recommendation to train pharmacists in clinical 
negotiation skills. 
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“...in terms of developing pharmacy leaders for the future of the 
profession there needs to be an emphasis on clinical negotiation 
skills... understanding of the pressures on government...training in 
negotiation skills and how the political process actually works...They 
need to have an ability to explain their profession to those in 
government...” 
(Participant 13: Professional organisation, Government organisation, non-
Pharmacist-Australia) 
 Leadership Development Programs 
Pharmacy leadership development (Theme)=>Pharmacy training recommendations 
(Subtheme)=>Leadership development programs (Code). 
The majority of participants provided recommendations for a diverse range of 
leadership development programs e.g. seminars, workshops, courses, 
conferences. 
“...I used to go to seminars and to events...we had a lot of speakers, 
and I think you learn from hearing about other peoples’ activities, and 
oh that sounds good, I can probably use some of that... I did an 
MBA...” 
(Participant 15: Board director, Retail pharmacy group director, Community 
pharmacist proprietor-Australia) 
“...for nearly the last 20 years, actually, I've accessed Executive 
Coaching. I got that originally through a women's leadership program 
I was part of when I was a Health Manager and I've continued with 
that and every job I've had, I always negotiate access executive 
coaching as part of the deal...” 
(Participant 17: Professional organisation, Board director, University sector, non-
Pharmacist-United Kingdom) 
“...It's about self-betterment. When I first started my full time career I 
went to Tech to learn management. I was doing more than the 
teacher in my job but I still picked up a few skills because I wanted to 
better myself...since then negotiation courses, conflict resolution 
courses which help me in my business and bettered me because 
there were times without that education that I couldn't solve the 
problem...” 
(Participant 19: Company director, Pharmaceutical industry, Retail pharmacy group 
director, non-Pharmacist-Australia) 
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“...we need structured sort of programmes or…Building those 
networks, I believe that’s what the organisations… I mean they’re 
doing it to some degree, but I think a lot more can be done...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
“...It should be more leadership through perhaps a leadership forum 
or a workshop, where they can give you, talk to you about 
leadership, some audio visual presentation, some role play...” 
(Participant 28: Professional organisation, Military organisation, University sector, 
Military pharmacist-Australia) 
Three participants recommended the importance of supporting the national 
pharmacy student body. 
“...I think supporting NAPSA is really valuable because that’s that 
snowballing effect of the growing pool of pharmacists that are 
perhaps the natural leaders...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia 
“...NAPSA has been very good at that level of the student body in 
developing the people that go to the NAPSA conference, and those 
that become involved in the executive...a lot of those people coming 
through are getting training in their own way, to potentially be future 
leaders within the pharmacy profession...” 
(Participant 11: Professional organisation, Board director, Community pharmacist-
Australia) 
One-third of the participants mentioned that continued professional development 
and professional networking was vital to leadership development. 
“...There are many number of networking opportunities available in 
the industry... there is any number of organisations, there is the 
Australian College of Pharmacy, the Society itself runs its own 
events, so I think there is lots of opportunity for young pharmacists to 
make connections...” 
(Participant 4: Professional organisation, Company director, non-Pharmacist-
Australia) 
“...getting people to come along to conferences or to events can be 
difficult. But that’s the best way of creating that network... So those 
links to existing things, the networking...And I used LinkedIn a lot… 
LinkedIn, from the professional networking point of view is 
underutilised in the pharmacy profession...” 
(Participant 27: Professional organisation, Consumer organisation, Company 
director, Advanced practice pharmacist-Australia) 
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A quarter of the participants articulated that the internship training program 
provided an opportunity to develop pharmacists. 
“...the intern program and graduate year, you know, internship year, 
it’s a great thing. It’s the first few months that determine your ability to 
think...” 
(Participant 20: Board director, Professional organisation, Community pharmacist 
proprietor-Australia) 
“...an intern program for an administrative department... PSA or the 
Guild or a combination and I think that an internship in pharmacy 
organisational type stuff is another way of developing leaders in the 
profession... that would go a long way to identifying and developing 
the leaders of the future...” 
(Participant 1: Professional organisation, Board director, Organisational pharmacist-
Australia) 
“...if you take mentoring to the next step you do need regular contact 
with a person. I suppose that’s why I referred to the intern program, 
because you know when you’re working for someone, if you can 
actually set up a bit of a structured mentor program then I think that 
could be very useful...” 
(Participant 2: Professional organisation, Board director, Community pharmacist 
proprietor-New Zealand) 
“...The guys at the meeting yesterday were all people who were 
talking about adding interns in their pharmacies...The way to 
maintain the uptake of professional services is to get an intern. And 
have an intern who have some rostered system where they roster 
with the pharmacist to handle S3s... But for me, it’s the way 
pharmacy should progress...” 
(Participant 22: Professional organisation, Consumer organisation, Pharmaceutical 
industry, Community pharmacist proprietor-Australia) 
 Chapter Summary 
This chapter presents participant views with regards to the theme pharmacy 
leadership development. Pharmacy leadership development relates to the 
definition of pharmacy leadership through maintaining and developing follower 
relationships, the essential reciprocal leadership process (Chapter 5.3). 
Participants reported pharmacy leadership development to be the training and 
development of pharmacists and pharmacy students in the profession. This 
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included the leadership development practices of coaching, mentoring, training, 
and networking. Participants identified the importance and need to provide 
experiences that develop pharmacists, that is, experiential leadership development 
(Section 10.2). Some participants, predominantly in the community pharmacy 
sector, reported a perceived disconnect between the training of pharmacy students 
at university and real-life pharmacy practice (Section 10.3), with some participants 
believing this disconnect was impacting leadership development. 
Mentorship was described as the guidance, advice and direction that is transferred 
between mentee and mentor. Mentorship was identified as the primary leadership 
development recommendation from the view point of the participants (Section 
10.4). Participants acknowledged that there was not enough mentorship in the 
pharmacy profession and that mentorship was a responsibility of the profession to 
ensure that pharmacy mentorship is sustainable (Section 10.4.2). Participants 
believed that unstructured mentorship was the most appropriate mentorship 
structure to improve the capacity of early career pharmacists (Section 10.4.4). 
Recruiting and training pharmacists to be mentors, mentorship time commitments, 
and manufacturing a mentorship environment were identified by participants as 
challenges to pharmacy mentorship and leadership development (Section 10.4.9). 
The traits of a mentor were reported to be inspiring, knowledgeable, generous, and 
provides guidance and advice (Section 10.4.14). These traits mirror several 
leadership traits that were used to define pharmacy leadership (Section 5.2), 
indicating that a mentor exhibiting these traits is displaying leadership. 
Participants reported that pharmacy training recommendations in the areas of 
business, clinical knowledge and leadership development were essential to 
developing the leadership capacity of early career pharmacists (Section 10.5). The 
intern training program was identified as a pivotal leadership development program 
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that provides a structured pathway to navigate graduates from university through 
their internship, and onto general pharmacist registration. The intern training 
program was believed to be ideally situated as a leadership development strategy 
to overcome the perceived university and practice disconnect (Section 10.3). 
The next chapter of this thesis (Chapter 11) will provide a discussion of all the 
qualitative findings chapters (chapter 4-10). 
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Chapter 11: Discussion of Qualitative Findings 
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 Introduction and Statement of Principal Findings 
This chapter of the thesis will discuss the findings from the preceding qualitative 
chapters (Chapters 5-10). This research set out to investigate and identify areas 
that impact the leadership development capability of Early Career Pharmacists 
(ECPs). To achieve this, the definition of pharmacy leadership and traits of an 
effective pharmacy leader were first identified. Then leadership development and 
mentorship in the profession were examined. And finally, the contextual challenges 
and opportunities facing the profession were explored. The principal finding of this 
qualitative research was the development of an Australian Pharmacy Leadership 
Theory (APL Theory) consisting of six major themes (Figure 11.1). The findings of 
each major theme have been previously presented (Chapters 5-10). 
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Figure 11.1 Australian pharmacy leadership—six major themes. 
 
 Discussion of Key Findings 
 Pharmacy Leadership 
Australian pharmacy research employing qualitative research methods has 
previously investigated leadership related pharmacy practice domains: 
organisational flexibility (93), practice change (90), managerial capability (8), and 
community pharmacy influences (14). The research presented in this thesis is 
unique due its specific focus on Australian pharmacy leadership. A specific 
research objective was to define pharmacy leadership from the perspectives of 
pharmacy leaders through exploring the definition and traits of effective pharmacy 
leadership. The first major theme emerging was the definition of pharmacy 
leadership which also answered the first qualitative research objective (Chapter 5). 
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Pharmacy leadership definition forms a central component in the APL Theory. 
Pharmacy leadership was defined through a constellation of leadership traits that 
were regarded as essential to leadership. Participants identified that the following 
leadership traits were pertinent to pharmacy leadership: vision, tacit knowledge, 
social capacity, competence, credibility, self-confidence, strategy, decisiveness, 
cognitive flexibility, pharmacy leadership motivators, responsibility, honesty, 
emotional intelligence, ethics and morals as essential components of pharmacy 
leadership (Section 5.2). 
The essence of pharmacy leadership is centered around a pharmacy leader having 
a vision. This incorporates a vision for their profession, a vision for their place of 
work, and a vision for their team (followers). There is a need for pharmacy leaders 
to articulate a clear vision, instilling confidence in their followers. Pharmacy leaders 
use social capacity traits to effectively communicate, motivating and inspiring their 
followers in the direction of the leadership vision. 
 Community Pharmacy Leadership 
Participants identified that community pharmacy leadership was a significant part 
of pharmacy leadership (Figure 11.1). This is due to the economic size and 
influence of the community pharmacy sector within the profession. Pharmacist 
business owners were reported to be leaders in their community pharmacies. 
Community pharmacy leadership vision was intrinsically linked to the pharmacy 
owner’s choice to implement either, the service or discount leadership approach 
within their pharmacy (Section 7.5-7.6). Interestingly, some participants identified 
that simply holding the position, pharmacist owner, does not equate to displaying 
effective leadership. Participants identified that pharmacy owners have an 
overwhelming resistance to changing their business leadership approach, contrary 
to the leadership trait, cognitive flexibility that is needed in effective leadership.  
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These findings support ideas identified in the literature that pharmacy owners are 
responsible for professional services (93), with the success of their business 
dependent on the management style adopted (8), the flexibility of their business 
operations (9), and their willingness to manage change (20,88). However, a unique 
finding of this investigation was the importance placed on the leadership approach 
adopted by pharmacy owners. A service leadership approach was associated with 
a vision that transforms the profession. This means that pharmacy owners in 
leadership positions need to move beyond their current pharmacy vision and adopt 
a leadership approach that encompasses professional services. This is essential to 
a broader transformational leadership vision for the profession. It was identified 
that to achieve this vision, effective community pharmacy leaders need to inspire 
and motivate their followers in the direction of their pharmacy’s vision. 
Pharmacist owners adopting a discount leadership approach were exhibiting a 
failed leadership with regards to expanding the role of pharmacists. A vision for the 
profession was identified by participants as the need to expand the role of 
pharmacists. This was reported in the major theme, the transformation challenge 
(Figure 11.1). Seizing expanded role opportunities requires community pharmacy 
leadership to transition to the service leadership approach. This approach will shift 
the reliance from pharmacist technical skills to utilising pharmacist clinical skills, 
transforming current pharmacy practice to focus on professional services. This 
finding is in line with previous research that has proposed community pharmacy 
leadership needs to employ differentiation strategies, such as the service 
leadership approach (7, 8, 20, 21) to handle external leadership influences (14).  
However, this means that pharmacy owners seizing professional service 
opportunities need to incorporate this as an integral part of their leadership 
approach. 
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 Leadership of the Pharmacy Profession 
The expanded role opportunity was the vision reported by participants as where 
the profession needs to go. Advanced pharmacy practice was identified as the 
start to seizing expanded pharmacist opportunities. Lessons were drawn from the 
nursing profession, who have enacted an expanded professional leadership vision. 
This is in line with the literature that has identified the nursing profession’s 
expanded leadership vision (60, 62). However, unlike the nursing profession, there 
were significant internal challenges restricting the profession’s ability to transform 
and enact a leadership vision that expands the role of pharmacists. The major 
challenge preventing the transformation was the profession’s disconnect with the 
external context. This has caused the leadership of the pharmacy profession to not 
be congruent with the broader health context, and may be an ongoing challenge 
that continues to isolate the profession with regards to engagement and inclusion 
with broader health policy.  
 The influence of the External Context 
This qualitative study had a specific objective to explore the contextual challenges 
and opportunities facing the pharmacy profession. These challenges and 
opportunities were identified when participants described community pharmacy 
leadership and leadership of the pharmacy profession. The first challenge 
identified was the professions disconnect with the external context. Both the 
profession and community pharmacies were fundamentally focusing on retail 
pharmacy, as opposed to expanding professional pharmacist services to enable 
the transformation. This marked the connection between the profession’s vision 
and the vision of pharmacy owners. The profession’s leadership needs to articulate 
a clear policy vision that increases pharmacy funding for professional services. 
One of the challenges identified was the need to change pharmacy remuneration. 
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This remuneration challenge has been noted in the literature (14, 94). However, a 
unique finding of this investigation identifies this challenge as a test of the 
profession’s leadership, to shift the remuneration for the technical dispensing of 
medicines to increased remuneration for professional services. This ultimately 
means that changing pharmacy remuneration may enable pharmacy owners to 
enact a service approach to leadership. There was need for pharmacy 
organisations (leaders) to provide pharmacist owners (followers) with business 
service strategy and support to implement the service leadership approach. This is 
in line with previous research identifying organisational leadership as essential to 
implementing effective processes and ensuring adequate planning needed to 
implement professional services as part of the service leadership approach (172). 
Furthermore, it is essential that there is integration and strength of support in the 
service environment (11). Unlike previous work however, this research identified 
the importance of the leadership development and support needed at a pharmacy 
level to nurture the professions transformation.  
Commodifying medicines was identified as an external factor influencing 
community pharmacy leadership. This was manifested as the intense competition 
between pharmacies through discounting of medicines, that has led to the rise of a 
new business model (14). This competition directly influenced the leadership 
approach adopted by pharmacy owners. This means that owners, responsible for 
community pharmacy leadership have one clear alternative strategy to differentiate 
their leadership approach. Pharmacy owners need to adopt a service leadership 
approach. This is in line with previous studies that have identified pharmacy 
owners need to adopt a leadership style that implements professional services (20, 
21). A unique finding of this investigation was the specific pharmacy leadership 
traits needed to implement the service leadership approach.  
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The network of community pharmacies around Australia collectively implementing 
a service leadership approach will facilitate the profession’s transformation needed 
to expand the role of pharmacists. This is in line with previous research that has 
identified that community pharmacies need to adopt professional services to 
expand the role of pharmacists (72). Commodifying medicines further impacts 
broader pharmacy leadership by impairing the profession’s image from the 
perspective of other health stakeholders. This resulted in a unique challenge 
impacting the profession’s leadership and collaboration with other health 
stakeholders. 
Organisational disunity between pharmacy organisations was a unique finding that 
emerged from this research (Section 9.3). The disunity was due to competing 
visions between pharmacy organisations manifested as political tensions. This 
disunity weakens the profession’s leadership vision facing outwards when dealing 
with health stakeholders, for example government, with regards to representation 
in the wider health context. This presents a unique leadership challenge that has 
manifested within the profession. This inhibited professional leadership vision 
prevents a shared leadership voice that is needed to expand the role of the 
pharmacists and transform the profession. This disunity further exacerbates the 
professions disconnect with the external health context. Particularly noticed by the 
hampered support resources being delivered by pharmacy organisations, that are 
needed to assist community pharmacies to implement expanded health services.   
The specific pharmacy leadership traits that were identified to meet and address 
the challenges were vision, tacit knowledge, cognitive flexibility, social capacity and 
emotional intelligence leadership traits. Pharmacy leaders need a vision for the 
profession that transforms the role of pharmacists and creates new and exciting 
opportunities for followers (pharmacists). The leadership trait tacit knowledge 
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allows pharmacy leaders to apply problem solving skills and knowledge to 
contextual challenges, and is critical for pharmacy leaders to provide effective 
leadership at a pharmacy and professional level. The ability to be flexible and 
adapt to changed circumstances is an essential trait of a pharmacy leader. At a 
community pharmacy level, pharmacy owners need cognitive flexibility to 
implement a service approach to leadership. At a professional level, pharmacy 
leaders need flexibility to adjust their leadership to challenges within the profession 
(organisational disunity) and challenges external to the profession (health 
stakeholders). Of paramount importance to developing professionals, pharmacy 
leaders need social capacity and emotional intelligence traits operating in unison. 
Pharmacy leaders need social capacity traits, such as active listening and effective 
communication to develop follower relationships. Emotional intelligence traits, self-
awareness and empathy are needed by pharmacy leaders to develop the 
leadership capacity of teams and individuals to move in a direction that is 
conducive to effective leadership. The identification of specific pharmacy 
leadership traits will be useful when designing future pharmacy leadership training 
and development pathways to improve the leadership capabilities of pharmacy 
professionals.  
 Pharmacy Leadership Development 
One of the overall aims of this thesis was to investigate and identify areas that 
impact the leadership development capability of Early Career Pharmacists (ECPs). 
This qualitative study had a specific objective to examine leadership development 
and mentorship in the pharmacy profession. Pharmacy leadership development 
emerged as an essential component of the APL Theory (Figure 11.1) and 
described the traits of a leader and leadership development strategies needed to 
develop a followership. Followership was identified as the reciprocal process of 
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leadership, consisting of developing and maintaining follower relationships, and 
was a central component to the APL Theory. Despite identifying the importance of 
followership, this research identified that participants believed there are poor 
pharmacist workforce conditions, limited career diversity, and an oversupply of 
pharmacists working in a fixed number of pharmacy employment outlets (Section 
6.5), seems to reflect a pharmacy leadership vision that has failed to meet the 
needs of followers (Section 5.3). 
The following leadership traits were identified as essential to the APL Theory and 
in particular leadership development. Social capacity traits, effective 
communication skills needed to inspire and motivate followers. Fair-mindedness 
and emotional intelligence were identified as critical to sustaining followership 
relationships (Section 5.2.3). Pharmacy leaders need to be nurturing, caring, and 
guide followers, characteristics closely associated with pharmacy leadership 
development, particularly mentorship in the profession. The description of 
pharmacy mentor traits identified by participants drew many parallels with the 
pharmacy leadership traits. Pharmacy mentors provided guidance and advice in a 
constructive facilitative manner, avoiding prescribing a set direction. Ideal mentors 
focused on inspiring and motivating pharmacists. The essential elements of 
pharmacy mentorship relationships were trust, respect, responsibility, inspiration 
and commitment. These findings are in line with previous research in the health 
professions that examined the qualities of ideal mentors (173). The findings of this 
study resonate with previous Australian research that has identified the need to 
implement mentorship across the profession (102). A unique finding emerging from 
this research was the need for pharmacy mentorship to be specific to areas of 
practice. This means that future pharmacy mentorship programs can be targeted 
and tailored to each specific area of pharmacy and incorporate the mentor traits 
needed to sustain a reciprocal mentorship relationship.   
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Participants identified several recommendations on how to create future pharmacy 
leaders. Pharmacy mentorship was identified as leadership development, the 
single most significant leadership development pathway required to develop the 
leadership capacity of ECPs. Providing experience opportunities was critical to 
developing pharmacy leadership. Participants identified that there was a need to 
implement increased pharmacy training in areas of clinical knowledge, business 
management and leadership development. In the nursing profession, leadership 
development training is increasingly being integrated into university and 
institutional training, resulting in a positive impact on the development of nurse 
practitioners (174). This presents the biggest leadership development opportunity 
for the profession, to incorporate both experiential and structured mentorship early 
in the training and development of pharmacists and pharmacy students.  
There was a perceived university training and practice disconnect identified by 
some participants, predominantly from community pharmacy. This finding builds on 
previous research that reported intern pharmacists were not well prepared for 
business management and working in a multidisciplinary teams (103). This is in 
line with the finding from pharmacy leaders identifying the importance of business 
training to ensure intern pharmacists’ workplace preparedness (Section 10.3.3). 
The intern training program was identified as a critical period to improve the 
leadership capacity of ECPs. This period presented the most opportune structured 
leadership program to develop the leadership capacity of ECPs to match university 
training and workplace practice. Intern pharmacists need to be competent in 
leadership and management prior to pharmacist general registration (56). This 
means that there is a need for the profession to dedicate greater training resources 
to develop the leadership capacity of intern pharmacists through the critical 
internship period. 
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 Qualitative Research Limitations 
The qualitative findings should be considered in light of the following research 
limitations. 
The first set of limitations relate to sample diversity. This research described the 
views of twenty-nine participants across the pharmacy sector, representing 
multiple stakeholders. While it explored perspectives across the pharmacy sector 
(in Table 4.1; Positions in pharmacy sector), not all sectors were represented 
equally. For example, participants were more representative of community and 
organisational pharmacy sectors providing a rich understanding of leadership in 
these areas, and is a major strength of this research. Further research into 
underrepresented pharmacy sectors presents an opportunity for future pharmacy 
leadership research investigations, albeit a limitation of this research. The findings 
of this research are context specific, extrapolation of the leadership findings to 
other leadership contexts needs to be done with caution. 
International pharmacy leadership perspectives were sought during the formative 
stages of this research to compare and contrast pharmacy health system 
leadership differences between countries with comparable healthcare systems in 
North America and Europe. Furthermore, to completely understand the 
international pharmacy leadership perspective (though outside the scope of this 
project), there needs to be further investigations of international participants. 
This research recruited pharmacy leaders, therefore, participants from lower to 
middle pharmacy leadership positions were not represented in this research. 
Pharmacy leaders tended to fall into the age range, 40 to 60 years. Despite 
attempts in the purposive sample to include participants in equal sex 
representation, only five of the twenty-nine participants were female. This is a 
 273 
 
limitation of the APL Theory as it is not representative of the pharmacy workforce, 
which is almost two-thirds female (175). Sex disparity in senior leadership positions 
has been noted more broadly in the literature (176), and is not unique to the 
pharmacy profession, with an Australian review finding that over three decades 
women have not attained leadership positions in any significant numbers (177). A 
similar study investigating key informants perceptions of community pharmacy 
influences had a similar sex breakdown (14). Further pharmacy leadership 
research needs to seek greater female leadership representation. 
A limitation of qualitative research is generalisability, and therefore the findings 
cannot be generalised to Australian pharmacy. Additionally, the accuracy of the 
interview data was not able to be confirmed, as the data was from participant 
experiences and understanding of truth as opposed to relying on the accuracy of 
the content. Interview bias is often a disadvantage of qualitative research, bias can 
be reduced by adopting sound interview techniques; such as allowing participants 
freedom to express their views, maintaining a conversational tone and suitable 
training and planning before interviews (138, 147). 
Several pharmacy sector reports have been released since the completion of data 
collection. There has been the release of the interim report from the Review of 
Pharmacy Remuneration and Regulation (123), and updated National Pharmacist 
Competency Standards identifying a diversified leadership and management 
domain (56). Further research needs to investigate the influence of these reports 
on pharmacy leadership. Furthermore, the pharmacy leadership context is 
continuously changing and further research needs to keep abreast of these 
changes to ensure research relevance. 
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 Qualitative Research Strengths 
The major strength of this research was the development of a novel understanding 
of Australian pharmacy leadership (APL Theory). Employing a constructivist 
grounded theory approach was essential in constructing the APL Theory, as it 
facilitated the investigation of pharmacy contextual nuances (148). Grounded 
theory provided the ability to focus on the specificity within the pharmacy context 
and flexibility to follow emerging themes (151). For example, the additional 
document analysis of government transcripts was incorporated due to the flexibility 
of this qualitative research, allowing themes to be clarified. Similar methodological 
approaches have been employed in the pharmacy profession (154, 155), and to 
investigate leadership in multiple contexts (108, 129, 131, 139). 
The decision to use individual interviews as the primary data collection method 
was done with the intention to ensure that leadership views of participants were not 
influenced by others. Employing a semi-structured interview guide sent to 
participants prior to the interview date facilitated a richer investigation of 
leadership, allowing participants time to consider and reflect on interview topics. 
The level of experience and expertise across the pharmacy sector included in the 
participant sample was a strength of this research. Previous research has failed to 
recruit participants representing the discount leadership approach (14), this 
research was able to ascertain the leadership views from this part of the pharmacy 
sector. 
 Conclusions 
Key findings of this qualitative research relating to the first objective identified that 
commodifying medicines, organisational disunity, and the professions disconnect 
with the external context were three major challenges inhibiting the profession from 
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transforming. Pharmacy transformation was needed to expand role of pharmacists. 
Key findings relating to the second objective defined pharmacy leadership through 
a constellation of traits and identified the importance of followership. Key findings 
relating to the third objective reported that pharmacy mentorship was critical to 
developing ECPs. Pharmacy training recommendations in business, clinical and 
leadership development were identified as essential to improving the leadership 
capacity of ECPs. The findings from this qualitative research highlighted the 
complex environment across two pharmacy leadership levels. An understanding of 
leadership context is critical to leadership development (18, 37). This was the first 
research to explore Australian pharmacy leadership and has provided a valuable 
understanding of the pharmacy leadership process explained by six major themes, 
constituting the APL Theory (Figure 11.1). There is now a diverse definition of 
pharmacy leadership that connects to community pharmacy leadership, the 
profession’s leadership and pharmacy leadership traits. The key traits that 
constituted pharmacy leadership were vision, tacit knowledge, social capacity, 
competence, credibility, self-confidence, strategy, decisiveness, cognitive flexibility, 
pharmacy leadership motivators, responsibility, honesty, emotional intelligence, 
ethics and morals. One of the novel themes emerging from this research was the 
knowledge and recommendations needed to improve pharmacy leadership 
development. Specifically, recommendations to improve the leadership capacity of 
ECPs. The primary recommendation was the importance and central role of 
pharmacy mentorship needed to improve the leadership capacity of ECPs. It was 
identified that a critical period in the leadership development of pharmacists is the 
graduate internship training period. This period marked the transition between 
university training and pharmacist registration. There was a need for pharmacy 
mentorship during this period across areas of business management, clinical 
knowledge and leadership development. 
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Intern pharmacists are supervised by their preceptor pharmacists, who perform the 
important role of teaching, coaching, guiding and mentoring intern pharmacists 
through this period of growth and development (178). The internship period 
provides a significant opportunity for preceptors (leaders) to provide experiential 
leadership development opportunities to intern pharmacists (followers). However, 
not much is known about the leadership development needs and experiences of 
intern pharmacists during this critical period of pharmacist leadership development. 
Therefore, the fourth part of this thesis, will investigate the leadership development 
needs and experiences of intern pharmacists during the final stages of their 
pharmacy internship. An understanding of these experiences is essential to 
building and informing leadership development strategies and recommendations 
that improve the leadership capacity of ECPs.  
 277 
 
Chapter 12: Investigating the Leadership Experiences of Australian pharmacy 
Interns 
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 Introduction 
The previous chapters in this thesis have presented the qualitative findings 
(Chapters 5-11), which examined and defined pharmacy leadership, generating the 
Australian Pharmacy Leadership Theory (APL, Figure 4.1). APL Theory provides 
an in-depth understanding of pharmacy leadership from participants who were 
pharmacy leaders in senior leadership positions across the pharmacy sector (see 
Table 4.1 and Table 4.2 for full participant demographics). Several pertinent 
findings related to leadership development emerged from the qualitative findings 
(Chapter 10) that have implications for Early Career Pharmacists (ECPs). 
Pharmacy leaders identified the importance of the professional development of 
intern pharmacists during their internship training period (Section 10.5.3). A 
perceived disconnect between university training and pharmacy practice (Section 
10.3) was reported, and the intern training period identified as a critical bridge 
across this reported divide. 
Leadership research investigating “followers” broadens the understanding of 
leadership through identifying the followership process (179, 180). In the pharmacy 
profession, an important leadership development relationship exists between intern 
pharmacists (followers) and their mentors, preceptor pharmacists (leaders) (178). 
Examining leadership from a followership perspective in the pharmacy profession 
will assist in developing a broader understanding of pharmacy leadership. 
Furthermore, investigating the formative leadership development relationship that 
exists between intern pharmacists and preceptor pharmacists will provide an 
understanding of factors that impact the leadership development capability of 
ECPs. 
Pharmacists in Australia are required to complete a period of supervised practice 
‘internship’ (Table 12.1) after successfully completing their university pharmacy 
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training and prior to attaining general pharmacist registration (103, 178). The 
Pharmacy Board of Australia (The Board) stipulates that on the pathway to general 
registration, an intern pharmacist must complete the following requirements during 
the internship year (181) (Table 12.1). 
Table 12.1 Requirements for Intern Pharmacist Seeking General Registration 
(178) 
Requirement Requirement details 
1 Register for provisional registration 
2 Nominate a preceptor and premises approved by the Board 
3 Enroll in an intern training program from an accredited provider 
4 Start and complete 1,824 supervised practice hours 
5 At 30% of their completed supervised practice hours, pass a written examination 
6 At 75% of their completed supervised practice hours, pass an oral examination 
7 
Upon completion of supervised practice hours apply for general registration as a pharmacist after 
passing the written and oral examinations 
 
The internship is a critical period of professional transformation that links the 
scientific, clinical and therapeutic knowledge about medicines and health care 
accomplished at university with real-life pharmacy practice settings (178). The 
pharmacist preceptor plays a fundamental and formative role in the development of 
the intern pharmacist (178), guiding the intern pharmacist through an experiential 
education program essential to meeting pharmacist entry-level competency 
standards (178). The experiential training program is called the Intern Training 
Program (internship) and is delivered by Intern Training Providers (ITPs). 
Successful completion of an approved internship is a mandatory requirement for 
the general registration of pharmacists in Australia (178). The internship is 12 
months in duration and follows the eight pharmacist competency domains set out 
in the National Competency Standards Framework for Pharmacists in Australia 
2016 (56, 178). Throughout the internship, the intern pharmacist is under the 
supervision of an experienced preceptor pharmacist in pharmacy practice (178). 
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This formative relationship forms part of an intern pharmacist’s first experiences of 
pharmacy leadership, and their structured leadership development in the 
profession of pharmacy. The preceptor assumes the role of the teacher, provides 
guidance and leads the intern by practical example, thus becoming guide and 
mentor to the intern pharmacist (178), with this relationship an example of the 
leader-follower reciprocal relationship (5). 
Over the past several years, the number of intern pharmacists undertaking their 
internship and entering the Australian pharmacy workforce has been on average 
approximately 1,800 intern pharmacists per year (111, 182, 183). In a study that 
assessed intern pharmacists’ preparedness to perform pharmacist activities during 
the first month of their internship year, intern pharmacists perceived that their 
pharmacy education training (university training) prepared them for some activities 
(103); for example, dispensing and patient care role. However the findings 
indicated that intern pharmacists perceived limitations in their university education, 
and identified that they felt ‘not prepared’ and/or ‘not well-prepared’ in other parts 
of pharmacy practice; for example, practice/business management, 
multidisciplinary team care and dispensing (103). 
There is a lack of literature examining the leadership development relationship that 
exists between the intern pharmacist and preceptor pharmacist. The leadership 
styles adopted by managers have been shown to be successful determinants in 
the leadership success of workforces (18, 29, 184), but there is scant 
understanding of the leadership styles adopted by preceptor pharmacists. One 
study has examined the formation of identity from the perspective of intern 
pharmacists (185). There is some evidence to support transformational leadership 
styles in the leadership development of pharmacy students (102). Building on the 
leadership development findings from the qualitative research, particularly the 
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identification of the internship training period as a leadership development program 
(Section 10.5.3), and the importance placed on mentorship in the pharmacy 
profession (Section 10.4.2). There is an opportunity to investigate factors that 
influence the leadership development of intern pharmacists transitioning through 
this pivotal period of professional development.  
 Research Aim and Objectives 
One of the overarching aim of this thesis is to investigate and identify areas that 
impact the leadership development capability of early career pharmacists. The 
specific aim of the quantitative research presented in this chapter was to build on 
the qualitative findings from previous chapters that identified the internship training 
period as critical to leadership development of intern pharmacists as ECPs. This 
research examined the leadership development relationship that exists between 
intern pharmacists (follower) and their preceptor pharmacist (leader) identifying 
factors essential to impacting leadership development. 
 Aim 
The aim of this study was determine intern pharmacists’ perceptions of their 
preceptor pharmacists’ leadership styles. 
 Specific Objectives 
1. To quantify intern pharmacists’ (followers) perceptions of their preceptor 
pharmacists’ (leader) leadership style. 
2. To compare intern pharmacists’ perceived leadership styles being employed by 
preceptor pharmacists across different pharmacy practice settings e.g. 
community pharmacy versus hospital pharmacy. 
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3. To investigate the relative influence of preceptor pharmacists’ leadership style 
on intern pharmacists’ outcomes of leadership outcomes. 
4. To determine demographic and workforce influences that impact intern 
pharmacists’ perceived leadership being employed by preceptor pharmacists. 
5. To determine the leadership development training needs that intern 
pharmacists are seeking to facilitate their pharmacy leadership development. 
6. To determine the leadership traits that intern pharmacists believe are important 
for pharmacists in leadership positions. 
 Quantitative Methods 
This research forms part of a larger research project presented in this thesis that 
employed qualitative and quantitative methods to answer the overall thesis aim. 
Initial qualitative interviews were used to define pharmacy leadership through the 
construction of the Australian Pharmacy Leadership Theory (Figure 4.1). The 
results of the qualitative study informed and developed in part, this quantitative 
study design (Figure 12-1). 
 283 
 
Figure 12.1 Research project. 
 
The combination of qualitative and quantitative research methods provides a richer 
contextual understanding of leadership (108, 186). Quantitative methods are 
essential to answering the aforementioned quantitative research aims and 
objectives. Quantitative methods provide the ability to test previously validated and 
constructed theories in an objective manner (187), for example, the use of 
questionnaires allow opportunities to analyse existing leadership theories (186). 
Quantitative methods extend the depth of understanding, building upon previous 
findings (18, 188). Quantitative findings are relatively independent of the 
researcher, reducing potential bias. Further, quantitative methods allow the ability 
to construct a research design that focuses on specific relationships, eliminating 
the confounding effect of variables that can influence results (187). Finally, 
quantitative methods are useful in studying large numbers of people which is 
particularly useful considering the large intern pharmacist workforce (175, 187). 
For these reasons, a quantitative research study was deemed appropriate to 
answer the research aims. 
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 Questionnaire 
Questionnaires are frequently used quantitative instruments in health care (189) 
and leadership (18, 108) research, with the design essential to ensure the results 
are valid, reliable and unbiased (189, 190). There are numerous factors needed to 
take into consideration when designing a questionnaire; most notably the mode of 
administration, question wording and sequencing, questionnaire appearance and 
content (190), are all important components to enhance participant response rates. 
Questionnaires are one of the most effective means to collect information in a 
timely and resourceful manner in large population numbers (187, 190), such as the 
intern pharmacist population. Employing questionnaires allows for a thorough 
population analysis to occur, investigating the differences across sex, practice 
settings and other key sociodemographic factors (190). Questionnaires provide the 
flexibility to use mixed-modal data collection, an essential strategy that reduces 
implementation costs and time constraints associated with administering 
questionnaires. More importantly, mixed-modes increases the accuracy by keeping 
the sources of error low (190). The advantages and strengths of one mode can 
overcome the weaknesses of another, this balance between modes further 
improves response rates and quality by reducing non-response error through 
catering to the behaviours of different types of respondents (190). This research 
employed mixed-modal questionnaires, consisting of an online and paper 
questionnaire data collection and recruitment strategy (Section 12.7-12.8). 
 Theoretical Framework 
Positioning pharmacy research investigating social phenomena within theoretical 
framework strengthens the research (191), as it provides a richer understanding of 
human behaviour within the context (192) as social phenomena is complex, and in 
order to unpack this complexity, researchers posit their investigation within a 
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theoretical framework (191). This approach ultimately provides richer insights and 
understanding into the social context in which the pharmacy practice research 
takes place (192). Similar methodology has been used to investigate practice 
change (90) and organisational flexibility in the Australian pharmacy context 
employing organisational theory (90, 93). Positing pharmacy leadership research 
through a theoretical framework provides a better methodological approach to 
understanding the pharmacy leadership. 
Transformation Leadership Theory is a leadership framework that is applicable to 
healthcare and was previously identified in this thesis (Chapter 2) as the most 
applicable leadership theory to Australian healthcare leadership and leadership 
development programs (50, 52, 107, 108). Transformational leadership describes a 
set of leadership behaviours adopted by people in leadership positions that elicit 
the support of followers, building trust and respect within the followership, 
ultimately transforming followers to higher levels of motivation and commitment 
(29) and employs significant levels of engagement in the leadership process (107), 
guiding followers towards a collective vision (29, 30). Transformational leadership 
allows a more complete understanding of the leadership process, as both the 
leader, the leadership context, and followers are recognised as important 
components in understanding the phenomenon (5). Transformation Leadership 
theory is part of the leadership literature called ‘the new leadership approach’ (31, 
193). In 1978, Burns theorised transformational and transactional leadership (30), 
with Bass operationalising the theory in 1985, exploring the concepts and placing 
them on different leadership continuums (29). There are several instruments that 
measure transformational leadership (18, 53, 194-197). The key point of difference 
is the ability of the instrument to measure a broad spectrum of leadership 
behaviours, such as transformational, transactional and other leadership 
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behaviours. Table 12.2, provides a succinct summary of the specifications of 
validated and widely used instruments that measure transformation leadership. 
Table 12.2 Specifications of Instruments That Measure Transformational 
Leadership (18, 53, 194-197) 
Questionnaire 
specifications 
Multifactor Leadership 
Questionnaire (MLQ) 
Transformational 
Leadership 
Questionnaire (TLQ) 
Leadership 
Behaviours Inventory 
(TLI) 
Leadership 
Practices Inventory 
(LPI) 
Number of leadership 
dimensions 
9 6 6 5 
Measures 
transactional 
leadership 
Yes No Yes No 
Measures 
passive/avoidant 
leadership 
Yes No No No 
Measures 
transformational 
leadership 
Yes Yes Yes Yes 
Measures outcomes 
of leadership  
Yes Yes Yes No 
Validated in multiple 
contexts 
Yes No No No 
Measure 
implemented in 
health sector 
Yes Yes No No 
The transformational leadership measure that is most appropriate to investigate 
the aims and objectives of this research is the Multifactor Leadership 
Questionnaire (MLQ). The MLQ is most appropriate for three main reasons. Firstly, 
the MLQ is one of the most widely used and validated instruments in multiple 
contexts that measure transformational leadership (193, 198, 199). Secondly, the 
MLQ has been employed to investigate leadership across the health sector (102, 
200), and in the nursing profession, the MLQ is the most extensively used and 
validated instrument to measure leadership (201). Thirdly, the strength of the MLQ 
is that it measures a full-range of leadership behaviours, including nine leadership 
factors across three types of leadership styles covering a broad spectrum of 
transactional, passive-avoidant and transformational leadership behaviours (Table 
12.3) (36, 37, 202-205). Leaders display transformational, transactional and/or 
passive/avoidant leadership behaviours, depending on the influence of the external 
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context (206). The MLQ was developed by attributing thirty-six questions, four 
questions to each of the nine leadership factors, and nine questions examining 
important outcomes of leadership, effectiveness, satisfaction and extra effort (37, 
196). 
Table 12.3 Multifactor Leadership Questionnaire Leadership Behaviours 
Definitions Adapted to Pharmacy 
Transformational Leadership  Definitions and leadership behaviours 
Idealized Influence (attributed) The preceptor shows power, confidence and specific ideals that are 
perceived by the intern pharmacist. Preceptors ability to shift intern 
pharmacists’ self-interest towards the interest of the greater mission. 
Idealized Influence (behaviour) The preceptor shows specific leadership behaviours and actions that 
reflect their values and beliefs.  
Inspirational Motivation The preceptor shows optimism and enthusiasm confidently 
communicating a vision for the future. Expectations are clearly 
communicated and through the preceptors’ personal commitment 
intern pharmacists transcend their own self-interest of the group to 
achieve the vision 
Intellectual Stimulation The preceptor creates a safe environment in which beliefs and ideals 
can be challenged and empowers intern pharmacists to challenge the 
status quo and take risks, encouraging new approaches.  
Individualised Consideration The preceptor relates to the intern pharmacist on an individual basis, 
elevating the confidence level of the intern pharmacist and working 
with them to develop and attain their full potential.  
Transactional Leadership   
Contingent Reward The preceptor identifies what needs to be accomplished and provides 
rewards to the intern pharmacist for meeting previous agreed upon 
tasks and expectations.  
Management-by-Exception (Active) The preceptor watches the intern pharmacist for mistakes and gets 
actively involved by taking the appropriate corrective action(s).  
Passive/Avoidant Leadership   
Management-by-Exception (Passive) The preceptor allows the intern pharmacist to complete their workplace 
duties on their own, and only gets involved if problems arise, or specific 
standards are not met.  
Laissez-faire The preceptor pharmacist avoids making decisions, avoids getting 
involved in important issues, and delays responding to urgent issues. 
Outcomes of Leadership  
Effectiveness Intern pharmacists belief that their preceptor exhibits effective 
leadership and that they are part of an effective group with their job-
related needs being met. 
Satisfaction Intern pharmacists satisfaction with their preceptors working 
relationship and leadership. 
Extra Effort Preceptors leadership results in intern pharmacists increased 
willingness to do more than is expected and exert extra effort.  
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 Study Population 
The participant population for investigation in this study was intern pharmacists, 
early career pharmacists currently completing their internship pharmacist training 
in Australia. The Pharmacy Board of Australia’s pharmacist registration data 
released in June 2016 prior to data collection, reports that there are 1,721 intern 
pharmacists in Australia, with a sex breakdown of 1,157 female and 570 male 
intern pharmacists respectively (175). 
 Ethical Considerations 
This research was approved by the University of Sydney Human Research Ethics 
Committee (Project number 2015/947) (Appendices: Appendix B Ethical 
Approvals). Permission from the authors of the MLQ was attained prior to use 
allowing for the examination of leadership in the Australian pharmacy profession 
(Appendices: Appendix B Ethical Approvals). 
 Questionnaire Design 
The study questionnaires were developed from previous qualitative findings from 
this research and transformational leadership research (37, 196). The 
questionnaire (Appendix D) consisted of five sections, pharmacy practice setting 
questions (Section 1); preceptor pharmacist questions (Section 2); Multifactor 
Leadership Questionnaire (Section 3); Australian pharmacy components (Section 
4); and participant cultural and demographic questions (Section 5). The central 
questionnaire was developed and then designed in paper and electronic versions 
to facilitate mixed modal administration. Paper and electronic questionnaires had 
the same five-section order, however differed in appearance. The survey contained 
primarily close-ended questions with single or multiple responses, with an ‘other’ 
category included where applicable. 
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The paper-version was designed specifically for implementation during organised 
pharmacy workshops. The paper questionnaires were printed on double sided 
pages, with the front page providing an in-depth description about the study 
(Participant Information Sheet, PIS) and providing the participants with contact 
information to further discuss or request information about the study. Both 
questionnaire versions provided completion instructions for participants at the start 
of the survey. The electronic questionnaires were designed employing branch 
logic, allowing participants to flow on with questions relating to their responses. In 
order to ensure that the paper-version of the questionnaire followed the same 
logic, the use of detailed instructions was included after all possible responses to 
each survey question. 
 Pharmacy Practice Setting Questions (Section 1) 
The first section of the questionnaire was designed to determine participants’ 
pharmacy practice setting information. Participants defined their pharmacy practice 
setting (community pharmacy, hospital pharmacy, and other pharmacy practice), 
location of their practice setting (rural, urban), and whether their pharmacy setting 
offers additional internship training. The leader’s distance with followers impacts on 
perceived leadership (207). To determine whether leadership distance impacts on 
the intern-preceptor relationship, one question measured frequency at which intern 
pharmacists and preceptors formally meet to discuss the interns’ leadership 
development and internship training. Electronic modes of communication are 
increasingly becoming part of the workforce and are known to influence leadership 
(208). One question examined the influence on leadership with regards to the 
frequency and use of electronic communication in the relationship between intern 
pharmacists and preceptor pharmacists. 
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 Questions Regarding Preceptor Pharmacist (Section 2) 
Several questions were included to attain information about preceptor pharmacists 
across all practice settings. The following information was collected to determine 
whether any characteristics of the preceptor pharmacist influence the intern-
preceptor leadership development relationship: 1) Preceptor’s job 
description/position in the pharmacy practice; 2) preceptor’s years of experience in 
pharmacy practice; 3) preceptor’s sex and age. The literature (Chapter 2) indicates 
that sex, years of practice experience, age, cultural and demographic factors 
influence leadership. Section 2 was designed to collect this necessary information 
about Australian preceptor pharmacists to determine whether there is an impact on 
the perceived leadership experienced by intern pharmacists. 
 Multifactor Leadership Questionnaire (Section 3) 
This section consisted of the Multifactor Leadership Questionnaire (MLQ) Rater 
Form (5X-short) which was used to measure the full-range of leadership 
behaviours. The 45-item MLQ measures 12 subscales: five subscales measure 
transformational leadership, two subscales measure transactional leadership, two 
subscales measure passive/avoidant leadership, and three subscales measure 
outcomes of leadership, intern pharmacists’ willingness to exert extra effort, intern 
pharmacists’ satisfaction with their preceptors’ leadership and intern pharmacists’ 
perception of preceptor pharmacists’ leadership effectiveness. The MLQ allows for 
self-rated responses on a 5-point Likert response scale. The responses range from 
‘0=Not at all’ to ‘4=Frequently, if not always’. Response options allow participants 
to measure the frequency of their preceptor pharmacists’ leadership behaviours. If 
a participant determines that an item is irrelevant, or if they are unsure or don’t 
know how to answer, participants were instructed to leave the answer blank. 
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Figure 12.2 An example of five items and scale from the Multifactor Leadership 
Questionnaire (MLQ). 
 
Due to copyright restrictions the full version 45-items, cannot be included. 
 Australian Pharmacy Components (Section 4) 
This section of the questionnaire included items derived from the qualitative 
findings presented early in this thesis (Chapters 5 and 7). Participants in the 
qualitative study, pharmacy leaders, identified leadership traits that were regarded 
as important to pharmacy leadership. The forty most used leadership traits to 
define pharmacy leadership were identified using NVIVO software, and were 
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randomly organised into four equal columns of 10-items. Participants were asked 
to only select 15 leadership traits that are important for pharmacists in pharmacy 
leadership positions. An open box response was designed to examine three areas 
of professional development from the perspective of intern pharmacists that are 
essential to impacting their leadership capacity. The open box responses were 
designed to attain high participant responses, with the question wording, question 
prompts and question length designed according to recommendations from 
Dillman (190). The open box responses provided the opportunity for collecting rich 
qualitative data that can be used to complement earlier qualitative findings (186). 
 Questions Related to Participant Cultural and Demographic 
Characteristics (Section 5) 
This section of questionnaire examined sociodemographic questions relating to 
participants’ demographic backgrounds, age (in years), sex (male/female), 
education (highest level), leadership roles and experience (formal and non-formal), 
and cultural questions adapted from the Australian Bureau of Statistics ‘House 
Form’, such as country of birth, other languages apart from English spoken at 
home, family ancestry, whether parents were born in Australia or overseas and 
whether the intern pharmacist completed secondary education in Australia or 
overseas (209). The final two questions (Question 5.19 and 5.20) of the 
questionnaire examined intern pharmacists’ self-assessment of their professional 
competence via a “Yes/No” response. For intern pharmacists selecting that they 
felt they are not competent, an open-box response was provided for participants to 
provide a longer response to outline the factors influencing their perception of their 
professional competence. 
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 Questionnaire Validation 
Questionnaire pilot testing was conducted over two-months during May and June 
2016, with the purpose to ensure that the questionnaire and other study materials 
were easy to understand, allowing participants the opportunity to provide 
constructive feedback, and to assess face validity. Participant feedback was 
reviewed by the researchers to determine whether the questionnaire in its current 
form would meet the study aims and objectives, and the overarching thesis aim. 
The questionnaire was piloted with twelve participants, all providing feedback 
during a post questionnaire interview with the primary researcher. Seven 
participants completed the online-version of the questionnaire and five participants 
completed the paper-version of the questionnaire. Any changes derived from the 
feedback were reflected across both surveys. Minimal data analysis occurred 
during pilot testing, the purpose was to check that the survey platform, Research 
Electronic Data Capture (REDCap) performed effective electronic capture, with the 
exports into Microsoft Excel synchronised, indicating that data files were in the 
correct format to be used by the computer statistical programs for further data 
analysis. The 12 completed pilot questionnaires were not used for subsequent data 
analysis. 
 Participant Recruitment 
Given the potential participant population of (n=1721) intern pharmacists, it was 
deemed that a targeted recruitment strategy was essential to increase participant 
response rates (190). Furthermore, our recruitment needed to follow ethics 
approval that did not allow direct contact by researchers (candidate or supervisors) 
to invite intern pharmacists (Section 12.5.1). Therefore, recruitment focused 
directly on intern training providers and pharmacy organisations that offer the 
intern training program. Currently, there are three pharmacy organisations 
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accredited by the Australian Pharmacy Council to offer the intern training program 
(178). An introductory email was sent to all three providers, inviting them to 
participate in this study, either through planning a workshop or by sharing study 
information with their members, intern pharmacists. The email contained study 
documents describing the research (Appendix D: Quantitative study materials) 
which included an Organisational Letter, Participant Information Statement, 
(Participant Circular), and the Australian Pharmacy Leadership Questionnaire. The 
email highlighted the voluntary participation in the research, for the intern training 
providers and their intern pharmacist members. The organisational letter 
emphasised the de-identified data collection procedure in place to protect 
participant confidentiality, taking into account the intern pharmacist-preceptor 
pharmacist workplace considerations. Participating intern provider organisations 
provided a letter of support to the researchers, prior to inviting their intern 
pharmacist members to participate in the study. 
 Pharmacy Intern Workshop Recruitment 
Pharmacy intern workshop recruitment was the preferred recruitment method in 
this study, as it provided the opportunity to improve participant response rates 
through direct contact with participants and the set time provided during the 
workshop for questionnaire completion. The primary challenge to this recruitment 
was gaining consent from intern training providers and then the logistics and time 
required to organise the workshop (190). 
 Electronic Mail Recruitment 
Electronic mail recruitment was the second recruitment method available to intern 
training providers. Providers shared study information by email with an 
accompanying Uniform Resource Locator (URL) electronic link, allowing 
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participants to access the online-version of the questionnaire via the secure 
REDCap survey platform. Electronic reminders have been proven to significantly 
increase response rates (210), reminding potential participants at various time 
points about completing the questionnaire. One reminder was given to non-
responding participants at day 25, delivered through the intern training provider. 
 Questionnaire Distribution and Collection: Paper-version 
The paper-version of the questionnaire was administered during planned 
pharmacy intern workshops. There were four pharmacy intern workshops 
organised during September and October 2016 in South Australia, Queensland, 
New South Wales and Victoria. The following process was followed in each 
workshop. The intern training provider staff introduced the researcher, who then 
provided a short 5-minute introduction to the research explaining the questionnaire 
to potential participants. The researcher followed an approved verbal transcript 
(Pharmacy Workshop Transcript) (Appendices: Appendix D). After the 5-minute 
introduction and fielding participant questions, he left the workshop venue to 
reduce any perception of participant coercion. From this point, intern training 
provider staff facilitated the remainder of the thirty-minute workshop. Twenty-
minutes was allocated for participants to complete the questionnaire. At the 
completion of the twenty-minutes, participants who willingly submitted 
questionnaires into the collection boxes provided inferred consent for their 
participation. After a participant submitted their questionnaire, they had the choice 
to enter the educational prize draw by writing their email on a blank piece of paper. 
After the workshop, provider staff sealed the collection boxes and handed them 
back to the researcher. 
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 Questionnaire Distribution and Collection: Online-version 
The online version of the questionnaire was administered after intern training 
providers sent an email to their intern pharmacist members, which contained a 
URL link directing participants to the questionnaire in the REDCap platform. The 
REDCap platform facilitates the rapid electronic capture of participant data entries 
into files formats needed for seamless data analysis, in a secure and functional 
platform (211). To increase response rates and encourage non-respondents, a 
reminder email was sent from intern training providers at day 25 to participate in 
the study. 
 Response 
The paper-version of the questionnaires was distributed to 449 intern pharmacists 
as part of the pharmacy intern workshop recruitment method. A total of 416 paper-
version questionnaires were returned. Non-usable questionnaires (paper-version 
surveys), due to multiple non-responses to sections, were removed (n=6). This 
resulted in a final sample of 410 paper-version questionnaires (response rate 
91.3%). The initial response rate of the questionnaire online-version was 12.0% 
(n=12). After the reminder the response rate increased to 18.5% (n=20). In total, 
twenty questionnaires were submitted through the online-survey recruitment. This 
resulted in a final combined sample of 430 completed surveys (combined response 
rate 77.2%), which is considered sufficient to perform descriptive statistical 
analyses, and confirmatory and exploratory factor analysis (Chapter 13). 
 Data Entry Process 
REDCap seamlessly converted completed online-version questionnaires into 
Microsoft Excel files. Data from the 410 complete paper-version questionnaires 
were entered into REDCap for statistical analyses in Microsoft Excel. During the 
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data entry of each paper questionnaire there were nine data checkpoints. All 410 
Questionnaires were entered this way by two researchers. A confirmatory data 
check was performed on two occasions, twenty entered surveys were cross 
checked by the alternate researcher to ensure participant responses from the 
paper questionnaires had been converted accurately to REDCap. There were no 
data entry errors found. At the completion of entering all 410 paper questionnaires, 
data was exported into Microsoft Excel. 
 Data Analysis 
All data were coded and entered into the Statistical Package for the Social 
Sciences (IBM SPPS 21.0.0.0) (SPSS Inc., 2012, Chicago, IL, www.spss.com). 
Not all responses to questions were completed and some questions allowed for 
multiple responses, therefore the number of responses varies for each question. 
Missing data were not inputted for any of the analyses. All statistical tests were 
performed at either the 5% or 1% level of significance. Descriptive and frequency 
distributions were generated for each of the variables. The first set of analyses 
involved descriptive statistical methods to examine the demographic data collected 
and general profile of respondents (Table 12.4 and Table 12.5). A descriptive 
statistical analyses of the data was then performed, which identified that one of the 
leadership factors, “Laisezz-faire”, was not normally distributed (Skewness 1.252; 
Kurtosis 1.535). Therefore, the data were analysed using Kruskal-Wallis and 
Mann-Whitney U tests appropriate for this type of non-parametric data. Data 
analyses generated item reliabilities (Cronbach’s alpha coefficients) for each of the 
leadership factors and outcomes of leadership subscales. Aggregated subscale 
scores were generated, producing means and standards deviations (Table 12.6). 
Means were calculated following the instructions provided by the author of the 
MLQ which described adding up the accumulated score in each subscale and 
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dividing by the number of items (196). Missing data was not included in the mean 
calculations. The next set of analyses performed produced mean scores for each 
of the nine leadership factors and three outcomes of leadership, for hospital and 
community pharmacy. Mann-Whitney U tests were performed on the data for 
hospital and community pharmacy, to establish which leadership behaviours 
demonstrated significant differences between practice settings (Table 12.7). Data 
analyses produced Spearman’s correlations (Table 12.8), to measure the 
association among mean scores of the nine leadership factors (idealised influence 
attributed, idealised influence behaviour, inspirational motivation, intellectual 
stimulation, individualised consideration, contingent reward, management-by-
exception-active, management-by-exception-active and Laissez-faire) and 
outcomes of leadership (effectiveness, satisfaction, extra effort). 
The next set of analyses examined the Australian pharmacy components (Section 
12.6.4). Leadership traits that intern pharmacists believe are needed in pharmacy 
leadership positions were analysed (Section 12.10.13). Frequency distributions 
were generated for each of the forty leadership traits to determine the popularity of 
traits in descending order (Table 12.9). NVIVO 11.4 was employed to thematically 
analyse the open-box responses to the professional development areas that 
interns require to improve their leadership development, and the reasons provided 
by interns to not being competent (self-assessed). 
A series of Confirmatory Factor Analysis (CFAs) and Exploratory Factor Analysis 
(EFAs) were conducted to test the psychometric properties of the MLQ in 
Australian pharmacy, full details of methods, results and discussion of these 
analyses are presented in Chapter 13. 
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 Results 
 Intern Pharmacist Demographic Characteristics 
Descriptive statistics were calculated for all intern pharmacists’ demographic 
characteristics. It can be seen from Table 12.4 that (1) 77.2% of intern pharmacists 
were in the age range 21-25 years; (2) 75.8% of intern pharmacists were female; 
(3) 62.6% of intern pharmacists were from the community pharmacy practice; 
36.5% of intern pharmacists were from hospital pharmacy practice; (4) 87.4% of 
intern pharmacists were from urban pharmacy locations; (5) 45.8% of intern 
pharmacists received workplace related intern training; 53.7% of intern 
pharmacists did not receive additional training from their workplace; (7) 57.4% of 
intern pharmacists reported to have previous leadership experience; (8) 21.2% of 
intern pharmacists held a previous degree or qualification; (9) 14.2% of intern 
pharmacists reported that they were not professionally competent to be a 
pharmacist with general registration; (10) 10.2% of intern pharmacists did not 
formally meet with their preceptors face-to-face to discuss intern training and 
professional development. 
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Table 12.4 Intern Pharmacists’ Demographic Characteristics (n=430) 
Demographic characteristics Frequency Relative Frequency (%) 
Intern pharmacist age (years)   
21-25 332 77.2 
26-29 58 13.5 
30-34 9 2.1 
35-39 3 0.7 
40-44 0 0.0 
45-49 1 0.2 
Missing 27  
Intern pharmacist sex   
Male  98 22.8 
Female  326 75.8 
Missing 6  
Pharmacy practice setting   
Community pharmacy 269 62.6 
Hospital pharmacy 157 36.5 
Multiple practices 4 0.9 
Missing 0  
Pharmacy practice location   
Urban location 376 87.4 
Rural location 45 10.5 
Missing 0  
Practice setting additional intern training    
Yes 197 45.8 
No  231 53.7 
Missing 2  
Intern pharmacist leadership experience   
Yes 247 57.4 
No  179 41.6 
Missing 4  
Intern pharmacist additional degrees or qualifications   
Yes 91 21.2 
No  332 77.2 
Missing 7  
Intern pharmacist competence self-assessment   
Yes 369 85.8 
No  59 14.2 
Missing 2  
Formal meeting with preceptor (face-to-face)    
About once daily 20 4.7 
Two to three times each week 40 9.3 
About once each week 85 19.8 
About once each fortnight 57 13.3 
About once each month 104 24.2 
About once every three months 80 18.6 
We do not meet at all  44 10.2 
Missing 0  
For certain variables the accumulative sum in the following tables does not equal to 100%, due to a percentage of 
missing responses. 
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 Preceptor Pharmacists’ Demographic Characteristics 
It can be seen from Table 12.5 that 54% of preceptor pharmacists were female; 
16% of preceptor pharmacists had 0-5 years’ experience, and 21% of preceptor 
pharmacists were pharmacy owners. 
Table 12.5 Preceptor Pharmacists’ Demographic Characteristics (n=430) 
Demographic characteristic Frequency Percentage 
Preceptor sex 
  
Male  196 45.6 
Female  233 54.2 
Missing 1  
Preceptor's years of pharmacy experience 
  
0-5 years 70 16.3 
5-10 years 137 31.9 
10-15 years 93 21.6 
15-20 years 42 9.8 
20-30 years 54 12.6 
30 years + 17 4 
Unsure 16 3.7 
Missing 1  
Preceptor pharmacist position 
  
Pharmacist in Charge 66 15.3 
Pharmacist Manager 88 20.5 
Full Time Employee Pharmacist 64 14.9 
Part Time Employee Pharmacist 13 3.0 
Pharmacist Owner 92 21.4 
Junior hospital pharmacist 12 2.8 
Intermediate hospital pharmacist 38 8.9 
Senior hospital pharmacist 27 6.3 
Director of pharmacy 13 3 
Missing 17  
For certain variables the accumulative sum in the following tables does not equal to 100%, due to a percentage of 
missing responses. 
 Leadership Factors and Outcomes of Leadership 
Means (M), standard deviations (SD) and internal reliabilities (α) for all nine 
leadership factors and three outcomes of leadership are presented in Table 12.6. 
The means fall on a scale of 0-4, with the higher the mean the more frequent the 
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leadership behaviour (Figure 12.2). Idealized influence (attributed) (M=2.80) was 
the most prominent set of preceptor leadership behaviours from the perception of 
intern pharmacists, followed by inspirational motivation (M=2.71), individualised 
consideration (M=2.61) and contingent reward (M=2.55). Passive-avoidant 
leadership behaviours, management-by-exception (passive) (M=0.88) and Laissez-
faire (0.73) were perceived by intern pharmacists less frequently, indicated by a 
lower mean score (frequency of the leadership behaviour). Scale reliabilities were 
determined by generating the Cronbach’s alpha (α) coefficients for leadership 
factors and outcomes of leadership. The reliability analysis indicated that all scales 
had high reliability, except the factor Laissez-faire (α=0.67). The cut-off, α=0.70 
was used to determine scale reliability. 
Table 12.6 Leadership Factors and Outcomes of Leadership 
Leadership factors N # Items Mean (M) SD α 
Transformational leadership factors 
     Idealized Influence (attributed) 416 4 2.80 0.83 0.72 
Idealized Influence (behaviour) 403 4 2.48 0.86 0.73 
Inspirational Motivation 413 4 2.71 0.91 0.82 
Intellectual Stimulation 393 4 2.47 0.86 0.74 
Individualised Consideration 408 4 2.61 0.93 0.76 
Transactional leadership factors 
     Contingent Reward 409 4 2.55 0.88 0.74 
Management-by-Exception (Active) 407 4 2.20 0.9 0.72 
Passive avoidant leadership factors 
     Management-by-Exception (Passive) 407 4 0.88 0.81 0.73 
Laissez-faire 421 4 0.73 0.75 0.67 
Organisational outcomes 
     Extra Effort 425 3 2.70 0.96 0.74 
Satisfaction 424 2 2.86 1.01 0.82 
Effectiveness 406 4 2.83 0.93 0.83 
Original response categories for MLQ leadership factors: 0=Not at all; 1=Once in a while; 2=Sometimes; 3=Fairly often; 
4=Frequently, if not always. N=number of completed responses across all four items; M=mean; SD=standard deviation; 
α= Cronbach’s alpha. 
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 Comparison of Hospital and Community Pharmacy 
Significant differences were identified between interns in hospital and community 
pharmacy at the level of significance p<0.05 (Table 12.7). Mann-Whitney tests 
demonstrated significant differences between community and hospital pharmacy 
on all five of the transformational leadership factors: idealized influence (attributed) 
(p<0.005), idealised influence (behaviour) (p<0.005), inspirational motivation 
(p<0.001), intellectual stimulation (p<0.001), and individualised consideration 
(p<0.001). Hospital pharmacy interns on the whole received greater perceived 
transformational leadership behaviours from their preceptors than community 
pharmacy interns. Mann-Whitney tests demonstrated significant differences 
between community and hospital pharmacy on both transactional leadership 
factors: contingent reward (p<0.001), and management-by-exception-active 
(p<0.001). Hospital pharmacy interns received greater perceived transactional 
contingent reward behaviours from their preceptors than community pharmacy 
interns. Community pharmacy interns received greater perceived management-by-
exception-active behaviours than hospital pharmacy interns. No significant 
differences were evident between hospital and community pharmacy with respect 
to passive-avoidant leadership factors: management-by-exception-passive 
(p=0.088), and Laissez-faire (p=0.312). Mann-Whitney tests demonstrated 
significant differences between community and hospital pharmacy on two of the 
leadership outcomes: effectiveness (p<0.05) and satisfaction (p<0.05), with the 
perceptions of hospital interns that the leadership effectiveness of their preceptors, 
and satisfaction with their preceptors’ leadership was greater than community 
interns. There was no significant difference with respect to the leadership outcome, 
extra effort (p=0.067). 
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Table 12.7 Comparison of Mean Scores for Leadership Factors Between Hospital 
and Community Pharmacy 
 
Hospital Pharmacy Community Pharmacy 
 Leadership factors M SD N M SD N U p-Value 
Transformational leadership 
 Idealized Influence (attributed) 2.9 0.84 151 2.41 0.88 261 17,168 0.029* 
Idealized Influence (behaviour) 2.61 0.79 147 2.41 0.88 252 16,065 0.026* 
Inspirational Motivation 2.94 0.89 150 2.57 0.91 244 14,618 <0.0001* 
Intellectual Stimulation 2.67 0.85 145 2.36 0.84 244 13,776 <0.0001* 
Individualised Consideration 2.80 0.91 152 2.49 0.92 256 15,001 <0.0001* 
Transactional leadership 
 Contingent Reward 2.72 0.89 151 2.44 0.86 256 15,424 <0.0001* 
Management-by-Exception (Active) 1.98 0.93 147 2.34 0.85 256 22,846 <0.0001* 
Passive avoidant leadership 
 Management-by-Exception (Passive) 0.84 0.89 149 0.9 0.77 255 22,912 0.088 
Laissez-faire 0.77 0.75 153 0.71 0.75 264 19,013 0.312 
Leadership outcomes 
 Extra Effort 2.8 0.94 155 2.64 0.97 266 18,125 0.067 
Satisfaction 3 1.05 155 2.79 0.98 265 17,370 0.007* 
Effectiveness 2.96 0.99 155 2.74 0.88 248 15,643 0.002* 
*Denotes	significant	p	value	(<0.5),	U=Mann-Whitney	U,	N=number	of	respondents	complete	responses,	M=Mean,	
SD=Standard	deviation.	
 The Influence of Preceptor Sex 
Preceptor sex was split 45.6% male to 54.2% female (Table 12.5). Mann-Whitney 
U tests demonstrated significance between preceptor sex on the transformational 
leadership factors, intellectual stimulation (p<0.005) and individualised 
consideration (p<0.001). Intern pharmacists perceived that female preceptors show 
higher transformational leadership than male preceptors. Intern pharmacists 
perceived that male preceptors exhibited greater passive-avoidant behaviours 
(management-by-exception-passive (p<0.05) than female preceptors. Furthermore, 
intern pharmacists perceived greater satisfaction and leadership effectiveness with 
female preceptors, outcomes of leadership, satisfaction (p<0.05) and effectiveness 
(p<0.001). 
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 The Influence of Preceptor Years of Pharmacy Experience 
Kruskal-Wallis analyses demonstrated no significant differences between any of 
the leadership factors and outcomes of leadership with respect to preceptor years 
of experience. 
 The Influence of Formal Training with Preceptors 
Kruskal-Wallis analyses demonstrated significant differences between the 
frequency of intern pharmacists formally meeting with their preceptors on eight 
leadership factors, and all three outcomes of leadership. The greater the frequency 
of interns and preceptors formally meeting resulted in significantly increased 
transformational leadership perceived by intern pharmacists (p<0.001) and 
transactional-contingent reward (p<0.001). The greater the frequency of meeting 
resulted in a significant decrease in passive-avoidant leadership behaviours 
perceived by intern pharmacists (p<0.005). The greater the frequency of meetings 
resulted in a significant increase all three outcomes of leadership (p<0.001). There 
were no significant differences identified with transactional-management-by-
exception-active (p=0.360). Intern pharmacists met with their preceptors about 
once every three months (18.6%), with some interns not meeting with their 
preceptors at all (10.2%) (Table 12.4). 
 The Influence of Electronic Communications with Preceptors 
Kruskal-Wallis analyses demonstrated significant differences between the 
frequency of intern pharmacists electronically communicating with their preceptors 
on eight leadership factors, and all three outcomes of leadership. Electronic 
communication was defined as electronic mail and short messaging services. The 
greater the frequency of interns and preceptors using electronic communications 
resulted in significantly increased transformational leadership perceived by intern 
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pharmacists (p<0.001) and transactional-contingent reward (p<0.001). The greater 
the frequency of using electronic communications resulted in a significant decrease 
in passive-avoidant leadership behaviours perceived by intern pharmacists 
(p<0.005). Furthermore, the greater the frequency and use of electronic 
communications resulted in a significant increase all three outcomes of leadership 
(p<0.001). There were no significant differences identified with transactional-
management-by-exception-active (p=0.360). 
 The Influence of Additional Workplace Related Training 
Mann-Whitney U tests demonstrated significance with intern pharmacists receiving 
additional workplace training (additional to the intern training program)  on all five 
transformational leadership factors (p<0.05): idealised influence attributed 
(p<0.05), idealised influence behaviour (p<0.001), inspirational motivation 
(p<0.001), intellectual stimulation (p<0.05), individualised consideration (p<0.05), 
the transactional leadership behaviour, contingent reward (p<0.001), the passive-
avoidant leadership behaviour management-by-exception-passive (p<0.05). This 
meant that intern pharmacists receiving additional workplace training perceived a 
significant increase in all transformational leadership behaviours and contingent 
reward behaviours from their preceptors, and less management-by-exception-
passive. Mann-Whitney U tests revealed significance between receiving additional 
training on all three leadership outcomes: extra effort (p<0.05), satisfaction 
(p<0.001), and effectiveness (p<0.001). Additional workplace training resulted in a 
significant increase in intern pharmacists’ perceptions of their preceptor’s 
leadership effectiveness, satisfaction with their preceptor’s leadership and were 
more willing to exert extra effort as a result of their preceptor’s leadership. Nearly 
half (45.8%) of intern pharmacists received additional workplace related internship 
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training in addition to the training offered by their intern training provider (Table 
12.4). 
 The Influence of Prior Leadership Experience 
Mann-Whitney U tests revealed significant differences with intern pharmacists who 
had prior leadership experience on one transformational leadership factor: 
individualised consideration (p<0.05). Intern pharmacists who had previous 
leadership experiences perceived their preceptor’s leadership behaviour 
individualised consideration (the preceptor treats the intern as an individual) to be 
significantly higher. 57.4% of intern pharmacists have had prior leadership 
experience (Table 12.4). 
 The Influence of Intern Pharmacist Competence 
Intern pharmacist self-assessment of their professional competence revealed 
85.8% of interns as competent, and 14.2% of interns as not competent (Table 
12.4). Mann-Whitney U tests demonstrated a significant difference with competent 
interns on all five transformational leadership factors (p<0.05): idealised influence 
attributed (p<0.05), idealised influence behaviour (p<0.05), inspirational motivation 
(p<0.001), intellectual stimulation (p<0.001), individualised consideration (p<0.05), 
and transactional leadership contingent reward (p<0.001). Competent interns (self-
assessed) perceived a significantly greater amount of transformational leadership 
behaviours and contingent reward behaviours from their preceptors. Mann-Whitney 
U tests further revealed significant differences on all three leadership outcomes: 
extra effort (p<0.001), satisfaction (p<0.001), and effectiveness (p<0.001). 
Competent interns (self-assessed) had significantly increased perceptions of their 
preceptors’ leadership effectiveness, satisfaction with their preceptor’s leadership 
 308 
 
and were more willing to exert extra effort as a result of their preceptor’s 
leadership. 
12.10.11.1 Intern Pharmacist Competence Examined 
In order to more carefully understand the reasons for intern pharmacists not being 
competent, open box responses were analysed. Thematic analysis identified that 
there were two primary reasons why intern pharmacists did not self-assess as 
competent. Thirteen intern pharmacists identified that they needed greater 
preceptor guidance. 
“...I feel I have not been guided/taught adequately by my preceptor 
due to his lack of knowledge/common sense...” 
Intern pharmacist 4 
“...Lack of guidance from preceptor and ongoing mentoring. I feel 
more confident when in the presence of older pharmacists...want to 
teach and train students. My preceptor has no interest...” 
Intern pharmacist 37 
“...I feel unguided and that my clinical skills are not up to scratch...” 
Intern pharmacist 98 
Forty-two intern pharmacists felt that they required greater clinical knowledge and 
experience, and they believed that increased clinical self-confidence and 
decisiveness led them to gain more practical experience. 
“...It could just be fear of being out on my own, but I worry I don't 
have enough knowledge to be making final decisions, I worry that if 
my work isn't being checked mistakes will slip through...” 
Intern pharmacist 312 
“...need more clinical knowledge, better communication skills, 
confidence...” 
Intern pharmacist 424 
“...Inadequate clinical knowledge, lack of confidence, poor 
knowledge of legal requirements for being a registered pharmacist...” 
Intern pharmacist 79 
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“...a lot of the time at work I do little self-directed activity. I feel like I 
need more confidence in myself before I can be by myself. My 
bosses give me tasks. I do little by myself...” 
Intern pharmacist 146 
“...still need to spend more time making independent decisions, need 
increased clinical knowledge and confidence...” 
Intern pharmacist 213 
“...Lack confidence to make decisions...” 
Intern pharmacist 371 
“...not completely confident counselling...giving patients advice...” 
Intern pharmacist 45 
 Correlations Between Leadership Factors and Outcomes of Leadership 
Spearman’s correlations were used to measure the association among the mean 
leadership factor scores (transformational, transactional and passive-avoidant 
leadership) and organisational outcomes (Extra effort, Effectiveness and 
Satisfaction) across the entire sample N=430 (Table 12.8). Spearman’s 
correlations determine which leadership style (transformational, transactional or 
passive-avoidant leadership) would demonstrate positive associations with the 
leadership outcome measures (Extra effort, Effectiveness and Satisfaction). There 
are statistically significant positive associations found between all transformational 
leadership factors (idealised influence attributed, idealised influence behaviour, 
inspirational motivation, intellectual stimulation, individualised consideration) and 
all three leadership outcomes (extra effort, satisfaction, effectiveness) at the 
p<0.01 level. Furthermore, the results indicated positive associations for individual 
transformational leadership factors (contingent reward and management-by-
exception-active) and the leadership outcomes (extra effort, satisfaction, 
effectiveness) at the p<0.01 level. Contingent reward has a similar association with 
the outcomes of leadership to all five transformational leadership factors. The 
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passive-avoidant leadership factors (management-by-exception-passive and 
Laissez-faire) are negatively associated with the outcomes of leadership. 
Table12.8 Leadership Factors and Outcomes of Leadership Correlations 
Subscales Extra Effort Satisfaction Effectiveness 
Idealized Influence (attributed) .707** .772** .777** 
Idealized Influence (behaviour) .629** .575** .628** 
Inspirational Motivation .673** .655** .715** 
Intellectual Stimulation .631** .645** .678** 
Individualised Consideration .680** .736** .750** 
Contingent Reward .662** .680** .716** 
Management-by-Exception (Active) .200** .165** .210** 
Management-by-Exception (Passive) -.343** -.445** -.456** 
Laissez-faire -.352** -.516** -.499** 
**. Note: All Spearman’s Correlations are significant at the 0.01 level (2-tailed);  
 Intern Pharmacist Preferred Leadership Traits 
The results of the highest rated leadership traits that intern pharmacists believed 
were important to pharmacists in leadership are presented in Table 12.9. The 
frequency relates to the number of intern pharmacists that preferred each trait 
based on a total of 430 intern pharmacists. The top five rated leadership traits were 
effective communication (83.3%; n=358), clinical knowledge (74.9%; n=322), 
respect (70.9%; n=305), active listener (68.4%; n=294) and responsibility (66.0%; 
n=284). The least five preferred leadership traits were courage (14.7%; n=63), 
creativity (13.5%; n=58), conviction (7.2%; n=31), power (5.3%; n=30), and 
financially successful (7.0%; n=23). 
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Table 12.9 Leadership Traits Interns Believe Were Important to Pharmacy 
Leadership 
Pharmacy leadership trait Frequency 
Relative 
Frequency (%) Admired leadership trait Frequency Percentage 
Effective communicator 358 83.3 Forward thinking 178 41.4 
Clinical Knowledge 322 74.9 Fair-minded 177 41.2 
Respectful 305 70.9 Provides Guidance 176 40.9 
Active Listener 294 68.4 Optimistic 174 40.5 
Responsible 284 66.0 Self-reflective 164 38.1 
Honest 266 61.9 Strategic Thinker 159 37.0 
Competent 261 60.7 Vision 147 34.2 
Confident 258 60.0 Drive and initiative 143 33.3 
Leads by Example 249 57.9 Business Knowledge 133 30.9 
Motivated 238 55.3 Credible 117 27.2 
Passionate 236 54.9 Innovative 108 25.1 
Empathetic 236 54.9 Socially Capable 107 24.9 
Mentor 222 51.6 Cognitively Intelligent 104 24.2 
Inspiring 214 49.8 Cognitively Flexible 81 18.8 
Ethically minded 201 46.7 Tenacious and resilient 71 16.5 
Emotionally intelligent 192 44.7 Courageous 63 14.7 
Trusting 191 44.4 Creativity 58 13.5 
Committed 181 42.1 Conviction 31 7.2 
Caring 181 42.1 Powerful 30 7.0 
Decisive 180 41.9 Financially Successful 23 5.3 
Frequency=number of intern pharmacists selecting the leadership trait based on 430 intern pharmacists 
 Intern Pharmacist Preferred Professional Development 
The open-box responses reported that 297 intern pharmacists identified that 
further clinical training and experience was needed in professional services and 
areas of advanced pharmacy practice. A total of 145 intern pharmacists reported 
that further business training was essential to their development. A total of 120 
intern pharmacists identified training in areas beyond pharmacy are needed to 
improve their leadership capacity. Structured mentorship was identified by 87 
intern pharmacists as the leadership development practice effective to delivering 
clinical, business and training beyond pharmacy. 
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 Chapter summary 
The discussion for this quantitative research is presented at the end of the next 
chapter (Chapter 13). This chapter (Chapter 12) performed the MLQ data analysis 
according to the authors direction for use (196), identifying intern pharmacists 
perceived leadership styles being employed by their preceptor pharmacists. It was 
reported earlier in this chapter (Section 12.10.4-12.10.12) that there was a positive 
association between the variables; pharmacy practice setting, preceptor sex, 
frequency of formal meetings, frequency of electronic communication, additional 
workplace related internship training, prior leadership experience and intern 
pharmacists’ competence (self-assessed) and the MLQ leadership factors and 
outcomes of leadership. There were several high correlations identified between 
leadership factors and the outcomes of leadership (Section 12.10.12), indicating a 
moderate to high degree of overlap in some of the factors. Furthermore, there is 
debate in the literature (193, 212-214) about the stability of the MLQ factor 
structure in different contexts. Further investigation examining the factor structure 
is needed to determine precisely how intern pharmacists conceptualise leadership. 
The next chapter (Chapter 13) will examine the psychometrics of the MLQ in the 
intern pharmacists’ population, and at the conclusion of the chapter there will be a 
combined quantitative discussion for this chapter (Chapter 12) and the next 
chapter (Chapter 13).  
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Chapter 13: Testing the Psychometric Properties of the Multifactor Leadership 
Questionnaire and Quantitative Discussion 
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 Introduction 
This chapter builds upon the previous chapter (Chapter 12) that examined the 
leadership styles being employed by preceptor pharmacists from the perspectives 
of intern pharmacists measured with the Multifactor Leadership Questionnaire 
(MLQ). The overarching aim of this thesis was to investigate and identify areas that 
impact the leadership development capability of early career pharmacists, building 
on the qualitative findings of the research. The qualitative study identified the 
internship training period as critical to impacting the leadership development of 
intern pharmacists, a critical group of early career pharmacists. There have been 
no previous studies that have examined the MLQ psychometric in the pharmacy 
profession. The need to test the MLQ in the pharmacy profession is further 
amplified given several criticisms in the literature that have challenged the validity 
of nine factor structure (212, 214-216). This chapter will investigate the 
psychometric properties of the MLQ in the intern pharmacist participant sample 
(n=430), presenting the methods as well as the results of the MLQ. 
 Multifactor Leadership Questionnaire 
The MLQ is designed to measure nine leadership factors across three leadership 
styles (Table 12.3)(37). There have been inconsistent findings with the number of 
leadership factors emerging, with findings indicating the unique contextual 
influences of leadership (212, 215), whether the contextual influences manifest 
through different professions, organisations and/or countries. The factor structure 
is not always stable when using the MLQ in different contexts (216-218). Despite 
the inconsistent findings that question the MLQ scale’s acceptance, the MLQ is 
currently one of the most widely used instruments to investigate leadership (193, 
213, 216, 218-220). One particular study examining only the transactional and 
passive/avoidant leadership behaviours recommended scale refinement for future 
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versions of the MLQ (213). In contrast, a large study examining the factor structure 
of the MLQ across a large and diverse sample (n=6,525) (193), from eighteen 
independent studies reflective of multiple industries, organisations and countries, 
reported that the MLQ supports and measures nine leadership factors (193, 221, 
222). 
In conclusion, the psychometric properties of the MLQ have been supported (38, 
193, 221, 222) and criticised (215, 217, 223), with very limited studies examining 
the factor structure in Australia (216), and insufficient studies investigating the 
factor structure in the pharmacy profession (102). Hence, this research provides an 
opportunity to investigate the psychometric properties of the MLQ in the Australian 
pharmacy context, with a focus on the individual level of analysis, that will focus 
inherently on the experiences of followers’, intern pharmacists, examining their 
leadership experiences during their final months of their internship year. An 
understanding of intern pharmacists’ leadership experiences will bring unique 
insights to the practice disconnect identified by participants (pharmacy leaders) in 
the earlier qualitative study. The results will help influence future pharmacist 
leadership training, research and development, as it will inform the unique 
requirements that shape the pivotal intern pharmacist-preceptor pharmacist 
relationship. Given the MLQ has not been administered to this population, it is 
important to investigate the derived dimensions. Therefore, the primary purpose of 
this study evolved into quantifying the psychometric properties of the MLQ in the 
intern pharmacist population. 
 Aim 
To investigate the psychometric properties of the MLQ among Australian intern 
pharmacists; and determine the association between the derived leadership 
dimensions and outcomes of leadership. 
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 Data Analysis 
IBM SPPS 21.0.0.0 (SPSS Inc., 2012, Chicago, IL, www.spss.com) was used for 
descriptive statistical analyses. Confirmatory factor analysis (CFA) and structural 
equation modelling (SEM) were performed with IBM AMOS 21.0.0 (SPSS Inc 
2012, Chicago, IL, www.amosdevelopment.com). CFA and SEM was performed 
and reported according to the guidance of Schrieber (224). CFA was performed on 
the multi-item latent constructs in order to establish their convergent validity. While 
it is acknowledged that the minimum sample size required to conduct CFA is 
influenced by many issues such as the factor loadings, number of indicators per 
factor, the number of factors and presence of missing data and non-normality 
(225), analyses of Monte-Carlo simulations suggest that the minimum sample size 
is 150 (226). For multi-group invariance testing the minimum sample size is 
suggested to be 100 cases in each group (227). Sample size estimates for the 
SEM were determined after the CFA had been completed, because of the high 
dependence of the number of factors and items. Using the method of Westlund, 
(228) with 5 latent constructs and 38 indicators (including the dependent variable) 
a sample size of more than 344 was deemed necessary in order to detect a 
minimum effect size of 0.20 with a power of 0.8 and p < .05. 
A full information maximum likelihood (FIML) estimator was used which allows for 
the use of data with missing cases. Therefore, the means and intercepts were 
estimated concurrently with the covariance matrix. Structural equation modelling 
with ML estimation requires the presence of multivariate normality. Therefore, prior 
to performing the confirmatory factor analysis, MLQ items were examined for 
evidence of skewness and kurtosis. 
Model fit was evaluated using several goodness-of-fit indices. Evidence of the 
appropriateness of the CFA model to best represent the data was obtained using a 
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combination of fit statistics as recommended by Hu & Bentler (229). Ideally, the 
Comparative Fit Index (CFI) and the Tucker Lewis Index (TLI) should approach 
0.95 and the root mean square error of approximation should be below 0.06. The 
guidance for CFI and TLI supersedes previous recommendations that the CFI and 
TLI should be above 0.90, noting however that in smaller sample sizes and in the 
presence of some multivariate non-normality there is a tendency for these stringent 
tests to reject well specified models (229). 
Convergent validity was assessed by inspection of the results from CFA. 
Standardised factor loadings should exceed 0.50 with statistical significance, in 
order to demonstrate high convergence on a common point (230). In addition, the 
average variance extracted should equal or exceed 50% (230). The reliability of 
the multi-item constructs were computed using the formula suggested by Fornell 
and Larcker (231). The composite reliability (CR) values equal to or greater than 
0.7 indicate that the construct of the model is reliable, although coefficients of 
between 0.5 and 0.8 may be considered acceptable during preliminary 
investigations (230). 
Discriminant validity was assessed according to the recommendations of Carter 
(232) using a hierarchy of more stringent than less stringent testing. Firstly, the 
most stringent test, the variance extracted test is applied (231). In this case, pairs 
of multi-item constructs were evaluated by comparing the variance extracted 
estimates for each construct, with the square of the correlation between the 2 
factors. Discriminant validity is demonstrated if both variance extracted estimates 
are greater than the squared correlation. If discriminant validity is not established in 
this manner, a less stringent nested modelling test was used as first described by 
Anderson and Gerbing (233). In this technique, a model is created where the 
correlation between a pair of constructs is fixed (constrained) to one and this is 
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compared to a model where parameters are freely estimated (unconstrained). A 
significant difference in the Chi square provides some evidence for discriminant 
validity. 
To determine whether the factor structure was consistent for each of two groups 
(Community pharmacy and hospital pharmacists), the technique of factorial 
invariance was employed (234). In this technique the CFA is run in 2 groups 
concurrently. Initially an unconstrained model tests for configural invariance which 
is demonstrated if RMSEA is less than or equal to 0.05. Configural invariance is 
the least stringent test and determines whether participants from different groups 
employ the same conceptual framework to answer the test items. Once configural 
invariance has been demonstrated then models with increasing level of constraint 
are run and goodness-of-fit indices are inspected. Non-invariance at each level is 
demonstrated when the change in comparative fit index (ΔCFI) is less than 0.01 
(234). According to Wu et al., factor scores from difference groups should only be 
compared when strict invariance is demonstrated (235). Strict invariance holds if 
configural invariance is demonstrated and when the factor loadings, intercepts and 
residual invariances are constrained to be equal for each model. 
Exploratory factor analysis was performed in order to explore the factorial structure 
of the MLQ among pharmacy interns working in community pharmacy. Following 
the guidance of Costello and Osborne (236), a maximum likelihood (ML) estimator 
was employed in order to provide the most generalizable solution along with an 
oblique rotation since the factors were expected to be correlated. Given the 
tendency of EFA to over-dimensionalize (237), a conservative approach was 
adopted to selecting the number of factors to retain, using the scree plot rather 
than the so-called Kaiser criterion. Items were removed from the model if the 
communality was below 0.3 and/or if the factor loading was below 0.4 (230). 
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 Results 
The hypothesised 9-factor CFA model for the MLQ provided a poor fit (N=430). 
While the high χ2 (1592, df =558, p < 0.001) is to be expected with a high sample 
size, the comparative fit indices were well below the 0.90 or 0.95 target levels (CFI 
= 0.82, TLI = 0.79) and the RMSEA was above the 0.06 target level (0.071). 
Inspection of the modifications indices (available within AMOS) indicated that 
improved fit could be obtained by allowing for correlated error terms. In addition, fit 
could be improved by drawing regression pathways between factors and items 
which were specified to be loaded onto other factors, indicating cross-loading. 
Therefore, a series of models were created in which cross-loading items were 
removed and correlated error terms created which made conceptual sense. These 
modifications were ceased once the CFA and RMSEA reached target levels. At 
that stage MLQ items 23, 21, 1 & 9 were deleted and correlated error terms were 
allowed between items 35 (leader expresses satisfaction when expectations met) 
and 36 (leader expresses confidence that goals will be achieved), and between 18 
(goes beyond self-interest for the good of the group) and 19 (treats me as an 
individual rather just a member of a group). The final fit statistics were (χ2 = 930, df 
= 426, p < 0.001, CFI = 0.90, TLI = 0.87, RMSEA = 0.057). However, there were 
several reasons why the model was rejected on conceptual grounds. Firstly, there 
were a high number of observed correlations (8) between factors in the model 
which exceed 0.95 and secondly the correlated error terms mentioned above were 
between items which were not within the same factor. Overall, this suggests that 
the 9 factor model specified a high number of factors which overlapped excessively 
and which indicates a lack of parsimony in the model. Therefore, a series of 
theoretically sound and previously published alternative models were tested. 
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 Confirmatory Factor Analyses of Existing Model 
All subsequent models tested had unacceptable fit and could not be successfully 
improved using the procedures described above. The initial fit statistics are 
presented in Table 13.1., in order of increasing levels of parsimony. 
Table 13.1. Confirmatory Factor Analyses – Competing Models (N = 430)a 
Model  Χ2 df Χ2/df CFI TLI RMSEA 
9factor 1592 558 2.85 0.83 0.79 0.071 
9factorHigherOrder 1836 583 3.15 0.79 0.76 0.077 
8factor 1666 566 2.94 0.82 0.78 0.073 
7factor 1702 573 2.97 0.81 0.78 0.073 
6factor 1711 579 2.96 0.81 0.78 0.073 
5factor 1757 584 3.01 0.80 0.78 0.074 
3factor 2023 591 3.42 0.76 0.73 0.081 
2factorV2 2026 593 3.42 0.76 0.73 0.081 
2factor 2044 593 3.45 0.78 0.73 0.082 
a χ2: the chi-square goodness-of-fit statistic, df: degree of freedom, CFI = comparative fit index; TLI = Tucker–Lewis 
Index; RMSEA = root mean square error of approximation 
Since an acceptable fit could not be achieved using any of the models, a decision 
was made to explore the factorial structure of the MLQ among interns’ perceptions 
of their preceptors’ leadership qualities. Given the exploratory nature of the 
investigation and the need to confirm factorial structure a decision was made to 
initially perform EFA on the data obtained from pharmacy interns working within 
community pharmacies (N = 269) and then to perform CFA on the data obtained 
from pharmacy interns working in hospital pharmacy (N = 157). There were four 
interns working in other sectors and these were omitted from these EFA and CFA 
steps. 
 Exploratory Factor Analysis Of Community Pharmacy Interns 
The EFA performed on the data from community pharmacy interns (N = 269) 
produced a Kaiser-Meyer-Olkin Measure of Sampling Adequacy result of 0.90 and 
a significant Bartlett’s Test of Sphericity (p < 0.001) which indicates sufficient 
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sample size. The initial solution provided eight factors with Eigenvalues above 1. 
Several of the factors had two items only and there were many items loading below 
0.4. The scree plot indicated a sudden change in direction at factor five (Figure 
13.1) and this indicates that a four factor solution is appropriate. A subsequent 
EFA was performed with the number of factors constrained to four. 
Figure 13.1 Scree plot of exploratory factor analysis (N = 269).	
 
The four factors explained 45% of the variance, however there were a number of 
items with low communalities and/or poor loadings. A series of models were 
specified where poorly fitting items were deleted until the target loadings and 
communalities were achieved. The final EFA included the original 36 MLQ items 
less seven items which were deleted (Items 2, 8, 10, 17, 23, 25, & 32). The final 
model explained 46% of the variance and there was only one item with cross-
loadings above 0.3 (Item 30, 0.38) and this was retained. The final EFA model is 
presented in Table 13.2. The four factors were named according to the convention 
of assigning names to the highest loading items and they were named: Factor 1 (8-
items), Strategic visionary leadership; Factor 2 (7-items) Passive avoidant 
 322 
 
leadership; Factor 3 (10-items) Personalised leadership; and Factor 4 (4-items) 
Failure focused leadership. 
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Table 13.2. Exploratory Factor Analysis – Community Pharmacy Interns (N = 269) 
MLQ factor MLQ full-length question 1 2 3 4 
Strategic visionary leadership factor; 8 items 
Idealized Influence (Behaviour) mlq_14; Specifies the importance of having a strong sense of purpose 0.836 -0.049 -0.018 -0.072 
Inspirational Motivation mlq_26; Articulates a compelling vision of the future 0.743 -0.075 0.02 0.025 
Idealized Influence (Behaviour) mlq_34; Emphasizes the importance of having a collective sense of mission 0.650 0.033 0.113 0.151 
Contingent Reward mlq_16; Makes clear what one can expect to receive when performance goals are achieved 0.630 -0.019 0.142 0.098 
Inspirational Motivation mlq_13; Talks enthusiastically about what needs to be accomplished 0.615 -0.164 0.137 -0.017 
Contingent Reward mlq_11; Discusses in specific terms who is responsible for achieving performance targets 0.570 0.032 0.001 0.171 
Inspirational Motivation mlq_9; Talks optimistically about the future 0.554 -0.015 0.135 -0.223 
Idealized Influence (Behaviour) mlq_6; Talks about their most important values and beliefs 0.524 0.011 0.03 0.115 
Passive avoidant leadership factor 7 items 
Management-by-Exception (Passive) mlq_12; Waits for things to go wrong before taking action -0.094 0.671 -0.072 0.031 
Laissez-faire mlq_5; Avoids getting involved when important issues arise -0.12 0.611 0.1 0.02 
Management-by-Exception (Passive) mlq_20; Demonstrates that problems must become chronic before taking action 0.009 0.595 -0.138 -0.007 
Laissez-faire mlq_7; Is absent when needed -0.056 0.593 -0.007 -0.134 
Management-by-Exception (Passive) mlq_3;Fails to interfere until problems become serious 0.144 0.578 -0.099 -0.069 
Laissez-faire mlq_33; Delays responding to urgent questions 0.132 0.533 -0.063 0.052 
Laissez-faire mlq_28; Avoids making decisions -0.101 0.481 0.099 0.041 
Personalised leadership factor; 10 items 
Contingent Reward mlq_35; Expresses satisfaction when I meet expectations 0.067 0.011 0.754 -0.212 
Idealized Influence (Attributed) mlq_21; Acts in ways that builds my respect 0 -0.158 0.740 -0.014 
Individualised Consideration mlq_19; Treats me as an individual rather than just as a member of a group -0.097 0.033 0.694 0.072 
Individualised Consideration mlq_31; Helps me to develop my strengths 0.235 -0.101 0.660 -0.032 
Inspirational Motivation mlq_36; Expresses confidence that goals will be achieved 0.223 -0.061 0.619 -0.117 
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MLQ factor MLQ full-length question 1 2 3 4 
Contingent Reward mlq_1; Provides me with assistance in exchange for my efforts 0.021 -0.154 0.550 0.073 
Intellectual Stimulation mlq_30; Gets me to look at problems from many different angles 0.338 0.012 0.531 0.002 
Individualised Consideration mlq_15; Spends time teaching and coaching 0.204 -0.133 0.477 0.11 
Idealized Influence (Attributed) mlq_18; Goes beyond self-interest for the good of the group 0.126 -0.078 0.455 0.17 
Individualised Consideration mlq_29; Considers me as having different needs, abilities, and aspirations from others 0.135 0.142 0.440 0.131 
Failure focused leadership factor; 4 items 
Management-by-Exception (Active) mlq_27; Directs my attention toward failures to meet standards 0.166 0.131 -0.106 0.659 
Management-by-Exception (Active) mlq_4; Focuses attention on irregularities, mistakes, exceptions, and deviations from standards 0.003 0.004 -0.076 0.643 
Management-by-Exception (Active) mlq_22; Concentrates his/her full attention on dealing with mistakes, complaints, and failures -0.059 -0.075 0.246 0.502 
Management-by-Exception (Active) mlq_24; Keeps track of all mistakes 0.047 -0.101 0.094 0.468 
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 Confirmatory Factor Analyses Hospital Interns 
The hypothesised 4-factor CFA model for the MLQ provided an initial better fit to 
the data for the 157 pharmacy interns working in hospitals compared with the initial 
fit of any of the previously specified models (Table 13.1) (χ2 = 677, df = 371, p < 
0.001, CFI = 0.87, TLI = 0.85, RMSEA = 0.073). However, while the fit was better it 
did not quite achieve the targets and so the modifications indices were inspected. It 
was apparent that model fit could be significantly improved by specifying two 
correlations between error terms and importantly, these were between errors terms 
within the same factor. The first was between Items 35 and 36 (as in the 9-factor 
model described above) and between 30 (my preceptor gets me to look at 
problems from different angles) and 31 (my preceptor helps me to develop my 
strengths). The model thus specified provided fit statistics which reached the target 
levels (χ2 = 620, df = 369, p < 0.001, CFI = 0.91, TLI = 0.89, RMSEA = 0.056). 
 Factor Structure Holds with Community Pharmacy Interns 
Since the factorial structure had been developed so far for pharmacy interns 
working within hospital pharmacies only, the next step in the model development 
was to determine whether the factorial structure holds for interns working in 
community pharmacies as well. For this purpose, tests of measurement invariance 
were performed. The first test performed was for configural invariance, meaning 
that the subjects from both groups used the same number of factors to complete 
the MLQ. This test revealed a RMSEA of 0.042, which was below the target being 
< 0.05. The next test was for weak invariance which indicates that for all items, one 
unit change in the item score is scaled to an equal unit change in the factor score 
across groups. The results of this test indicated that the ΔCFI was 0.001 which 
was below the target of < 0.01. This indicates weak invariance. The next test was 
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for strong invariance which essentially indicates that factor scores across groups 
are equal. The results of this test indicated that the ΔCFI was 0.015 which was 
above the target of < 0.01 and indicates a lack of strong invariance. Combined 
these results provide additional evidence for the four factor structure of the MLQ 
among pharmacy interns, however it is not likely that overall factor scores are 
identical across groups. 
 Confirmatory Factor Analyses Outcomes of Leadership 
The next step of the analysis was to confirm the factorial structure of the three 
MLQ subscales (outcomes of leadership) for subjects’ evaluations of leadership, 
extra effort, effectiveness and satisfaction. A CFA model was specified with three 
factors including items 37-45. The CFA performed on the data for the whole group 
(N=430) provided acceptable fit statistics (χ2 = 61, df = 24, p < 0.001, CFI = 0.99, 
TLI = 0.97, RMSEA = 0.060). However, between factors Effectiveness and 
Satisfaction, there was an observed correlation of unity. The least stringent test of 
discriminant validity revealed lack of discrimination in the form of a non-significant 
Δχ2 (0.056). Since the other pair of correlations were significantly below unity (0.86 
and 0.90), a decision was made to create a new model with just two outcomes of 
leadership factors including Effort and a factor which combined the items of 
Effectiveness and Satisfaction. In the final step of model development, the 4-factor 
MLQ was combined with the 2-factor outcomes of leadership in a new CFA model. 
The fit statistics were acceptable (χ2 = 1434, df = 648, p < 0.001, CFI = 0.91, TLI = 
0.90, RMSEA = 0.053). Table 13.3. presents the factor loadings for each item 
along with composite reliability (CR) scores and average (AVE) variance extracted 
for each of the derived scales for the complete data (N =430). The results reveal 
that each of the derived scales has acceptable composite reliability and average 
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variance extracted, thereby providing evidence of convergent validity of all of the 
scales.
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Table 13.3. Factor Loadings of Items from the CFA Along with Composite Reliability and Average Variance Extracted for Each of the 
Derived Scales1. 
Factor Item Unstandardized 
Regression Weights 
Standard Errors Standardised Regress 
Weights 
Composite Reliability Average Variance 
Extracted 
1. Strategic visionary 
leadership 
mlq_14 1.00  0.80 0.93 61.2% 
mlq_26 0.85 0.05 0.74 
mlq_13 0.85 0.05 0.78 
mlq_34 0.83 0.05 0.72 
mlq_16 0.91 0.05 0.76 
mlq_6 0.61 0.06 0.51 
mlq_9 0.72 0.05 0.62 
mlq_11 0.75 0.06 0.60 
2. Passive avoidant 
leadership 
mlq_12 1.00  0.80 0.88 50.0% 
mlq_3 0.97 0.07 0.67 
mlq_5 0.76 0.06 0.62 
mlq_20 0.82 0.06 0.68 
mlq_7 0.76 0.06 0.60 
mlq_28 0.63 0.07 0.48 
mlq_33 0.73 0.07 0.53 
3. Personalised 
leadership 
mlq_19 1.00  0.67 0.94 62.5% 
mlq_35 1.08 0.08 0.72 
mlq_21 1.16 0.08 0.79 
mlq_36 1.12 0.08 0.78 
mlq_31 1.31 0.09 0.81 
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Factor Item Unstandardized 
Regression Weights 
Standard Errors Standardised Regress 
Weights 
Composite Reliability Average Variance 
Extracted 
mlq_1 0.99 0.08 0.67 
mlq_30 1.07 0.08 0.70 
mlq_18 1.07 0.08 0.67 
mlq_29 0.76 0.09 0.42 
mlq_15 1.24 0.09 0.75 
4. Failure focused 
leadership 
mlq_4 1.00  0.64 0.81 51.2% 
mlq_27 0.97 0.11 0.64 
mlq_22 0.89 0.10 0.61 
mlq_24 0.95 0.11 0.62 
5. Extra effort mlq_39 1.00  0.37 0.85 68.8% 
mlq_42 2.35 0.31 0.90 
mlq_44 2.32 0.30 0.92 
6. Effectiveness/ 
satisfaction 
mlq_37 1.00  0.81 0.94 73.8% 
mlq_40 1.01 0.06 0.71 
mlq_43 0.82 0.05 0.67 
mlq_45 1.06 0.05 0.82 
mlq_38 1.12 0.05 0.84 
mlq_41 1.00 0.05 0.84 
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 Correlation Between Derived Factor Structure and Outcomes of 
Leadership 
A correlation matrix between factors was derived from the CFA and is presented in 
Table 13.4. There was only one observed correlation which was above 0.90 and 
this was between Personalised leadership and Effectiveness/Satisfaction (α = 
0.97). The square of the correlation between the factors was greater than the 
average variance extracted from the factors, thereby indicating that the most 
stringent test of discriminant validity was not met. While the least stringent test of 
discriminant validity revealed some evidence of discrimination in the form of a 
significant Δχ2 (12, p = 0.001), practically speaking the correlation of 0.97 is 
essentially unity. 
Table 13.4. Correlation Matrix of Measurement Scales 
Factor 1 2 3 4 
5 
1. Vision & purpose 1    
 
2. Avoidant leadership -0.45*** 1   
 
3. Failure focussed 0.28*** 0.01ns 1  
 
4. Personalised feedback 0.80*** -0.64*** 0.20** 1 
 
5. Extra effort 0.78*** -0.57*** 0.21*** 0.87*** 
1 
6. Effectiveness & Satisfaction 0.74*** -0.69*** 0.19*** 0.97*** 
0.88*** 
** (p = 0.001), *** (p < 0.001), ns = non-significant 
 Relationships Between Variables in Structural Model 
Given that some evidence for discriminant validity was provided however, a 
decision was made to test the relationships between the variables in a structural 
model. For the structural model, the dependent variables were the two derived 
outcomes of leadership, merged from initially three outcomes of leadership due to 
a correlation of unity identified (Section 13.5.5). Hence, the two variables were 
Extra Effort and Effectiveness/Satisfaction. The independent predictors were the 
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four perceptions of leadership styles and behaviours; Strategic visionary 
leadership; Passive avoidant leadership; Personalised leadership; and Failure 
focused leadership, along with a single covariate, whether the intern worked in 
community pharmacy or not. However, there remains significant doubt as to 
“separateness” of the independent variable Personalised leadership and one of the 
dependent variables Effectiveness/Satisfaction and the results of the model testing 
must be carefully considered. Fit statistics were adequate (χ2 = 1434, df = 680, p < 
0.001, CFI = 0.91, TLI = 0.90, RMSEA = 0.053) and model explained 96% of the 
variation in Effectiveness/Satisfaction and 77% of the variation in Extra Effort. 
Figure 13.2 provides the results of hypothesis testing. Personalised leadership had 
a very strongly positive effect on Effectiveness/Satisfaction (β = 0.97, p < 0.001) 
and on Extra Effort (β = 0.63, p < 0.001). Strategic visionary leadership had a 
positive effect on Extra Effort (β = 0.25, p < 0.001) and Passive avoidant 
leadership had a very small but significant negative effect on 
Effectiveness/Satisfaction (β = -0.12, p = 0.003). None of the other pathways were 
significant including the influence of the covariate. 
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Figure 13.2 Structural equation model – the influence of preceptor leadership 
factors on outcomes of leadership. 
The numbers indicate the standardised regression coefficients. **, p < 0.01; ***, 
p < 0.001. χ2 = 1434, df = 680, p < 0.001, CFI = 0.91, TLI = 0.90, RMSEA = 0.053. 
 Summary of Statistical Findings 
The results have identified that there is no fit with all the previous MLQ models 
reported in the literature with regards to the intern pharmacist population. An 
exploration with community pharmacy interns identified a four-factor MLQ model. 
This model was then confirmed with hospital pharmacy interns. Further tests 
indicated that the four-factor model fits both community and hospital interns. It was 
confirmed that the three outcomes of leadership (Extra Effort, Satisfaction and 
Effectiveness) are in fact two outcomes of leadership, Effort and 
Effectiveness/Satisfaction, due to high correlations. Therefore, a new four factor 
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MLQ model with two outcomes of leadership emerged to represent the intern 
pharmacist population. The findings suggest that preceptors adopting a 
pesonalised leadership style promotes intern perceptions of preceptor leadership 
effectiveness/satisfaction, and interns’ willingness to exert extra effort. 
 Discussion 
 Introduction 
This section will cover the discussion for quantitative research methods and 
findings in this thesis (Chapter 12 and Chapter 13). Furthermore, this chapter will 
draw associations between the emerging quantitative findings and the previous 
qualitative findings (Chapters 4-11). This quantitative study evolved from two 
significant findings identified in the qualitative study; the significance of the 
pharmacy internship period acting as a bridge between university training and 
authentic pharmacy practice, and the formative leadership development 
relationship between intern pharmacists and preceptor pharmacists. This study set 
out to determine intern pharmacists’ perceptions of their preceptor pharmacists’ 
leadership styles. An understanding of this pivotal leadership development period 
is essential to investigating areas that impact the leadership development 
capability of early career pharmacists. 
 Statement of Principal Findings 
This research has identified several new and key findings, whilst building on the 
existing pharmacy practice and leadership literature. This research has provided a 
fascinating insight into the variables that have the greatest influence on intern 
pharmacists’ self-reported leadership behaviours and outcomes of leadership with 
regards to their preceptors. There was empirical evidence provided that the 
following variables: 1) Hospital practice setting; 2) Female preceptors; 3) Increased 
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frequency of preceptor training; 4) Increased frequency of electronic 
communications; 5) Additional workplace related internship training; and 6) Intern 
pharmacist competence, significantly increased the five transformational 
leadership behaviours (Chapter 12). Furthermore, the originality of this research is 
that there is new understanding of how intern pharmacists perceive leadership, 
which produced a four factor MLQ leadership model, providing strong evidence 
that intern pharmacists conceptualise leadership differently, through four 
leadership factors that are unique to the pharmacy context (Chapter 13). This is 
confirmed by the fact the all other MLQ leadership models that have been 
investigated and reported in the literature did not fit the intern pharmacist 
population (Table 13.1). 
The findings of this research will be discussed with relation to the two quantitative 
chapters: first, discussion of the key findings relating to the chapter 12 aim and 
specific objectives, and then discussion of key findings relating to the chapter 13 
aims. 
 Chapter 12: Discussion of Key Findings 
The first objective was to quantify intern pharmacists’ perceptions of their preceptor 
pharmacists’ leadership style. The most frequent leadership behaviours perceived 
by all intern pharmacists, from hospital and community pharmacy, were the five 
transformational leadership behaviours and transactional contingent reward 
(Section 12.10.3). This means that from the perspective of intern pharmacists, they 
received a greater frequency of transformational leadership behaviours and 
contingent reward, when compared with the full range of leadership behaviours: 
transformational, transactional and passive-avoidant. These findings are line with 
previous Australian norms (238), however the transformational leadership 
behaviours were less frequent from the perspective of intern pharmacists. 
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Furthermore, compared to other industries (221) and countries (212), the 
transformational leadership behaviours from the perspective of intern pharmacists 
were less frequent. This would suggest that there is a need to improve the training 
of preceptor pharmacists to increase the frequency of their transformational 
leadership behaviours in line with other contexts. From the perspective of interns, 
receiving reduced transformational leadership behaviours changes their perception 
of their preceptor’s leadership effectiveness. 
The second objective was to compare intern pharmacists’ perceived leadership 
styles being employed by preceptor pharmacists across different pharmacy 
practice settings. It was determined that pharmacy practice settings influenced 
perceived leadership behaviours and outcomes of leadership. Intern pharmacists 
from hospital practice settings perceived a significant increase in the frequency of 
all five transformational leadership behaviours and transactional contingent reward 
compared to community pharmacy interns (Section 12.10.4). Furthermore, hospital 
pharmacy interns perceived their preceptors’ leadership to be greatly more 
effective, and provided greater satisfaction than community pharmacy interns’. This 
noteworthy difference in hospital pharmacy interns perceived leadership is 
associated with their different workplace environments. Hospital pharmacy 
leadership offers pharmacists greater career diversity and provides increased 
development opportunities (Section 8.6.1). This is due to hospital pharmacy 
leadership entrenching pharmacists as part of the broader healthcare team, seizing 
pharmacist expanded role opportunities that increase career diversity. 
Furthermore, the qualitative study identified that there was a lack of professional 
career diversity and employment opportunities available to pharmacists, 
particularly early career pharmacists employed in the community pharmacy sector 
(Section 6.5.1). This finding is consistent with previous Australian research that 
reported pharmacists leave the profession due to dissatisfaction with their 
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professional environment, and lack of career paths and opportunities available 
(239). These workforce conditions highlight that intern pharmacists’ needs are not 
being addressed in community pharmacy practices, with the needs of followers’ 
previously identified to be essential to effective leadership (Section 5.2). This is of 
particular concern when considering that the majority of pharmacists are employed 
in community pharmacies, raising the question whether this environment is 
conducive to developing pharmacy leaders.  
The next objective was to ascertain the relative influence of preceptor pharmacists’ 
leadership style on intern pharmacists’ outcomes of leadership. Previous research 
has identified that leadership styles are associated with outcomes of leadership, 
which was supported by the findings from this research (38, 240). All five 
transformational leadership factors and transactional contingent reward are 
positively associated with extra effort, effectiveness and satisfaction. This provides 
great insights to the leadership needed to develop intern pharmacists. Preceptor 
pharmacists need to adopt transformational leadership behaviours, such as 
coaching and mentoring in order to influence intern pharmacists’ willingness to 
exert extra effort. Previous studies have confirmed that the leadership factor 
contingent reward is highly positively correlated with transformational leadership 
factors, displaying a similar relationship to outcomes of leadership (212, 219, 241). 
This means that contingent reward is perceived to have similar influence on the 
outcomes of leadership compared with transformational behaviours. 
The passive-avoidant leadership factors (Management-by-Exception-Passive and 
Laissez Faire) were negatively associated with the outcomes of leadership 
(Section 12.10.12, Table 12.8). From the perspective of intern pharmacists, they 
believed that effective preceptor leadership is associated with receiving the five 
transformational and contingent reward leadership behaviours from their 
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preceptors. Receiving passive-avoidant leadership behaviours was associated with 
ineffective preceptor leadership. There are several practical implications from 
these meaningful insights. It provides preceptors an understanding of what 
leadership styles are effective to connect with their interns. This is essential to 
developing intern pharmacist leadership capacity. It provides professional 
organisations that develop intern training programs the knowledge to include 
specialised and targeted training material to assist preceptor pharmacists to further 
understand and develop their mentoring potential. The qualitative study identified 
that there were several challenges preventing pharmacists assuming mentorship 
positions, one of which was a reluctance to assume the position (Section 10.4.13), 
and it was reported that there is confusion with how to be a pharmacy mentor 
(Section 10.4.9.3). This suggests there is a need to train preceptors on how to be 
mentors, and to understand their leadership styles to effectively engage intern 
pharmacists. Transformational leadership behaviours have previously been shown 
to be positively associated with extra effort, effectiveness and satisfaction (241). 
This is in line with findings from the nursing profession that indicate that 
transformational leadership behaviours are associated with extra effort (214). 
Transactional leadership behaviours, with the exception of contingent reward has 
been shown to be negatively associated with leadership outcomes (241). This 
research supports previous findings that a combination of transformational and 
transactional leadership behaviours is associated with better outcomes (202, 242). 
The most effective leadership employs a full range of leadership styles that 
combines transformational and transactional leadership (37). These findings 
provide meaningful insights to the preceptor leadership styles that induce improved 
leadership outcomes from intern pharmacists. The correlations between the 
derived four-factor MLQ leadership model and the two outcomes of leadership are 
discussed in Section 13.5.7. 
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The next objective was to determine demographic and workforce influences that 
impact intern pharmacists’ perceived leadership being employed by preceptor 
pharmacists. Additional training was the first factor to influence intern pharmacist 
perceived leadership. Intern pharmacists receiving additional workplace related 
training perceived a significant increase in all five transformational leadership 
behaviours and transactional contingent reward compared to intern pharmacists 
that did not receive additional training (Section 12.10.9). Intern pharmacists who 
received additional training noticed their preceptor’s leadership not only to be more 
effective, they derived greater satisfaction from their preceptor’s leadership style. 
This provides strong support for pharmacy workplaces to include additional training 
to improve the leadership development of intern pharmacists. Additional workplace 
training seems to be linked to the communication and face-to-face training with 
preceptors. The greater the frequency of formal face-to-face training and 
professional development with preceptors, the greater the intern’s perceived 
transformational leadership (Section 12.10.7). The qualitative study identified that 
pharmacist leadership training was lacking (Section 10.3.1), and that there was not 
enough mentorship (Section 10.4.2.1). Providing further pharmacy training in 
business management, clinical knowledge and leadership development was 
identified as essential to train future pharmacist leaders (Section 10.5). This means 
that additional workplace training, particularly the frequency of face-to-face formal 
training with preceptors results in greater preceptor leadership effectiveness. 
However, despite further training being identified by pharmacy leaders as essential 
to improve leadership capacity, the profession structurally does not support 
enough leadership development and mentorship. 
Furthermore, increased frequency of formal face-to-face training decreased 
perceived passive-avoidant leadership behaviours. The greater the frequency of 
formal face-to-face training resulted in a significant increase all three outcomes of 
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leadership. These findings are contrary to findings from the qualitative study that 
recommended unstructured mentorship to improve the leadership capacity of early 
career pharmacists (Section 10.4.4). It is interesting to note that interns preferred 
more structured mentorship while the participating pharmacy leaders preferred a 
more unstructured approach. The hypothesis for this may be due to the fact that 
intern pharmacists are still developing their skills and competencies. A structured 
approach to leadership development (mentorship) will provide intern pharmacists 
with greater confidence and systematic training that is needed for their skill and 
competency development. Some evidence to support this hypothesis emerges 
when examining why intern pharmacists were not competent (Section 12.10.11.1). 
Intern pharmacists wanted greater preceptor guidance to improve their clinical 
decision-making and they needed more training. Further leadership development 
training in clinical and business areas of practice were identified as essential. 
Interestingly, structured mentorship was identified as the medium to provide this 
training (Section 10.4). This would suggest that additional training, and greater 
face-to-face training with preceptors will improve intern pharmacists’ competence. 
This echoes previous Australian research that has identified that intern 
pharmacists enter the workforce with greater expectations of clinical experiences 
to develop their clinical knowledge and competence (185). The value of 
empowering intern pharmacists with clinical knowledge and experience was 
identified in an asthma intervention study (243). Pharmacy leaders at their stage of 
career have developed a broad range of leadership traits and could be overlooking 
the fundamental structure that is necessary to improve the leadership capacity of 
ECPs. This contrast in the leadership development structure between interns and 
leaders provides a rich opportunity for further investigation. Furthermore, this 
highlights that the profession needs to provide leadership development 
opportunities in areas of identified need to ensure intern pharmacist professional 
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development. The results of this investigation provide unique recommendations to 
pharmacy organisations involved with the training of intern pharmacists to modify 
their approach to include additional preceptor training, intern pharmacist workplace 
training, and practice specific training opportunities. Successful implementation of 
these training recommendations will develop the leadership capacity and 
competence of intern pharmacists.  
Preceptor sex was the second factor to significantly influence intern pharmacist 
perceived leadership. Intern pharmacists perceived that female preceptors 
exhibited greater transformational leadership behaviours than male preceptors 
(Section 12.10.5). Intern pharmacists perceived greater satisfaction and believed 
that female preceptors’ leadership styles were more effective than male 
preceptors. This matched a finding from the qualitative study that identified unique 
emotional intelligence traits exhibited by female leaders that were important in 
developing and nurturing relationships. This seems to be a contributing reason why 
intern pharmacists perceived female preceptors to be more effective leaders. 
These findings are in line with previous research that has identified femininity to be 
strongly associated with effective leadership (244). Furthermore, female leaders 
report significantly higher transformational leadership behaviours than male 
leaders (238), and female leaders are believed to exhibit greater transformational 
leadership and contingent reward behaviours (245), which manifests as a positive, 
encouraging and inspiring leadership style (246). The transformational leadership 
behaviours are consistent with the female gender’s role for being supportive and 
considerate in their approach with followership relationships (246). Female 
preceptors placed greater individual consideration, spent more time coaching and 
developing interns resulting in intern pharmacists perceiving female preceptors to 
be more effective leaders. Further research opportunities may examine the 
influence of gender on leadership development.  
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The next objective was to determine the leadership traits that intern pharmacists 
believe were important for pharmacists in leadership positions. There were 
differences noted between the leadership traits preferred by intern pharmacists 
compared to those defined by pharmacy leaders. Pharmacy leaders reported a 
constellation of leadership traits that formed the focus of the pharmacy leadership 
definition (Section 5.2). Central to pharmacy leadership were the traits: vision, 
social capacity, self-confidence, competence, cognitive flexibility, decisiveness, 
responsibility and honesty. Pharmacy leaders reported the need for financial 
literacy and business skills as essential to pharmacy leadership. Juxtaposed, intern 
pharmacists did not resonate with financial success or business knowledge. 
Interestingly, clinical knowledge was deemed to be much more important from the 
perspective of intern pharmacists (Section 12.10.13). Considering that clinical 
knowledge was an area of need identified by intern pharmacists to improve their 
professional development, coupled with the fact that a lack of clinical confidence 
and decision-making was a driving impetus for interns not being competent. There 
was no surprise to identify the importance of the leadership trait clinical knowledge 
to intern pharmacists. Pharmacy leaders identified that the profession was training 
effective graduates that are emerging with significant clinical skills (Section 10.3.2). 
This reports a distortion in the understanding between intern pharmacists and 
pharmacy leaders, with regards to the need for clinical and business leadership 
traits. It seems that the distortion is a factor influencing a perceived disconnect 
between university training and graduate workplace practice (Section 10.3). This 
means that there is stark contrast between the training needs of intern 
pharmacists, and the training recommendations of pharmacy leaders that needs to 
be addressed to improve leadership development. There were several further 
leadership trait contrasts between intern pharmacists and pharmacy leaders. 
Differences were noted with the leadership traits cognitive flexibility, social 
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capacity, vision, credibility and power between intern pharmacists and pharmacy 
leaders. The frequency of these traits were preferred significantly less by intern 
pharmacists compared to the importance placed on these traits by pharmacy 
leaders when they defined pharmacy leadership. 
It seems that intern pharmacists conceptualised leadership differently, preferring 
traits that were fundamental to leadership development. Intern pharmacists 
preferred leaders to be: respectful, active listeners, effective communicators, 
honest, lead by example, provide mentoring, motivate and inspire. This was similar 
to the qualitative findings identifying the traits of a pharmacy mentor (Section 
10.4.14) and the essential elements that the reciprocal mentorship relationship was 
founded, trust and respect (Section 10.4.10). A pharmacy leader to intern 
pharmacists is one who builds and sustains close relationships with their team. 
Pharmacy leaders defined leadership with traits that were more associated with 
conceptualising leadership with a larger picture view. While leadership is 
conceptualised differently between intern and preceptor pharmacists, these 
findings support the notion that practical changes can be made to intern 
pharmacist training that results in improved leadership development. 
 Chapter 13: Discussion of Key Findings 
The aim of chapter 13 was to investigate the psychometric properties of the MLQ 
among Australian intern pharmacists; and determine the association between the 
derived leadership dimensions and outcomes of leadership. Intern pharmacists 
conceptualise leadership with four factor MLQ leadership model (Table 13.2), 
different to any of the previous models examining the MLQ psychometrics (Table 
13.1). There is a similarity with a study that investigated the MLQ factor structure in 
a group of Finnish nurses (214), identifying a three leadership factor MLQ model 
when using EFA. Several differences were noted with this research: Firstly, the 
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study used an older version of the MLQ that consisted of 87-items, compared to 
the 45-items newer MLQ employed in this research (2). The Finnish study 
identified that a modified six factor MLQ leadership fit their data. However, the 
researcher did cross-validate the factor structure emerging from the EFA that 
produced a three factor MLQ leadership model (204). The second pertinent 
difference is the Finnish employed a longitudinal approach to their data collection 
recruiting nurses with varied career experience across the nursing workforce (204).  
Unlike previous work the MLQ findings in the intern pharmacist population are 
unique. Particularly with regards to the reduction in the outcomes of leadership that 
emerged (Section 13.5.5).  
Different findings across various countries may indicate a lack of MLQ validity 
across different cultures (38). Furthermore, different organisational and 
professional specific backgrounds have delivered different factor structures when 
employing the MLQ (204, 212, 214). This research confirms that in the Australian 
pharmacy setting with an intern pharmacist population a different MLQ model has 
emerged from the original nine-factor model. This ultimately means that importing 
leadership theories designed in other contexts, and applying them to the Australian 
pharmacy context may not be as effective as building a leadership theory that is 
created from the pharmacy context and incorporates the professions unique 
idiosyncrasies.  
 Methodological Limitations 
There are several limitations from the quantitative research in this thesis. A 
combination of online and workshop recruitment was employed to ensure several 
intern training providers participated. The online recruitment delivered low 
response rates, primarily due to the recruitment method being significantly less 
targeted than the workshop recruitment. Online email reminders to participate were 
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less effective than the call to action to participate delivered during face-to-face 
workshops. However, an adequate response rate was obtained from the pharmacy 
workshops, allowing all appropriate statistical analyses to be conducted to address 
the study objectives. The study findings have been derived from self-report data of 
intern pharmacists and their perceived leadership experienced from their preceptor 
pharmacist. Self-report data are subject to personal bias. Furthermore, the data 
are not actual data about the preceptors, but perceived data. Data were not 
collected from preceptor pharmacists’ self-assessment of their own leadership 
styles and behaviours. Content validity and reliability for the sections 1,2,4 and 5 of 
the questionnaire are a methodological limitation of this research.  
Another limitation of this research in comparison to similar studies is the cross-
sectional nature of the study design. Future studies examining pharmacy 
leadership need to employ a longitudinal approach to the study design, 
investigating the leadership phenomenon in the pharmacy profession over time 
and identifying the impact of interventions on the leadership process. Other studies 
have employed data collection at follow-up times in a longitudinal approach with 
different population samples (214) and other studies have included a time lag 
between collecting the outcomes of leadership (184). 
This research had a limited sampling and recruitment focus, only targeting one 
sub-group in the pharmacist workforce (intern pharmacists). Further research 
needs to examine greater coverage of the pharmacy workforce, for example 
pharmacy students’, mid-career pharmacists. 
 Methodological Strengths 
A strength of the research in this thesis is the combination of qualitative and 
quantitative research methods that have provided a more complete understanding 
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of Australian pharmacy leadership and has provided recommendations to improve 
the leadership capacity of early career pharmacists (186). 
One of the major strengths and contributions of this quantitative research was the 
rigorous analysis undertaken to investigate the psychometric properties of the 
MLQ. There was no parsimony with any existing leadership models in the 
literature. Confirming the exploratory four-factor model with CFA with adequate 
sample sizes signifies the rigorous methodological approach adopted in this 
research. Previous research adopting this approach have failed to cross-validate 
and address adequate sample size subgroup comparisons (204). There is no 
knowledge of any other studies that have investigated the factor structure of the 
outcomes of leadership (extra effort, satisfaction and effectiveness), a novel 
methodologic strength was testing the psychometric of the outcomes of leadership. 
 Summary of Quantitative Discussion 
This chapter discussed the quantitative research findings from Chapter 12 and 
Chapter 13. This quantitative research has provided new insights into the formative 
leadership development relationship between intern pharmacists and preceptor 
pharmacists. The chapter first discussed the most frequent preceptor pharmacist 
leadership behaviours from the perspective of intern pharmacists. There was a 
discussion pertaining to the empirical evidence supporting variables that influenced 
intern pharmacists’ perceived leadership. Intern pharmacists’ preferred leadership 
traits were discussed with the leadership traits provided by pharmacy leaders when 
defining leadership. Finally, the novel four factor MLQ model with two outcomes of 
leadership was discussed with relation to the literature. The findings of this 
research adds value to inform future preceptor pharmacist training and improve 
intern pharmacist leadership development capacity. The next chapter (Chapter 14) 
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will conclude this thesis and identify future research directions and practical 
implications emerging from this thesis. 
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Chapter 14: Conclusions and Future Directions 
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 Introduction 
The overall aim of the research presented in this thesis was to investigate and 
identify areas that impact on leadership development of early career pharmacists. 
Qualitative and quantitative methods were used as part of the research project to 
achieve this aim. The first study explored Australian pharmacy leadership using 
qualitative methods (Chapters 3-11), with the second study examining the pivotal 
leadership relationship between intern pharmacists and their preceptor pharmacist 
during the period of perceived practice disconnect identified by pharmacy leaders, 
the intern year (Chapters 12-13). The discussion in this thesis has occurred in two 
chapters. Chapter 11 discussed the qualitative research findings, and Chapter 13 
interpreted and discussed the quantitative research findings. This chapter brings 
together both parts of the research and provides a collective conclusion to the 
research undertaken in this thesis. 
 Overall Conclusion 
The statement of principal findings for the qualitative research was previously 
presented (Section 11.1), with the statement of principal findings for the 
quantitative research presented in Section 13.6.2. This section will provide a 
succinct summary that compares and contrasts the principal findings from the 
qualitative and quantitative research findings (Table 14.1). 
Table 14.1 Principal Leadership Development Findings 
Qualitative principal findings Quantitative principal findings 
Pharmacy leadership traits used to define leadership 
(Section 5.2) 
Intern pharmacist preferred leadership traits 
(Table 12.9) 
Pharmacy leadership development recommendations 
(Section 10.5) 
Intern pharmacist further training areas identified 
(Section 12.10.14) 
Unstructured pharmacy mentorship 
(Section 10.4.4) 
Personalised leadership factor is most effective 
(Table 13.2; Figure 13.2) 
 Structured pharmacy mentorship preferred 
(Section 12.10.14) 
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There were differences in the leadership traits preferred by intern pharmacists 
(Chapter 12, Section 12.10.13) and used by pharmacy leaders to define leadership 
(Chapter 5, Section 5.2), which was discussed in depth Chapter 13 (Section 
13.6.3). Intern pharmacists preferred leadership traits resembling a close 
mentorship relationship. Intern pharmacists desired a relationship based on trust, 
respect, regular contact, and focused on areas that increased their clinical 
competence. Pharmacy leaders identified leadership traits that were focused on 
‘big picture’ pharmacy leadership, encompassing vision, social capacity, cognitive 
flexibility, confidence and decisiveness. It was expected that those starting their 
professional careers (intern pharmacists) would differ in their understanding of 
leadership compared with those representing pharmacy leadership in the 
profession. What emerged as unique was the fact that intern pharmacists 
resonated with leadership in terms of leadership development. Further, intern 
pharmacists desired greater leadership development opportunities in a structured 
relationship with trusted mentors. This contrast indicates an inter-generational 
disconnect with regards to pharmacy leadership traits between intern pharmacists 
and pharmacy leaders. 
The inter-generational disconnect was further evident when examining the 
difference in pharmacy training recommendations between intern pharmacists and 
pharmacy leaders. Pharmacy leaders predominantly recommended the need for 
business management training and leadership development programs (Chapter 
10, Section 10.4). Intern pharmacists were interested in business training, however 
there was a greater demand for leadership development in clinical areas, 
particularly with training in professional services and advanced areas of practice. 
Evidence of the inter-generational disconnect was also apparent when analysing 
the differences in preferred leadership development structure. Pharmacy leaders 
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believed that unstructured leadership development was needed to develop future 
pharmacy leaders, whilst interns starting their professional careers were seeking 
structured leadership development training and mentorship. This means that there 
was a lack of congruency in leadership development structure that needs to be 
addressed to facilitate the emergence of pharmacy leaders in the future. Unique 
insights were gained from the four factor MLQ model that can be used to evaluate 
the leadership capacity of intern pharmacists. Preceptors embracing a 
personalised leadership style, which is a combination of transformational and 
contingent reward factors were perceived to exhibit effective leadership. Upon 
closer examination, personalised leadership focuses on developing intern 
strengths, treats interns as individuals, spends time teaching and coaching, and 
acts in ways that builds the interns respect. This is clear evidence that preceptor 
pharmacists need to adopt a leadership development approach that embraces 
individualised consideration and mentorship in order to improve the leadership 
capacity and development of intern pharmacists. This may be challenging to 
achieve as the pharmacy workforce environment, particularly community pharmacy 
was identified to have limited career opportunities and diversity. Furthermore, there 
was a repressive leadership culture impacting leadership emergence, particularly 
influencing early career pharmacists. The understanding of what leadership was 
most effective from a follower development perspective (intern pharmacists) 
formed the principal finding emerging from the quantitative research. Informing 
those that train and develop ECPs (preceptor pharmacists) with regards to the 
most effective leadership styles needed will improve the leadership development of 
ECPs.   
The principal finding that emerged from the qualitative research in this thesis was 
the Australian Pharmacy Leadership Theory (APL Theory, Figure 4.1). The APL 
Theory consisted of six major themes.  The definition of Australian pharmacy 
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leadership was a novel finding, as it provided a connection through a constellation 
of leadership traits to the other major themes. A pharmacy leadership vision was 
paramount to the definition of pharmacy leadership at several levels.  Pharmacy 
leaders needed to have a vision, a vision for their personal direction, a vision for 
their place of work, and a vision for their profession. Central to achieving this vision 
was developing and maintaining follower relationships. This connected with the 
theme, pharmacy leadership development (APL Theory). Pharmacy leadership 
development was critically focused on the intern pharmacist training period, and 
provided the impetus between the qualitative and quantitative research. 
Leadership development was associated with several essential pharmacy 
leadership traits: social capacity, emotional intelligence, cognitive flexibility and the 
ability of pharmacy leaders to inspire followers in the direction of the pharmacy 
vision. This concept of a pharmacy leader, “leading self”, “leading others” and 
“leading change” was strongly echoed in Australia’s health leadership framework, 
Health LEADS.  
A significant part of the pharmacy leadership definition examined community 
pharmacy leadership (APL Theory). This was primarily due to the community 
pharmacy sector being the dominant employer and pathway for pharmacy practice 
in Australia. Community pharmacy leadership was intrinsically linked to the 
leadership approach adopted by pharmacist business owners. There was a clear 
decision to implement a service leadership approach or a discount leadership 
approach. The community pharmacy network moving in a direction that delivers 
improved and expanded professional services (service leadership approach) was 
reported to expand the role of pharmacists. This movement across the community 
pharmacy network was central to the profession’s leadership vision (APL Theory, 
expanded role opportunity). However, there were significant pharmacy contextual 
challenges preventing this transformation (APL Theory, Pharmacy sector 
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leadership influences).  This was the profession’s transformation challenge (APL 
Theory). The challenge was for the profession to overcome contextual challenges 
in order to achieve pharmacist expanded role opportunities. Failure to seize 
expanded pharmacist opportunities was identified to be a continuation of the status 
quo across the pharmacy sector. This was manifested as a community pharmacy 
model intrinsically linked to the technical dispensing process with remuneration 
explicitly connected to the medicine supply function. The fear identified, was that in 
time, the profession may fail to transform.  This will result in a profession that is left 
behind from the wider health context.  
These original findings emerging from this thesis have significant implications for 
pharmacy practice and have unlocked new and exciting research opportunities to 
further investigate.  
 Meaning of this Research: Implications for Practice 
This research has provided insights into the formative leadership development 
relationship between intern pharmacists and preceptor pharmacists prior to general 
pharmacist registration. The findings of this research add value to inform future 
preceptor pharmacist training and improve intern pharmacist training and 
development, specifically around the National Pharmacist Competency 
Standards, Domain 4: Leadership and Management. These research findings 
present practical implications for implementing leadership development strategies 
to improve leadership development of early career pharmacists. There are 
practical implications for pharmacy organisations and pharmacists charged with 
the training and development of pharmacy students and early career pharmacists. 
There is a clear message for pharmacy stakeholders directly involved in the 
training and development of ECPs. Specifically, pharmacy organisations delivering 
the intern training program, universities training pharmacy students, and preceptor 
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pharmacists guiding and mentoring intern pharmacists in a variety of different 
pharmacy practice settings. There is now an improved understanding into the 
pharmacy leadership development needs during the internship training period from 
those receiving the training, intern pharmacists. These research findings present 
the potential to improve the leadership capacity through the following measures 
that focus on preceptors, intern pharmacists, intern training providers and 
pharmacy practice settings. 
 Implications for Preceptor Pharmacists 
There is a need for targeted preceptor training that is incorporated into the 
internship training program, providing preceptors an understanding of their 
leadership behaviours. The training will develop preceptors to implement effective 
leadership behaviours that resonate with intern pharmacists. The preceptor training 
will cover important pharmacy mentorship strategies. The training will assist 
preceptors to build an individualised relationship that incorporates regular 
structure, commitment and training. It is believed that this type of preceptor training 
incorporated into the internship training program will improve the leadership 
capacity of intern pharmacists. 
 Implications for Practice Specific Training 
There is a need to include practice specific training to assist in the development of 
intern pharmacists. The additional (to the intern training program) workplace 
related training needs to focus on areas that improve the competence of intern 
pharmacists and target their leadership development needs. This type of training 
falls outside the intern training program and is the responsibility of the preceptor 
pharmacist. There needs to be an awareness from pharmacy owners and 
preceptors of the importance placed on additional workplace related needs.  
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 Implications for Intern Training Providers 
The implications for intern training providers is twofold. Building upon the 
aforementioned, there needs to be preceptor specific training incorporated into the 
training program. Furthermore, there is a need to include leadership development 
components within the training program that improve the leadership capacity of 
intern pharmacists and that focus on identified intern leadership development 
needs. These changes can be incorporated and implemented in the design of 
future intern programs. 
 Implications for Intern Pharmacists 
Using the research insights from this thesis to modify the internship training period, 
future intern pharmacists will experience a diversified intern training program that 
incorporates important leadership and professional development components. This 
enhanced training will improve the leadership development and transition of intern 
pharmacists from university into practice, and onto general registration. 
 Unanswered Questions and Future Research 
 Future Pharmacy Leadership Research 
The findings of the research presented in this thesis provide several directions for 
future research. Future research needs to address the qualitative and quantitative 
methodological limitations (Chapter 13, Section 13.6.5 and Chapter 11, Section 
11.3). There is a need to conduct further quantitative research to examine 
leadership at multiple levels of the pharmacy workforce, everything in-between 
intern pharmacists and pharmacy leaders. There is a need to test the current 29-
item four factor MLQ model with diverse samples from across the pharmacy 
workforce. The research goal will be to continue testing and re-testing the 
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questionnaire until there is a final version that can be employed to measure 
leadership across the pharmacy workforce. This will be instrumental in the training, 
assessment, and development of Australian pharmacists.  
Future research needs to diversify the study design, moving from the current 
cross-sectional design to examine leadership with data collection at several 
longitudinal time points and testing the influence of a leadership development 
intervention, which will provide a more holistic understanding of the factors that 
impact pharmacy leadership development. This will allow test-retest reliability of 
the proposed 29-item four factor MLQ model, and verify the leadership structure 
with other data. 
There is a need for further pharmacy leadership research to understand how 
pharmacy preceptors see themselves as leaders. This can be achieved by 
employing qualitative research techniques that will allow the flexibility to 
understand this crucial part of pharmacy leadership development. In addition, 
further research needs to investigate preceptor pharmacists’ self-assessment of 
their own leadership behaviours to provide a better understanding of the factors 
that impact the pivotal leadership development relationship. There are 
opportunities to investigate preceptor pharmacists’ leadership (self-assessed) 
utilising qualitative methods (interviews) and quantitative methods 
(questionnaires). This combination of mixed methods will provide rich insights into 
the leadership development needed to build the capacity of ECPs from the 
perspective of preceptor pharmacists.  
This can be achieved by utilising quantitative research methods that can be mixed 
with the future preceptor qualitative data, for example triangulation of data to 
provide richer insights. 
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The research presented in this thesis has explored Australian pharmacy leadership 
and examined and identified factors that impact the leadership development 
capacity of early career pharmacists. Pharmacy leadership is critical to 
sustainability of individual community pharmacies and uniting the professions 
leadership. Leadership contributes to the strategic operations and professional 
service delivery of community pharmacies. Effective leadership is essential for the 
profession to transform and enact expanded role opportunities for pharmacists. 
Pharmacy leadership development is vital to the developing future pharmacy 
leaders and ensuring leadership emergence. This thesis has presented a 
significant body of work that expands the current understanding of pharmacy 
leadership and pharmacy leadership development. This thesis has started the 
investigations to develop a pharmacy leadership measurement tool that will 
improve the leadership capacity of pharmacy professionals, with a particular focus 
on improving and impacting the leadership development of ECPs. The future 
sustainability of the profession will be determined by capacity to improve the 
leadership development of ECPs. 
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